Sentence,class,file
Antimicrob Agents Chemother 2011; 55:1162-72; PMID:21173186; http://dx.doi.org/10.1128/AAC.,Non-OADS,/arxiv_data1/oa_pdf/2f/aa/viru-3-421.PMC3485979.pdf
Eur J Clin Microbiol Infect Dis 2009; 28:1007-11; PMID:19296137; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2f/aa/viru-3-421.PMC3485979.pdf
J Antimicrob Chemother 2008; 61:1182-3; PMID: 18285315; http://dx.doi.org/10.1093/jac/dkn065 118.,Non-OADS,/arxiv_data1/oa_pdf/2f/aa/viru-3-421.PMC3485979.pdf
J Antimicrob Chemother 2012; 67:1806-7; PMID:22454491; http://dx.doi.org/10.1093/jac/dks122 119.,Non-OADS,/arxiv_data1/oa_pdf/2f/aa/viru-3-421.PMC3485979.pdf
Antimicrob Agents Chemother 2012; 56:3402-5; PMID:22491684; http://dx.doi.org/10.1128/AAC.,Non-OADS,/arxiv_data1/oa_pdf/2f/aa/viru-3-421.PMC3485979.pdf
Antimicrob Agents Chemother 2005; 49:1865-71; PMID:15855508; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2f/aa/viru-3-421.PMC3485979.pdf
Clin Infect Dis 1995; 21:1406-10; PMID:8749624; http://dx.doi.org/10.1093/clinids/ 21.6.1406 122.,Non-OADS,/arxiv_data1/oa_pdf/2f/aa/viru-3-421.PMC3485979.pdf
J Antimicrob Chemother 2000; 46:79-86; PMID:10882693; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2f/aa/viru-3-421.PMC3485979.pdf
Antimicrob Agents Chemother 2001; 45: 1387-93; PMID:11302800; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/2f/aa/viru-3-421.PMC3485979.pdf
J Antimicrob Chemother 1997; 39:519-22; PMID: 9145826; http://dx.doi.org/10.1093/jac/39.4.519 127.,Non-OADS,/arxiv_data1/oa_pdf/2f/aa/viru-3-421.PMC3485979.pdf
Circulation 2005; 111:e394-434; PMID:15956145; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2f/aa/viru-3-421.PMC3485979.pdf
Antimicrob Agents Chemother 2011; 55:4821-7; PMID:21807979; http://dx.doi.org/10.1128/AAC.00141-11 129.,Non-OADS,/arxiv_data1/oa_pdf/2f/aa/viru-3-421.PMC3485979.pdf
J Antimicrob Chemother 2003; 52: 514-7; PMID:12917251; http://dx.doi.org/10.1093/ jac/dkg360 432 Virulence Volume 3 Issue 5,Non-OADS,/arxiv_data1/oa_pdf/2f/aa/viru-3-421.PMC3485979.pdf
Scand J Infect Dis 2008; 40:968-72; PMID:18767002; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/2f/aa/viru-3-421.PMC3485979.pdf
Antimicrob Agents Chemother 2009; 53:4305-10; PMID: 19667290; http://dx.doi.org/10.1128/AAC.00444-09 132.,Non-OADS,/arxiv_data1/oa_pdf/2f/aa/viru-3-421.PMC3485979.pdf
Chemotherapy 2011; 57:426-33; PMID: 22122863; http://dx.doi.org/10.1159/000330458 134.,Non-OADS,/arxiv_data1/oa_pdf/2f/aa/viru-3-421.PMC3485979.pdf
Open Microbiol J 2008; 2:79-84; PMID:19088915; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/2f/aa/viru-3-421.PMC3485979.pdf
J Antimicrob Chemother 1999; 44:251-61; PMID: 10473233; http://dx.doi.org/10.1093/jac/44.2.251 137.,Non-OADS,/arxiv_data1/oa_pdf/2f/aa/viru-3-421.PMC3485979.pdf
Scand J Infect Dis 2010; 42:491-9; PMID:20524781; http://dx.doi.org/10.3109/00365541003699623 138.,Non-OADS,/arxiv_data1/oa_pdf/2f/aa/viru-3-421.PMC3485979.pdf
Clin Infect Dis 2007; 45: 1343-6; PMID:17968832; http://dx.doi.org/10.1086/ 522656 140.,Non-OADS,/arxiv_data1/oa_pdf/2f/aa/viru-3-421.PMC3485979.pdf
Antimicrob Agents Chemother 2007; 51:1559-62; PMID:17283190; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2f/aa/viru-3-421.PMC3485979.pdf
Antimicrob Agents Chemother 2005; 49:5166-8; PMID:16304195; http://dx.doi.org/10.1128/AAC.,Non-OADS,/arxiv_data1/oa_pdf/2f/aa/viru-3-421.PMC3485979.pdf
"Int J Antimicrob Agents 2009; 34:8-, e1-9; PMID:19162449; http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/2f/aa/viru-3-421.PMC3485979.pdf
Antimicrob Agents Chemother 2009; 53:5300-2; PMID:19752276; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2f/aa/viru-3-421.PMC3485979.pdf
"PLoS Pathog 2012; 8:e1002500; PMID:22291596;   http://dx.doi.org/10.1371/journal.ppat.1002500 Anne C. Doble, David M. Bulmer, Lubna Kharraz, Michail H. Karavolos and C.M.",Non-OADS,/arxiv_data1/oa_pdf/e5/9c/viru-3-446.PMC3485982.pdf
"Anjam Khan*; Centre for Bacterial Cell Biology; Institute for Cell and Molecular  Biosciences; The Medical School; University of Newcastle; Newcastle, UK; *Email: anjam.khan@ncl.ac.uk; http://dx.doi.org/10.4161/viru.20993 enzymes, to coordinate longitudinal cell wall  synthesis and hence cell shape (Bendezú and  de Boer, J Bacteriol 2008; van den Ent et al., EMBO 2010).",Non-OADS,/arxiv_data1/oa_pdf/e5/9c/viru-3-446.PMC3485982.pdf
"Cell Host Microbe 2012; 11:7-18; PMID:22264509;   http://dx.doi.org/10.1016/j.chom.2011.11.011 Jennifer C. Volz1,* and Alan F .",OADS,/arxiv_data1/oa_pdf/e5/9c/viru-3-446.PMC3485982.pdf
"Cowman2; 1The Wellcome T rust Sanger Institute; Cambridge, UK; 2The Walter and Eliza Hall Institute for Medical Research;   Melbourne, VIC Australia; *Email: jv4@sanger.ac.uk; http://dx.doi.org/10.4161/viru.20994 Adherence of Plasmodium falciparum-infected  erythrocytes to the endothelium is associated  with morbidity and mortality from malaria  in humans.",Non-OADS,/arxiv_data1/oa_pdf/e5/9c/viru-3-446.PMC3485982.pdf
"Proc Natl Acad Sci USA 2012; 109:3469–74; PMID:22331877;   http://dx.doi.org/10.1073/pnas.1201031109 Yuanxi Xu, Yibao Ma and Hongmin Sun*; Department of Internal Medicine; University of Missouri Hospital and Clinics; Columbia, MO USA;   *Email: sunh@health.missouri.edu; http://dx.doi.org/10.4161/viru.21039 The emergence of antibiotic resistance among  human pathogens is a major cause of concern for public health.",Non-OADS,/arxiv_data1/oa_pdf/e5/9c/viru-3-446.PMC3485982.pdf
"Proc Natl Acad Sci USA 2012; 109:4550–5; PMID:22393007;  http://dx.doi.org/10.1073/pnas.1113219109 Bernadette C. Young1 and Daniel J. Wilson1,2; 1Nuffield Department of Clinical Medicine; Experimental Medicine Division; University of Oxford; Oxford, UK; 2Well- come T rust Centre for Human Genetics; University of Oxford; Oxford, UK; Email: bernadette.young@ndm.ox.ac.uk and daniel.wilson@ndm.ox.ac.uk;   http://dx.doi.org/10.4161/viru.21189 In a recent paper appearing in the Proceedings  of the National Academy of Sciences of the United States of America, Young and col- leagues report the case of a persistent car - rier of Staphylococcus aureus who went on  to develop a virulent bloodstream infection  (Young et al., Proc Natl Acad Sci USA 2012).",Non-OADS,/arxiv_data1/oa_pdf/e5/9c/viru-3-446.PMC3485982.pdf
"Cell Host Microbe 2012; 11:70–80; PMID:22264514;   http://dx.doi.org/10.1016/j.chom.2011.12.004 Timur O. Yarovinsky; Section of Cardiovascular Medicine; Department of Internal Medicine; Yale University School of Medicine; New Haven, CT USA;   Email: timur.yarovinsky@yale.edu; http://dx.doi.org/10.4161/viru.21329 Staphylococcus aureus is a leading cause of  community-acquired and health care-associ-ated pneumonia.",Non-OADS,/arxiv_data1/oa_pdf/e5/9c/viru-3-446.PMC3485982.pdf
"PLoS Pathog 2012; 8:e1002500; PMID:22291596;   http://dx.doi.org/10.1371/journal.ppat.1002500 Anne C. Doble, David M. Bulmer, Lubna Kharraz, Michail H. Karavolos and C.M.",Non-OADS,/arxiv_data1/oa_pdf/b6/d4/viru-3-449.PMC3485983.pdf
"Anjam Khan*; Centre for Bacterial Cell Biology; Institute for Cell and Molecular  Biosciences; The Medical School; University of Newcastle; Newcastle, UK; *Email: anjam.khan@ncl.ac.uk; http://dx.doi.org/10.4161/viru.20993 enzymes, to coordinate longitudinal cell wall  synthesis and hence cell shape (Bendezú and  de Boer, J Bacteriol 2008; van den Ent et al., EMBO 2010).",Non-OADS,/arxiv_data1/oa_pdf/b6/d4/viru-3-449.PMC3485983.pdf
"Cell Host Microbe 2012; 11:7-18; PMID:22264509;   http://dx.doi.org/10.1016/j.chom.2011.11.011 Jennifer C. Volz1,* and Alan F .",OADS,/arxiv_data1/oa_pdf/b6/d4/viru-3-449.PMC3485983.pdf
"Cowman2; 1The Wellcome T rust Sanger Institute; Cambridge, UK; 2The Walter and Eliza Hall Institute for Medical Research;   Melbourne, VIC Australia; *Email: jv4@sanger.ac.uk; http://dx.doi.org/10.4161/viru.20994 Adherence of Plasmodium falciparum-infected  erythrocytes to the endothelium is associated  with morbidity and mortality from malaria  in humans.",Non-OADS,/arxiv_data1/oa_pdf/b6/d4/viru-3-449.PMC3485983.pdf
"Proc Natl Acad Sci USA 2012; 109:3469–74; PMID:22331877;   http://dx.doi.org/10.1073/pnas.1201031109 Yuanxi Xu, Yibao Ma and Hongmin Sun*; Department of Internal Medicine; University of Missouri Hospital and Clinics; Columbia, MO USA;   *Email: sunh@health.missouri.edu; http://dx.doi.org/10.4161/viru.21039 The emergence of antibiotic resistance among  human pathogens is a major cause of concern for public health.",Non-OADS,/arxiv_data1/oa_pdf/b6/d4/viru-3-449.PMC3485983.pdf
"Proc Natl Acad Sci USA 2012; 109:4550–5; PMID:22393007;  http://dx.doi.org/10.1073/pnas.1113219109 Bernadette C. Young1 and Daniel J. Wilson1,2; 1Nuffield Department of Clinical Medicine; Experimental Medicine Division; University of Oxford; Oxford, UK; 2Well- come T rust Centre for Human Genetics; University of Oxford; Oxford, UK; Email: bernadette.young@ndm.ox.ac.uk and daniel.wilson@ndm.ox.ac.uk;   http://dx.doi.org/10.4161/viru.21189 In a recent paper appearing in the Proceedings  of the National Academy of Sciences of the United States of America, Young and col- leagues report the case of a persistent car - rier of Staphylococcus aureus who went on  to develop a virulent bloodstream infection  (Young et al., Proc Natl Acad Sci USA 2012).",Non-OADS,/arxiv_data1/oa_pdf/b6/d4/viru-3-449.PMC3485983.pdf
"Cell Host Microbe 2012; 11:70–80; PMID:22264514;   http://dx.doi.org/10.1016/j.chom.2011.12.004 Timur O. Yarovinsky; Section of Cardiovascular Medicine; Department of Internal Medicine; Yale University School of Medicine; New Haven, CT USA;   Email: timur.yarovinsky@yale.edu; http://dx.doi.org/10.4161/viru.21329 Staphylococcus aureus is a leading cause of  community-acquired and health care-associ-ated pneumonia.",Non-OADS,/arxiv_data1/oa_pdf/b6/d4/viru-3-449.PMC3485983.pdf
"PLoS Pathog 2012; 8:e1002500; PMID:22291596;   http://dx.doi.org/10.1371/journal.ppat.1002500 Anne C. Doble, David M. Bulmer, Lubna Kharraz, Michail H. Karavolos and C.M.",Non-OADS,/arxiv_data1/oa_pdf/a9/79/viru-3-452.PMC3485984.pdf
"Anjam Khan*; Centre for Bacterial Cell Biology; Institute for Cell and Molecular  Biosciences; The Medical School; University of Newcastle; Newcastle, UK; *Email: anjam.khan@ncl.ac.uk; http://dx.doi.org/10.4161/viru.20993 enzymes, to coordinate longitudinal cell wall  synthesis and hence cell shape (Bendezú and  de Boer, J Bacteriol 2008; van den Ent et al., EMBO 2010).",Non-OADS,/arxiv_data1/oa_pdf/a9/79/viru-3-452.PMC3485984.pdf
"Cell Host Microbe 2012; 11:7-18; PMID:22264509;   http://dx.doi.org/10.1016/j.chom.2011.11.011 Jennifer C. Volz1,* and Alan F .",OADS,/arxiv_data1/oa_pdf/a9/79/viru-3-452.PMC3485984.pdf
"Cowman2; 1The Wellcome T rust Sanger Institute; Cambridge, UK; 2The Walter and Eliza Hall Institute for Medical Research;   Melbourne, VIC Australia; *Email: jv4@sanger.ac.uk; http://dx.doi.org/10.4161/viru.20994 Adherence of Plasmodium falciparum-infected  erythrocytes to the endothelium is associated  with morbidity and mortality from malaria  in humans.",Non-OADS,/arxiv_data1/oa_pdf/a9/79/viru-3-452.PMC3485984.pdf
"Proc Natl Acad Sci USA 2012; 109:3469–74; PMID:22331877;   http://dx.doi.org/10.1073/pnas.1201031109 Yuanxi Xu, Yibao Ma and Hongmin Sun*; Department of Internal Medicine; University of Missouri Hospital and Clinics; Columbia, MO USA;   *Email: sunh@health.missouri.edu; http://dx.doi.org/10.4161/viru.21039 The emergence of antibiotic resistance among  human pathogens is a major cause of concern for public health.",Non-OADS,/arxiv_data1/oa_pdf/a9/79/viru-3-452.PMC3485984.pdf
"Proc Natl Acad Sci USA 2012; 109:4550–5; PMID:22393007;  http://dx.doi.org/10.1073/pnas.1113219109 Bernadette C. Young1 and Daniel J. Wilson1,2; 1Nuffield Department of Clinical Medicine; Experimental Medicine Division; University of Oxford; Oxford, UK; 2Well- come T rust Centre for Human Genetics; University of Oxford; Oxford, UK; Email: bernadette.young@ndm.ox.ac.uk and daniel.wilson@ndm.ox.ac.uk;   http://dx.doi.org/10.4161/viru.21189 In a recent paper appearing in the Proceedings  of the National Academy of Sciences of the United States of America, Young and col- leagues report the case of a persistent car - rier of Staphylococcus aureus who went on  to develop a virulent bloodstream infection  (Young et al., Proc Natl Acad Sci USA 2012).",Non-OADS,/arxiv_data1/oa_pdf/a9/79/viru-3-452.PMC3485984.pdf
"Cell Host Microbe 2012; 11:70–80; PMID:22264514;   http://dx.doi.org/10.1016/j.chom.2011.12.004 Timur O. Yarovinsky; Section of Cardiovascular Medicine; Department of Internal Medicine; Yale University School of Medicine; New Haven, CT USA;   Email: timur.yarovinsky@yale.edu; http://dx.doi.org/10.4161/viru.21329 Staphylococcus aureus is a leading cause of  community-acquired and health care-associ-ated pneumonia.",Non-OADS,/arxiv_data1/oa_pdf/a9/79/viru-3-452.PMC3485984.pdf
"PLoS Pathog 2012; 8:e1002500; PMID:22291596;   http://dx.doi.org/10.1371/journal.ppat.1002500 Anne C. Doble, David M. Bulmer, Lubna Kharraz, Michail H. Karavolos and C.M.",Non-OADS,/arxiv_data1/oa_pdf/a6/10/viru-3-454.PMC3485985.pdf
"Anjam Khan*; Centre for Bacterial Cell Biology; Institute for Cell and Molecular  Biosciences; The Medical School; University of Newcastle; Newcastle, UK; *Email: anjam.khan@ncl.ac.uk; http://dx.doi.org/10.4161/viru.20993 enzymes, to coordinate longitudinal cell wall  synthesis and hence cell shape (Bendezú and  de Boer, J Bacteriol 2008; van den Ent et al., EMBO 2010).",Non-OADS,/arxiv_data1/oa_pdf/a6/10/viru-3-454.PMC3485985.pdf
"Cell Host Microbe 2012; 11:7-18; PMID:22264509;   http://dx.doi.org/10.1016/j.chom.2011.11.011 Jennifer C. Volz1,* and Alan F .",OADS,/arxiv_data1/oa_pdf/a6/10/viru-3-454.PMC3485985.pdf
"Cowman2; 1The Wellcome T rust Sanger Institute; Cambridge, UK; 2The Walter and Eliza Hall Institute for Medical Research;   Melbourne, VIC Australia; *Email: jv4@sanger.ac.uk; http://dx.doi.org/10.4161/viru.20994 Adherence of Plasmodium falciparum-infected  erythrocytes to the endothelium is associated  with morbidity and mortality from malaria  in humans.",Non-OADS,/arxiv_data1/oa_pdf/a6/10/viru-3-454.PMC3485985.pdf
"Proc Natl Acad Sci USA 2012; 109:3469–74; PMID:22331877;   http://dx.doi.org/10.1073/pnas.1201031109 Yuanxi Xu, Yibao Ma and Hongmin Sun*; Department of Internal Medicine; University of Missouri Hospital and Clinics; Columbia, MO USA;   *Email: sunh@health.missouri.edu; http://dx.doi.org/10.4161/viru.21039 The emergence of antibiotic resistance among  human pathogens is a major cause of concern for public health.",Non-OADS,/arxiv_data1/oa_pdf/a6/10/viru-3-454.PMC3485985.pdf
"Proc Natl Acad Sci USA 2012; 109:4550–5; PMID:22393007;  http://dx.doi.org/10.1073/pnas.1113219109 Bernadette C. Young1 and Daniel J. Wilson1,2; 1Nuffield Department of Clinical Medicine; Experimental Medicine Division; University of Oxford; Oxford, UK; 2Well- come T rust Centre for Human Genetics; University of Oxford; Oxford, UK; Email: bernadette.young@ndm.ox.ac.uk and daniel.wilson@ndm.ox.ac.uk;   http://dx.doi.org/10.4161/viru.21189 In a recent paper appearing in the Proceedings  of the National Academy of Sciences of the United States of America, Young and col- leagues report the case of a persistent car - rier of Staphylococcus aureus who went on  to develop a virulent bloodstream infection  (Young et al., Proc Natl Acad Sci USA 2012).",Non-OADS,/arxiv_data1/oa_pdf/a6/10/viru-3-454.PMC3485985.pdf
"Cell Host Microbe 2012; 11:70–80; PMID:22264514;   http://dx.doi.org/10.1016/j.chom.2011.12.004 Timur O. Yarovinsky; Section of Cardiovascular Medicine; Department of Internal Medicine; Yale University School of Medicine; New Haven, CT USA;   Email: timur.yarovinsky@yale.edu; http://dx.doi.org/10.4161/viru.21329 Staphylococcus aureus is a leading cause of  community-acquired and health care-associ-ated pneumonia.",Non-OADS,/arxiv_data1/oa_pdf/a6/10/viru-3-454.PMC3485985.pdf
"PLoS Pathog 2012; 8:e1002500; PMID:22291596;   http://dx.doi.org/10.1371/journal.ppat.1002500 Anne C. Doble, David M. Bulmer, Lubna Kharraz, Michail H. Karavolos and C.M.",Non-OADS,/arxiv_data1/oa_pdf/86/61/viru-3-457.PMC3485986.pdf
"Anjam Khan*; Centre for Bacterial Cell Biology; Institute for Cell and Molecular  Biosciences; The Medical School; University of Newcastle; Newcastle, UK; *Email: anjam.khan@ncl.ac.uk; http://dx.doi.org/10.4161/viru.20993 enzymes, to coordinate longitudinal cell wall  synthesis and hence cell shape (Bendezú and  de Boer, J Bacteriol 2008; van den Ent et al., EMBO 2010).",Non-OADS,/arxiv_data1/oa_pdf/86/61/viru-3-457.PMC3485986.pdf
"Cell Host Microbe 2012; 11:7-18; PMID:22264509;   http://dx.doi.org/10.1016/j.chom.2011.11.011 Jennifer C. Volz1,* and Alan F .",OADS,/arxiv_data1/oa_pdf/86/61/viru-3-457.PMC3485986.pdf
"Cowman2; 1The Wellcome T rust Sanger Institute; Cambridge, UK; 2The Walter and Eliza Hall Institute for Medical Research;   Melbourne, VIC Australia; *Email: jv4@sanger.ac.uk; http://dx.doi.org/10.4161/viru.20994 Adherence of Plasmodium falciparum-infected  erythrocytes to the endothelium is associated  with morbidity and mortality from malaria  in humans.",Non-OADS,/arxiv_data1/oa_pdf/86/61/viru-3-457.PMC3485986.pdf
"Proc Natl Acad Sci USA 2012; 109:3469–74; PMID:22331877;   http://dx.doi.org/10.1073/pnas.1201031109 Yuanxi Xu, Yibao Ma and Hongmin Sun*; Department of Internal Medicine; University of Missouri Hospital and Clinics; Columbia, MO USA;   *Email: sunh@health.missouri.edu; http://dx.doi.org/10.4161/viru.21039 The emergence of antibiotic resistance among  human pathogens is a major cause of concern for public health.",Non-OADS,/arxiv_data1/oa_pdf/86/61/viru-3-457.PMC3485986.pdf
"Proc Natl Acad Sci USA 2012; 109:4550–5; PMID:22393007;  http://dx.doi.org/10.1073/pnas.1113219109 Bernadette C. Young1 and Daniel J. Wilson1,2; 1Nuffield Department of Clinical Medicine; Experimental Medicine Division; University of Oxford; Oxford, UK; 2Well- come T rust Centre for Human Genetics; University of Oxford; Oxford, UK; Email: bernadette.young@ndm.ox.ac.uk and daniel.wilson@ndm.ox.ac.uk;   http://dx.doi.org/10.4161/viru.21189 In a recent paper appearing in the Proceedings  of the National Academy of Sciences of the United States of America, Young and col- leagues report the case of a persistent car - rier of Staphylococcus aureus who went on  to develop a virulent bloodstream infection  (Young et al., Proc Natl Acad Sci USA 2012).",Non-OADS,/arxiv_data1/oa_pdf/86/61/viru-3-457.PMC3485986.pdf
"Cell Host Microbe 2012; 11:70–80; PMID:22264514;   http://dx.doi.org/10.1016/j.chom.2011.12.004 Timur O. Yarovinsky; Section of Cardiovascular Medicine; Department of Internal Medicine; Yale University School of Medicine; New Haven, CT USA;   Email: timur.yarovinsky@yale.edu; http://dx.doi.org/10.4161/viru.21329 Staphylococcus aureus is a leading cause of  community-acquired and health care-associ-ated pneumonia.",Non-OADS,/arxiv_data1/oa_pdf/86/61/viru-3-457.PMC3485986.pdf
"93 Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA )Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp Case Report Langerhans’ cell histiocytosis involving posterior  elements of the dorsal spine: An unusual cause of  extradural spinal mass in an adult Devendra K. Tyagi, Srikant Balasubramaniam, Hemant V. Savant Department of Neurosurgery, T.N.",Non-OADS,/arxiv_data1/oa_pdf/97/ed/JCVJS-2-93.PMC3485993.pdf
"82 Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA )Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp Original Article Activ C cervical disc replacement for myelopathy McGonagle L., Cadman S., Chitgopkar S. D., Canavan L., O’Malley M., Shackleford I. M. Department  of Trauma and Orthopaedics, Warrington and Halton Hospitals NHS Foundation Trust, UK Corresponding author: Mr. Lorcan McGonagle, 7 Bryanston Road, Liverpool, L17 7 AL, UK.",Non-OADS,/arxiv_data1/oa_pdf/66/50/JCVJS-2-82.PMC3485995.pdf
Available from: http://www.nice.org.uk/guidance/IPG341.,Non-OADS,/arxiv_data1/oa_pdf/66/50/JCVJS-2-82.PMC3485995.pdf
"102 Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA )Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp Access this article online Quick Response Code: Website:   www.jcvjs.com DOI:    10.4103/0974-8237.100076 Letters to Editor Posterior transodontoid  fixation (Kotli technique):  Not for all odontoid  fractures The concern on clinical  use of recombinant  human bone  morphogenetic protein-2 Sir, The recent publication on the recombinant human bone  morphogenetic protein-2 (rhBMP-2) is very interesting.",Non-OADS,/arxiv_data1/oa_pdf/ee/61/JCVJS-2-102a.PMC3485996.pdf
"55 Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA )Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp Editorial ‘Only fixation’ as rationale treatment for spinal canal  stenosis Atul Goel Department of Neurosurgery, K.E.M.",Non-OADS,/arxiv_data1/oa_pdf/0e/e7/JCVJS-2-55.PMC3485997.pdf
"99 Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA )Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp Case Report Aneurysmal bone cyst of thoracic spine mimicking  spinal tuberculosis Shobhit Mathur, Yashant Aswani, Shilpa S. Sankhe, Priya R. Hira Department of Radiology, King Edward Memorial Hospital, Parel, Mumbai, Maharashtra, India Corresponding author: Dr. Shobhit Mathur, Department of Radiology, King Edward Memorial Hospital, Parel, Mumbai, Maharashtra – 400012, India.",Non-OADS,/arxiv_data1/oa_pdf/b9/c5/JCVJS-2-99.PMC3485998.pdf
"102 Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA )Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp Access this article online Quick Response Code: Website:   www.jcvjs.com DOI:    10.4103/0974-8237.100076 Letters to Editor Posterior transodontoid  fixation (Kotli technique):  Not for all odontoid  fractures The concern on clinical  use of recombinant  human bone  morphogenetic protein-2 Sir, The recent publication on the recombinant human bone  morphogenetic protein-2 (rhBMP-2) is very interesting.",Non-OADS,/arxiv_data1/oa_pdf/cc/23/JCVJS-2-102b.PMC3485999.pdf
"77 Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA )Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp Original Article Normal variation of diffusion tensor parameters of the  spinal cord in healthy subjects at 3.0-Tesla Uda T ., Takami T ., Sakamoto S.1, Tsuyuguchi N., Yamagata T ., Ohata K. Departments of Neurosurgery and 1Radiology, Osaka City University Graduate School of Medicine, Osaka City, Japan Corresponding author: Dr. Takehiro Uda, Department of Neurosurgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku,   Osaka 545-8585, Japan.",Non-OADS,/arxiv_data1/oa_pdf/12/fd/JCVJS-2-77.PMC3486000.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/12/fd/JCVJS-2-77.PMC3486000.pdf
"62 Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA )Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp Original Article Significant relationship between local angle at fused  segments and C2-7 angle: Average duration of longer  than 20 years after anterior cervical discectomy and  fusion Nagata T ., Takami T ., Yamagata T ., Uda T ., Naito K., Ohata K. Department of Neurosurgery, Osaka City University Graduate School of Medicine, Osaka, Japan Corresponding author: Dr. Toshihiro Takami, MD, Department of Neurosurgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku,  Osaka 545-8585, Japan.",Non-OADS,/arxiv_data1/oa_pdf/70/f9/JCVJS-2-62.PMC3486001.pdf
"67 Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA )Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp Original Article Evaluation of the subaxial injury classification system Joaquim A. F ., Lawrence B.1, Daubs M.1, Brodke D.1, Patel A. A.2 Department of Neurology, Neurosurgery Division, State University of Campinas, Campinas-SP , Brazil, 1Department of Orthopaedics and Neurosur - gery, University of Utah, Salt Lake City Utah, 2Department of Orthopaedic Surgery and Rehabilitation, Loyola University, Chicago, IL, USA Corresponding author: Dr. Andrei F .",Non-OADS,/arxiv_data1/oa_pdf/de/0a/JCVJS-2-67.PMC3486002.pdf
"57 Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA )Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp Review Article Penetrating spinal injuries and their management Kumar A., Pandey P .",Non-OADS,/arxiv_data1/oa_pdf/a9/a1/JCVJS-2-57.PMC3486003.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/a9/a1/JCVJS-2-57.PMC3486003.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/a9/a1/JCVJS-2-57.PMC3486003.pdf
"96 Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA )Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp Case Report The transparaspinal approach: A novel technique for  one-step removal of dumb-bell-shaped spinal tumors Deepak Kumar Singh, Neha Singh1, Manu Rastogi2, Mazhar Husain2 Departments of Neurosurgery, Dr. RML Institute of Medical Sciences, 1Department of Radiodiagnosis, Chatrapati Sahuji Maharaj Medical Univer - sity, 2Department of Neurosurgery, Sahara Hospital, Lucknow, India Corresponding Author: Dr. Deepak Kumar Singh, Department of Neurosurgery, Dr. RML Institute of Medical Sciences, Lucknow, India.",Non-OADS,/arxiv_data1/oa_pdf/4a/e5/JCVJS-2-96.PMC3486004.pdf
"73 Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA)Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp Original Article Cervical vertebrae anomalies in patients with class III  skeletal malocclusion Shahin Emami Meibodi, Hadi Parhiz, Mohammad Hosein Kalantar Motamedi1, Asal Fetrati,  Elham Morshedi Meibodi2, Arash Meshkat2 Department of Orthodontics, Azad University of Medical Sciences, Dental Branch, 1Trauma Research Center, Baqiyatallah University of Medical Sci - ences, Tehran, 2Dentist, Private Practice, Tehran, Iran Corresponding author: Prof. MHK Motamedi, DDS, Africa expwy.",Non-OADS,/arxiv_data1/oa_pdf/42/4a/JCVJS-2-73.PMC3486005.pdf
"86 Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA )Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp Case Report An interesting clinical association of short neck with  an unusual laryngeal anomaly Rakesh Pinninti1, Thirulogachandar E.1,2, Noorul Ameen K. H.1 1Departments of Medicine and 2General Medicine, Government Stanley Hospital, Chennai, Tamil Nadu, India Corresponding author: Dr. Rakesh Pinninti, Doshi apartments, Chennai, India.",Non-OADS,/arxiv_data1/oa_pdf/14/c9/JCVJS-2-86.PMC3486006.pdf
"89 Journal of Craniovertebral  Junction and SpineJ JC VS Editor-in-Chief :  Atul Goel  (INDIA )Open Access   HTML Format For entire Editorial Board visit :  http://www.jcvjs.com/editorialboard.asp Case Report One-stage surgery through posterior approach-for L5- S1 spondyloptosis Hikmet Turan Suslu, Erhan Celikoglu, Ali Borekcı, Tufan Hıcdonmez, Hüsnü Suslu1 Neurosurgery Clinic, 1Anesthesiogly Clinic, Dr. Lutfi Kirdar Kartal Research and Training Hospital, Istanbul, Turkey Corresponding author: Dr. Hikmet Turan Suslu, Neurosurgery Clinic, Dr. Lutfi Kırdar Kartal Research and Training Hospital Kartal – Istanbul, Turkey.",Non-OADS,/arxiv_data1/oa_pdf/88/35/JCVJS-2-89.PMC3486007.pdf
This is an Open Access article distributed under the terms of theCreative Commons Attribution Non-Commercial Share AlikeLicense (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/1c/59/bio-01-07-629.PMC3486706.pdf
Real-time PCR signal was normalized to a standard curve andfold enrichment was calculated using a ‘ ‘signal over background method’ ’ as permanufacturer’s instructions (http://www.invitrogen.com/site/us/en/home/Products-and-Services/Applications/epigenetics-noncoding-rna-research/Chromatin- Remodeling/Chromatin-Immunoprecipitation-ChIP/chip-analysis.html).,OADS,/arxiv_data1/oa_pdf/1c/59/bio-01-07-629.PMC3486706.pdf
To view this ﬁle please visit the journal online (http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/6f/b9/amiajnl-2011-000705.PMC3486730.pdf
"Baltimore (MD): CMS, 2010. http://cms.gov/ehrincentiveprograms/ (accessed 30 Aug 2011).",OADS,/arxiv_data1/oa_pdf/6f/b9/amiajnl-2011-000705.PMC3486730.pdf
2008. http://wiki.hl7.org/index.php?,Non-OADS,/arxiv_data1/oa_pdf/a8/62/amiajnl-2011-000763.PMC3486731.pdf
2011. https://wiki.nci.nih.gov/x/cxRlAQ (accessed 21 Sep 2011).,OADS,/arxiv_data1/oa_pdf/a8/62/amiajnl-2011-000763.PMC3486731.pdf
http://isatab.sourceforge.net (accessed 21 Sep 2011).,OADS,/arxiv_data1/oa_pdf/a8/62/amiajnl-2011-000763.PMC3486731.pdf
2009. http://www.hl7.org/Special/ committees/clingenomics/overview.cfm (accessed 21 Sep 2011).,Non-OADS,/arxiv_data1/oa_pdf/a8/62/amiajnl-2011-000763.PMC3486731.pdf
2012. https://wiki.nci.nih.gov/ x/CIHbAQ (accessed 8 Feb 2012).12. International Organization for Standardization.,OADS,/arxiv_data1/oa_pdf/a8/62/amiajnl-2011-000763.PMC3486731.pdf
http://www.iso.org/iso/home.html (accessed 21 Sep 2011).,Non-OADS,/arxiv_data1/oa_pdf/a8/62/amiajnl-2011-000763.PMC3486731.pdf
2011. http://www.sparxsystems.com/ products/ea/index.html (accessed 21 Sep 2011).,OADS,/arxiv_data1/oa_pdf/a8/62/amiajnl-2011-000763.PMC3486731.pdf
2011. http://ncit.nci.nih.gov/ncitbrowser/ (accessed 21 Sep 2011).,OADS,/arxiv_data1/oa_pdf/a8/62/amiajnl-2011-000763.PMC3486731.pdf
2011. https://cabig.nci.nih.gov/tools/ catissuesuite (accessed 21 Sep 2011).,OADS,/arxiv_data1/oa_pdf/a8/62/amiajnl-2011-000763.PMC3486731.pdf
2011. https://cabig.nci.nih.gov/tools/caArray (accessed 21 Sep 2011).,OADS,/arxiv_data1/oa_pdf/a8/62/amiajnl-2011-000763.PMC3486731.pdf
2011. https://wiki.nci.nih.gov/ x/4Q9y (accessed 21 Sep 2011).,OADS,/arxiv_data1/oa_pdf/a8/62/amiajnl-2011-000763.PMC3486731.pdf
2011. https://wiki.nci.nih.,Non-OADS,/arxiv_data1/oa_pdf/a8/62/amiajnl-2011-000763.PMC3486731.pdf
2010. https://cananolab.nci.nih.gov/ caNanoLab/ (accessed 21 Sep 2011).,OADS,/arxiv_data1/oa_pdf/a8/62/amiajnl-2011-000763.PMC3486731.pdf
2009. http://gforge.nci.,Non-OADS,/arxiv_data1/oa_pdf/a8/62/amiajnl-2011-000763.PMC3486731.pdf
2009. https://wiki.nci.nih.gov/download/ attachments/39912351/ICR_Interoperability_Scenarios_20090212.doc (accessed 22 Sep 2011).,OADS,/arxiv_data1/oa_pdf/a8/62/amiajnl-2011-000763.PMC3486731.pdf
2011. https://wiki.nci.nih.gov/download/attachments/ 23401587/Experiment+Model+Implementation+Guide.docx (accessed 28 Apr 2011).,OADS,/arxiv_data1/oa_pdf/a8/62/amiajnl-2011-000763.PMC3486731.pdf
2011. https://wiki.nci.,Non-OADS,/arxiv_data1/oa_pdf/a8/62/amiajnl-2011-000763.PMC3486731.pdf
2011. http://ncientarch.info/sandbox/ LSDAM2_2_1/ (accessed 22 Sep 2011).,OADS,/arxiv_data1/oa_pdf/a8/62/amiajnl-2011-000763.PMC3486731.pdf
2011. https://wiki.nci.nih.gov/x/vZv9AQ (accessed 19 Sep 2011).,OADS,/arxiv_data1/oa_pdf/a8/62/amiajnl-2011-000763.PMC3486731.pdf
2011. https://wiki.nci.nih.gov/x/ ZwVyAQ (accessed 8 Feb 2012).,OADS,/arxiv_data1/oa_pdf/a8/62/amiajnl-2011-000763.PMC3486731.pdf
https://wiki.nci.nih.gov/download/attachments/23401587/ LS+DAM+2_2Future+Activities+Compilation.docx?version= 1&modiﬁcationDate=1304986410000 (accessed 22 Sep 2011).,OADS,/arxiv_data1/oa_pdf/a8/62/amiajnl-2011-000763.PMC3486731.pdf
2011. https://wiki.nci.nih.gov/ x/CIHbAQ (accessed 18 Sep 2011).,OADS,/arxiv_data1/oa_pdf/a8/62/amiajnl-2011-000763.PMC3486731.pdf
To view this ﬁle please visit the journal online (http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/91/1e/amiajnl-2012-000960.PMC3486732.pdf
2012. http://epic.com/ 5.,Non-OADS,/arxiv_data1/oa_pdf/91/1e/amiajnl-2012-000960.PMC3486732.pdf
Secondary Daedalus SoftwaredDaedalus BTM dResearch 2012. http://www.daedalussoftware.com/ website/products_btm_research.asp 6.,Non-OADS,/arxiv_data1/oa_pdf/91/1e/amiajnl-2012-000960.PMC3486732.pdf
2011. http://www.hhs.gov/news/press/2011pres/07/20110722a.html (accessed 23 Jul 2011).Table 1 Breakdown of patient consent by document type Consent type Count Percentage of total Consent with notiﬁcation 15 421 82.6% Consent without notiﬁcation 691 3.7% Consent refused 990 5.3% Consent deferred 1562 8.4% Consent withdrawn 4 0.0% Total 18 668 under a ‘yes’ consent.,Non-OADS,/arxiv_data1/oa_pdf/91/1e/amiajnl-2012-000960.PMC3486732.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseAugust 2012 |  66  | e2550 | Page 1 of 4Video Article Use of a Hanging-weight System for Liver Ischemia in Mice Michael Zimmerman1, Eunyoung Tak2, Maria Kaplan1, Mercedes Susan Mandell2, Holger K. Eltzschig2, Almut Grenz2 1UCH Transplant Center, University of Colorado, Denver 2Department of Anesthesiology, University of Colorado, Denver Correspondence to: Almut Grenz at almut.grenz@ucdenver.edu URL: http://www.jove.com/video/2550 DOI: doi:10.3791/2550 Keywords: Medicine, Issue 66, Physiology, Immunology, targeted gene deletion, murine model, liver failure, ischemia, reperfusion, video demonstration Date Published: 8/7/2012 Citation: Zimmerman, M., Tak, E., Kaplan, M., Mandell, M.S., Eltzschig, H.K., Grenz, A.",Non-OADS,/arxiv_data1/oa_pdf/d8/7a/jove-66-2550.PMC3486745.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/2550/ Protocol General remarks.,Non-OADS,/arxiv_data1/oa_pdf/d8/7a/jove-66-2550.PMC3486745.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseAugust 2012 |  66  | e3981 | Page 1 of 11Video Article Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models Duong D. Tu*1, Abhishek Seth*1, Eun Seok Gil2, David L. Kaplan2, Joshua R. Mauney1, Carlos R. Estrada Jr.1 1Children's Hospital Boston, Harvard Medical School 2Tufts University *These authors contributed equally Correspondence to: Joshua R. Mauney at joshua.mauney@childrens.harvard.edu , Carlos R. Estrada Jr. at carlos.estrada@childrens.harvard.edu URL: http://www.jove.com/video/3981 DOI: doi:10.3791/3981 Keywords: Bioengineering, Issue 66, Medicine, Biomedical Engineering, Physiology, Silk, bladder tissue engineering, biomaterial, scaffold, matrix, augmentation, cystometry Date Published: 8/9/2012 Citation: Tu, D.D., Seth, A., Gil, E.S., Kaplan, D.L., Mauney, J.R., Estrada, C.R.",Non-OADS,/arxiv_data1/oa_pdf/b2/8a/jove-66-3981.PMC3486757.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/3981/ Protocol Surgical Methods 1.,Non-OADS,/arxiv_data1/oa_pdf/b2/8a/jove-66-3981.PMC3486757.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseAugust 2012 |  66  | e4022 | Page 1 of 6Video Article Generation of an Immortalized Murine Brain Microvascular Endothelial Cell Line as an In Vitro Blood Brain Barrier Model Malgorzata Burek1, Ellaine Salvador1, Carola Y. Förster1 1Klinik und Poliklinik für Anästhesiologie, University of Wurzburg Correspondence to: Carola Y. Förster at Foerster_C@klinik.uni-wuerzburg.de URL: http://www.jove.com/video/4022 DOI: doi:10.3791/4022 Keywords: Immunology, Issue 66, Neuroscience, Blood-brain barrier, in vitro  cell culture models, brain, microvascular endothelial cells, immortalization, cEND Date Published: 8/29/2012 Citation: Burek, M., Salvador, E., Förster, C.Y.",Non-OADS,/arxiv_data1/oa_pdf/1e/bc/jove-66-4022.PMC3486758.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4022/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/1e/bc/jove-66-4022.PMC3486758.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseAugust 2012 |  66  | e4036 | Page 1 of 6Video Article A Human Fallopian Tube Model for Investigation of C. trachomatis  Infections Stefan Jerchel1, Gudrun Knebel2, Peter König2, Michael K. Bohlmann3, Jan Rupp1,4 1Institute of Medical Microbiology and Hygiene, University of Lübeck 2Institute of Anatomie, University of Lübeck 3Department of Obstetrics and Gynecology, University Hospital of Schleswig-Holstein, University of Lübeck 4Medical Clinic III, University Hospital of Schleswig-Holstein, University of Lübeck Correspondence to: Jan Rupp at Jan.Rupp@uk-sh.de URL: http://www.jove.com/video/4036 DOI: doi:10.3791/4036 Keywords: Medicine, Issue 66, Infection, Microbiology, Physiology, Chlamydia trachomatis , human fallopian tube, tissue model, scanning electron microscopy, transmission electron microscopy Date Published: 8/11/2012 Citation: Jerchel, S., Knebel, G., König, P., Bohlmann, M.K., Rupp, J.",Non-OADS,/arxiv_data1/oa_pdf/59/a9/jove-66-4036.PMC3486760.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4036/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/59/a9/jove-66-4036.PMC3486760.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseAugust 2012 |  66  | e4132 | Page 1 of 7Video Article Generation, Purification, and Characterization of Cell-invasive DISC1 Protein Species Verian Bader1, Philipp Ottis1, Martin Pum2, Joseph P. Huston2, Carsten Korth1 1Department of Neuropathology, Medical School Düsseldorf, Germany 2Center of Behavioral Neuroscience, University of Düsseldorf Correspondence to: Carsten Korth at ckorth@uni-duesseldorf.de URL: http://www.jove.com/video/4132 DOI: doi:10.3791/4132 Keywords: Molecular Biology, Issue 66, Neuroscience, Medicine, Genetics, Protein aggregate, aggresome, cell invasiveness, protein conformational disease, DISC1, DISC1opathy, purification, recombinant protein, multimerization, protein labeling, brain, rat, neuroscience Date Published: 8/30/2012 Citation: Bader, V., Ottis, P., Pum, M., Huston, J.P., Korth, C. Generation, Purification, and Characterization of Cell-invasive DISC1 Protein Species.",Non-OADS,/arxiv_data1/oa_pdf/fb/b5/jove-66-4132.PMC3486765.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4132/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/fb/b5/jove-66-4132.PMC3486765.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseAugust 2012 |  66  | e4218 | Page 1 of 7Video Article Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy Chung Wong1, Evan Vosburgh1,2, Arnold J. Levine2,3, Lei Cong2, Eugenia Y. Xu1,2 1Raymond and Beverly Sackler Foundation 2The Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey 3School of Natural Sciences, Institute for Advanced Study, Princeton, New Jersey Correspondence to: Eugenia Y. Xu at xueu@umdnj.edu URL: http://www.jove.com/video/4218 DOI: doi:10.3791/4218 Keywords: Cancer Biology, Issue 66, Medicine, Neuroscience, Cell Culture, Tissue Engineering, 3D model, multicellular spheroids, therapeutic drugs, neuroendocrine tumor cell lines, agarose overlay platform, paraffin embedding Date Published: 8/14/2012 Citation: Wong, C., Vosburgh, E., Levine, A.J., Cong, L., Xu, E.Y.",Non-OADS,/arxiv_data1/oa_pdf/b6/bb/jove-66-4218.PMC3486771.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4218/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/b6/bb/jove-66-4218.PMC3486771.pdf
"ISSN 2234-3806  • eISSN 2234-3814  385 http://dx.doi.org/10.3343/alm.2012.32.6.385 www.annlabmed.orgAnn Lab Med 2012;32:385-391 http://dx.doi.org/10.3343/alm.2012.32.6.385Original Article Diagnostic Hematology Correlations between Janus Kinase 2  V617F Allele  Burdens and Clinicohematologic Parameters in   Myeloproliferative Neoplasms  Jung-Sook Ha, M.D.1, Yu-Kyung Kim, M.D.2, Soon-Il Jung, M.D.3, He-Ra Jung, M.D.4, and In-Sung Chung, M.D.5 Department of Laboratory Medicine1, Keimyung University School of Medicine, Daegu; Department of Laboratory Medicine2, Kyungbook National University  School of Medicine, Daegu; Department of Laboratory Medicine3, Yeungnam University College of Medicine, Daegu; Departments of Pathology4,  Occupational and Environmental Medicine5, Keimyung University School of Medicine, Daegu, Korea Background:  This study evaluated potential correlations between the allele burden of the  Janus kinase 2 (JAK2) V617F mutation and clinicohematologic characteristics in patients  with myeloproliferative neoplasms (MPN).",OADS,/arxiv_data1/oa_pdf/23/b3/alm-32-385.PMC3486931.pdf
JAK2  V617F allele burden in myeloproliferative neoplasms 386www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.385study was undertaken to: (1) determine whether MPN patients  harboring the JAK2 V617F mutation exhibit different clinicohe- matologic characteristics than patients lacking it; and (2) iden- tify whether the allele burden of the JAK2 V617F mutation is as- sociated with the severity of clinicohematologic features of MPN.,Non-OADS,/arxiv_data1/oa_pdf/23/b3/alm-32-385.PMC3486931.pdf
JAK2  V617F allele burden in myeloproliferative neoplasms 387 http://dx.doi.org/10.3343/alm.2012.32.6.385 www.annlabmed.orgsubgroup carried the highest mean JAK2 V617F allele burden  (66.0%±24.9%) compared with ET (40.5%±25.2%) and PMF  patients (31.5%±37.0%) (P=0.00).,Non-OADS,/arxiv_data1/oa_pdf/23/b3/alm-32-385.PMC3486931.pdf
JAK2  V617F allele burden in myeloproliferative neoplasms 388www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.385Table 3.,Non-OADS,/arxiv_data1/oa_pdf/23/b3/alm-32-385.PMC3486931.pdf
JAK2  V617F allele burden in myeloproliferative neoplasms 389 http://dx.doi.org/10.3343/alm.2012.32.6.385 www.annlabmed.orglated the 0-25% or 26-50% groups.,Non-OADS,/arxiv_data1/oa_pdf/23/b3/alm-32-385.PMC3486931.pdf
"JAK2  V617F allele burden in myeloproliferative neoplasms 390www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.385decreased mean cell volume, serum ferritin level, and erythro- poietin level), myelopoiesis (e.g., increased WBC count, neutro- phil count, and serum lactate dehydrogenase level), neutrophil  activation (e.g., elevated leukocyte count and alkaline phospha- tase level), and high complication rate in MPN [9-18].",Non-OADS,/arxiv_data1/oa_pdf/23/b3/alm-32-385.PMC3486931.pdf
"JAK2  V617F allele burden in myeloproliferative neoplasms 391 http://dx.doi.org/10.3343/alm.2012.32.6.385 www.annlabmed.org“erythremic” and less “thrombocythemic”: a molecular, histologic, and  clinical study.",Non-OADS,/arxiv_data1/oa_pdf/23/b3/alm-32-385.PMC3486931.pdf
"ISSN 2234-3806  • eISSN 2234-3814  392www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.392Ann Lab Med 2012;32:392-398 http://dx.doi.org/10.3343/alm.2012.32.6.392Original Article Diagnostic Hematology Correction of Pseudoreticulocytosis in Leukocytosis  Samples Using the Sysmex XE-2100 Analyzer   Depends on the Type and Number of White Blood Cells Ahhyun Kim, M.D., Joonhong Park, M.D., Myungshin Kim, M.D., Jihyang Lim, M.D., Eun-Jee Oh, M.D., Yonggoo Kim, M.D., Yeon-Joon Park, M.D., and Kyungja Han, M.D.",OADS,/arxiv_data1/oa_pdf/a5/49/alm-32-392.PMC3486932.pdf
Correction of pseudoreticulocytosis in leukocytosis samples 393 http://dx.doi.org/10.3343/alm.2012.32.6.392 www.annlabmed.orgreticulocyte fraction (IRF) is one of the reticulocyte indices gen- erated by automated analyzers [7].,OADS,/arxiv_data1/oa_pdf/a5/49/alm-32-392.PMC3486932.pdf
Correction of pseudoreticulocytosis in leukocytosis samples 394www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.392Table 1.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/alm-32-392.PMC3486932.pdf
"Correction of pseudoreticulocytosis in leukocytosis samples 395 http://dx.doi.org/10.3343/alm.2012.32.6.392 www.annlabmed.orgthe reticulocyte scattergram was abnormal, with the flag.",Non-OADS,/arxiv_data1/oa_pdf/a5/49/alm-32-392.PMC3486932.pdf
"Correction of pseudoreticulocytosis in leukocytosis samples 396www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.392count and IRF were 1.22% and 14.6%, respectively, on the XE- 2100 analyzer.",OADS,/arxiv_data1/oa_pdf/a5/49/alm-32-392.PMC3486932.pdf
Correction of pseudoreticulocytosis in leukocytosis samples 397 http://dx.doi.org/10.3343/alm.2012.32.6.392 www.annlabmed.orgcyte scattergrams.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/alm-32-392.PMC3486932.pdf
Correction of pseudoreticulocytosis in leukocytosis samples 398www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.392REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/alm-32-392.PMC3486932.pdf
"ISSN 2234-3806  • eISSN 2234-3814  399 http://dx.doi.org/10.3343/alm.2012.32.6.399 www.annlabmed.orgAnn Lab Med 2012;32:399-406 http://dx.doi.org/10.3343/alm.2012.32.6.399Original Article Clinical Microbiology Evaluation of a Multiplex Real-time PCR Assay for the  Detection of Respiratory Viruses in Clinical Specimens Insoo Rheem, M.D.1, Joowon Park, M.D.1, Tae-Hyun Kim, Ph.D.2, and Jong Wan Kim, M.D.1 Department of Laboratory Medicine1, Dankook University College of Medicine, Institute of Tissue Regeneration Engineering (ITREN)2, Dankook University,  Cheonan, Korea Background:  In this study, we evaluated the analytical performance and clinical potential  of a one-step multiplex real-time PCR assay for the simultaneous detection of 14 types of  respiratory viruses using the AdvanSure RV real-time PCR Kit (LG Life Sciences, Korea).",Non-OADS,/arxiv_data1/oa_pdf/03/a7/alm-32-399.PMC3486933.pdf
Real-time PCR for respiratory virus detection 400www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.399ruses [7].,OADS,/arxiv_data1/oa_pdf/03/a7/alm-32-399.PMC3486933.pdf
"Real-time PCR for respiratory virus detection 401 http://dx.doi.org/10.3343/alm.2012.32.6.399 www.annlabmed.orgwas compared to the previously reported LOD (95%) values of  Food and Drug Administration (FDA)-approved commercial RV  test kits as follows: Proflu plus (Gen-Probe Inc., San Diego, CA,  USA) [19], Simplex Flu A/B & RSV (Focus Diagnostics, Cypress,  CA, USA) [20], Verigene RV Nucleic Acid Test (Nanosphere,  Northbrook, IL, USA) [21] and xTAG RVP FAST (Luminex, Aus- tin, TX, USA) [22].",Non-OADS,/arxiv_data1/oa_pdf/03/a7/alm-32-399.PMC3486933.pdf
"Real-time PCR for respiratory virus detection 402www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.399RT-PCR mix (Roche, Mannheim, Germany), 5 μL of outer primer  set, and 5 μL of extracted sample DNA or RNA.",OADS,/arxiv_data1/oa_pdf/03/a7/alm-32-399.PMC3486933.pdf
Real-time PCR for respiratory virus detection 403 http://dx.doi.org/10.3343/alm.2012.32.6.399 www.annlabmed.orgsay procedure used for the clinical samples for RV detection  with the AdvanSure RV real-time PCR detection Kit.,Non-OADS,/arxiv_data1/oa_pdf/03/a7/alm-32-399.PMC3486933.pdf
"Real-time PCR for respiratory virus detection 404www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.399 Multiplex real-time RT-PCR is a recognized technique offering  a faster and effective technology for the rapid detection of vi- ruses than the conventional diagnostic methods of virus culture,  antigen tests, or direct immunofluorescence [29].",Non-OADS,/arxiv_data1/oa_pdf/03/a7/alm-32-399.PMC3486933.pdf
Real-time PCR for respiratory virus detection 405 http://dx.doi.org/10.3343/alm.2012.32.6.399 www.annlabmed.orgAcknowledgement The present research was conducted by the research fund of  Dankook University in 2010.,Non-OADS,/arxiv_data1/oa_pdf/03/a7/alm-32-399.PMC3486933.pdf
http://www.accessdata.fda.gov/cdrh_docs/reviews/ K073029.pdf (Updated on 2007).,OADS,/arxiv_data1/oa_pdf/03/a7/alm-32-399.PMC3486933.pdf
http://www.access- data.fda.gov/cdrh_docs/pdf10/K102170.pdf (Updated on Nov 2010).,OADS,/arxiv_data1/oa_pdf/03/a7/alm-32-399.PMC3486933.pdf
http://www.access- data.fda.gov/cdrh_docs/pdf8/K083088.pdf (Updated on May 2009).,OADS,/arxiv_data1/oa_pdf/03/a7/alm-32-399.PMC3486933.pdf
http://www.accessdata.fda.gov/cdrh_docs/pdf10/K103776.pdf (Updated  on July 2011).,OADS,/arxiv_data1/oa_pdf/03/a7/alm-32-399.PMC3486933.pdf
Real-time PCR for respiratory virus detection 406www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.399RVP.,OADS,/arxiv_data1/oa_pdf/03/a7/alm-32-399.PMC3486933.pdf
"ISSN 2234-3806  • eISSN 2234-3814  407 http://dx.doi.org/10.3343/alm.2012.32.6.407 www.annlabmed.orgAnn Lab Med 2012;32:407-412 http://dx.doi.org/10.3343/alm.2012.32.6.407Original Article Clinical Microbiology Methicillin-resistant Staphylococcus aureus  in Nasal  Surveillance Swabs at an Intensive Care Unit:   An Evaluation of the LightCycler MRSA Advanced Test Hee Jin Huh, M.D.1, Eu Suk Kim, M.D.2, and Seok Lae Chae, M.D.1 Department of Laboratory Medicine1, Dongguk University Ilsan Hospital, Goyang; Department of Internal Medicine2, Seoul National University Bundang  Hospital, Seongnam, Korea Background:  We compared the LightCycler MRSA advanced test (Roche Diagnostics,  Germany) with enrichment culture methods to evaluate the relative diagnostic perfor - mance of the LightCycler MRSA advanced test for active surveillance in a high-prevalence  setting.",Non-OADS,/arxiv_data1/oa_pdf/fd/05/alm-32-407.PMC3486934.pdf
Evaluation of the LightCycler MRSA advanced test 408www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.407[5].,OADS,/arxiv_data1/oa_pdf/fd/05/alm-32-407.PMC3486934.pdf
Evaluation of the LightCycler MRSA advanced test 409 http://dx.doi.org/10.3343/alm.2012.32.6.407 www.annlabmed.org5.,Non-OADS,/arxiv_data1/oa_pdf/fd/05/alm-32-407.PMC3486934.pdf
Evaluation of the LightCycler MRSA advanced test 410www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.407(MSSA) was detected by culture in 6 cases.,Non-OADS,/arxiv_data1/oa_pdf/fd/05/alm-32-407.PMC3486934.pdf
"Evaluation of the LightCycler MRSA advanced test 411 http://dx.doi.org/10.3343/alm.2012.32.6.407 www.annlabmed.orgthe clinical setting of high MRSA prevalence, it is postulated that  the main disadvantages of PCR assays are the possibility of the  detection of residual DNA from nonviable bacteria [6].",Non-OADS,/arxiv_data1/oa_pdf/fd/05/alm-32-407.PMC3486934.pdf
Evaluation of the LightCycler MRSA advanced test 412www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.407O’Connell B.,Non-OADS,/arxiv_data1/oa_pdf/fd/05/alm-32-407.PMC3486934.pdf
"ISSN 2234-3806  • eISSN 2234-3814  413 http://dx.doi.org/10.3343/alm.2012.32.6.413 www.annlabmed.orgAnn Lab Med 2012;32:413-419 http://dx.doi.org/10.3343/alm.2012.32.6.413Original Article Clinical Microbiology Clonal Spread of Carbapenem Non-susceptible   Acinetobacter baumannii  in an Intensive Care Unit in  a Teaching Hospital in China Qiao Zhong, M.D., Weidong Xu, M.D., Yuanjian Wu, M.D., and Hongxing Xu, M.D.",Non-OADS,/arxiv_data1/oa_pdf/2a/fb/alm-32-413.PMC3486935.pdf
Clonal spread of carbapenem non-susceptible A. baumannii  414www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.413OXA-type carbapenemase genes and mobilize these genes  among the strains [11].,Non-OADS,/arxiv_data1/oa_pdf/2a/fb/alm-32-413.PMC3486935.pdf
"All sequencing reactions were performed using an ABI prism  sequencer 3730 (Applied Biosystems, Foster City, CA, USA),  and the sequence data were analyzed by using BLAST at the  NCBI website (http://www.ncbi.nlm.nih.gov).",OADS,/arxiv_data1/oa_pdf/2a/fb/alm-32-413.PMC3486935.pdf
The sequences of these 7 housekeeping genes were an- alyzed using the Pubmlst database (http://pubmlst.org/abau- mannii/).,OADS,/arxiv_data1/oa_pdf/2a/fb/alm-32-413.PMC3486935.pdf
The eBURST algorithm (ver- sion 3; http://eburst.mlst.net/) was used to assign STs to CCs,OADS,/arxiv_data1/oa_pdf/2a/fb/alm-32-413.PMC3486935.pdf
Clonal spread of carbapenem non-susceptible A. baumannii   415 http://dx.doi.org/10.3343/alm.2012.32.6.413 www.annlabmed.organd to assess the genetic relationship with definition of the  groups sharing alleles at ≥6 of 7 loci [21].,Non-OADS,/arxiv_data1/oa_pdf/2a/fb/alm-32-413.PMC3486935.pdf
Clonal spread of carbapenem non-susceptible A. baumannii  416www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.413test.,Non-OADS,/arxiv_data1/oa_pdf/2a/fb/alm-32-413.PMC3486935.pdf
Clonal spread of carbapenem non-susceptible A. baumannii   417 http://dx.doi.org/10.3343/alm.2012.32.6.413 www.annlabmed.orgtics of A. baumannii isolates in our ICU.,Non-OADS,/arxiv_data1/oa_pdf/2a/fb/alm-32-413.PMC3486935.pdf
Clonal spread of carbapenem non-susceptible A. baumannii  418www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.413CC92 in our medical ICU.,Non-OADS,/arxiv_data1/oa_pdf/2a/fb/alm-32-413.PMC3486935.pdf
"Clonal spread of carbapenem non-susceptible A. baumannii   419 http://dx.doi.org/10.3343/alm.2012.32.6.413 www.annlabmed.orgMD, et al.",Non-OADS,/arxiv_data1/oa_pdf/2a/fb/alm-32-413.PMC3486935.pdf
"ISSN 2234-3806  • eISSN 2234-3814  420www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.420Ann Lab Med 2012;32:420-425 http://dx.doi.org/10.3343/alm.2012.32.6.420Original Article Diagnostic Immunology  Elecsys Hepatitis B Surface Antigen Quantitative   Assay: Performance Evaluation and Correlation with  Hepatitis B Virus DNA during 96 Weeks of Follow-up in Chronic Hepatitis B Patients Hyun Ji Lee, M.D.1, Shine Young Kim, M.D.1, Sun Min Lee, M.D.1, Jeong Heo, M.D.2, Hyung Hoi Kim, M.D.1,3,  Chulhun L. Chang, M.D.1, Eun Yup Lee, M.D.1, and Han Chul Son, M.D.1 Departments of Laboratory Medicine1 and Internal Medicine2, Pusan National University School of Medicine; Medical Research Institute3, Pusan National  University Hospital, Busan, Korea Background:  Treatment for chronic hepatitis B aims to suppress virus replication and virus  sequestration in hepatocytes.",OADS,/arxiv_data1/oa_pdf/b9/28/alm-32-420.PMC3486936.pdf
Performance evaluation of HBsAg quantitative assay 421 http://dx.doi.org/10.3343/alm.2012.32.6.420 www.annlabmed.orgas the transcriptional template for host RNA polymerase II.,OADS,/arxiv_data1/oa_pdf/b9/28/alm-32-420.PMC3486936.pdf
Performance evaluation of HBsAg quantitative assay 422www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.420say).,OADS,/arxiv_data1/oa_pdf/b9/28/alm-32-420.PMC3486936.pdf
"Performance evaluation of HBsAg quantitative assay 423 http://dx.doi.org/10.3343/alm.2012.32.6.420 www.annlabmed.orgthe assays was weak (r=0.438, P=0.002).",OADS,/arxiv_data1/oa_pdf/b9/28/alm-32-420.PMC3486936.pdf
Performance evaluation of HBsAg quantitative assay 424www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.420(PPV) of 72% for achieving a sustained virologic response after  the start of the treatment and a negative predictive value (NPV)  of 81%.,Non-OADS,/arxiv_data1/oa_pdf/b9/28/alm-32-420.PMC3486936.pdf
Performance evaluation of HBsAg quantitative assay 425 http://dx.doi.org/10.3343/alm.2012.32.6.420 www.annlabmed.orgease phase influences correlation with viral load and intrahepatic hepa- titis B virus markers.,Non-OADS,/arxiv_data1/oa_pdf/b9/28/alm-32-420.PMC3486936.pdf
"ISSN 2234-3806  • eISSN 2234-3814  426www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.426Ann Lab Med 2012;32:426-428 http://dx.doi.org/10.3343/alm.2012.32.6.426Brief Communication  Clinical Microbiology Antifungal Susceptibility to Amphotericin B, Fluconazole,  Voriconazole, and Flucytosine in Candida  Bloodstream  Isolates from 15 Tertiary Hospitals in Korea  Sook-In Jung, M.D.1, Jong Hee Shin, M.D.2, Hyun-Jung Choi, M.D.2, Min-Young Ju, M.S.2, Soo-Hyun Kim, M.D.2,  Wee Gyo Lee, M.D.3, Yeon-Joon Park, M.D.4, and Kyungwon Lee, M.D.5, for the Korean Study Group for Candidemia Departments of Internal Medicine1 and Laboratory Medicine2, Chonnam National University Medical School, Gwangju; Department of Laboratory Medicine3,  Ajou University College of Medicine, Suwon; Department of Laboratory Medicine4, The Catholic University of Korea College of Medicine, Seoul; Department  of Laboratory Medicine and Research Institute of Bacterial Resistance5, Yonsei University College of Medicine, Seoul, Korea The in vitro antifungal susceptibility of 636 Candida bloodstream isolates collected from 15  tertiary hospitals in Korea was determined using the Vitek-2 yeast susceptibility system  (bioMérieux, France).",Non-OADS,/arxiv_data1/oa_pdf/b8/66/alm-32-426.PMC3486937.pdf
"Antifungal susceptibility of Candida  bloodstream isolates 427 http://dx.doi.org/10.3343/alm.2012.32.6.426 www.annlabmed.orgwith the Vitek-2 system was performed according to the manu- facturer’s instructions [1, 2].",Non-OADS,/arxiv_data1/oa_pdf/b8/66/alm-32-426.PMC3486937.pdf
"Antifungal susceptibility of Candida  bloodstream isolates 428www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.426was used as reference standard, supporting our previous report  that Vitek-2 is more sensitive for detecting amphotericin B resis- tance among Candida species than the CLSI method [4].",Non-OADS,/arxiv_data1/oa_pdf/b8/66/alm-32-426.PMC3486937.pdf
"ISSN 2234-3806  • eISSN 2234-3814  429 http://dx.doi.org/10.3343/alm.2012.32.6.429 www.annlabmed.orgAnn Lab Med 2012;32:429-432 http://dx.doi.org/10.3343/alm.2012.32.6.429Brief Communication Transfusion Medicine Sensitization to Multiple Rh Antigens by Transfusion of  Random Donor Platelet Concentrates in a -D- Phenotype Patient Jae Won Yun, M.D.1, Eun-Suk Kang, M.D.1, Chang-Seok Ki, M.D.1, Kwang Cheol Koh, M.D.2, and Dae Won Kim, M.D.1 Departments of Laboratory Medicine & Genetics1, Medicine2, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea The -D- phenotype is a rare Rh phenotype that strongly expresses D antigen without C, c,  E, or e antigens.",Non-OADS,/arxiv_data1/oa_pdf/54/94/alm-32-429.PMC3486938.pdf
A -D- patient sensitized to Rh antigens by platelet transfusion 430www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.429bleeding.,Non-OADS,/arxiv_data1/oa_pdf/54/94/alm-32-429.PMC3486938.pdf
A -D- patient sensitized to Rh antigens by platelet transfusion 431 http://dx.doi.org/10.3343/alm.2012.32.6.429 www.annlabmed.org The genotype of deceased mother of the patient was pre- sumed to be -D-/cDE according to the pedigree analysis.,Non-OADS,/arxiv_data1/oa_pdf/54/94/alm-32-429.PMC3486938.pdf
A -D- patient sensitized to Rh antigens by platelet transfusion 432www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.429born.,Non-OADS,/arxiv_data1/oa_pdf/54/94/alm-32-429.PMC3486938.pdf
"ISSN 2234-3806  • eISSN 2234-3814  433 http://dx.doi.org/10.3343/alm.2012.32.6.433 www.annlabmed.orgAnn Lab Med 2012;32:433-437 http://dx.doi.org/10.3343/alm.2012.32.6.433Case Report Clinical Microbiology A Case of Helicobacter cinaedi  Bacteremia in an  Asplenic Patient Soo-Kyung Kim, M.D.1, Eun-Jung Cho, M.D.1, Heungsup Sung, M.D.1, Dongheui An, M.D.1, Sook-Ja Park, M.T.1,  Mi-Na Kim, M.D.1, and Gi-Byoung Nam, M.D.2  Departments of Laboratory Medicine1 and Internal Medicine2, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea Helicobacter cinaedi is an enterohepatic species.",Non-OADS,/arxiv_data1/oa_pdf/ad/ff/alm-32-433.PMC3486939.pdf
"H. cinaedi  bacteremia in an asplenic patient 434www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.433 On admission, his body temperature, pulse rate, respiration  rate, and blood pressure were 36.4˚C, 113/min, 25/min, and  133/76 mmHg, respectively.",Non-OADS,/arxiv_data1/oa_pdf/ad/ff/alm-32-433.PMC3486939.pdf
According to a search of the Basic Local  Alignment Search Tool (BLAST) database (http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/ad/ff/alm-32-433.PMC3486939.pdf
H. cinaedi  bacteremia in an asplenic patient 435 http://dx.doi.org/10.3343/alm.2012.32.6.433 www.annlabmed.orgcontaining 7% sheep blood.,Non-OADS,/arxiv_data1/oa_pdf/ad/ff/alm-32-433.PMC3486939.pdf
"H. cinaedi  bacteremia in an asplenic patient 436www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.433fections, iron overload, and diabetes mellitus [13].",Non-OADS,/arxiv_data1/oa_pdf/ad/ff/alm-32-433.PMC3486939.pdf
H. cinaedi  bacteremia in an asplenic patient 437 http://dx.doi.org/10.3343/alm.2012.32.6.433 www.annlabmed.orgmia and pneumonia in two splenectomized patients.,Non-OADS,/arxiv_data1/oa_pdf/ad/ff/alm-32-433.PMC3486939.pdf
"ISSN 2234-3806  • eISSN 2234-3814  438www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.438Ann Lab Med 2012;32:438-441 http://dx.doi.org/10.3343/alm.2012.32.6.438Case Report Clinical Microbiology Subcutaneous Phaeohyphomycosis Caused by Exophiala  salmonis Young Ahn Yoon, M.D.1, Kyung Sun Park, M.D.1, Jang Ho Lee, M.T.1, Ki-Sun Sung, M.D.2, Chang-Seok Ki, M.D.1,  and Nam Yong Lee, M.D.1 Departments of Laboratory Medicine and Genetics1, Orthopedic Surgery2, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea We report a case of subcutaneous infection in a 55-yr-old Korean diabetic patient who  presented with a cystic mass of the ankle.",Non-OADS,/arxiv_data1/oa_pdf/71/ef/alm-32-438.PMC3486940.pdf
Phaeohyphomycosis caused by Exophiala salmonis 439 http://dx.doi.org/10.3343/alm.2012.32.6.438 www.annlabmed.orgthe cystic mass.,Non-OADS,/arxiv_data1/oa_pdf/71/ef/alm-32-438.PMC3486940.pdf
Phaeohyphomycosis caused by Exophiala salmonis 440www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.438 We performed direct sequencing analysis of the internal tran- scribed spacer (ITS) region of the ribosomal DNA (rDNA) for  identification of the fungi upto the species level.,OADS,/arxiv_data1/oa_pdf/71/ef/alm-32-438.PMC3486940.pdf
Phaeohyphomycosis caused by Exophiala salmonis 441 http://dx.doi.org/10.3343/alm.2012.32.6.438 www.annlabmed.orgseptate hyphae with numerous annellides.,Non-OADS,/arxiv_data1/oa_pdf/71/ef/alm-32-438.PMC3486940.pdf
"ISSN 2234-3806  • eISSN 2234-3814  442www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.442Ann Lab Med 2012;32:442-444 http://dx.doi.org/10.3343/alm.2012.32.6.442Case Report Transfusion Medicine The First Korean Case Report of Anti-Gerbich  You La Jeon, M.D.1,4, Tae Sung Park, M.D.2, Sun Young Cho, M.D.2, Seung Hwan Oh, M.D.3, Myeong Hee Kim, M.D.4,  So Young Kang, M.D.4, and Woo-In Lee, M.D.4 Department of Medicine1, Kyung Hee University Graduate School Seoul; Department of Laboratory Medicine2, Kyung Hee University School of Medicine  Seoul; Department of Laboratory Medicine3, Inje University College of Medicine, Busan; Department of Laboratory Medicine4, Kyung Hee University Hospital  at Gangdong, Seoul, Korea In this study, we report the first Korean case of an anti-Gerbich (Ge) alloantibody to a high- incidence antigen that belongs to the Ge blood group system.",Non-OADS,/arxiv_data1/oa_pdf/bd/54/alm-32-442.PMC3486941.pdf
The first Korean case report of anti-Gerbich  443 http://dx.doi.org/10.3343/alm.2012.32.6.442 www.annlabmed.orging between the patient’s serum and the 5-unit B+ packed red  blood cells (RBCs) yielded incompatible results.,Non-OADS,/arxiv_data1/oa_pdf/bd/54/alm-32-442.PMC3486941.pdf
The first Korean case report of anti-Gerbich  444www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.442only to maternal anti-Ge3-mediated hemolysis but also to severe  hemolytic disease of the newborn (HDN) due to the phagocyto- sis of Ge-positive erythroid progenitors by monocytes [10].,Non-OADS,/arxiv_data1/oa_pdf/bd/54/alm-32-442.PMC3486941.pdf
"ISSN 2234-3806  • eISSN 2234-3814  445 http://dx.doi.org/10.3343/alm.2012.32.6.445 www.annlabmed.orgAnn Lab Med 2012;32:445-449 http://dx.doi.org/10.3343/alm.2012.32.6.445Case Report Diagnostic Genetics Additional Genomic Aberrations Identified by Single  Nucleotide Polymorphism Array-Based Karyotyping in an Acute Myeloid Leukemia Case with Isolated del(20q) Abnormality  Chorong Hahm, M.D.1, Yeung Chul Mun, M.D.2, Chu Myong Seong, M.D.2, Wha Soon Chung, M.D.1, and Jungwon Huh, M.D.1 Departments of Laboratory Medicine1 and Internal Medicine2, Ewha Womans University School of Medicine, Seoul, Korea Prognosis is known to be better in cases with isolated chromosomal abnormalities than in  those with complex karyotypes.",Non-OADS,/arxiv_data1/oa_pdf/26/37/alm-32-445.PMC3486942.pdf
"Additional aberrations in an AML case with isolated del(20q) 446www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.445 Recently, single nucleotide polymorphism array (SNP-A)- based karyotyping has been applied as a high-resolution whole- genome scanning tool.",OADS,/arxiv_data1/oa_pdf/26/37/alm-32-445.PMC3486942.pdf
"In order to detect the somatic ori- gin copy number alterations distinguished from constitutional  polymorphic copy number variants (CNVs), the lesions identi- fied using SNP-A were compared with the database of genomic  variants (http://projects.tcag.ca/variation/).",OADS,/arxiv_data1/oa_pdf/26/37/alm-32-445.PMC3486942.pdf
Additional aberrations in an AML case with isolated del(20q) 447 http://dx.doi.org/10.3343/alm.2012.32.6.445 www.annlabmed.orgtherapy with cytarabine (15 mg/m2).,Non-OADS,/arxiv_data1/oa_pdf/26/37/alm-32-445.PMC3486942.pdf
Additional aberrations in an AML case with isolated del(20q) 448www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.445tage during the AML transformation and may be associated with  a poor prognosis [7].,Non-OADS,/arxiv_data1/oa_pdf/26/37/alm-32-445.PMC3486942.pdf
Additional aberrations in an AML case with isolated del(20q) 449 http://dx.doi.org/10.3343/alm.2012.32.6.445 www.annlabmed.orgClonal selection of 11q CN-LOH and CBL gene mutation in a serially  studied patient during MDS progression to AML.,Non-OADS,/arxiv_data1/oa_pdf/26/37/alm-32-445.PMC3486942.pdf
"ISSN 2234-3806  • eISSN 2234-3814  450www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.450Ann Lab Med 2012;32:450-451 http://dx.doi.org/10.3343/alm.2012.32.6.450Letter to the Editor Diagnostic Hematology Hemoglobin Andrew-Minneapolis: Hemolytic   Erythrocytosis and Severe Iron Overload in Toxic Liver  Cirrhosis Berndt Zur, M.D., Birgit Stoffel-Wagner, M.D., and Michael Ludwig, Ph.D. Department of Clinical Chemistry and Clinical Pharmacology, The University of Bonn, Bonn, Germany We report this case involving a 50-yr-old man of Central Euro- pean descent who presented at our outpatient department with  psoriasis.",Non-OADS,/arxiv_data1/oa_pdf/93/23/alm-32-450.PMC3486943.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/23/alm-32-450.PMC3486943.pdf
"Hb Andrew-Minneapolis and iron overload 451 http://dx.doi.org/10.3343/alm.2012.32.6.450 www.annlabmed.orglow HbA1c levels because fasting glucose values were repeat- edly >200 mg/dL, and daily blood glucose levels were always  pathologically high.",Non-OADS,/arxiv_data1/oa_pdf/93/23/alm-32-450.PMC3486943.pdf
"ISSN 2234-3806  • eISSN 2234-3814  452www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.452Ann Lab Med 2012;32:452-454 http://dx.doi.org/10.3343/alm.2012.32.6.452Letter to the Editor Diagnostic Hematology Rare Frameshift Mutation Cys475Tyrfs*11 in the   BCR/ABL  Kinase Domain Contributes to Imatinib  Mesylate Resistance in 2 Korean Patients with Chronic   Myelogenous Leukemia Sang Hyuk Park, M.D., Hyun-Sook Chi, M.D., Mi-Ryang Kwon, M.D., Young-Uk Cho, M.D., Seongsoo Jang, M.D.,   and Chan-Jeoung Park, M.D.",Non-OADS,/arxiv_data1/oa_pdf/2d/84/alm-32-452.PMC3486944.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2d/84/alm-32-452.PMC3486944.pdf
"Cys475Tyrfs*11 in the BCR/ABL  kinase domain in CML  453 http://dx.doi.org/10.3343/alm.2012.32.6.452 www.annlabmed.org(forward: 5’-CAT CAT TCA ACG GTG GCC GAC GG-3’, reverse:  5’-GTT GCA CTC CCT CAG GTA GTC-3’), ABL-B (forward: 5’- GAA GAA ATA CAG CCT GAC GGT G-3’, reverse: 5’-CGT CGG  ACT TGA TGG AGA A-3’), and ABL-C (forward: 5’-TGA CAG  GGG ACA CCT ACA CA-3’, reverse: 5’-ATC TCA GGC ACG TCA  GTG GT-3’).",Non-OADS,/arxiv_data1/oa_pdf/2d/84/alm-32-452.PMC3486944.pdf
The identified mutation was described according to  the Human Gene Variation Society guidelines (http://www.hgvs.,Non-OADS,/arxiv_data1/oa_pdf/2d/84/alm-32-452.PMC3486944.pdf
Cys475Tyrfs*11 in the BCR/ABL  kinase domain in CML  454www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.452regimen is essential for the management of these patients.,Non-OADS,/arxiv_data1/oa_pdf/2d/84/alm-32-452.PMC3486944.pdf
http://www.sanger.,Non-OADS,/arxiv_data1/oa_pdf/2d/84/alm-32-452.PMC3486944.pdf
"ISSN 2234-3806  • eISSN 2234-3814  455 http://dx.doi.org/10.3343/alm.2012.32.6.455 www.annlabmed.orgAnn Lab Med 2012;32:455-456 http://dx.doi.org/10.3343/alm.2012.32.6.455Letter to the Editor Clinical Microbiology Prevalence of Seasonal Influenza Viruses and Pandemic  H1N1 Virus in Beijing from 2008 to 2012 Shujuan Cui, Ph.D.1, Lili Tian, Ph.D.1, Xiaomin Peng, M.D.1, Guilan Lu, Ph.D.1, Weixian Shi, Ph.D.1, Dongmei Meng, M.D.2,  and Quanyi Wang, Ph.D.1 Institute for Infectious Disease and Endemic Disease Control1, Beijing Center for Disease Prevention and Control, Beijing; Department of Pharmaceutical  Engineering2, Heze University, Shandong, China In northern China, influenza circulates on a seasonal and regu- lar basis during the winter-spring season [1].",Non-OADS,/arxiv_data1/oa_pdf/d2/4e/alm-32-455.PMC3486945.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/4e/alm-32-455.PMC3486945.pdf
"Prevalence of seasonal influenza viruses and pandemic H1N1 virus 456www.annlabmed.org http://dx.doi.org/10.3343/alm.2012.32.6.455period 1 to period 4, the positive prevalence rate of FluA(H1N1)  decreased sharply year by year (period 1, 8.12%; period 2, 2.9%;  period 3, 0.32%; and period 4, 0%), especially for period 4,  where no positive case of FluA(H1N1) was recorded.",Non-OADS,/arxiv_data1/oa_pdf/d2/4e/alm-32-455.PMC3486945.pdf
"For exam ple, although mutations at position +5  of the 5' -splicing donor site have  frequent ly been reported to  produce  a range of effects in various genes  [17-19], the iden- tified mutation in this case was not the clear cause of the  splic ing abnormalit ies based on an evaluation with  genomic  analysis  software (MutationTaster; http://www.mutation - taster.",Non-OADS,/arxiv_data1/oa_pdf/38/8f/TOCHGENJ-6-27.PMC3486960.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licen-ses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/8f/TOCHGENJ-6-27.PMC3486960.pdf
Available: http://www.dia- betesatlas.org/.,Non-OADS,/arxiv_data1/oa_pdf/67/a6/TOCMJ-6-126.PMC3486961.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/61/TODENTJ-6-170.PMC3486963.pdf
"EditorialAsia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2012.2.4.231 Asia Pac Allergy 2012;2:231-232 Implementation of guidelines, allergy programs,  and the October issue Yoon-Seok Chang* Division of Allergy and Clinical Immunology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National Uni - versity College of Medicine, Seongnam 463-802, Korea As the prevalence of allergic diseases such as asthma, allergic  rhinitis, and atopic dermatitis increased worldwide, the role  of not only allergy specialists but also general practitioners  has become more important.",Non-OADS,/arxiv_data1/oa_pdf/cb/69/apa-2-231.PMC3486965.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/cb/69/apa-2-231.PMC3486965.pdf
apallergy.orgChang YSAsia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.4.231 2323.1% (severe reactions: 0.02–0.04%) for low-osmolar ionic contrast  [6].,Non-OADS,/arxiv_data1/oa_pdf/cb/69/apa-2-231.PMC3486965.pdf
"Asia Pacific allergypISSN 2233-8276 · eISSN 2233-8268 Current Review http://dx.doi.org/10.5415/apallergy.2012.2.4.233 Asia Pac Allergy 2012;2:233-236 Management of allergic rhinitis in general    practitioners De Yun Wang* Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore For patients suffering from allergic rhinitis (AR), general  practitioners (GPs) are often their first source of medical advice.",Non-OADS,/arxiv_data1/oa_pdf/c0/df/apa-2-233.PMC3486966.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/c0/df/apa-2-233.PMC3486966.pdf
apallergy.orgWang DYAsia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.4.233 234physician’s management of AR patients in primary care practice is  still not fully understood due to a limited numbers of studies [4-12].,Non-OADS,/arxiv_data1/oa_pdf/c0/df/apa-2-233.PMC3486966.pdf
apallergy.orgAllergic rhinitis in general practitioners http://dx.doi.org/10.5415/apallergy.2012.2.4.233 235 a nominal fee.,Non-OADS,/arxiv_data1/oa_pdf/c0/df/apa-2-233.PMC3486966.pdf
"apallergy.orgWang DYAsia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.4.233 236Manuel S, Meltzer EO, Mohammad Y, Mullol J, Naclerio R, O’Hehir RE,  Ohta K, Ouedraogo S, Palkonen S, Papadopoulos N, Passalacqua G,  Pawankar R, Popov TA, Rabe KF, Rosado-Pinto J, Scadding GK, Simons  FE, Toskala E, Valovirta E, van Cauwenberge P , Wang DY, Wickman  M, Yawn BP , Yorgancioglu A, Yusuf OM, Zar H, Annesi-Maesano  I, Bateman ED, Ben Kheder A, Boakye DA, Bouchard J, Burney P ,  Busse WW, Chan-Yeung M, Chavannes NH, Chuchalin A, Dolen WK,  Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Keith  PK, Kemp JP , Klossek JM, Larenas-Linnemann D, Lipworth B, Malo  JL, Marshall GD, Naspitz C, Nekam K, Niggemann B, Nizankowska- Mogilnicka E, Okamoto Y, Orru MP , Potter P , Price D, Stoloff SW,  Vandenplas O, Viegi G, Williams D. Allergic Rhinitis and its Impact on  Asthma (ARIA) 2008 update.",Non-OADS,/arxiv_data1/oa_pdf/c0/df/apa-2-233.PMC3486966.pdf
Asia Pacific allergypISSN 2233-8276 · eISSN 2233-8268 Current Review http://dx.doi.org/10.5415/apallergy.2012.2.4.237 Asia Pac Allergy 2012;2:237-241 Eosinophilic esophagitis: which role for food and  inhalant allergens?,Non-OADS,/arxiv_data1/oa_pdf/49/9e/apa-2-237.PMC3486967.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/49/9e/apa-2-237.PMC3486967.pdf
"  apallergy.orgRidolo E, et al.Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.4.237 238conditions such as gastroesophageal reflux disease, parasitic  infections, and Crohn’s disease.",Non-OADS,/arxiv_data1/oa_pdf/49/9e/apa-2-237.PMC3486967.pdf
"apallergy.orgEosinophilic esophagitis: the role of allergens http://dx.doi.org/10.5415/apallergy.2012.2.4.237 239 by EoE associated with allergic rhinitis, bronchial asthma and  symptoms exacerbation during the pollen season, biopsies  obtained during the pollen season demonstrated moderate  to severe esophagus eosinophilic infiltration, while in winter  esophageal biopsies showed only a mild infiltrate in absence  of eosinophils [18].",Non-OADS,/arxiv_data1/oa_pdf/49/9e/apa-2-237.PMC3486967.pdf
"  apallergy.orgRidolo E, et al.Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.4.237 240of cases and a reduction in esophageal eosinophilic infiltration  from 55.8 ± 24.6 to 8.4 ± 8.4 eosinophils/HPF [28].",Non-OADS,/arxiv_data1/oa_pdf/49/9e/apa-2-237.PMC3486967.pdf
apallergy.orgEosinophilic esophagitis: the role of allergens http://dx.doi.org/10.5415/apallergy.2012.2.4.237 2417.,Non-OADS,/arxiv_data1/oa_pdf/49/9e/apa-2-237.PMC3486967.pdf
"Original ArticleAsia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2012.2.4.242 Asia Pac Allergy 2012;2:242-247 Immediate hypersensitivity reactions to IV non- ionic iodinated contrast in computed     tomography Jonathan Ho1, Roger J. Kingston1, Noel Young1,2,*, Constance H. Katelaris3, and Doungkamol Sindhusake2,4 1Department of Radiology, Centre for Biomedical Imaging Research and Development (CBIRD), Westmead Hospital, Darcy Road, Westmead,  NSW 2145, Australia 2University of Western Sydney, Campbelltown, NSW 2560, Australia 3University of Western Sydney and Campbelltown Hospital, Therry Road, Campbelltown, NSW 2560, Australia 4Department of Public Health and Community Medicine, Westmead Hospital, Westmead, NSW 2145, Australia Background: With use of computed tomography (CT), intravenous contrast media is used routinely to help define anatomy and  identify any pathology.",Non-OADS,/arxiv_data1/oa_pdf/38/c8/apa-2-242.PMC3486968.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/38/c8/apa-2-242.PMC3486968.pdf
"apallergy.orgReactions after iodinated IV contrast in CT http://dx.doi.org/10.5415/apallergy.2012.2.4.242 243 INTRODUCTION Some years ago non-ionic iodinated contrast agents largely  replaced ionic agents, due to their better safety profile, with an  immediate hypersensitivity reaction rate of 3.13% compared to  12% with ionics [1].",Non-OADS,/arxiv_data1/oa_pdf/38/c8/apa-2-242.PMC3486968.pdf
"Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.4.242 244Table 1 denotes the number of patients, and rates of reactions,  from the varied referral sources and by sex segregation.",Non-OADS,/arxiv_data1/oa_pdf/38/c8/apa-2-242.PMC3486968.pdf
apallergy.orgReactions after iodinated IV contrast in CT http://dx.doi.org/10.5415/apallergy.2012.2.4.242 245any mild urticaria or pruritis.,Non-OADS,/arxiv_data1/oa_pdf/38/c8/apa-2-242.PMC3486968.pdf
Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.4.242 246may be valuable in further evaluating this recorded phenomenon.,Non-OADS,/arxiv_data1/oa_pdf/38/c8/apa-2-242.PMC3486968.pdf
Available from: http://www.acr.org/~/media/ACR/Documents/ PDF/QualitySafety/Resources/Contrast%20Manual/ABCD%20 Approach%20for%20Patient%20Evaluation%20and%20Treatment.,Non-OADS,/arxiv_data1/oa_pdf/38/c8/apa-2-242.PMC3486968.pdf
Available from: http://www.cultureandrecreation.gov.au/articles/ weather/.,Non-OADS,/arxiv_data1/oa_pdf/38/c8/apa-2-242.PMC3486968.pdf
apallergy.orgReactions after iodinated IV contrast in CT http://dx.doi.org/10.5415/apallergy.2012.2.4.242 247in the occurrence of late adverse skin reactions to iodine-based  contrast media.,Non-OADS,/arxiv_data1/oa_pdf/38/c8/apa-2-242.PMC3486968.pdf
"Original ArticleAsia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2012.2.4.248 Asia Pac Allergy 2012;2:248-255 Differences in airway inflammation according to  atopic status in patients with chronic rhinitis Jae-Woo Kwon1,2,3, Tae-Wan Kim1,2, Kyung-Mook Kim1,2, Jae-Woo Jung1,2, Sang-Heon Cho1,2, Kyung-Up Min1,2,   You-Young Kim1,2, and Heung-Woo Park1,2,* 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea 2Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul 110-460, Korea 3Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam 463-707, Korea Background: Chronic rhinitis is a heterogeneous group of diseases that cause nasal inflammation.",Non-OADS,/arxiv_data1/oa_pdf/b3/93/apa-2-248.PMC3486969.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/b3/93/apa-2-248.PMC3486969.pdf
apallergy.orgAirway inflammation in various chronic rhinitis http://dx.doi.org/10.5415/apallergy.2012.2.4.248 249 co-morbidities are manifestations of one disease process which  affects different parts of the airway [1-3].,Non-OADS,/arxiv_data1/oa_pdf/b3/93/apa-2-248.PMC3486969.pdf
"Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.4.248 250GlaxoSmithKline, Brentford, UK), 4.5% hypertonic saline was  administered using an ultrasonic nebulizer at 4.5 mL/min (Omron  Co., Tokyo, Japan), and repeated up to four times at 5 min intervals  unless >10% fall in FEV1 occurred, in which induction procedure  was stopped.” And then sputum processing was performed as  previously described [15].",Non-OADS,/arxiv_data1/oa_pdf/b3/93/apa-2-248.PMC3486969.pdf
apallergy.orgAirway inflammation in various chronic rhinitis http://dx.doi.org/10.5415/apallergy.2012.2.4.248 251 without nasal polyposis ( p < 0.001).,Non-OADS,/arxiv_data1/oa_pdf/b3/93/apa-2-248.PMC3486969.pdf
Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.4.248 252Table 2.,Non-OADS,/arxiv_data1/oa_pdf/b3/93/apa-2-248.PMC3486969.pdf
"apallergy.orgAirway inflammation in various chronic rhinitis http://dx.doi.org/10.5415/apallergy.2012.2.4.248 253 nasal obstruction and rhinorrhea [16, 17].",Non-OADS,/arxiv_data1/oa_pdf/b3/93/apa-2-248.PMC3486969.pdf
Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.4.248 254evidence for asthma and rhinitis comorbidity.,Non-OADS,/arxiv_data1/oa_pdf/b3/93/apa-2-248.PMC3486969.pdf
apallergy.orgAirway inflammation in various chronic rhinitis http://dx.doi.org/10.5415/apallergy.2012.2.4.248 255 30.,Non-OADS,/arxiv_data1/oa_pdf/b3/93/apa-2-248.PMC3486969.pdf
"Original ArticleAsia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2012.2.4.256 Asia Pac Allergy 2012;2:256-263 Interferon-alpha inhibits airway eosinophila and  hyperresponsiveness in an animal asthma model Yasuko Kikkawa, Kumiya Sugiyama*, Kazuki Obara, Hirokuni Hirata, Yasutsugu Fukushima, Masao Toda,    and Takeshi Fukuda Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University, 880 Kita-kobayashi, Mibu, Tochigi 321-0293, Japan Background: Asthma is characterized by a chronic inflammatory process involving high numbers of inflammatory cells and mediators  which have multiple inflammatory effects on the airway.",Non-OADS,/arxiv_data1/oa_pdf/bb/2f/apa-2-256.PMC3486970.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/bb/2f/apa-2-256.PMC3486970.pdf
apallergy.orgIFN-α inhibits airway hyperresponsiveness http://dx.doi.org/10.5415/apallergy.2012.2.4.256 257 of eosinophils causes eosinophilic airway inflammation.,Non-OADS,/arxiv_data1/oa_pdf/bb/2f/apa-2-256.PMC3486970.pdf
Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.4.256 258with a 200 mesh screen was snugly applied to the face in order  to measure the flow rate.,Non-OADS,/arxiv_data1/oa_pdf/bb/2f/apa-2-256.PMC3486970.pdf
"apallergy.orgIFN-α inhibits airway hyperresponsiveness http://dx.doi.org/10.5415/apallergy.2012.2.4.256 259 cytometry for expression of CD11b, LFA-1a, and VLA4 before and  after PAF stimulation.",Non-OADS,/arxiv_data1/oa_pdf/bb/2f/apa-2-256.PMC3486970.pdf
"Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.4.256 2601 expression was inhibited dose-dependently by IFN-alpha ( p  < 0.01, p < 0.05).",Non-OADS,/arxiv_data1/oa_pdf/bb/2f/apa-2-256.PMC3486970.pdf
apallergy.orgIFN-α inhibits airway hyperresponsiveness http://dx.doi.org/10.5415/apallergy.2012.2.4.256 261  cells and the adherence of eosinophils to vascular endothelial  cells.,Non-OADS,/arxiv_data1/oa_pdf/bb/2f/apa-2-256.PMC3486970.pdf
Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.4.256 262increased and other signaling pathways in malignant diseases will  be constructed to be increased ICAM-1 expression by IFN-alpha  treatment.,Non-OADS,/arxiv_data1/oa_pdf/bb/2f/apa-2-256.PMC3486970.pdf
"apallergy.orgIFN-α inhibits airway hyperresponsiveness http://dx.doi.org/10.5415/apallergy.2012.2.4.256 263 J, Rizzetto M, Shouval D, Sola R, Terg RA, Yoshida EM, Adda N,  Bengtsson L, Sankoh AJ, Kieffer TL, George S, Kauffman RS, Zeuzem  S; ADVANCE Study Team.",OADS,/arxiv_data1/oa_pdf/bb/2f/apa-2-256.PMC3486970.pdf
"Original ArticleAsia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2012.2.4.264 Asia Pac Allergy 2012;2:264-268 Contribution of serum IL-4 and IgE to the early  prediction of horse serum allergies in guinea pigs Gui Nan Xiao* and Qing Ping Sun Department of Pharmacology and Toxicology, Guangdong Institute for Food and Drug Control, Guangzhou 510180, People’s Republic of China Background: Horse serum (HS) was a strong allergen for xenogeneic animals.",Non-OADS,/arxiv_data1/oa_pdf/56/a0/apa-2-264.PMC3486971.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/56/a0/apa-2-264.PMC3486971.pdf
"apallergy.orgIL4 and IgE in early prediction of drug allergy http://dx.doi.org/10.5415/apallergy.2012.2.4.264 265 long examination period (about 2-3 weeks) and more subjective  assessment index (including hair-pricking , shiveri ng, retching, etc.)",Non-OADS,/arxiv_data1/oa_pdf/56/a0/apa-2-264.PMC3486971.pdf
Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.4.264 266in a month  with  ELISA method followed by the instructions  manual .,Non-OADS,/arxiv_data1/oa_pdf/56/a0/apa-2-264.PMC3486971.pdf
apallergy.orgIL4 and IgE in early prediction of drug allergy http://dx.doi.org/10.5415/apallergy.2012.2.4.264 267   reactions after  challenged by injecting 10%HS or AFC once in d14  and d21 (Tab le 5).,OADS,/arxiv_data1/oa_pdf/56/a0/apa-2-264.PMC3486971.pdf
"Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.4.264 268of serum IL-4 and total IgE are more objective than subjective  phenomena of allergic reactions in guinea  pigs such as hair- pricking , coughing, sneezing , continuous coughing and so on .",Non-OADS,/arxiv_data1/oa_pdf/56/a0/apa-2-264.PMC3486971.pdf
"Asia Pacific allergypISSN 2233-8276 · eISSN 2233-8268 Hypothesis & Experience Original Article http://dx.doi.org/10.5415/apallergy.2012.2.4.269 Asia Pac Allergy 2012;2:269-274 Effect of bathing on atopic dermatitis during   the summer season Hakyoung Kim1, Jeongsuk Ban2, Mi-Ran Park2,3, Do-Soo Kim2,3, Hye-Young Kim4, Youngshin Han2,3, Kangmo Ahn2,3,  and Jihyun Kim2,3,* 1Department of Pediatrics, Chung-Ang University College of Medicine, Seoul 156-861, Korea 2Environmental Health Center for Atopic Diseases, Samsung Medical Center, Seoul 135-710, Korea 3Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135-710, Korea 4Department of Pediatircs, Medical Research Institute, Pusan National University College of Medicine, Busan 602-739, Korea Background: There are little objective data regarding the optimal practice methods of bathing, although bathing and the use of  moisturizers are the most important facets to atopic dermatitis (AD) management.",Non-OADS,/arxiv_data1/oa_pdf/0b/d2/apa-2-269.PMC3486972.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/0b/d2/apa-2-269.PMC3486972.pdf
"Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.4.269 270    care such as proper application of moisturizers and bathing/ showers [2, 4, 7 , 8].",Non-OADS,/arxiv_data1/oa_pdf/0b/d2/apa-2-269.PMC3486972.pdf
"apallergy.orgBathing and atopic dermatitis http://dx.doi.org/10.5415/apallergy.2012.2.4.269 271information was not recorded or who applied moisturizers less  than once a day, 81 patients (48 boys and 33 girls) completed this  study.",Non-OADS,/arxiv_data1/oa_pdf/0b/d2/apa-2-269.PMC3486972.pdf
Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.4.269 272     that the use of moisturizers had less of an effect on the study  results because humidity is high during the summer months.,Non-OADS,/arxiv_data1/oa_pdf/0b/d2/apa-2-269.PMC3486972.pdf
"apallergy.orgBathing and atopic dermatitis http://dx.doi.org/10.5415/apallergy.2012.2.4.269 273previous reports about the need for the use of weakly acidic soap,  in terms of skin barrier disruption of AD [10, 11].",Non-OADS,/arxiv_data1/oa_pdf/0b/d2/apa-2-269.PMC3486972.pdf
Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.4.269 274in disease knowledge through an education program of atopic  dermatitis.,Non-OADS,/arxiv_data1/oa_pdf/0b/d2/apa-2-269.PMC3486972.pdf
Available from: http://www.nice.org.uk/CG057.,Non-OADS,/arxiv_data1/oa_pdf/0b/d2/apa-2-269.PMC3486972.pdf
"Asia Pacific allergypISSN 2233-8276 · eISSN 2233-8268 Educational & Teaching Material Review http://dx.doi.org/10.5415/apallergy.2012.2.4.275 Asia Pac Allergy 2012;2:275-279 The Finnish Allergy Programme 2008-2018     - scientific rationale and practical implementation Tari Haahtela*, Erkka Valovirta, Paula Kauppi, Erja Tommila, Kimmo Saarinen, Leena von Hertzen, Mika J. Mäkelä,    and the Finnish Allergy Programme Group Skin and Allergy Hospital, Helsinki University Hospital, 00029 HUCH, Helsinki, Finland There are no nationwide, comprehensive public health programmes on allergic disorders with set goals and systematic follow-up.",Non-OADS,/arxiv_data1/oa_pdf/ab/7e/apa-2-275.PMC3486973.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/ab/7e/apa-2-275.PMC3486973.pdf
"apallergy.orgHaahtela T, et al.Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.4.275 276    Recent results from North Karelian teenagers have prompted the  so called biodiversity hypothesis, which enlarges the hygiene-  and microbial deprivation hypotheses by taking into account the  interrelationships of three DNA compartments: human cells, skin- mucosal microbiomes and environmental microbiomes [1-3].",Non-OADS,/arxiv_data1/oa_pdf/ab/7e/apa-2-275.PMC3486973.pdf
apallergy.orgThe Finnish Allergy Programme 2008-2018 http://dx.doi.org/10.5415/apallergy.2012.2.4.275 277active treatment has been taken.,Non-OADS,/arxiv_data1/oa_pdf/ab/7e/apa-2-275.PMC3486973.pdf
"apallergy.orgHaahtela T, et al.Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.4.275 278    (GINA) [17], and WHO/GARD (Global Alliance against Chronic  Respiratory Diseases).",OADS,/arxiv_data1/oa_pdf/ab/7e/apa-2-275.PMC3486973.pdf
"apallergy.orgThe Finnish Allergy Programme 2008-2018 http://dx.doi.org/10.5415/apallergy.2012.2.4.275 279 C, Worm M, Wright J, Zuberbier T. MeDALL (Mechanisms of the  Development of ALLergy): an integrated approach from phenotypes  to systems medicine.",Non-OADS,/arxiv_data1/oa_pdf/ab/7e/apa-2-275.PMC3486973.pdf
"Case ReportAsia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2012.2.4.280 Asia Pac Allergy 2012;2:280-282 Biphasic anaphylaxis to gemifloxacin İnsu Yilmaz1,*, Serkan Doğan2, Nuri Tutar1, Asiye Kanbay1, Hakan Büyükoğlan1, and Ramazan Demir1 1Department of Chest Diseases, Faculty of Medicine, Erciyes University, Kayseri 38030, Turkey 2Department of Gastroenterology, Faculty of Medicine, Erciyes University, Kayseri 38030, Turkey Anaphylaxis have been documented as adverse effects of ciprofloxacin, ofloxacin, norfloxacin, levofloxacin, and moxifloxacin.",Non-OADS,/arxiv_data1/oa_pdf/89/d2/apa-2-280.PMC3486974.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/89/d2/apa-2-280.PMC3486974.pdf
apallergy.orgGemifloxacin anaphylaxis http://dx.doi.org/10.5415/apallergy.2012.2.4.280 281 were administered.,Non-OADS,/arxiv_data1/oa_pdf/89/d2/apa-2-280.PMC3486974.pdf
Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2012.2.4.280 282Ther 2000;22:798-817.,Non-OADS,/arxiv_data1/oa_pdf/89/d2/apa-2-280.PMC3486974.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/e7/dmj-36-317.PMC3486977.pdf
"Copyright © 2012 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2012;36:317-327 Clinical Relevance of Adipokines Matthias Blüher Department of Medicine, University of Leipzig, Leipzig, Germany The incidence of obesity has increased dramatically during recent decades.",Non-OADS,/arxiv_data1/oa_pdf/51/e7/dmj-36-317.PMC3486977.pdf
Review Obesity and Metabolic Syndrome http://dx.doi.org/10.4093/dmj.2012.36.5.317 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/51/e7/dmj-36-317.PMC3486977.pdf
"318Blüher M Diabetes Metab J 2012;36:317-327 http://e-dmj.org Since then, the search for novel adipokines, but more impor - tantly the molecular characterization of newly identified adi - pokines with unknown function represents a major topic in  obesity research.",Non-OADS,/arxiv_data1/oa_pdf/51/e7/dmj-36-317.PMC3486977.pdf
319Clinical relevance of adipokines Diabetes Metab J 2012;36:317-327 http://e-dmj.org 1α) [3-5].,Non-OADS,/arxiv_data1/oa_pdf/51/e7/dmj-36-317.PMC3486977.pdf
320Blüher M Diabetes Metab J 2012;36:317-327 http://e-dmj.org [36].,Non-OADS,/arxiv_data1/oa_pdf/51/e7/dmj-36-317.PMC3486977.pdf
321Clinical relevance of adipokines Diabetes Metab J 2012;36:317-327 http://e-dmj.org fashion [15].,Non-OADS,/arxiv_data1/oa_pdf/51/e7/dmj-36-317.PMC3486977.pdf
"322Blüher M Diabetes Metab J 2012;36:317-327 http://e-dmj.org of different mouse models with recombinant vaspin leads to  sustained glucose lowering and reduction of food intake [48],  suggesting vaspin as a treatment target for future pharmaco - logical therapies of obesity and its related metabolic diseases.",Non-OADS,/arxiv_data1/oa_pdf/51/e7/dmj-36-317.PMC3486977.pdf
"323Clinical relevance of adipokines Diabetes Metab J 2012;36:317-327 http://e-dmj.org centrations are associated with obesity, insulin resistance, and  abdominal fat distribution [14,51].",Non-OADS,/arxiv_data1/oa_pdf/51/e7/dmj-36-317.PMC3486977.pdf
324Blüher M Diabetes Metab J 2012;36:317-327 http://e-dmj.org obesity related disorders including impaired insulin sensitivity  is not necessarily directly related to fat mass.,Non-OADS,/arxiv_data1/oa_pdf/51/e7/dmj-36-317.PMC3486977.pdf
"325Clinical relevance of adipokines Diabetes Metab J 2012;36:317-327 http://e-dmj.org A, Y akar S. Obesity and type 2 diabetes are associated with an  increased risk of developing cancer and a worse prognosis: ep - idemiological and mechanistic evidence.",Non-OADS,/arxiv_data1/oa_pdf/51/e7/dmj-36-317.PMC3486977.pdf
326Blüher M Diabetes Metab J 2012;36:317-327 http://e-dmj.org 27.,Non-OADS,/arxiv_data1/oa_pdf/51/e7/dmj-36-317.PMC3486977.pdf
327Clinical relevance of adipokines Diabetes Metab J 2012;36:317-327 http://e-dmj.org and metabolomic profiling of serum reveals association of the  complement system with obesity and identifies novel markers  of body fat mass changes.,Non-OADS,/arxiv_data1/oa_pdf/51/e7/dmj-36-317.PMC3486977.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/04/dmj-36-328.PMC3486978.pdf
"Copyright © 2012 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2012;36:328-335 Transcriptional Regulation of Pyruvate Dehydrogenase  Kinase Ji Yun Jeong1, Nam Ho Jeoung2, Keun-Gyu Park1, In-Kyu Lee1 1Department of Internal Medicine, Kyungpook National University School of Medicine, 2Department of Fundamental Medical & Pharmaceutical Sciences, Catholic University of Daegu, Daegu, Korea The pyruvate dehydrogenase complex (PDC) activity is crucial to maintains blood glucose and ATP levels, which largely depends  on the phosphorylation status by pyruvate dehydrogenase kinase (PDK) isoenzymes.",Non-OADS,/arxiv_data1/oa_pdf/b6/04/dmj-36-328.PMC3486978.pdf
"Four PDK isoenzymes (PDK1, 2, 3, and 4) are known to be Review Pathophysiology http://dx.doi.org/10.4093/dmj.2012.36.5.328 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/b6/04/dmj-36-328.PMC3486978.pdf
329Transcriptional regulation of pyruvate dehydrogenase kinase  Diabetes Metab J 2012;36:328-335 http://e-dmj.org expressed in a tissue-specific manner in mammals.,Non-OADS,/arxiv_data1/oa_pdf/b6/04/dmj-36-328.PMC3486978.pdf
"Diabetes Metab J 2012;36:328-335 http://e-dmj.org C2C12 cells, which facilitates fatty acid uptake in muscle, in - duced FOXO1 expression, thereby contributing to the up-reg - ulation of muscle PDK4 expression.",Non-OADS,/arxiv_data1/oa_pdf/b6/04/dmj-36-328.PMC3486978.pdf
331Transcriptional regulation of pyruvate dehydrogenase kinase  Diabetes Metab J 2012;36:328-335 http://e-dmj.org increase in PDK4 expression by interrupting the binding be - tween FOXO and the IRE [9].,Non-OADS,/arxiv_data1/oa_pdf/b6/04/dmj-36-328.PMC3486978.pdf
Diabetes Metab J 2012;36:328-335 http://e-dmj.org ing fasting and participates in preventing hypoglycemia.,Non-OADS,/arxiv_data1/oa_pdf/b6/04/dmj-36-328.PMC3486978.pdf
333Transcriptional regulation of pyruvate dehydrogenase kinase  Diabetes Metab J 2012;36:328-335 http://e-dmj.org in adipose tissue only in HFD rats.,Non-OADS,/arxiv_data1/oa_pdf/b6/04/dmj-36-328.PMC3486978.pdf
Diabetes Metab J 2012;36:328-335 http://e-dmj.org creased insulin sensitivity in postobese patients.,Non-OADS,/arxiv_data1/oa_pdf/b6/04/dmj-36-328.PMC3486978.pdf
335Transcriptional regulation of pyruvate dehydrogenase kinase  Diabetes Metab J 2012;36:328-335 http://e-dmj.org 29.,Non-OADS,/arxiv_data1/oa_pdf/b6/04/dmj-36-328.PMC3486978.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/8c/dmj-36-336.PMC3486979.pdf
"Copyright © 2012 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2012;36:336-344 Management of Type 2 Diabetes Mellitus in Older  Adults Kyung Soo Kim1, Soo Kyung Kim1, Kyung Mi Sung2, Y ong Wook Cho1, Seok Won Park1 1Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam,  2College of Nursing & Institute of Health Sciences, Gyeongsang National University, Jinju, Korea In the near future, the majority of patients with diabetes will be adults aged 65 or older.",Non-OADS,/arxiv_data1/oa_pdf/28/8c/dmj-36-336.PMC3486979.pdf
"PHYSICAL FRAILTY IN OLDER ADULTS  WITH DIABETES Physical disability In older adults with diabetes, risks of disabilities related to mo - bility and daily tasks are increased by two-fold over those with -Review Clinical Care http://dx.doi.org/10.4093/dmj.2012.36.5.336 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/28/8c/dmj-36-336.PMC3486979.pdf
337Management of elderly diabetes Diabetes Metab J 2012;36:336-344 http://e-dmj.org out diabetes [5].,Non-OADS,/arxiv_data1/oa_pdf/28/8c/dmj-36-336.PMC3486979.pdf
"Diabetes Metab J 2012;36:336-344 http://e-dmj.org Approximately 30% of people with diabetes have depressive  symptomatology, 10% have major depression, and recent stud - ies have shown that people with diabetes have two-fold in - creased odds of depression compared with individuals without  diabetes [22-25].",Non-OADS,/arxiv_data1/oa_pdf/28/8c/dmj-36-336.PMC3486979.pdf
339Management of elderly diabetes Diabetes Metab J 2012;36:336-344 http://e-dmj.org tion rate (eGFR) of less than 30 mL/min.,Non-OADS,/arxiv_data1/oa_pdf/28/8c/dmj-36-336.PMC3486979.pdf
Diabetes Metab J 2012;36:336-344 http://e-dmj.org [36].,Non-OADS,/arxiv_data1/oa_pdf/28/8c/dmj-36-336.PMC3486979.pdf
341Management of elderly diabetes Diabetes Metab J 2012;36:336-344 http://e-dmj.org to edema.,Non-OADS,/arxiv_data1/oa_pdf/28/8c/dmj-36-336.PMC3486979.pdf
Diabetes Metab J 2012;36:336-344 http://e-dmj.org rea National Health and Nutrition Examination Survey  (KNHANES V-1).,Non-OADS,/arxiv_data1/oa_pdf/28/8c/dmj-36-336.PMC3486979.pdf
Available from: http://knhanes.cdc.go.kr  (updated 2012 Jan 5).,OADS,/arxiv_data1/oa_pdf/28/8c/dmj-36-336.PMC3486979.pdf
Available from: http://www.cdc.gov/diabetes/ pubs/pdf/ndfs_2011.pdf (updated 2012 Jan 10).,Non-OADS,/arxiv_data1/oa_pdf/28/8c/dmj-36-336.PMC3486979.pdf
"343Management of elderly diabetes Diabetes Metab J 2012;36:336-344 http://e-dmj.org A, Poulter N, Travert F, Woodward M; ADV ANCE Collabora - tive Group.",Non-OADS,/arxiv_data1/oa_pdf/28/8c/dmj-36-336.PMC3486979.pdf
Diabetes Metab J 2012;36:336-344 http://e-dmj.org tes mellitus compared to sulfonylurea.,Non-OADS,/arxiv_data1/oa_pdf/28/8c/dmj-36-336.PMC3486979.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/af/dmj-36-345.PMC3486980.pdf
"Copyright © 2012 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2012;36:345-349 C-Peptide and Vascular Complications in Type 2  Diabetic Subjects Seok Man Son Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, Korea Corresponding author:  Seok Man Son Department of Internal Medicine, Pusan National University School of  Medicine, and Diabetes Center and Endocrine Clinic, Pusan National  University Yangsan Hospital, 20 Geumo-ro, Mulgeum-eup,Yangsan 626-770,  Korea E-mail: sonsm@pusan.ac.krC-peptide is a small peptide comprised of 31 amino acids, with  a short half-life of approximately 30 minutes.",Non-OADS,/arxiv_data1/oa_pdf/48/af/dmj-36-345.PMC3486980.pdf
Some groups Editorial Complications http://dx.doi.org/10.4093/dmj.2012.36.5.345 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/48/af/dmj-36-345.PMC3486980.pdf
346Son SM Diabetes Metab J 2012;36:345-349 http://e-dmj.org have shown that C-peptide administration in type 1 diabetes  results in amelioration of diabetes-induced renal and nerve  dysfunction.,Non-OADS,/arxiv_data1/oa_pdf/48/af/dmj-36-345.PMC3486980.pdf
"347C-peptide and diabetic vascular diseases Diabetes Metab J 2012;36:345-349 http://e-dmj.org C-peptide also co-localizes with VSMCs in the media of early  arteriosclerotic lesions in some diabetic subjects, it has been  suggested that C-peptide could also exhibit biological activity  in these cells [34].",Non-OADS,/arxiv_data1/oa_pdf/48/af/dmj-36-345.PMC3486980.pdf
348Son SM Diabetes Metab J 2012;36:345-349 http://e-dmj.org 11.,Non-OADS,/arxiv_data1/oa_pdf/48/af/dmj-36-345.PMC3486980.pdf
349C-peptide and diabetic vascular diseases Diabetes Metab J 2012;36:345-349 http://e-dmj.org 34.,Non-OADS,/arxiv_data1/oa_pdf/48/af/dmj-36-345.PMC3486980.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/51/dmj-36-350.PMC3486981.pdf
"Copyright © 2012 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2012;36:350-356 The Association of Self-Reported Coronary Heart  Disease with Diabetes Duration in Korea  Hye Mi Kang, Yun Jeong Lee, Dong-Jun Kim Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea  Background:  This study aimed to investigate the association of diabetes duration with self-reported coronary heart disease (CHD)  in Korea.",Non-OADS,/arxiv_data1/oa_pdf/53/51/dmj-36-350.PMC3486981.pdf
"Diabetes duration could  be an important determinant for CHD in T2DM, as a longer  duration of diabetes is associated with an increased risk of Original Article Epidemiology http://dx.doi.org/10.4093/dmj.2012.36.5.350 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/53/51/dmj-36-350.PMC3486981.pdf
351Coronary heart disease and diabetes duration Diabetes Metab J 2012;36:350-356 http://e-dmj.org CVD [11-15].,Non-OADS,/arxiv_data1/oa_pdf/53/51/dmj-36-350.PMC3486981.pdf
Diabetes Metab J 2012;36:350-356 http://e-dmj.org the increase in diabetes duration.,Non-OADS,/arxiv_data1/oa_pdf/53/51/dmj-36-350.PMC3486981.pdf
"353Coronary heart disease and diabetes duration Diabetes Metab J 2012;36:350-356 http://e-dmj.org CHD risk factors, this increasing CHD trend was unchanged.",Non-OADS,/arxiv_data1/oa_pdf/53/51/dmj-36-350.PMC3486981.pdf
Diabetes Metab J 2012;36:350-356 http://e-dmj.org those of non-diabetes after adjusting for several risk factors.,Non-OADS,/arxiv_data1/oa_pdf/53/51/dmj-36-350.PMC3486981.pdf
355Coronary heart disease and diabetes duration Diabetes Metab J 2012;36:350-356 http://e-dmj.org [25] reported the relationship between coronary arterial lesion  on coronary angiogram and clinical CHD risk factors.,OADS,/arxiv_data1/oa_pdf/53/51/dmj-36-350.PMC3486981.pdf
Diabetes Metab J 2012;36:350-356 http://e-dmj.org heart disease mortality.,Non-OADS,/arxiv_data1/oa_pdf/53/51/dmj-36-350.PMC3486981.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/a1/dmj-36-357.PMC3486982.pdf
"Copyright © 2012 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2012;36:357-363 Cardio-Metabolic Features of Type 2 Diabetes Subjects  Discordant in the Diagnosis of Metabolic Syndrome  Sa Rah Lee1, Ying Han2, Ja Won Kim3, Ja Y oung Park4, Ji Min Kim5, Sunghwan Suh6, Mi-Kyoung Park7, Hye-Jeong Lee8,  Duk Kyu Kim7 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Sevrance-Uva Surgical Hospital, Busan, 2Department of Medicine, Dong-A University Graduate School, Busan, 3Department of Medicine, Ulsan University Hospital, Ulsan, 4Department of Medicine, Busan St. Mary’s Medical Center, Busan, 5Department of Medicine, Hanseo Hospital, Busan, 6Division of Endocrinology & Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 7Division of Endocrinology and Metabolism, Department of Internal Medicine, 8Department of Pharmacology, Dong-A University College of Medicine, Busan,  Korea Background:  The aim of this study is to investigate the cardio-metabolic parameters and surrogate markers of insulin resistance  in a discordant group of type 2 diabetes (T2DM) subjects who satisfy the Adults Treatment Panel (ATP) III criteria, but not the  International Diabetes Federation (IDF) criteria, for metabolic syndrome (MetS).",Non-OADS,/arxiv_data1/oa_pdf/1f/a1/dmj-36-357.PMC3486982.pdf
Ethnicity-specific waist circumference (WC) cut-off points Original Article Obesity and Metabolic Syndrome http://dx.doi.org/10.4093/dmj.2012.36.5.357 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/1f/a1/dmj-36-357.PMC3486982.pdf
Diabetes Metab J 2012;36:357-363 http://e-dmj.org were incorporated into the International Diabetes Federation  (IDF) new definition of MetS in 2005 [8].,Non-OADS,/arxiv_data1/oa_pdf/1f/a1/dmj-36-357.PMC3486982.pdf
"359Cardio-metabolic features of T2DM discordant group of mets Diabetes Metab J 2012;36:357-363 http://e-dmj.org nicians using a Siemens-Acuson SEQUOIA 512 (Siemens, Er - langen, Germany).",Non-OADS,/arxiv_data1/oa_pdf/1f/a1/dmj-36-357.PMC3486982.pdf
"Diabetes Metab J 2012;36:357-363 http://e-dmj.org RESULTS Prevalence of MetS and the discordant group The prevalence of MetS in the MetS a group was 73.6%, with  68.2% using the KSSO WC cut-off (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/1f/a1/dmj-36-357.PMC3486982.pdf
"361Cardio-metabolic features of T2DM discordant group of mets Diabetes Metab J 2012;36:357-363 http://e-dmj.org for men and 80 cm for women; however, the KSSO proposed  WC cut-off values of 90 cm for men and 85 cm for women  [14,19].",Non-OADS,/arxiv_data1/oa_pdf/1f/a1/dmj-36-357.PMC3486982.pdf
Diabetes Metab J 2012;36:357-363 http://e-dmj.org metabolic syndrome criteria on cardiovascular disease risk in  people with newly diagnosed type 2 diabetes.,Non-OADS,/arxiv_data1/oa_pdf/1f/a1/dmj-36-357.PMC3486982.pdf
363Cardio-metabolic features of T2DM discordant group of mets Diabetes Metab J 2012;36:357-363 http://e-dmj.org 23.,Non-OADS,/arxiv_data1/oa_pdf/1f/a1/dmj-36-357.PMC3486982.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/3b/dmj-36-364.PMC3486983.pdf
"Copyright © 2012 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2012;36:364-370 Effects of a 6-Month Exenatide Therapy on HbA1c and  Weight in Korean Patients with Type 2 Diabetes:   A Retrospective Cohort Study Juyoung Shin, Jin-Sun Chang, Hun-Sung Kim, Sun-Hee Ko, Bong-Yun Cha, Ho-Y oung Son, Kun-Ho Y oon, Jae-Hyoung Cho Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea Background:  While many studies have shown the good efficacy and safety of exenatide in patients with diabetes, limited infor - mation is available about exenatide in clinical practice in Korean populations.",Non-OADS,/arxiv_data1/oa_pdf/56/3b/dmj-36-364.PMC3486983.pdf
"Therefore, clinicians have turned their attention to exenatide.Original Article Clinical Care/Education http://dx.doi.org/10.4093/dmj.2012.36.5.364 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/56/3b/dmj-36-364.PMC3486983.pdf
"365The effectiveness of exenatide in Koreans Diabetes Metab J 2012;36:364-370 http://e-dmj.org  Although many exenatide studies have shown good efficacy  and safety in diabetic patients, limited information is available  from real clinical practice in Korea.",Non-OADS,/arxiv_data1/oa_pdf/56/3b/dmj-36-364.PMC3486983.pdf
"Diabetes Metab J 2012;36:364-370 http://e-dmj.org enatide monotherapy for treatment naive patients, n=9/52),  group 2 (addition of exenatide to ongoing OHA treatment,  n=12/52), group 3 (substitution of exenatide for one kind of  OHA, n=23/52), and group 4 (addition of exenatide and OHAs,  n=8/52).",Non-OADS,/arxiv_data1/oa_pdf/56/3b/dmj-36-364.PMC3486983.pdf
"367The effectiveness of exenatide in Koreans Diabetes Metab J 2012;36:364-370 http://e-dmj.org mean values for HbA1c and FBG, while they had the lowest  mean value for age.",Non-OADS,/arxiv_data1/oa_pdf/56/3b/dmj-36-364.PMC3486983.pdf
"Diabetes Metab J 2012;36:364-370 http://e-dmj.org indicated by the linear model of the regression analysis ( β= -0.896, P<0.001) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/56/3b/dmj-36-364.PMC3486983.pdf
"369The effectiveness of exenatide in Koreans Diabetes Metab J 2012;36:364-370 http://e-dmj.org monotherapy or combined therapy with OHAs including met - formin, sulfonylurea, and thiazolidinedione.",Non-OADS,/arxiv_data1/oa_pdf/56/3b/dmj-36-364.PMC3486983.pdf
Diabetes Metab J 2012;36:364-370 http://e-dmj.org year follow-up of intensive glucose control in type 2 diabetes.,Non-OADS,/arxiv_data1/oa_pdf/56/3b/dmj-36-364.PMC3486983.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/76/01/dmj-36-371.PMC3486984.pdf
"Copyright © 2012 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2012;36:371-378 The Risk of Bladder Cancer in Korean Diabetic Subjects  Treated with Pioglitazone  Sun Ok Song*, Kwang Joon Kim*, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee Division of Endocrinology and Metabolism, Department of Internal Medicine, Severance Hospital, Y onsei University College of Medicine, Seoul, Korea Background:  There is growing concern regarding the increased incidence of bladder cancer in diabetic patients using pioglitazone.",Non-OADS,/arxiv_data1/oa_pdf/76/01/dmj-36-371.PMC3486984.pdf
"There are numerous ethnic and cultural differences between  Korean populations and Caucasian populations, including dif -Original Article Complications http://dx.doi.org/10.4093/dmj.2012.36.5.371 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/76/01/dmj-36-371.PMC3486984.pdf
Diabetes Metab J 2012;36:371-378 http://e-dmj.org ferences in medical milieu.,Non-OADS,/arxiv_data1/oa_pdf/76/01/dmj-36-371.PMC3486984.pdf
"373Effects of pioglitazone on bladder cancer risks in Korea Diabetes Metab J 2012;36:371-378 http://e-dmj.org Of these 507 subjects, 178 were excluded, leaving 329 patients  who fulfilled the aforementioned criteria for final inclusion in  the study.",Non-OADS,/arxiv_data1/oa_pdf/76/01/dmj-36-371.PMC3486984.pdf
"Diabetes Metab J 2012;36:371-378 http://e-dmj.org 0.001), smoking (64.1% vs. 11.7%, P<0.001), and proportions  of other coexisting cancers (11.0% vs. 2.0%, P<0.001) were  significantly higher in the case group than in the control group.",Non-OADS,/arxiv_data1/oa_pdf/76/01/dmj-36-371.PMC3486984.pdf
"375Effects of pioglitazone on bladder cancer risks in Korea Diabetes Metab J 2012;36:371-378 http://e-dmj.org  According to the Korean Central Cancer Registry (KCCR)  [13], the age-standardized rate (ASR) of bladder cancer in Ko - rea decreased between 2004 and 2008; the ASRs of bladder  cancer across both genders for 2004, 2005, 2006, 2007, and  2008 were 5.2, 5.2, 5.0, 5.0, and 4.9/100,000, respectively.",OADS,/arxiv_data1/oa_pdf/76/01/dmj-36-371.PMC3486984.pdf
Diabetes Metab J 2012;36:371-378 http://e-dmj.org center.,Non-OADS,/arxiv_data1/oa_pdf/76/01/dmj-36-371.PMC3486984.pdf
Available from: http://ncc.re.kr/manage/man -,Non-OADS,/arxiv_data1/oa_pdf/76/01/dmj-36-371.PMC3486984.pdf
377Effects of pioglitazone on bladder cancer risks in Korea Diabetes Metab J 2012;36:371-378 http://e-dmj.org age03_033_view.jsp?bbsnum=209&hSelSearch=&hTxtKeywo rd=&current_page=1&cd=null (updated 2010 Dec 28).,OADS,/arxiv_data1/oa_pdf/76/01/dmj-36-371.PMC3486984.pdf
Diabetes Metab J 2012;36:371-378 http://e-dmj.org Supplementary Fig.,Non-OADS,/arxiv_data1/oa_pdf/76/01/dmj-36-371.PMC3486984.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f0/99/dmj-36-379.PMC3486985.pdf
"Copyright © 2012 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2012;36:379-387 Correlations between Glucagon Stimulated C-peptide  Levels and Microvascular Complications in Type 2  Diabetes Patients Hye-Jin Y oon1, Y oun-Zoo Cho1, Ji-young Kim1, Byung-Joon Kim1, Keun-Y oung Park1, Gwan-Pyo Koh2, Dae-Ho Lee2,  Dong-Mee Lim1  1Division of Endocrinology and Metabolism, Konyang University Hospital, Konyang University College of Medicine, Daejeon,  2Division of Endocrinology and Metabolism, Jeju National University Hospital, Jeju National University College of Medicine, Jeju, Korea Background:  This study aimed to investigate whether stimulated C-peptide is associated with microvascular complications in  type 2 diabetes mellitus (DM).",Non-OADS,/arxiv_data1/oa_pdf/f0/99/dmj-36-379.PMC3486985.pdf
"According to recent studies, however, C-peptide has  been considered an active peptide hormone with an important  physiologic function and an intracellular signaling function Original Article Complications http://dx.doi.org/10.4093/dmj.2012.36.5.379 pISSN 2233-6079 · eISSN 2233-6087",Non-OADS,/arxiv_data1/oa_pdf/f0/99/dmj-36-379.PMC3486985.pdf
Diabetes Metab J 2012;36:379-387 http://e-dmj.org [3].,Non-OADS,/arxiv_data1/oa_pdf/f0/99/dmj-36-379.PMC3486985.pdf
"381C-peptide and microvascular complication Diabetes Metab J 2012;36:379-387 http://e-dmj.org peptide, respectively).",Non-OADS,/arxiv_data1/oa_pdf/f0/99/dmj-36-379.PMC3486985.pdf
Diabetes Metab J 2012;36:379-387 http://e-dmj.org Table 1.,Non-OADS,/arxiv_data1/oa_pdf/f0/99/dmj-36-379.PMC3486985.pdf
"383C-peptide and microvascular complication Diabetes Metab J 2012;36:379-387 http://e-dmj.org cally significant association between microvascular complica - tions and C-peptide groups (basal C-peptide, ΔC-peptide),  which was likely because of the small-sized groups involved in  our study.",Non-OADS,/arxiv_data1/oa_pdf/f0/99/dmj-36-379.PMC3486985.pdf
"Diabetes Metab J 2012;36:379-387 http://e-dmj.org with nephropathy prevalence, which was statistically signifi - cant (stimulated C-peptide: -2.17, P=0.03) (Table 6).",Non-OADS,/arxiv_data1/oa_pdf/f0/99/dmj-36-379.PMC3486985.pdf
"385C-peptide and microvascular complication Diabetes Metab J 2012;36:379-387 http://e-dmj.org C-peptide, high ΔC-peptide).",Non-OADS,/arxiv_data1/oa_pdf/f0/99/dmj-36-379.PMC3486985.pdf
Diabetes Metab J 2012;36:379-387 http://e-dmj.org reactivity was revealed to be associated with diabetic microan - giopathy [21].,Non-OADS,/arxiv_data1/oa_pdf/f0/99/dmj-36-379.PMC3486985.pdf
387C-peptide and microvascular complication Diabetes Metab J 2012;36:379-387 http://e-dmj.org C-Peptide in the regulation of microvascular blood flow.,Non-OADS,/arxiv_data1/oa_pdf/f0/99/dmj-36-379.PMC3486985.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e1/d7/dmj-36-388.PMC3486986.pdf
"Copyright © 2012 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2012;36:388-389 Balsamic Vinegar Improves High Fat-Induced Beta  Cell Dysfunction via Beta Cell ABCA1 ( Diabetes Metab  J 2012;36:275-9 ) Jae-Hyoung Cho Department of Endocrinology and Metabolism, Seoul St. Mary’s Hospital, The Catholic University of Korea School of Medicine, Seoul, Korea Corresponding author:  Jae-Hyoung Cho Department of Endocrinology and Metabolism, Seoul St. Mary’s Hospital,  The Catholic University of Korea School of Medicine, 222 Banpo-daero,  Seocho-gu, Seoul 137-701, Korea E-mail: drhopper@catholic.ac.krIt is well known that lipotoxicity can cause β-cells injury and/ or dysfunction as well as glucotoxicity [1-4].",Non-OADS,/arxiv_data1/oa_pdf/e1/d7/dmj-36-388.PMC3486986.pdf
Diabetes 2002;   51 Suppl 3:S405-13.Letter http://dx.doi.org/10.4093/dmj.2012.36.5.388 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/e1/d7/dmj-36-388.PMC3486986.pdf
389Balsamic vinegar improves beta cell dysfunction Diabetes Metab J 2012;36:388-389 http://e-dmj.org 2.,Non-OADS,/arxiv_data1/oa_pdf/e1/d7/dmj-36-388.PMC3486986.pdf
"D I A B E T E S  & M E T A B O L I S M  J O U R N A L This is an Open Access article distributed under the terms of the Creative Commons At - tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/a2/dmj-36-390.PMC3486987.pdf
"Copyright © 2012 Korean Diabetes Association  http://e-dmj.orgDiabetes Metab J 2012;36:390 Balsamic Vinegar Improves High Fat-Induced Beta  Cell Dysfunction via Beta Cell ABCA1 ( Diabetes Metab  J 2012;36:275-9 ) Hannah Seok, Bong Soo Cha Division of Endocrinology and Metabolism, Department of Internal Medicine, Y onsei University College of Medicine, Seoul, Korea Corresponding author:  Bong Soo Cha Department of Internal Medicine, Y onsei University College of Medicine,   50 Y onsei-ro, Seodaemun-gu, Seoul 120-752, Korea E-mail: bscha@yuhs.acWe sincerely appreciate the interest and comments regarding  our study, “Balsamic Vinegar Improves High Fat-Induced Beta  Cell Dysfunction via Beta Cell ABCA1, ” which was published  in Diabetes & Metabolism Journal 2012;36:275-9.",Non-OADS,/arxiv_data1/oa_pdf/6f/a2/dmj-36-390.PMC3486987.pdf
Endocrinology 2002;143:339-42.Response http://dx.doi.org/10.4093/dmj.2012.36.5.390 pISSN 2233-6079 · eISSN 2233-6087,Non-OADS,/arxiv_data1/oa_pdf/6f/a2/dmj-36-390.PMC3486987.pdf
"Korean J Thorac Cardiovasc Surg 2012;45:275-286 □ Review  □ http://dx.doi.or g/10.5090/k jtcs.2012.45.5.275 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 275 −Division of Cardiothoracic Surgery, St. Louis University Hospit al Received: July 11, 2012, Revised: August 16, 2012, Accepted: Au gust 17, 2012 Corresponding author: Hendrick B Barner, Division of Cardiothora cic Surgery, St. Louis University Hospital, 3635 Vista Ave, St.  L o u i s ,  M O   63110, USA (Tel) 1-314-577-8359 (Fax) 1-314-577-8315 (E-mail) hbarner@slu.",Non-OADS,/arxiv_data1/oa_pdf/b2/dc/kjtcs-45-275.PMC3487010.pdf
"Korean J Thorac Cardiovasc Surg 2012;45:287-294 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2012.45.5.287 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 287 −Department of Thoracic and Cardi ovascular Surgery, Seoul Nation al University Hospital, Seoul National University College of Me dicine Received: December 23, 2011, Revised: March 14, 2012, Accepted:  April 4, 2012 Corresponding author: Yong Jin Kim, Department of Thoracic and C ardiovascular Surgery, Seoul Nat ional University Children’s Hos pital, Seoul  National University College of Medicine, 101 Daehak-ro, Jongno- gu, Seoul 110-744, Korea (Tel) 82-2-2072-3638 (Fax) 82-2-745-5209 (E-mail) kyj@plaza.snu .ac.kr  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/9c/76/kjtcs-45-287.PMC3487011.pdf
"Korean J Thorac Cardiovasc Surg 2012;45:295-300 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2012.45.5.295 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 295 −Department of Thoracic and Cardiovascular Surgery, 1Seoul National University Bundang Hospital, Seoul National Univ ersity College of  Medicine, 2Asan Medical Center, University of Ulsan College of Medicine, 3Dongguk University Ilsan Hospital, Dongguk University College o f  Medicine Received: March 21, 2012, Revised: May 16, 2012, Accepted: May 19, 2012 Corresponding author: Kay-Hyun Park, Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospi tal, Seoul  National University College of Medicine, 82 Gumi-ro 173beon-gil , Bundang-gu, Seongnam 463-707, Korea (Tel) 82-31-787-7141 (Fax) 82-31-787-4050 (E-mail) drkhpark@yah oo.co.kr  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/e7/0b/kjtcs-45-295.PMC3487012.pdf
"Korean J Thorac Cardiovasc Surg 2012;45:301-307 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2012.45.5.301 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 301 −Department of Thoracic and Cardiovascular Surgery, 1Inje University Sanggye Paik Hospital, Inje University College of Medicine, 2Seoul  National University Bundang Hosp ital, Seoul National University  College of Medicine, 3Eulji University Hospital, Eulji University School of  Medicine Received: January 21, 2012, Revised: July 10, 2012, Accepted: J uly 15, 2012 Corresponding author: Kay-Hyun Park, Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospi tal, Seoul  National University College of Medicine, 82 Gumi-ro 173beon-gil , Bundang-gu, Seongnam 463-707, Korea (Tel) 82-31-787-7140 (Fax) 82-31-787-4050 (E-mail) drkhpark@yah oo.co.kr  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/36/a2/kjtcs-45-301.PMC3487013.pdf
"Korean J Thorac Cardiovasc Surg 2012;45:308-315 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2012.45.5.308 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 308 −Department of Thoracic and Cardi ovascular Surgery, Seoul Nation al University Hospital, Seoul National University College of Me dicine †This paper was presented at the 46th annual meeting of the Soci ety of Thoracic Surgeons, Fort L auderdale, Florida, January 24- 27, 2010.",Non-OADS,/arxiv_data1/oa_pdf/6f/30/kjtcs-45-308.PMC3487014.pdf
"Korean J Thorac Cardiovasc Surg 2012;45:316-319 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2012.45.5.316 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 316 −1Department of Thoracic and Cardiovascular Surgery, Pusan Nation al University Hospital, Pusan National University School of Med icine,  2Department of Emergency Medicine, Samsung Changwon Hospital, Su ngkyunkwan University School of Medicine †T h i s  s t u d y  w a s  p r e s e n t e d  i n  t h e  Asian Society for Cardiovascula r and Thoracic Surgeons-Associati on of Thoracic and Cardiovascu lar Surgeons  of Asia (ASCVTS-ATCSA) 2011 Phuket, Thailand.",Non-OADS,/arxiv_data1/oa_pdf/d4/24/kjtcs-45-316.PMC3487015.pdf
"Korean J Thorac Cardiovasc Surg 2012;45:320-322 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2012.45.5.320 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 320 −Departments of 1Thoracic and Cardiovascular Surgery, 2Cardiology, Hanyang University College of Medicine Received: March 26, 2012, Revised: May 12, 2012, Accepted: May 19, 2012 Corresponding author: Young Hak Kim, Department of Thoracic and Cardiovascular Surgery, Hanyang U niversity Seoul Hospital, Hany ang  University College of Medicine, 222 Wangsimni-ro, Seongdong-gu,  S e o u l  1 3 3 - 7 9 1 ,  K o r e a (Tel) 82-2-2290-8469 (Fax) 82-2-2290-8470 (E-mail) yhkim@hanyan g.ac.kr  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/f4/57/kjtcs-45-320.PMC3487016.pdf
"Korean J Thorac Cardiovasc Surg 2012;45:323-325 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2012.45.5.323 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 323 −1Division of Cardiovascular Surge ry, Department of Cardiothoraci c Surgery, 2Division of Vascular Surgery, Department of Surgery, 3Division of  Cardiology, Department of Medici ne, Samsung Medical Center, Sun gkyunkwan University School of Medicine Received: February 27, 2012, Revised: March 3, 2012, Accepted: March 7, 2012 Corresponding author: Wook Sung Kim, Department of Cardiovascula r Surgery, Samsung Medical Center, Sungkyunkwan University Scho ol of  Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea (Tel) 82-2-3410-3486 (Fax) 82-2-3410-0089 (E-mail) wooksungkim@ yahoo.com  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/04/a6/kjtcs-45-323.PMC3487017.pdf
"Korean J Thorac Cardiovasc Surg 2012;45:326-329 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2012.45.5.326 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 326 −Department of Thoracic and Cardi ovascular Surgery, Kangbuk Sams ung Medical Center, Sungkyunkwan University School of Medicine Received: March 8, 2012, Revised: July 17, 2012, Accepted: July  2 0 ,  2 0 1 2 Corresponding author: Tae Yun Oh, Department of Thoracic and Car diovascular Surgery, Kangbuk Samsung Medical Center, Sungkyunkw an  University School of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul  110-746, Korea (Tel) 82-2-2001-2150 (Fax) 82-2-2001-2148 (E-mail) chtoh@samsun g.com  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/db/36/kjtcs-45-326.PMC3487018.pdf
"Korean J Thorac Cardiovasc Surg 2012;45:330-333 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2012.45.5.330 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 330 −Departments of 1Thoracic and Cardiovascular Surgery and 2Surgery, Pusan National University School of Medicine Received: February 21, 2012, Revised: June 1, 2012, Accepted: J une 4, 2012 Corresponding author: Sung Woon Chung, Department of Thoracic an d Cardiovascular Surgery, Pusan National University Hospital, P usan  National University School of Medicine, 179 Gudeok-ro, Seo-gu, Busan 602-739, Korea (Tel) 82-51-240-7263 (Fax) 82-51-243-9389 (E-mail) chungsungwoo n@hanmail.net  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/98/df/kjtcs-45-330.PMC3487019.pdf
"Korean J Thorac Cardiovasc Surg 2012;45:334-337 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2012.45.5.334 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 334 −Department of Thoracic and Cardi ovascular Surgery, Pusan Nation al University School of Medicine Received: February 1, 2012, Revised: February 27, 2012, Accepte d: March 3, 2012 Corresponding author: Seunghwan Song, Department of Thoracic and  Cardiovascular Surgery, Pusan N ational University Hospital, Pu san  National University School of Medicine, 179 Gudeok-ro, Seo-gu, Busan 602-739, Korea (Tel) 82-51-240-7267 (Fax) 82-51-243-9389 (E-mail) song77.sh@gm ail.com  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/c8/51/kjtcs-45-334.PMC3487020.pdf
"Korean J Thorac Cardiovasc Surg 2012;45:338-341 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2012.45.5.338 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 338 −Department of Thoracic and Cardi ovascular Surgery, Dankook Univ ersity Hospital, Dankook University College of Medicine Received: March 26, 2012, Revised: May 11, 2012, Accepted: May 19, 2012 Corresponding author: Jae-Wook Ryu, Department of Thoracic and C ardiovascular Surgery, Dankook University Hospital, Dankook Uni versity  College of Medicine, 201 Manghya ng-ro, Dongnam-gu, Cheonan 330- 180, Korea (Tel) 82-41-550-3985 (Fax) 82-41-550-3983 (E-mail) j3thorax@cho l.com  C The Korean Society for Thoracic and Cardiovascular Surgery.",Non-OADS,/arxiv_data1/oa_pdf/6b/90/kjtcs-45-338.PMC3487021.pdf
"Korean J Thorac Cardiovasc Surg 2012;45:342-344 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2012.45.5.342 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 342 −Department of Thoracic and Cardi ovascular Surgery, Ewha Womans University School of Medicine Received: April 6, 2012, Revised: June 11, 2012, Accepted: June  1 3 ,  2 0 1 2 Corresponding author: Tae Hee Won, Department of Thoracic and Ca rdiovascular Surgery, Ewha Womans University School of Medicine , 1071  Anyangcheon-ro, Yangcheon-gu, Seoul 158-710, Korea (Tel) 82-2-2650-5151 (Fax) 82-2-2650-2652 (E-mail) wth@ewha.ac.",Non-OADS,/arxiv_data1/oa_pdf/be/64/kjtcs-45-342.PMC3487022.pdf
"Korean J Thorac Cardiovasc Surg 2012;45:345-347 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2012.45.5.345 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 345 −Department of Thoracic and Cardi ovascular Surgery, Catholic Uni versity of Daegu School of Medicine Received: March 5, 2012, Revised: June 13, 2012, Accepted: Augu st 3, 2012 Corresponding author: Ki-Sung Park, Department of Thoracic and C ardiovascular Surgery, Catholic University of Daegu School of M edicine, 33  Duryugongwon-ro 17-gil, Nam-gu, Daegu 705-718, Korea (Tel) 82-53-650-4567 (Fax) 82-53-629-6963 (E-mail) kspark69@cu.",Non-OADS,/arxiv_data1/oa_pdf/d5/85/kjtcs-45-345.PMC3487023.pdf
"Korean J Thorac Cardiovasc Surg 2012;45:348-350 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2012.45.5.348 ISSN: 2233-601X (Print)   ISSN: 2093-6516 (Online) − 348 −Department of Thoracic and Cardi ovascular Surgery, Ewha Womans University School of Medicine Received: April 9, 2012, Revised: May 21, 2012, Accepted: June 4, 2012 Corresponding author: Tae Hee Won, Department of Thoracic and Ca rdiovascular Surgery, Ewha Womans University School of Medicine , 1071  Anyangcheon-ro, Yangcheon-gu, Seoul 158-710, Korea (Tel) 82-2-2650-5151 (Fax) 82-2-2650-2652 (E-mail) wth@ewha.ac.",Non-OADS,/arxiv_data1/oa_pdf/64/28/kjtcs-45-348.PMC3487024.pdf
Available from:   http://www.censusindia.gov.in/Metadata/Metada.,OADS,/arxiv_data1/oa_pdf/e1/d1/APC-5-156.PMC3487204.pdf
"Source of Support:  Nil, Conflict of Interest:  None declared Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.",Non-OADS,/arxiv_data1/oa_pdf/e1/d1/APC-5-156.PMC3487204.pdf
Proteomics  Clin Appl 2008;2:387-410. http://ro.uow.edu.au/ scipapers/72.,OADS,/arxiv_data1/oa_pdf/0c/de/APC-5-169.PMC3487207.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/9c/33/APC-5-191.PMC3487211.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/bf/90/APC-5-207.PMC3487217.pdf
http://www.who.int/entity/selection_medicines/committees/expert/18/ applications/Misoprostol_safety_review.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5d/8c/PCR-3-102.PMC3487224.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/5d/8c/PCR-3-102.PMC3487224.pdf
Available from: http://care.diabetesjournals.org/content/35/ Supplement_1/S4.full.pdf+html.,Non-OADS,/arxiv_data1/oa_pdf/73/62/PCR-3-109.PMC3487225.pdf
Available from: http://articles.latimes.com/2011/jan/19/ business/la-fi-mannkind-diabetes-20110119.,Non-OADS,/arxiv_data1/oa_pdf/73/62/PCR-3-109.PMC3487225.pdf
Available from: http://www.ciscrp.org/ professional/facts_pat.html#5.,Non-OADS,/arxiv_data1/oa_pdf/46/da/PCR-3-87.PMC3487230.pdf
Available from: http://rajyasabha.nic.in/ http://164.100.47.5/qsearch/ qsearch.aspx.,Non-OADS,/arxiv_data1/oa_pdf/46/da/PCR-3-87.PMC3487230.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/46/da/PCR-3-87.PMC3487230.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/46/da/PCR-3-87.PMC3487230.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/68/00/PCR-3-95.PMC3487232.pdf
Available from: http://www.ssat.com/cgi-bin/hemorr.cgi 5.,Non-OADS,/arxiv_data1/oa_pdf/83/83/JAIM-3-115.PMC3487235.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/7f/fc/JAIM-3-130.PMC3487238.pdf
Available from: http://www.ncbi.nlm.nih.gov/genbank.,Non-OADS,/arxiv_data1/oa_pdf/c1/80/JAIM-3-136.PMC3487239.pdf
Available from: http://www.mbio.ncsu.edu//bioedit.,Non-OADS,/arxiv_data1/oa_pdf/c1/80/JAIM-3-136.PMC3487239.pdf
15. http://ctri.nic.in/Clinicaltrials/showallp.php?mid1=3044&EncHid=&userName=Ayusoft.,Non-OADS,/arxiv_data1/oa_pdf/1c/61/JAIM-3-150.PMC3487241.pdf
"Humanity in medicine: Lessons from three  teachers.Nat Med JIndia 2001;14.Available from:http://www.nmji.in/archives/Volume-14/issue-4/speaking-for-myself-1.pdf (accessed on March 16, 2012) 5.",Non-OADS,/arxiv_data1/oa_pdf/3d/5c/JAIM-3-158.PMC3487242.pdf
"The Academy Orations and Awards, National Academy  of Medical Sciences (India) Available from: http://www.nams-india.in/docs_pdfs/Oration%20and%20Awards.pdf.",Non-OADS,/arxiv_data1/oa_pdf/3d/5c/JAIM-3-158.PMC3487242.pdf
Available from:http://www.nagauniv.org.in/menu/vcdesk/Recent%20Trends%20in%20Biodiversity%20Researches%20-%20Silchar.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3d/5c/JAIM-3-158.PMC3487242.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/74/1a/JPP-3-217.PMC3487269.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/74/1a/JPP-3-217.PMC3487269.pdf
Available from: http://www.who-umc.org/DynPage.,Non-OADS,/arxiv_data1/oa_pdf/e7/49/JPP-3-228.PMC3487270.pdf
Available  from: http://www.anmat.gov.ar.,Non-OADS,/arxiv_data1/oa_pdf/e7/49/JPP-3-228.PMC3487270.pdf
Available from: http://www.portal.anvisa.gov.br.,Non-OADS,/arxiv_data1/oa_pdf/e7/49/JPP-3-228.PMC3487270.pdf
Available from: http://www.tga.gov.au.,Non-OADS,/arxiv_data1/oa_pdf/e7/49/JPP-3-228.PMC3487270.pdf
Available from: https://www.nzphvc-01.otago.ac.nz.,Non-OADS,/arxiv_data1/oa_pdf/e7/49/JPP-3-228.PMC3487270.pdf
Available from: http://www.fda.gov/ medwatch.,Non-OADS,/arxiv_data1/oa_pdf/e7/49/JPP-3-228.PMC3487270.pdf
Available  from: http://www.hc-sc.gc.ca.,Non-OADS,/arxiv_data1/oa_pdf/e7/49/JPP-3-228.PMC3487270.pdf
Available from: http://www.cdsco.nic.in [Last  accessed on 2010 Dec 22].,Non-OADS,/arxiv_data1/oa_pdf/e7/49/JPP-3-228.PMC3487270.pdf
Available from: http://www.bpfk.gov.my.,Non-OADS,/arxiv_data1/oa_pdf/e7/49/JPP-3-228.PMC3487270.pdf
Available from: http://www.hsa.gov.sg.,Non-OADS,/arxiv_data1/oa_pdf/e7/49/JPP-3-228.PMC3487270.pdf
Available from:  http://www.mhra.gov.uk.,Non-OADS,/arxiv_data1/oa_pdf/e7/49/JPP-3-228.PMC3487270.pdf
Available from: http://www.lakemedelsverket.se.,Non-OADS,/arxiv_data1/oa_pdf/e7/49/JPP-3-228.PMC3487270.pdf
Available from: http://www.pharmacyboardkenya.org.,Non-OADS,/arxiv_data1/oa_pdf/e7/49/JPP-3-228.PMC3487270.pdf
Available from: http://www.kznhealth.gov.za.,Non-OADS,/arxiv_data1/oa_pdf/e7/49/JPP-3-228.PMC3487270.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/91/d6/JPP-3-233.PMC3487271.pdf
Internet J Health2004;3: Available  from:http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijh/ vol3n2/icu.xml 4.,OADS,/arxiv_data1/oa_pdf/f0/6c/JPP-3-242.PMC3487272.pdf
The Guide to Pharmacology (http://www.guidetopharmacology.,Non-OADS,/arxiv_data1/oa_pdf/ce/83/JPP-3-291.PMC3487286.pdf
Available from:  http://www.drugs.com/pro/lusedra.html [Last accessed on 2012 Feb 02].4.,Non-OADS,/arxiv_data1/oa_pdf/06/28/JPP-3-293.PMC3487287.pdf
Available from: http://www.fda.gov/ohrms/dockets/ac/08/briefing/2008- 4354b1-01-FDA.pdf [Last accessed on 2011 Oct 07].,Non-OADS,/arxiv_data1/oa_pdf/06/28/JPP-3-293.PMC3487287.pdf
"Arlt at marlt@research.balgrist.ch URL: http://www.jove.com/video/4162 DOI: doi:10.3791/4162 Keywords: Cancer Biology, Issue 66, Medicine, Molecular Biology, Cellular Biology, lung metastasis, lacZ-tagging, 5-Bromo-4-chloro-3-indolyl-beta- D-galactoside (X-Gal) staining, in-situ  lung perfusion, metastases, imaging Date Published: 8/21/2012 Citation: Arlt, M.J., Born, W., Fuchs, B.",Non-OADS,/arxiv_data1/oa_pdf/19/40/jove-66-4162.PMC3487289.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4162/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/19/40/jove-66-4162.PMC3487289.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseAugust 2012 |  66  | e4166 | Page 1 of 6Video Article An In vitro  Co-infection Model to Study Plasmodium falciparum -HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells Guadalupe Andreani1, Dominic Gagnon1, Robert Lodge1, Michel J. Tremblay1, Dave Richard1 1Infectious Disease Research Center, CHUL (CHUQ), Quebec City, Quebec, Canada Correspondence to: Dave Richard at dave.richard@crchul.ulaval.ca URL: http://www.jove.com/video/4166 DOI: doi:10.3791/4166 Keywords: Immunology, Issue 66, Infection, Medicine, Malaria, HIV-1, Monocyte-Derived Macrophages, PBMC, Red blood cells, Dendritic Cells, Co-infections, Parasites, Plasmodium falciparum , AIDS Date Published: 8/15/2012 Citation: Andreani, G., Gagnon, D., Lodge, R., Tremblay, M.J., Richard, D. An In vitro  Co-infection Model to Study Plasmodium falciparum -HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells.",Non-OADS,/arxiv_data1/oa_pdf/1e/d5/jove-66-4166.PMC3487290.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/4166/ Protocol Note: Experiments with HIV-1 and Plasmodium falciparum  must be performed in the proper biosafety level laboratories (BSL2 for parasites, and BSL3 for HIV-1 and co-infections) and special precaution must be taken when using potentially infected human blood.",Non-OADS,/arxiv_data1/oa_pdf/1e/d5/jove-66-4166.PMC3487290.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseAugust 2012 |  66  | e4297 | Page 1 of 6Video Article Plaque Assay for Murine Norovirus Mariam B. Gonzalez-Hernandez1, Juliana Bragazzi Cunha1, Christiane E. Wobus1 1Department of Microbiology and Immunology, University of Michigan, Ann Arbor Correspondence to: Christiane E. Wobus at cwobus@umich.edu URL: http://www.jove.com/video/4297 DOI: doi:10.3791/4297 Keywords: Virology, Issue 66, Immunology, Infection, Medicine, Microbiology, Molecular Biology, plaque assay, norovirus, murine norovirus, MNV, murine macrophages, RAW 264.7 cells Date Published: 8/22/2012 Citation: Gonzalez-Hernandez, M.B., Bragazzi Cunha, J., Wobus, C.E.",Non-OADS,/arxiv_data1/oa_pdf/22/f9/jove-66-4297.PMC3487293.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4297/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/22/f9/jove-66-4297.PMC3487293.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/91/14/PC-2-291.PMC3487299.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.,Non-OADS,/arxiv_data1/oa_pdf/91/14/PC-2-291.PMC3487299.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/d5/60/PC-2-327.PMC3487301.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/1c/b9/PC-2-340.PMC3487302.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/ac/4f/PC-2-359.PMC3487304.pdf
A  ful l list  of participating MESA Investigators and institutions can be found at http://www.mesa - nhlbi.org.,Non-OADS,/arxiv_data1/oa_pdf/ee/27/PC-2-379.PMC3487307.pdf
"[5] and four groups of CHDLs have been identiﬁed in imipenem-resistant (IR) A. baumannii , including intrinsic and chromosomally located OXA-51-like b-lactamases and acquired OXA-23-like, OXA-24-/ The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/ >.",Non-OADS,/arxiv_data1/oa_pdf/ae/58/S0950268811002871a.PMC3487480.pdf
MLST was performed on selected strains of representative PFGE types according to the Institut Pasteur scheme [9] (http://www.pasteur.fr/recherche/genopole/PF8/mlst/ Abaumannii.html).,Non-OADS,/arxiv_data1/oa_pdf/ae/58/S0950268811002871a.PMC3487480.pdf
"the molecular size marker, were applied to the Fragment Size Calculator (http://www.basic.northwes- tern.edu/biotools/SizeCalc.html) for determination of the plasmid size.",OADS,/arxiv_data1/oa_pdf/ae/58/S0950268811002871a.PMC3487480.pdf
(Email: Bernd-Alois.Tenhagen@bfr.bund.de) The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/ >.,Non-OADS,/arxiv_data1/oa_pdf/a0/92/S095026881200009Xa.PMC3487481.pdf
"spatype and MLST were determined using Ridom Staphtype software (Ridom GmbH, Germany) and the S. aureus MLST database (http://www.saureus.mlst.",OADS,/arxiv_data1/oa_pdf/a0/92/S095026881200009Xa.PMC3487481.pdf
"Munich, Germany: Ludwigs-Max- imilians-Universita ¨t (http://edoc.ub.uni-muenchen.de/ 11531/1/Frick_Johannes.pdf), 2010.",Non-OADS,/arxiv_data1/oa_pdf/a0/92/S095026881200009Xa.PMC3487481.pdf
(Email: charlotte.metcalf@zoo.ox.ac.uk) The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/ >.,Non-OADS,/arxiv_data1/oa_pdf/4b/cb/S0950268812000131a.PMC3487482.pdf
"However, it is not clear, that these targets can be met in all countries: in 2009, WHO-UNICEF estimates for global routine measles vaccine cover- age of infants and young children were 82%, with just 69% for the African region (http://apps.who.int/ immunization_monitoring/en/globalsummary/time series/tswucoveragedtp3.htm; accessed 23 December 2010; note some countries in each region have at- tained the goal).",Non-OADS,/arxiv_data1/oa_pdf/4b/cb/S0950268812000131a.PMC3487482.pdf
"Switching from the measles vaccine to the MR vaccine entails an increase in cost – in 2010 the UNICEF discounted price per dose was US$0.8–1.50 for MMR and US$0.53 for MR, compared to US$0.22 for measles (http://www.unicef.org/supply/) – but no additionalresources would be required for distribution: the combined vaccine would simply be substituted for the monovalent vaccine.",Non-OADS,/arxiv_data1/oa_pdf/4b/cb/S0950268812000131a.PMC3487482.pdf
NOTE Supplementary material accompanies this paper on the Journal’s website (http://journals.cambridge.org/ hyg).,Non-OADS,/arxiv_data1/oa_pdf/4b/cb/S0950268812000131a.PMC3487482.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/ >.,Non-OADS,/arxiv_data1/oa_pdf/80/bc/S0950268812000192a.PMC3487483.pdf
"Ampliﬁcation and sequencing used methods and primers from published protocols [16, 29] and the MLST website (http://pubmlst.org/).",OADS,/arxiv_data1/oa_pdf/80/bc/S0950268812000192a.PMC3487483.pdf
"Traces were assembled using Sequence Typing Analysis and Retrieval System software developed by Dr Man-Suen Chan and Dr Nicki Ventress [(http://sara.molbiol.ox.ac.uk/ userweb/mchan/stars/adminguide.htm) fUniversity of Oxford, 2001].",OADS,/arxiv_data1/oa_pdf/80/bc/S0950268812000192a.PMC3487483.pdf
Consensus were queriedagainst the pubMLST Campylobacter database (http://pubmlst.org/campylobacter/) to give an allele number and sequence types using standard Campylobacter MLST nomenclature [29].,OADS,/arxiv_data1/oa_pdf/80/bc/S0950268812000192a.PMC3487483.pdf
NOTE Supplementary material accompanies this paper on the Journal’s website (http://journals.cambridge.org/ hyg).,Non-OADS,/arxiv_data1/oa_pdf/80/bc/S0950268812000192a.PMC3487483.pdf
"Laboratory reports of Campylobacter cases reported to the Health Protection Agency Centre for Infections England and Wales, 1989–2009 (http://www.hpa.org.uk/Topics/InfectiousDiseases/Infect ionsAZ/Campylobacter/ EpidemiologicalData/campyDataEw/) Accessed 13 October 2011.",Non-OADS,/arxiv_data1/oa_pdf/80/bc/S0950268812000192a.PMC3487483.pdf
"Campylobacter in- fection rates by age, England and Wales, 2000–2009 (http://www.hpa.org.uk/Topi cs/Infectious Diseases/ InfectionsAZ/Campylobacter/EpidemiologicalData/ campyDataEWAgeRates/).",Non-OADS,/arxiv_data1/oa_pdf/80/bc/S0950268812000192a.PMC3487483.pdf
Detecting NoV RNA in water suspected of causing illness helps conﬁrm that a gastroenteritis The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/ >.,Non-OADS,/arxiv_data1/oa_pdf/62/a1/S0950268812000374a.PMC3487484.pdf
http: //dx.doi.org/10.1099/ijs.0.044875-0 .http://ijs.sgmjournals.org/content /early/2012/10/02/ijs.0.044875-0 .,Non-OADS,/arxiv_data1/oa_pdf/c4/b1/mBio.00377-12.PMC3487773.pdf
"As noted, seven whole-genome sequences of dermatophyte species have now been generated (see the Broad Institute’s Der-matophyte Comparative Database at http://www.broadinstitute.org /annotation/genome/dermatophyte-comparative/MultiHome.html ): the nuclear genome and mitochondrial sequences of Mi- crosporum canis ,Microsporum gypseum ,Trichophyton equinum , Trichophyton rubrum , and Trichophyton tonsurans (1), as well as the availability of Arthroderma benhamiae and Trichophyton ver- rucosum genome sequences (10).",OADS,/arxiv_data1/oa_pdf/e3/09/mBio.00381-12.PMC3487774.pdf
http://dx.doi.org/10.1101/cshperspect .a004721 .,Non-OADS,/arxiv_data1/oa_pdf/25/b7/mBio.00401-12.PMC3487775.pdf
http://dx.doi.org/10.1101 /cshperspect.a004697 .,Non-OADS,/arxiv_data1/oa_pdf/25/b7/mBio.00401-12.PMC3487775.pdf
http://dx.doi.org/10.1126/stke .3572006re13 .,Non-OADS,/arxiv_data1/oa_pdf/cb/dd/mBio.00411-12.PMC3487776.pdf
http://dx.doi.org /10.1101/cshperspect.a000158 .,Non-OADS,/arxiv_data1/oa_pdf/cb/dd/mBio.00411-12.PMC3487776.pdf
"In addition, no hasABC homologues were identiﬁed in the MGAS10750 genome using the basic local align-ment search tool (BLAST; http://blast.ncbi.nlm.nih.gov/Blast .cgi).",OADS,/arxiv_data1/oa_pdf/66/3c/mBio.00413-12.PMC3487777.pdf
The atomic coordinates and structure factors (code 2LV7 ) have been deposited in the Protein Data Bank ( http://wwpdb.org/ ).,OADS,/arxiv_data1/oa_pdf/ff/d5/zbc38231.PMC3488092.pdf
"2010. http://www.shpr.se/ en/Publications/DocumentsReports.aspx Tarasevicius S, Busevicius M, Robertsson O, Wingstrand H. Dual mobility  cup reduces dislocation rate after arthroplasty for femoral neck fracture.",Non-OADS,/arxiv_data1/oa_pdf/62/a1/ORT-1745-3674-083-442.PMC3488169.pdf
Available from http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1287147699571  HELICS.,Non-OADS,/arxiv_data1/oa_pdf/b4/88/ORT-1745-3674-083-449.PMC3488170.pdf
"Available from http://helics.univ-lyon1.fr/  Herberts P, Malchau H. Long-term registration has improved the quality  of hip replacement: a review of the Swedish THR Register comparing 160,000 cases.",Non-OADS,/arxiv_data1/oa_pdf/b4/88/ORT-1745-3674-083-449.PMC3488170.pdf
"Available from http://www.centraloffice-europe.com/nof2010/detail.asp?id=109  Malchau H, Garellick G, Eisler T, Karrholm J, Herberts P. Presidential guest  address: the Swedish Hip Registry: increasing the sensitivity by patient outcome data.",Non-OADS,/arxiv_data1/oa_pdf/b4/88/ORT-1745-3674-083-449.PMC3488170.pdf
"Available from http://nrlweb.ihelse.net/eng/Report_2010.pdf  Trampuz A, Widmer A F. Infections associated with orthopedic implants.",Non-OADS,/arxiv_data1/oa_pdf/b4/88/ORT-1745-3674-083-449.PMC3488170.pdf
2011; http://nrlweb.ihelse.net/Rap-porter/Rapport2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/29/0a/ORT-1745-3674-083-459.PMC3488171.pdf
2010; http://www.shpr.se/Libraries/Documents/ AnnualReport-2009.sflb.ashx.,Non-OADS,/arxiv_data1/oa_pdf/29/0a/ORT-1745-3674-083-459.PMC3488171.pdf
2011; http://www.shpr.se/Libraries/Documents/AnnualReport-2010-3.sflb.ashx.,Non-OADS,/arxiv_data1/oa_pdf/29/0a/ORT-1745-3674-083-459.PMC3488171.pdf
2011; http://www.dmac.adelaide.edu.au/aoanjrr/documents/AnnualReports2011/AnnualReport_2011_WebVersion.pdf.,Non-OADS,/arxiv_data1/oa_pdf/29/0a/ORT-1745-3674-083-459.PMC3488171.pdf
2011; http://rikshoft.se/se/images/stories/arsrapporter/arsrapport2010.pdf.,Non-OADS,/arxiv_data1/oa_pdf/29/0a/ORT-1745-3674-083-459.PMC3488171.pdf
A complete list of all prosthesis brands used in the study can  be found in the annual report for 2010 from the NAR (http://nrlweb.ihelse.net/default.htm).,Non-OADS,/arxiv_data1/oa_pdf/66/fa/ORT-1745-3674-083-467.PMC3488172.pdf
The secondary outcome measure  was the EQ-5D (http://www.euroqol.,Non-OADS,/arxiv_data1/oa_pdf/66/fa/ORT-1745-3674-083-467.PMC3488172.pdf
"This is an Open Access article distributed underthe terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.DOI: 10.1093/infdis/jis597 1652 JID 2012:206 (1 December) Warren-Gash et al",Non-OADS,/arxiv_data1/oa_pdf/e3/f7/jis597.PMC3488196.pdf
"The CALIBER research record linkages leading to these results was funded by the Wellcome Trust (086091/Z/08/Z; http://www.wellcome.ac.uk/ ) and the UK National Institute of Health Research (RP-PG-0407 –10314; http:// www.nihr.ac.uk/ ; principle investigator, H. H.).",Non-OADS,/arxiv_data1/oa_pdf/e3/f7/jis597.PMC3488196.pdf
2010 .http://www.bhf.org.uk/publications/view-publication.,Non-OADS,/arxiv_data1/oa_pdf/e3/f7/jis597.PMC3488196.pdf
http://www.gprd.com/ products/database .,OADS,/arxiv_data1/oa_pdf/e3/f7/jis597.PMC3488196.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/6f/19/gks636.PMC3488204.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/4c/d3/gks666.PMC3488205.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/d1/c0/gks678.PMC3488206.pdf
The sourcecode of MetaVelvet is freely available at http://metavelvet.dna.bio.keio.ac.jp under the GNU General Public License and is distributed as a bundle with ‘Velvet’.,OADS,/arxiv_data1/oa_pdf/d1/c0/gks678.PMC3488206.pdf
Performances on simulated datasets We used the ‘DWGSIM package’ in the DNAA package (available at http://sourceforge.net/projects/dnaa/) toartiﬁcially generate metagenome sequence reads.,OADS,/arxiv_data1/oa_pdf/d1/c0/gks678.PMC3488206.pdf
The three metagenomic datasets were downloaded fromthe NCBI Sequence Read Archive (http://www.ncbi.nlm.nih.gov/sra; ERR011101–ERR011104 for the MH0006 dataset; ERR011117–ERR011123 for the MH0012 dataset; ERR011192–ERR011193 for the MH0047dataset).,OADS,/arxiv_data1/oa_pdf/d1/c0/gks678.PMC3488206.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/84/34/gks680.PMC3488207.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/97/fd/gks697.PMC3488208.pdf
"Furtherprocessing of short reads was mainly based on samtools(14) and the Python interface pysam (see: http://www.cgat.org/ /C24andreas/documentation/pysam/contents.htmle160 Nucleic Acids Research, 2012, Vol.",OADS,/arxiv_data1/oa_pdf/97/fd/gks697.PMC3488208.pdf
"The package will be made available along with the relevant documentation at: http://www.bsse.ethz.ch/egg/software/index (16 July 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/97/fd/gks697.PMC3488208.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/a7/23/gks698.PMC3488209.pdf
An efficient and easy-to-use webinterface (available at http://www.babelomics.org)based on HTML5 technologies is also provided torun the algorithm and represent the network.INTRODUCTION There is now a wide consensus on the fact that most of the biological functionality of the cell arises from complex interactions between their molecular components (1).Such interacting components deﬁne operational entitiesor modules to which different elementary functions can be attributed.,OADS,/arxiv_data1/oa_pdf/9a/e8/gks699.PMC3488210.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/9a/e8/gks699.PMC3488210.pdf
NetworkMiner is available within the Babelomics envir- onment (http://www.babelomics.org) within the section of functional analysis.,OADS,/arxiv_data1/oa_pdf/9a/e8/gks699.PMC3488210.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/6f/0c/gks708.PMC3488211.pdf
"NC_001570,NW_001091935, ..., NW_001092755) were downloaded from NCBI (http://www.ncbi.nlm.nih.gov/).",OADS,/arxiv_data1/oa_pdf/6f/0c/gks708.PMC3488211.pdf
Non-parametric statisticaltests were performed with the R package (http://www.R-project.org).,OADS,/arxiv_data1/oa_pdf/6f/0c/gks708.PMC3488211.pdf
"The benchmark datasets constructed here, the species- speciﬁc parameter sets for 61 divergent eukaryotic species, as well as the source codes of Spaln2 can be down- loaded for free from http://www.genome.ist.i.kyoto-u.ac .jp//C24aln_user/.",OADS,/arxiv_data1/oa_pdf/6f/0c/gks708.PMC3488211.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/49/44/gks709.PMC3488212.pdf
"MATERIALS AND METHODS Reference-based compression scheme High compression of genetic variation data for entire populations is accomplished by mapping the data to anexisting reference map (dbSNP), National Center forBiotechnology Information’s free public database ofsingle-nucleotide polymorphism (SNP) available athttp://www.ncbi.nlm.nih.gov/projects/SNP/.",OADS,/arxiv_data1/oa_pdf/49/44/gks709.PMC3488212.pdf
Compressing HapMap III population data HAPZIPPER effectiveness was demonstrated on phased data of 18 HapMap (Phase III draft 2) populations down- loaded from http://hapmap.ncbi.nlm.nih.gov/downloads/ phasing/2009-02_phaseIII/HapMap3_r2/.,OADS,/arxiv_data1/oa_pdf/49/44/gks709.PMC3488212.pdf
Updated versions are availableat https://bitbucket.org/pchanda/hapzipper/downloads/ HapZipper.tar.bz2 under GNU (version 3 or later) general public license with sample data for testing.Further details about the compressed ﬁle structure canbe found in our user guide available with the tool.,Non-OADS,/arxiv_data1/oa_pdf/49/44/gks709.PMC3488212.pdf
"Genome Technology , http://www.genomeweb.com/informatics/so-long-data-depression.",Non-OADS,/arxiv_data1/oa_pdf/49/44/gks709.PMC3488212.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/1d/79/gks718.PMC3488213.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/b8/8c/gks726.PMC3488214.pdf
"AVAILABILITY OF DATA All datasets generated for this article, the annotated human proteome as well as input ﬁles for the used simu-lators are available for download at http://people.inf.ethz.ch/eschaper/tandem_repeats.",OADS,/arxiv_data1/oa_pdf/b8/8c/gks726.PMC3488214.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/25/48/gks727.PMC3488215.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/97/dd/gks739.PMC3488216.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/99/c6/gks744.PMC3488217.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/00/47/gks747.PMC3488218.pdf
"Analysis of nucleosome position and TF-binding site databases The fraction of TF-binding sites within the nucleosome dyad, entry exit and linker regions were determined withthe reported consensus map of nucleosome positions (38)(http://refnucl.atlas.bx.psu.edu/) and TF-binding sites (39)(http://fraenkel.mit.edu/improved_map/) in S. cerevisiae .",OADS,/arxiv_data1/oa_pdf/00/47/gks747.PMC3488218.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/6d/6a/gks748.PMC3488219.pdf
Ten micrograms of puriﬁed total RNAs was then used for northern blot analysis following a protocol from the Bartel Lab (http://web.wi.mit.edu/bartel/pub/ protocols.html) with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride chemical crosslinking (27).,OADS,/arxiv_data1/oa_pdf/6d/6a/gks748.PMC3488219.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/3a/6a/gks750.PMC3488220.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/13/df/gks753.PMC3488221.pdf
"Data access Sequence data is available in the SRA database (http://www.ncbi.nlm.nih.gov/sra/, 6 August 2012, date last accessed) with the following accession numbers:SRP014319.",OADS,/arxiv_data1/oa_pdf/13/df/gks753.PMC3488221.pdf
"ISBN 3-900051-07-0,URL http://www.R-project.org/ (6 August 2012, date lastaccessed).",Non-OADS,/arxiv_data1/oa_pdf/13/df/gks753.PMC3488221.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/a9/3d/gks756.PMC3488222.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/68/91/gks758.PMC3488223.pdf
A large (800 bp) PLG promoter fragment has beenisolated by YY1 ChIP and the sequence is available inthe BIOBASE database (http://www.biobase-inter-national.com).,OADS,/arxiv_data1/oa_pdf/68/91/gks758.PMC3488223.pdf
( A) YY1 binding sites location relative to the TSS ( + 1) of the human PLG promoter (http://www.biobase- international.com).,Non-OADS,/arxiv_data1/oa_pdf/68/91/gks758.PMC3488223.pdf
( D) LMDs simulations demonstrating local DNA breathing dynamics in 305 bp long humanPLG promoter fragment (http://www.biobase-international.com).,OADS,/arxiv_data1/oa_pdf/68/91/gks758.PMC3488223.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/db/25/gks761.PMC3488224.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/ca/b9/gks763.PMC3488225.pdf
An ensemble approach to RNA design is thus well worthpursuing as a complement to existing approaches.RNA-ensign is available at http://csb.cs.mcgill.ca/ RNAensign.INTRODUCTION The design of RNA sequences with speciﬁc folding pro- perties is a critical problem in synthetic biology.,Non-OADS,/arxiv_data1/oa_pdf/f2/af/gks768.PMC3488226.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/f2/af/gks768.PMC3488226.pdf
The ﬁnal dataset contains 50 sequences of sizes ranging from 22to 100 nt and is available at http://csb.cs.mcgill.ca/ RNAensign.,OADS,/arxiv_data1/oa_pdf/f2/af/gks768.PMC3488226.pdf
", 108–119, PUBMED at: http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/f2/af/gks768.PMC3488226.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/f7/f7/gks769.PMC3488227.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/21/5f/gks770.PMC3488228.pdf
"Using the JASPAR CORE transcription factor database(http://jaspar.genereg.net/cgi-bin/jaspar_db.pl) (47–50), we identiﬁed an evolutionary conserved putative CTCF binding site within this region (Supplementary FigureS5A).",OADS,/arxiv_data1/oa_pdf/21/5f/gks770.PMC3488228.pdf
"http://jaspar.genereg .net/cgi/jaspar_db.pl (19 May 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/21/5f/gks770.PMC3488228.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/70/bd/gks772.PMC3488229.pdf
Normalized mRNA abundances ofSchizosaccharomyces pombe during a short-term response to nitrogen starvation (22) were downloaded fromArrayExpress (http://www.ebi.ac.uk/microarray-as/ae/) under accession E-TABM-784.,OADS,/arxiv_data1/oa_pdf/70/bd/gks772.PMC3488229.pdf
"The tRNA GCNs of species weredownloaded from the Genomic tRNA Database (http://lowelab.ucsc.edu/GtRNAdb/), (24).",OADS,/arxiv_data1/oa_pdf/70/bd/gks772.PMC3488229.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/eb/81/gks775.PMC3488230.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/06/f7/gks776.PMC3488231.pdf
"MATERIALS AND METHODS Human genome and annotations We used the human genome hg19 build (http://www.ncbi .nlm.nih.gov/projects/ genome/guide/human/index.shtml)from the University of California Santa Cruz GenomeBioinformatics Site (http://genome.ucsc.edu) which wasused as the reference for mapping raw reads (30).RefSeq genes (in total 40 845, of which 30 623 were simi-larly retrieved from the site and only unique entries were used for analysis), CpG island (CGI) positions (28 691) and ORegAnno (http://genome.ucsc.edu)(23 089) datasets were similarly retrieved from the UCSCGenome Browser for the same build of the humangenome.",OADS,/arxiv_data1/oa_pdf/06/f7/gks776.PMC3488231.pdf
"To plot the data we have used Venny (http://bioinfogp.cnb.csic.es/tools/ venny/index.html).Nucleic Acids Research, 2012, Vol.",OADS,/arxiv_data1/oa_pdf/06/f7/gks776.PMC3488231.pdf
They are also thankful to NIH Roadmap to Epigenomics Consortium for maintaining an open access to the datasets depositedin NIH Roadmap Epigenomics Project Data Listings at http://nihroadmap.nih.gov/epigenomics/.,Non-OADS,/arxiv_data1/oa_pdf/06/f7/gks776.PMC3488231.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/ff/6c/gks780.PMC3488232.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/b1/c5/gks783.PMC3488233.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/a8/95/gks786.PMC3488234.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/d4/fc/gks787.PMC3488235.pdf
"One is a pair present in Stenotrophomonas maltophilia that presented similarity tothe mraW RNA motif, associated with peptidoglycan syn- thesis (RFAM, http://rfam.sanger.ac.uk) and to the ISStma8 transposase (IS110 family).",Non-OADS,/arxiv_data1/oa_pdf/d4/fc/gks787.PMC3488235.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/66/a0/gks789.PMC3488236.pdf
"Target prediction To perform target prediction, the 30-UTR sequence of 17 330 human protein-coding genes was retrieved from the UCSC genome database, and the sequences of all mature miRNAs were downloaded from miRBase (http://www.mirbase.org/).",OADS,/arxiv_data1/oa_pdf/66/a0/gks789.PMC3488236.pdf
Target prediction and contextscore analyses were performed using the TargetScan_50.pl and TargetScan_Context_Scores.pl scripts downloaded from the TargetScan website (http://www.targetscan.org/ vert_50/).,OADS,/arxiv_data1/oa_pdf/66/a0/gks789.PMC3488236.pdf
The resulting networks wereexported to Cytoscape (http://cytoscape.org/index.php)for visualization and network topology analysis.,OADS,/arxiv_data1/oa_pdf/66/a0/gks789.PMC3488236.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/b4/ae/gks790.PMC3488237.pdf
Computer graphic representations were prepared using the program PyMOL (http://www.pymol.org).,OADS,/arxiv_data1/oa_pdf/b4/ae/gks790.PMC3488237.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/24/08/gks791.PMC3488238.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/98/f5/gks795.PMC3488239.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/4a/a4/gks796.PMC3488240.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/df/1b/gks798.PMC3488241.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/b1/3a/gks801.PMC3488242.pdf
org) and Bioconductor (http://www.bioconductor.org).,OADS,/arxiv_data1/oa_pdf/b1/3a/gks801.PMC3488242.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/49/cb/gks802.PMC3488243.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/cd/ed/gks804.PMC3488244.pdf
"Visualizations by genome–transcriptome browser The details of mapped reads, SNVs, indels, microarray probes position, contigs from transcriptome de novo assembly and gene annotations were visualized usingGBrowse (50) publicly available at http://sysbio.se/Yseq .Moreover, ﬁve published RNA-seq data of S. cerevisiae grew under normal conditions in the study of Drinnenberget al.",OADS,/arxiv_data1/oa_pdf/cd/ed/gks804.PMC3488244.pdf
"To allow the direct com- parison between RNA-seq data generated in this studyand the transcriptomic data of different S. cerevisiae strains sequenced in other works ,we included selected published RNA-seq data into the library of the browser.The browser is publicly available at http://sysbio.se/Yseq.The detailed screen shot of the transcriptome browser isshown in Supplementary Figure S7.",OADS,/arxiv_data1/oa_pdf/cd/ed/gks804.PMC3488244.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/91/0b/gks805.PMC3488245.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/a6/f4/gks807.PMC3488246.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/77/4c/gks810.PMC3488247.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/80/6d/gks812.PMC3488248.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/81/b6/gks813.PMC3488249.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/66/74/gks815.PMC3488250.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/b3/f6/gks818.PMC3488251.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/e2/19/gks819.PMC3488252.pdf
"The signiﬁcantly changed genes were also compared with ChAP-seq results, and the GO enrichment was analyzed using Toppgene (http:// http://toppgene.cchmc.org/) and Ingenuity Pathway Analysis (IPA).Data analysis ChAP-seq peak ﬁnding FindPeaks 4.0.10 (37) was used to generate peaks for all the ChAP-seq and ChIP-seq data of SUMO-1 with options of subpeaks 0.5, trim 0.2.",OADS,/arxiv_data1/oa_pdf/e2/19/gks819.PMC3488252.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/29/8e/gks820.PMC3488253.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/ab/20/gks822.PMC3488254.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/a5/70/gks823.PMC3488255.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/1e/5b/gks824.PMC3488256.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/92/49/gks825.PMC3488257.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/ce/6c/gks826.PMC3488258.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/6c/8e/gks827.PMC3488259.pdf
"Conservation analysis was performed by Cistrome analysis pipeline (http://cistrome.dfci.harvard.edu/ap/)using a 300-bp window and the average vertebrate PhastCons metric (30,31).",OADS,/arxiv_data1/oa_pdf/6c/8e/gks827.PMC3488259.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/66/70/gks838.PMC3488260.pdf
"http://dx.doi.org/10.3345/kjp.2012.55.10.359 Korean J Pediatr 2012;55(10):359-366 eISSN 1738-1061 • pISSN 2092-7258Review article 359Enterovirus infection in Korean children and anti- enteroviral potential candidate agents Although most enterovirus infections are not serious enough to be life  threatening, several enteroviruses such as enterovirus 71 are responsible  for severe, potentially life-threatening disease.",Non-OADS,/arxiv_data1/oa_pdf/ce/bb/kjped-55-359.PMC3488610.pdf
"Key words: Enterovirus, Antiviral agents, Medicinal plantsKwi Sung Park, PhD1, Young Jin Choi, MD,  PhD2, Joon Soo Park, MD, PhD3 1Chungcheongnam-do Institute of Health and  Environmental Research, Daejeon, Departments of  2Laboratory Medicine and 3Pediatrics, Soonchunhyang  University Cheonan Hospital, Soonchunhyang Uni - versity College of Medicine, Cheonan, Korea Received: 9 May 2012, Accepted: 25 August 2012 Corresponding author: Joon Soo Park, MD, PhD Department of Pediatrics, Soonchunhyang University  Cheonan Hospital, Soonchunhyang University College of  Medicine, 31 Suncheonhyang 6-gil, Dongnam-gu, Cheonan  330-930, Korea Tel: +82-41-570-2163, Fax: +82-41-572-4996,  E-mail: pjstable@schmc.ac.kr  Copyright © 2012 by The Korean Pediatric Society This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ce/bb/kjped-55-359.PMC3488610.pdf
"Korean J Pediatr  2012;55(10):359-366 • http://dx.doi.org/10.3345/kjp.2012.55.10.359     361 children and young adults, and different HEV serotypes are  spreading globally each year.",Non-OADS,/arxiv_data1/oa_pdf/ce/bb/kjped-55-359.PMC3488610.pdf
Korean J Pediatr  2012;55(10):359-366 • http://dx.doi.org/10.3345/kjp.2012.55.10.359     363 2) SCH series The SCH series developed by Schering-Plough inhibits plaque  formation of several HEVs and protects mice infected with either  CVB3 or ECV9 from mortality.,Non-OADS,/arxiv_data1/oa_pdf/ce/bb/kjped-55-359.PMC3488610.pdf
Korean J Pediatr  2012;55(10):359-366 • http://dx.doi.org/10.3345/kjp.2012.55.10.359     365 compounds in a search for antiviral agents against HEVs in the  future.,Non-OADS,/arxiv_data1/oa_pdf/ce/bb/kjped-55-359.PMC3488610.pdf
http://dx.doi.org/10.3345/kjp.2012.55.10.367 Korean J Pediatr 2012;55(10):367-370 eISSN 1738-1061 • pISSN 2092-7258Review article 367Renal scar formation after urinary tract infection in  children Urinary tract infection (UTI) is a common bacterial illness in children.,Non-OADS,/arxiv_data1/oa_pdf/06/84/kjped-55-367.PMC3488611.pdf
"Key words:  Urinary tract infection, Renal scar, Vesico-ureteral reflux,  ChildYoung Seo Park, MD Department of Pediatrics, Asan Medical Center, Uni­ versity of Ulsan College of Medicine, Seoul, Korea Received: 17 May 2012, Accepted: 18 July 2012 Corresponding author: Young Seo Park, MDDepartment of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Song - pa-gu, Seoul 138-736, Korea Tel: +82-2-3010-3376, Fax: +82-2-473-3725E-mail: yspark@amc.seoul.kr Copyright © 2012 by The Korean Pediatric Society This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by ­ nc/3.0/) which permits unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/84/kjped-55-367.PMC3488611.pdf
"Korean J Pediatr  2012;55(10):367-370 • http://dx.doi.org/10.3345/kjp.2012.55.10.367     369 with renal scarring, and it may take up to 8 years to develop14).",Non-OADS,/arxiv_data1/oa_pdf/06/84/kjped-55-367.PMC3488611.pdf
Available  from: http://www.nice.org.uk/CG054.,Non-OADS,/arxiv_data1/oa_pdf/06/84/kjped-55-367.PMC3488611.pdf
"http://dx.doi.org/10.3345/kjp.2012.55.10.371 Korean J Pediatr 2012;55(10):371-376 eISSN 1738-1061 • pISSN 2092-7258Original article 371Puromycin aminonucleoside modulates p130Cas of  podocytes  Purpose:  Puromycin aminonucleoside (PAN) specifically injures podo - cytes, leading to foot process effacement, actin cytoskeleton disorga - nization, and abnormal distribution of slit diaphragm proteins.",Non-OADS,/arxiv_data1/oa_pdf/01/14/kjped-55-371.PMC3488612.pdf
"Key words:  Cytoskeleton, p130Cas, Podocytes cell, Puromycin amino - nucleosideT ae-Sun Ha, MD1,2, Ji-Young Choi, MS2, Hye- Young Park, BS2 1Department of Pediatrics, 2Postgraduate School,  Chungbuk National University College of Medicine,  Cheongju, Korea Received: 22 November 2011, Revised: 18 April 2012 Accepted: 9 July 2012 Corresponding author: Tae-Sun Ha, MD Department of Pediatrics, Chungbuk National University  College of Medicine, 52 Naesudong-ro, Heungdeok-gu,  Cheongju 361-804, Korea   Tel: +82-43-269-6374, Fax: +82-43-264-6620 E-mail: tsha@chungbuk.ac.kr  Copyright © 2012 by The Korean Pediatric Society This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/14/kjped-55-371.PMC3488612.pdf
Korean J Pediatr  2012;55(10):371-376 • http://dx.doi.org/10.3345/kjp.2012.55.10.371     373 4.,Non-OADS,/arxiv_data1/oa_pdf/01/14/kjped-55-371.PMC3488612.pdf
Korean J Pediatr  2012;55(10):371-376 • http://dx.doi.org/10.3345/kjp.2012.55.10.371     375 cytoskeleton.,Non-OADS,/arxiv_data1/oa_pdf/01/14/kjped-55-371.PMC3488612.pdf
http://dx.doi.org/10.3345/kjp.2012.55.10.377 Korean J Pediatr 2012;55(10):377-382 eISSN 1738-1061 • pISSN 2092-7258Original article 377Clinical features and surgical outcomes of complete  transposition of the great arteries  Purpose: This single-center study aimed to assess the clinical features  and surgical approaches and outcomes of complete transposition of  the great arteries (TGA).,Non-OADS,/arxiv_data1/oa_pdf/b3/e3/kjped-55-377.PMC3488613.pdf
"Key words: Dextro-looped transposition of the great arteries, Post - operative complications, Reoperation, MortalitySuk Jin Hong, MD1, Hee Joung Choi, MD2,  Yeo Hyang Kim, MD3, Myung Chul Hyun,  MD1, Sang Bum Lee, MD1, Joon Yong Cho,  MD4 1Department of Pediatrics, Kyungpook National  University School of Medicine, Daegu, 2Department  of Pediatrics, CHA Gumi Medical Center, CHA  University College of Medicine, Gumi, 3Department of  Pediatrics, Keimyung University School of Medicine,  Daegu, 4Department of Thoracic and Cardiovascular  Surgery, Kyungpook National University School of  Medicine, Daegu, Korea Received: 8 July 2011, Revised: 8 March 2012 Accepted: 9 July 2012 Corresponding author: Myung Chul Hyun, MD Department of Pediatrics, Kyungpook National University  Hospital, Kyungpook National University School of Medi - cine, 130 Dongdeok-ro, Jung-gu, Daegu 700-721, Korea Tel: +82-53-420-5704, Fax: +82-53-425-6683,  E-mail: mchyun@knu.ac.kr Copyright © 2012 by The Korean Pediatric Society This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/e3/kjped-55-377.PMC3488613.pdf
"Korean J Pediatr  2012;55(10):377-382 • http://dx.doi.org/10.3345/kjp.2012.55.10.377     379 body weight at diagnosis of 3.4±0.6 kg (range, 2.4 to 5.3 kg) (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/b3/e3/kjped-55-377.PMC3488613.pdf
Korean J Pediatr  2012;55(10):377-382 • http://dx.doi.org/10.3345/kjp.2012.55.10.377     381 the postoperative complication and mortality between the coronary  artery patterns.,Non-OADS,/arxiv_data1/oa_pdf/b3/e3/kjped-55-377.PMC3488613.pdf
"http://dx.doi.org/10.3345/kjp.2012.55.10.383 Korean J Pediatr 2012;55(10):383-387 eISSN 1738-1061 • pISSN 2092-7258Original article 383Cognitive and other neuropsychological profiles in  children with newly diagnosed benign rolandic epilepsy Purpose: Although benign rolandic epilepsy (BRE) is a benign condi - tion, it may be associated with a spectrum of behavioral, psychiatric,  and cognitive disorders.",Non-OADS,/arxiv_data1/oa_pdf/70/55/kjped-55-383.PMC3488614.pdf
"Key words: Rolandic epilepsy, Cognition, Intelligence test, Attention  deficit disorder with hyperactivity, Executive functionSoonhak Kwon, MD, Hye-Eun Seo, MD, Su  Kyeong Hwang, MD  Department of Pediatrics, Kyungpook National  University Hospital, Kyungpook National University  School of Medicine, Daegu, Korea Received: 9 April 2012, Revised: 6 June 2012 Accepted: 11 June 2012Corresponding author: Soonhak Kwon, MDDepartment of Pediatrics, Kyungpook National University Hospital, Kyungpook National University School of Medi - cine, 130 Dongdeok-ro, Jung-gu, Daegu 700-721, KoreaTel: +82-53-420-5704, Fax: +82-53-425-6683, E-mail: shkwon@knu.ac.kr Copyright © 2012 by The Korean Pediatric Society This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/55/kjped-55-383.PMC3488614.pdf
"Korean J Pediatr  2012;55(10):383-387 • http://dx.doi.org/10.3345/kjp.2012.55.10.383     385 [PIQ], 104.2±17 .6), frontal executive function (EIQ, 102.4±24.5),  memory (MQ, 105.9±14.9), attention, and other neuropsychological measurements, even though a child revealed borderline cognitive function (FIQ, 71; VIQ, 73; PIQ, 75).",Non-OADS,/arxiv_data1/oa_pdf/70/55/kjped-55-383.PMC3488614.pdf
Korean J Pediatr  2012;55(10):383-387 • http://dx.doi.org/10.3345/kjp.2012.55.10.383     387 21.,Non-OADS,/arxiv_data1/oa_pdf/70/55/kjped-55-383.PMC3488614.pdf
http://dx.doi.org/10.3345/kjp.2012.55.10.388 Korean J Pediatr 2012;55(10):388-392 eISSN 1738-1061 • pISSN 2092-7258Original article 388LIN28B polymorphisms are associated with central  precocious puberty and early puberty in girls Purpose: Single-nucleotide polymorphism (SNP) markers within  LIN28B  have been reported to be related to the timing of pubertal  growth.,Non-OADS,/arxiv_data1/oa_pdf/89/f6/kjped-55-388.PMC3488615.pdf
"Copyright © 2012 by The Korean Pediatric Society This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/89/f6/kjped-55-388.PMC3488615.pdf
Korean J Pediatr  2012;55(10):388-392 • http://dx.doi.org/10.3345/kjp.2012.55.10.388     389 girls.,Non-OADS,/arxiv_data1/oa_pdf/89/f6/kjped-55-388.PMC3488615.pdf
"Korean J Pediatr  2012;55(10):388-392 • http://dx.doi.org/10.3345/kjp.2012.55.10.388     391 Discussion Recently, variation in or near the LIN28B  gene has been found  associated with age at menarche in four independent genome-wide  association (GWA) studies, and, in one of them, the allele associated  with earlier age at menarche was also associated with other markers  of pubertal timing (earlier breast development; earlier voice breaking  and more advanced pubic hair development; faster tempo of height  growth and shorter adult height)4-7).",Non-OADS,/arxiv_data1/oa_pdf/89/f6/kjped-55-388.PMC3488615.pdf
"http://dx.doi.org/10.3345/kjp.2012.55.10.393 Korean J Pediatr 2012;55(10):393-396 eISSN 1738-1061 • pISSN 2092-7258Case report 393Complete trisomy 14 mosaicism: first live-born case  in Korea Trisomy 14 mosaicism is a rare chromosome disorder characterized by  delayed development, failure to thrive, and facial dysmorphism.",Non-OADS,/arxiv_data1/oa_pdf/04/bd/kjped-55-393.PMC3488616.pdf
"Key words:  Chromosome 14 trisomy, Chromosome disorders Yun Jung Hur, MD, Taegyu Hwang, MD Department of Pediatrics, Inje University Haeundae  Paik Hospital, Inje University College of Medicine, Busan, Korea Received: 22 September 2011, Revised: 3 March 2012 Accepted: 9 May 2012Corresponding author: Taegyu Hwang, MDDepartment of Pediatrics, Inje University Haeundae Paik Hospital, Inje University College of Medicine, 875 Haeun-daero, Haeundae-gu, Busan 612-862, KoreaTel: +82-51-797-2006; Fax: +82-51-797-0032E-mail: H00105@paik.ac.kr Copyright © 2012 by The Korean Pediatric Society This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/bd/kjped-55-393.PMC3488616.pdf
Korean J Pediatr  2012;55(10):393-396 • http://dx.doi.org/10.3345/kjp.2012.55.10.393     395 compared clinical phenotype for complete and partial trisomy based  on previously reported cases (Table 1).,Non-OADS,/arxiv_data1/oa_pdf/04/bd/kjped-55-393.PMC3488616.pdf
"http://dx.doi.org/10.3345/kjp.2012.55.10.397 Korean J Pediatr 2012;55(10):397-402 eISSN 1738-1061 • pISSN 2092-7258Case report 397Magnetic resonance imaging and spectroscopic  analysis in 5 cases of Pelizaeus-Merzbacher disease:  metabolic abnormalities as diagnostic tools  Pelizaeus-Merzbacher disease (PMD) is a rare, X-linked recessive  disorder characterized by dysmyelination in the central nervous  system.",Non-OADS,/arxiv_data1/oa_pdf/d5/37/kjped-55-397.PMC3488617.pdf
"Key words: Pelizaeus-Merzbacher disease, Proteolipid protein,  Magnetic resonance spectroscopyEun Lee, MD1, Mi-Sun Yum, MD1, Hae-Won  Choi, MD1, Han-Wook Yoo, MD1,2, Su Jeong  You, MD3, Eun-Hye Lee, MD4, Tae-Sung Ko,  MD1 1Department of Pediatrics, 2Medical Genetics Clinic and  Laboratory, Asan Medical Center Children’s Hospital,  University of Ulsan College of Medicine, Seoul,  3Department of Pediatrics, Inje University Sanggye Paik  Hospital, Inje University College of Medicine, Seoul,  4Department of Pediatrics, Kyung Hee University  School of Medicine, Seoul, Korea Received: 22 September 2011, Revised: 14 February 2012 Accepted: 16 April 2012 Corresponding author: Tae-Sung Ko, MD  Department of Pediatrics, Asan Medical Center Children’s  Hospital, University of Ulsan College of Medicine, 88  Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea Tel: +82-2-3010-3390, Fax: +82-2-473-3725,  E-mail: tsko@amc.seoul.kr Copyright © 2012 by The Korean Pediatric Society This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/37/kjped-55-397.PMC3488617.pdf
"Korean J Pediatr  2012;55(10):397-402 • http://dx.doi.org/10.3345/kjp.2012.55.10.397     399 this point, her developmental state was equivalent to that of a 3- to  4-month-old infant, by the Korean infant and child developmental  screening test (KICDT).",Non-OADS,/arxiv_data1/oa_pdf/d5/37/kjped-55-397.PMC3488617.pdf
"Korean J Pediatr  2012;55(10):397-402 • http://dx.doi.org/10.3345/kjp.2012.55.10.397     401 psychomotor delay, seizure, stridor, feeding difficulties, ataxia,  and hypotonia progressing to spasticity.",Non-OADS,/arxiv_data1/oa_pdf/d5/37/kjped-55-397.PMC3488617.pdf
"Key Words :  Osteoporosis · Ovariectomized rat · Calcium · Spinal bone fusion.Laboratory Investigation • Received : April 10, 2012  • Revised : July 25, 2012  • Accepted : October 4, 2012 • Address for reprints : Kyoung-Tae Kim, M.D., Ph.D.  Department of Neurosurgery, Kyungpook National University Hospital, 130 Dongdeok-ro, Jung-gu, Daegu 700-721, Korea  Tel : +82-53-420-5657,  Fax : +82-53-423-0504,  E-mail : nskimkt7@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 52  : 281-287, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.281 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/33/77/jkns-52-281.PMC3488633.pdf
"Key Words :  Delayed facial palsy · Microvascular decompression · Delayed cranial palsy · Delayed hearing loss · Delayed abducens palsy.Clinical Article • Received : March 30, 2012  • Revised : July 25, 2012  • Accepted : October 4, 2012 • Address for reprints : Kwan Park, M.D., Ph.D.  Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, Korea   Tel : +82-2-3410-3499,  Fax : +82-2-3410-0048,  E-mail : kwanpark@skku.edu • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 52  : 288-292, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.288 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/9d/37/jkns-52-288.PMC3488634.pdf
"Department of Neurosurgery, Sanggye Paik Hospital, Inje University College of Medicine, 1342 Dongil-ro, Nowon-gu, Seoul 139-707, Korea  Tel : +82-2-950-1039,  Fax : +82-2-950-1040,  E-mail : seth72@hanmail.net  • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean neurosurg soc 52  : 293-299, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.293 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/c4/6b/jkns-52-293.PMC3488635.pdf
"Key Words :  Anterior cervical surgery · Foraminotomy · Uncinate process, Vertebral artery · Nerve root.clinical Article • Received : May 3, 2012  • Revised : August 10, 2012  • Accepted : October 4, 2012 • Address for reprints : Jae Chil Chang, M.D., Ph.D.  Department of Neurosurgery, Soonchunhyang University Seoul Hospital, 59 Daesagwan-ro, Yongsan-gu, Seoul 140-743, Korea   Tel : +82-2-709-9268,  Fax : +82-2-792-5976,  E-mail : j7chang@gmail.com  • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean neurosurg Soc 52  : 300-305, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.300 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/d5/2d/jkns-52-300.PMC3488636.pdf
"Department of Neurosurgery, Kyungpook National University Hospital, 130 Dongdeok-ro, Jung-gu, Daegu 700-721, Korea   Tel : +82-53-420-5656,  Fax : +82-53-423-0504,  E-mail : jparkmd@hotmail.com  • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 52  : 306-311, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.306 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/4e/6a/jkns-52-306.PMC3488637.pdf
"Department of Neurosurgery, Dongguk University Ilsan Hospital, 814 Siksa-dong, Ilsandong-gu, Goyang 410-773, Korea  Tel : +82-31-961-7323,  Fax : +82-31-961-7327,  E-mail : drseraph@lycos.co.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 52  : 312-319, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.312 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/6e/b1/jkns-52-312.PMC3488638.pdf
"Department of Neurosurgery, Kyungpook National University Hospital, 130 Dongdeok-ro, Jung-gu, Daegu 700-721, Korea   Tel : +82-53-420-5656,  Fax : +82-53-423-0504,  E-mail : jparkmd@hotmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 52  : 320-324, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.320 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/31/cd/jkns-52-320.PMC3488639.pdf
"Key Words :  Arachnoid cysts · Central nervous system cysts · Congenital · Neuroendoscopy · Child.Clinical Article • Received : March 21, 2012  • Revised : August 14, 2012  • Accepted : October 4, 2012 • Address for reprints : Young-Shin Ra, M.D., Ph.D.  Department of Neurosurgery, Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea  Tel : +82-2-3010-3560,  Fax : +82-2-476-6738,  E-mail : ysra@amc.seoul.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 52  : 325-333, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.325 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/89/2e/jkns-52-325.PMC3488640.pdf
"Key Words :  Survival time · Gamma knife radiosurgery · Whole brain radiation therapy · Metastases · Lung cancer.Clinical Article • Received : April 4, 2012  • Revised : August 28, 2012  • Accepted : October 4, 2012 • Address for reprints : Eun-Jeong Koh, M.D., Ph.D.   Department of Neurosurgery, Chonbuk National University Medical School/Hospital, 20 Geonji-ro, Deokjin-gu, Jeongju 561-712, Korea  Tel : +82-63-250-1870,  Fax : +82-63-277-3273,  E-mail : kohejns@jbnu.ac.kr  • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 52  : 334-338, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.334 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/2b/a8/jkns-52-334.PMC3488641.pdf
"Department of Neurosurgery, Gyeongsang National University School of Medicine, 79 Gangnam-ro, Jinju 660-702, Korea  Tel : +82-55-750-8112,  Fax : +82-55-759-0817,  E-mail : kongs70@hanmail.net • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean neurosurg soc 52  : 339-345, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.339 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/14/9f/jkns-52-339.PMC3488642.pdf
"Department of Neurosurgery, Cheongju St. Mary’s Hospital, 173-19 Juseong-ro, Sangdang-gu, Cheongju 360-568, Korea   Tel : +82-43-219-8467,  Fax : +82-43-211-7925,  E-mail : somalh@naver.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 52  : 346-352, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.346 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/14/73/jkns-52-346.PMC3488643.pdf
"Department of Neurosurgery, School of Medicine, Chosun University, 365 Pilmun-daero, Dong-gu, Gwangju 501-717, Korea   Tel : +82-62-220-3126,  Fax : +82-62-227-4575,  E-mail : chosunns@chosun.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 52  : 353-358, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.353 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/2c/2c/jkns-52-353.PMC3488644.pdf
"Department of Neurosurgery, Hanyang University College of Medicine, Seoul Hospital, 222 Wangsimni-ro, Seongdong-gu, Seoul 133-792, Korea   Tel : +82-2-2290-8496,  Fax : +82-2-2281-0954,  E-mail : pkh2325@hanyang.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 52  : 359-364, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.359 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/ee/6c/jkns-52-359.PMC3488645.pdf
"Key Words :  ALIF · Anterior interbody fusion · Multilevel ALIF · Pelvic incidence · Anterior lumbar cage · Sagittal balance.clinical Article • Received : December 31, 2011  • Revised : July 5, 2012  • Accepted : October 4, 2012 • Address for reprints : Dae-Jean Jo, M.D., Ph.D.  Spine Center, Kyung Hee University Hospital at Gangdong, 892 Dongnam-ro, Gangdong-gu, Seoul 134-727, Korea  Tel : +82-2-440-8402,  Fax : +82-2-440-8404,  E-mail : apuzzo@hanmail.net • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean neurosurg Soc 52  : 365-371, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.365 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/68/20/jkns-52-365.PMC3488646.pdf
"Department of Neurosurgery, Dong-San Medical Center, Keimyung University School of Medicine, 56 Dalseong-ro, Jung-gu, Daegu 700-712, Korea  Tel : +82-53-250-7730,  Fax : +82-53-250-7356,  E-mail : ppori2k@naver.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 52  : 372-376, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.372 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/e3/75/jkns-52-372.PMC3488647.pdf
"Key Words :  Traumatic brain injury · Diffuse axonal injury · Magnetic resonance imaging · Corpus callosum · Non-hemorrhagic.clinical Article • Received : May 11, 2012  • Revised : July 25, 2012  • Accepted : October 4, 2012 • Address for reprints : Yong Sook Park, M.D., Ph.D.  Department of Neurosurgery, Chung-Ang University Hospital, 102 Heukseok-ro, Dongjak-gu, Seoul 156-755, Korea  Tel : +82-2-6299-1610,  Fax : +82-2-821-8409,  E-mail : cuttage@cau.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean neurosurg Soc 52  : 377-383, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.377 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/5a/16/jkns-52-377.PMC3488648.pdf
"Key Words :  Spinal · Cord · Nerve root · Cervical spine · Thoracic spine · Cadaveric study.clinical Article • Received : May 3, 2012  • Revised : July 30, 2012  • Accepted : October 4, 2012 • Address for reprints : Jae Chil Chang, M.D., Ph.D.  Department of Neurosurgery, Soonchunhyang University Hospital, 59 Daesagwan-ro, Yongsan-gu, Seoul 140-743, Korea  Tel : +82-2-709-9268,  Fax : +82-2-792-5976,  E-mail : j7chang@gmail.com  • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean neurosurg Soc 52  : 384-390, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.384 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/65/5f/jkns-52-384.PMC3488649.pdf
"• This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 52  : 391-395, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.391 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/80/94/jkns-52-391.PMC3488650.pdf
"Department of Neurosurgery, Incheon St. Mary’s Hospital, The Catholic University of Korea College of Medicine, 56 Dongsu-ro, Bupyeong-gu, Incheon 403-720, Korea  Tel : +82-32-280-5867,  Fax : +82-32-280-5991,  E-mail : argus3620@gmail.com  • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean neurosurg Soc 52  : 396-403, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.396 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/6f/1d/jkns-52-396.PMC3488651.pdf
"Case Report • Received : May 24, 2012  • Revised : September 15, 2012  • Accepted : October 10, 2012 • Address for reprints : Ealmaan Kim, M.D., Ph.D.  Department of Neurosurgery, Keimyung University School of Medicine, 56 Dalseong-ro, Jung-gu, Daegu 700-712, Korea  Tel : +82-53-250-7730,  Fax : +82-53-250-7356,  E-mail : bach1158@dsmc.or.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 52  : 404-406, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.404 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/96/0e/jkns-52-404.PMC3488652.pdf
"Key Words :  Spinal hemangioma · Indocyanine green videoangiography · Spinal cavernous · Hemangioma · Spinal epidural hemangioma.case report • Received : February 3, 2012  • Revised : August 28, 2012  • Accepted : October 4, 2012 • Address for reprints : Sang Hyung Lee, M.D., Ph.D.  Department of Neurosurgery, Seoul National University, Boramae Medical Center, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul 156-707, Korea   Tel : +82-2-870-2302,  Fax : +82-2-870-2709,  E-mail : nslee@snu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean neurosurg soc 52  : 407-409, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.407 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/59/92/jkns-52-407.PMC3488653.pdf
"Key Words :  Allergy · Eosinophilic myelitis · Intramedullary tumor · Toxocariasis.Case Report • Received : June 9, 2012  • Revised : September 27, 2012  • Accepted : October 10, 2012 • Address for reprints : Woo Jin Choe, M.D., Ph.D.  Department of Neurosurgery, Konkuk University School of Medicine, 120-1 Neungdong-ro, Gwangjin-gu, Seoul 143-729, Korea  Tel : +82-2-2030-7625,  Fax : +82-2-2030-7359,  E-mail : s1nsman@chol.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean neurosurg soc 52  : 410-413, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.410 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/db/4a/jkns-52-410.PMC3488654.pdf
"Key Words :  Penetrating · Foreign body · Orbit · Craniocerebral trauma.case report • Received : June 8, 2012  • Revised : August 28, 2012  • Accepted : October 4, 2012 • Address for reprints : Seong-Ho Kim, M.D., Ph.D.  Department of Neurosurgery, Yeungnam University College of Medicine, 170 Hyeongchung-ro, Nam-gu, Daegu 705-717, Korea  Tel : +82-53-620-3790,  Fax : +82-53-620-3770,  E-mail : shkim@med.yu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean neurosurg soc 52  : 414-416, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.414 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/0a/ac/jkns-52-414.PMC3488655.pdf
"Key Words :  Intradural extramedullary spinal cord neoplasm · Neonate · Congenital.Case Report • Received : May 29, 2012  • Revised : June 25, 2012  • Accepted : October 4, 2012 • Address for reprints : Seong-Ho Kim, M.D., Ph.D.  Department of Neurosurgery, College of Medicine, Yeungnam University, 170 Hyeonchung-ro, Nam-gu, Daegu 705-717, Korea   Tel : +82-53-620-3790,  Fax : +82-53-620-3770,  E-mail : shkim@med.yu.ac.kr • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 52  : 417-419, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.417 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/e2/6d/jkns-52-417.PMC3488656.pdf
"Key Words :  Aspergillosis · Brain abscess · Neuroaspergillosis · Voriconazole.Case Report • Received : June 21, 2012  • Revised : September 27, 2012  • Accepted : October 10, 2012 • Address for reprints : Dong-Jun Lim, M.D., Ph.D.  Department of Neurosurgery, Korea University Ansan Hospital, 123 Jeokgeum-ro, Danwon-gu, Ansan 425-707, Korea  Tel : +82-31-412-5053,  Fax : +82-31-412-5054,  E-mail : nsdjlim@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 52  : 420-422, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.420 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/89/e9/jkns-52-420.PMC3488657.pdf
"Department of Neurosurgery, Gyeongsang National University School of Medicine, 79 Gangnam-ro, Jinju 660-702, Korea  Tel : +82-55-750-8112,  Fax : +82-55-759-0817,  E-mail : ns4793@hanmail.net • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean neurosurg soc 52  : 423-426, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.423 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/ce/87/jkns-52-423.PMC3488658.pdf
"Key Words :  Cervical cord tumor · Split-spinous laminectomy · Quadrant tube retractor.Technical Note • Received : April 10, 2012  • Revised : August 18, 2012  • Accepted : October 4, 2012 • Address for reprints : Kyoung-Tae Kim, M.D., Ph.D.  Department of Neurosurgery, Kyungpook National University Hospital, 130 Dongdeok-ro, Jung-gu, Daegu 700-721, Korea  Tel : +82-53-200-5657,  Fax : +82-53-423-0504,  E-mail : nskimkt7@gmail.com • This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)     which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.J Korean Neurosurg Soc 52  : 427-431, 2012http://dx.doi.org/10.3340/jkns.2012.52.4.427 Copyright © 2012 The Korean Neurosurgical Society  Print ISSN 2005-3711  On-line ISSN 1598-7876 www.jkns.or.kr",Non-OADS,/arxiv_data1/oa_pdf/e2/d1/jkns-52-427.PMC3488659.pdf
To view these ﬁles please visit the journal online (http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cb/51/jmedgenet-2012-101155.PMC3488700.pdf
To view these ﬁles please visit the journal online (http://dx.doi.org/10.1136/jmedgenet- 2012-101155).,Non-OADS,/arxiv_data1/oa_pdf/cb/51/jmedgenet-2012-101155.PMC3488700.pdf
B36 dbSNP b126; http://www.hapmap.org) that cover the common genetic variants in theVPS35 gene using an r 2threshold of 0.8 –1.0 to select tag SNPs for VPS35 gene.,Non-OADS,/arxiv_data1/oa_pdf/cb/51/jmedgenet-2012-101155.PMC3488700.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2012-001330).,Non-OADS,/arxiv_data1/oa_pdf/d8/3c/bmjopen-2012-001330.PMC3488701.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2012-001324).,Non-OADS,/arxiv_data1/oa_pdf/cf/c0/bmjopen-2012-001324.PMC3488702.pdf
"10In 2010, another campaign the Safer Hospital Programme (http://www.sikkerpatient.",Non-OADS,/arxiv_data1/oa_pdf/cf/c0/bmjopen-2012-001324.PMC3488702.pdf
2011. http://www.sikkerpatient.dk/about-sikker-patient/ the-danish-safer-hospital-programme.aspx (accessed 11 Mar 2011).,Non-OADS,/arxiv_data1/oa_pdf/cf/c0/bmjopen-2012-001324.PMC3488702.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001386).,Non-OADS,/arxiv_data1/oa_pdf/8c/05/bmjopen-2012-001386.PMC3488705.pdf
http://www.statice.,Non-OADS,/arxiv_data1/oa_pdf/8c/05/bmjopen-2012-001386.PMC3488705.pdf
To view these filesplease visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001420).,OADS,/arxiv_data1/oa_pdf/2e/90/bmjopen-2012-001420.PMC3488706.pdf
http://www.dh.gov.uk/en/Publicationsandstatistics/PublishedSurvey/NationalsurveyofNHSpatients/Nationalsurveycancer/index.htm(accessed 19 Dec 2011).,Non-OADS,/arxiv_data1/oa_pdf/85/87/bmjopen-2012-001437.PMC3488707.pdf
"London: Department of Health, The Stationery Office, 2005. http://www.nao.org.uk/publications/0405/tackling_cancer.aspx (accessed19 Dec 2011).",Non-OADS,/arxiv_data1/oa_pdf/85/87/bmjopen-2012-001437.PMC3488707.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001465).,Non-OADS,/arxiv_data1/oa_pdf/93/aa/bmjopen-2012-001465.PMC3488708.pdf
Secondary Statistical bulletin2011 2011. http://www.emcdda.europa.eu/stats11 (accessed 18Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/93/aa/bmjopen-2012-001465.PMC3488708.pdf
http://www.emcdda.europa.eu/publications/country-overviews(accessed 18 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/93/aa/bmjopen-2012-001465.PMC3488708.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001477).,Non-OADS,/arxiv_data1/oa_pdf/5c/75/bmjopen-2012-001477.PMC3488709.pdf
"London: Economic and Social Research Council, 2010; http://www.restore.ac.uk/geo-refer/36229dtuks00y19810000.php (accessed 1 October 2010).",Non-OADS,/arxiv_data1/oa_pdf/5c/75/bmjopen-2012-001477.PMC3488709.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001485).,Non-OADS,/arxiv_data1/oa_pdf/1a/5f/bmjopen-2012-001485.PMC3488710.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2012-001521).,Non-OADS,/arxiv_data1/oa_pdf/2b/00/bmjopen-2012-001521.PMC3488711.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001554).,Non-OADS,/arxiv_data1/oa_pdf/f4/61/bmjopen-2012-001554.PMC3488712.pdf
"New Delhi: Ministry of Health and Family Welfare, 2010. http://mohfw.nic.in/Health%20English%20Report.pdf (accessed on 11th July 2011).",Non-OADS,/arxiv_data1/oa_pdf/d9/ed/bmjopen-2012-001557.PMC3488714.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2012-001421).,Non-OADS,/arxiv_data1/oa_pdf/9b/2b/bmjopen-2012-001421.PMC3488715.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2012-001575).,Non-OADS,/arxiv_data1/oa_pdf/78/25/bmjopen-2012-001575.PMC3488716.pdf
http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD006471/frame.html (accessed 30 Jun 2011).,OADS,/arxiv_data1/oa_pdf/78/25/bmjopen-2012-001575.PMC3488716.pdf
To view these filesplease visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001616).,OADS,/arxiv_data1/oa_pdf/69/dd/bmjopen-2012-001616.PMC3488717.pdf
"Funding The study is supported by an unrestricted grant from the foundation ‘Coeur de la Tour ’(http://www.coeurdelatour.ch) from Geneva, Switzerland.",Non-OADS,/arxiv_data1/oa_pdf/69/dd/bmjopen-2012-001616.PMC3488717.pdf
2010. http://www.niaid.nih.gov/topics/strepThroat/Documents/groupasequelae.pdf (accessed4 June 2012) 4.,Non-OADS,/arxiv_data1/oa_pdf/69/dd/bmjopen-2012-001616.PMC3488717.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001592).,Non-OADS,/arxiv_data1/oa_pdf/e4/81/bmjopen-2012-001592.PMC3488718.pdf
"Additional records were identi ﬁed from abstracts presented at major scienti ﬁc meetings in 2011: namely, the 60th Annual Scienti ﬁc Session of the American College of Cardiology (http://www.abstractsonline.com/plan/AdvancedSearch.aspx), the XXIII Congress of the International Society of Thrombosis and Haemostasis (http://onlinelibrary.wiley.com/doi/10.1111/jth.2011.9.issue-s2/issuetoc) and the American Heart Association Scienti ﬁc Session 2011 (http://circ.ahajournals.org/ content/vol124/21_MeetingAbstracts).",Non-OADS,/arxiv_data1/oa_pdf/e4/81/bmjopen-2012-001592.PMC3488718.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001410).,Non-OADS,/arxiv_data1/oa_pdf/38/67/bmjopen-2012-001410.PMC3488719.pdf
To view these filesplease visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001620).,OADS,/arxiv_data1/oa_pdf/6f/82/bmjopen-2012-001620.PMC3488720.pdf
http://www.ibridgenetwork.org/uctech/salgia-thoracic-oncology-access-template (accessed 21 Jan 2011) 22.,Non-OADS,/arxiv_data1/oa_pdf/6f/82/bmjopen-2012-001620.PMC3488720.pdf
"http://www.ibridgenetwork.org/uctech/salgia-thoracic-oncology-redcap-database-sop(accessed 21 Jan 2011) Carey GB, Kazantsev S, Surati M, et al.BMJ Open 2012; 2:e001620.",Non-OADS,/arxiv_data1/oa_pdf/6f/82/bmjopen-2012-001620.PMC3488720.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001625).,Non-OADS,/arxiv_data1/oa_pdf/e6/8c/bmjopen-2012-001625.PMC3488721.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001649).,Non-OADS,/arxiv_data1/oa_pdf/88/02/bmjopen-2012-001649.PMC3488722.pdf
To view these filesplease visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001677).,OADS,/arxiv_data1/oa_pdf/a7/47/bmjopen-2012-001677.PMC3488723.pdf
http://www.aidsdatahub.org/dmdocuments/UNGASS_2012_Pakistan_Narrative_Report.pdf(accessed Aug 2012) 2.,Non-OADS,/arxiv_data1/oa_pdf/a7/47/bmjopen-2012-001677.PMC3488723.pdf
2006. http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Consultations/Closedconsultations/DH_4124412 (last accessed7 Oct 2012).,OADS,/arxiv_data1/oa_pdf/62/cf/bmjopen-2012-001639.PMC3488724.pdf
"General Surgery of Childhood Report, Scotland, 2008. http://www.specialchildrensservices.scot.nhs.uk/Documents/org00005.pdf(last accessed 7 Oct 2012).",Non-OADS,/arxiv_data1/oa_pdf/62/cf/bmjopen-2012-001639.PMC3488724.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001676).,Non-OADS,/arxiv_data1/oa_pdf/2d/6d/bmjopen-2012-001676.PMC3488725.pdf
"The detailed data files of the WHO Mortality Database, 2010. http://www.who.int/whosis/mort/download/en/index.html (accessed 7 May 2012).",OADS,/arxiv_data1/oa_pdf/2d/6d/bmjopen-2012-001676.PMC3488725.pdf
"Surton: P N Lee Statistics and Computing Ltd., 2009. http://www.pnlee.co.uk/ISS.htm (accessed 21 Jul 2011).",Non-OADS,/arxiv_data1/oa_pdf/2d/6d/bmjopen-2012-001676.PMC3488725.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001684).,Non-OADS,/arxiv_data1/oa_pdf/7a/5e/bmjopen-2012-001684.PMC3488726.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001711).,Non-OADS,/arxiv_data1/oa_pdf/a4/cc/bmjopen-2012-001711.PMC3488727.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2012-001689).,Non-OADS,/arxiv_data1/oa_pdf/31/93/bmjopen-2012-001689.PMC3488728.pdf
http://www.ifcc.org/ifccfiles/docs/190404200805.pdf (accessed 19 October 2012).,Non-OADS,/arxiv_data1/oa_pdf/31/93/bmjopen-2012-001689.PMC3488728.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001736).,Non-OADS,/arxiv_data1/oa_pdf/f8/09/bmjopen-2012-001736.PMC3488730.pdf
Medline web interface at http://www.pubmed.gov was also searched.,OADS,/arxiv_data1/oa_pdf/f8/09/bmjopen-2012-001736.PMC3488730.pdf
2006. http://www.nice.org.uk/nicemedia/live/10903/28934/28934.pdf (accessed 21 Sep 2012).,Non-OADS,/arxiv_data1/oa_pdf/f8/09/bmjopen-2012-001736.PMC3488730.pdf
"Institute of Health and Clinical Excellence, 2006. http://www.nice.org.uk/nicemedia/live/10903/28936/28936.pdf (accessed 21 Sep 2012).",Non-OADS,/arxiv_data1/oa_pdf/f8/09/bmjopen-2012-001736.PMC3488730.pdf
To view these filesplease visit the journal online ((http://dx.doi.org/10.1136/ bmjopen-2012-001776).,Non-OADS,/arxiv_data1/oa_pdf/df/e1/bmjopen-2012-001776.PMC3488732.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2012-001799).,Non-OADS,/arxiv_data1/oa_pdf/7e/65/bmjopen-2012-001799.PMC3488734.pdf
2004. http://www.raosoft.com/samples ize.html.,Non-OADS,/arxiv_data1/oa_pdf/7e/65/bmjopen-2012-001799.PMC3488734.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001810).,Non-OADS,/arxiv_data1/oa_pdf/3c/4c/bmjopen-2012-001810.PMC3488735.pdf
Data sharing statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.b6t13.,OADS,/arxiv_data1/oa_pdf/3c/4c/bmjopen-2012-001810.PMC3488735.pdf
Prev Chronic Dis 2006;3:0180. http://www.cdc.gov/pcd/issues/2006/apr/05_0180.htm 6.,OADS,/arxiv_data1/oa_pdf/3c/4c/bmjopen-2012-001810.PMC3488735.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001790).,Non-OADS,/arxiv_data1/oa_pdf/12/00/bmjopen-2012-001790.PMC3488736.pdf
http://news.bbc.,Non-OADS,/arxiv_data1/oa_pdf/12/00/bmjopen-2012-001790.PMC3488736.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001918).,Non-OADS,/arxiv_data1/oa_pdf/af/1e/bmjopen-2012-001918.PMC3488737.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001926).,Non-OADS,/arxiv_data1/oa_pdf/61/1e/bmjopen-2012-001926.PMC3488738.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-002024).,Non-OADS,/arxiv_data1/oa_pdf/ef/b2/bmjopen-2012-002024.PMC3488739.pdf
"UNAIDS Global Reference group on Estimates, Modelling and Projections http://www.epidem.org (accessed 15 December 2011).",OADS,/arxiv_data1/oa_pdf/da/21/bmjopen-2012-000926.PMC3488742.pdf
"2010, http://www.unaids.org/en/dataanalysis/tools/ estimation projection package epp/12.",Non-OADS,/arxiv_data1/oa_pdf/da/21/bmjopen-2012-000926.PMC3488742.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2012-000998).,Non-OADS,/arxiv_data1/oa_pdf/9f/c2/bmjopen-2012-000998.PMC3488743.pdf
The original and the follow-up studies were approved by the Tasmanian Human Research Ethics Committee and registered in the Australian New Zealand Clinical Trials Registry (http://www.ANZCTR.org.au/ACTRN12609000177257.aspx) and the WHO Clinical Trials Registry (http://www.who.int/trialsearch/trial.,Non-OADS,/arxiv_data1/oa_pdf/9f/c2/bmjopen-2012-000998.PMC3488743.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2012-001007).,Non-OADS,/arxiv_data1/oa_pdf/d8/1d/bmjopen-2012-001007.PMC3488745.pdf
"Search methods for identification of studies We searched the following sources: ▸MEDLINE ▸MEDLINE In-Process ▸EMBASE ▸The Cochrane Library, all sections ▸NHS health technology assessment (HTA) ▸Science Citation Index Expanded (SCI expanded) ▸On-going Trials Registers –Clinical Trials (http://www.clinicaltrials.gov) –Current Control Trials (http://www.controlled- trials.com/) 2 Clar C, Gill JA, Court R, et al.BMJ Open 2012; 2:e001007.",Non-OADS,/arxiv_data1/oa_pdf/d8/1d/bmjopen-2012-001007.PMC3488745.pdf
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM262990.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d8/1d/bmjopen-2012-001007.PMC3488745.pdf
July 2007. http://www.oecd.org/ (accessed 9 Sept 2012).,Non-OADS,/arxiv_data1/oa_pdf/bc/96/bmjopen-2012-001029.PMC3488746.pdf
"Data Sharing Statement Extra data can be accessed via the Dryad data repository at http://datadryad.org/ with the doi:10.5061/dryad.kt8tf.Table 2 Risk factors for poor outcome (postoperative uncorrected visual acuity <6/60) VariablesUnivariate analysis p ValueMultivariate analysis p Value Crude OR (95% CI) Adjusted OR (95% CI) Gender (male : female) 0.60 (0.33 to 1.11) 0.12 0.63 (0.33 to 1.2) 0.16 Age in years ( ≤70 vs >70) 0.47 (0.06 to 3.52) 0.5 0.4 (0.05 to 3.11) 0.39 With or without associated ocular pathology 6.96 (3.31 to 14.67) <0.001 7.43 (3.37 to 16.39) <0.001MSICS versus phacoemulsification 1.74 (0.93 to 3.23) 0.08 1.5 (0.77 to 2.91) 0.23Complication versus no complication 5.70 (3.0 to 10.83) <0.001 5.6 (2.84 to 11.06) <0.001H-L goodness of fit ( χ 2) 8.62 0.07 H-L, Hosmer Lemeshow test; MSICS, manual small incision cataract surgery.",Non-OADS,/arxiv_data1/oa_pdf/2b/f6/bmjopen-2012-001035.PMC3488747.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001162).,Non-OADS,/arxiv_data1/oa_pdf/9b/d7/bmjopen-2012-001162.PMC3488749.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001071).,Non-OADS,/arxiv_data1/oa_pdf/df/63/bmjopen-2012-001071.PMC3488750.pdf
To view these filesplease visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001231).,OADS,/arxiv_data1/oa_pdf/c5/8e/bmjopen-2012-001231.PMC3488751.pdf
(Updated 2010) http://www.goldcopd.org/ Guidelineitem.asp?l1=2&l2=1&intId=989 (accessed 17 May 2011).32.,Non-OADS,/arxiv_data1/oa_pdf/c5/8e/bmjopen-2012-001231.PMC3488751.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001253).,Non-OADS,/arxiv_data1/oa_pdf/6e/3a/bmjopen-2012-001253.PMC3488752.pdf
2 February 2011. http://nigeriaworld.com/articles/2011/feb/012.htm/(accessed 2 Feb 2011).,Non-OADS,/arxiv_data1/oa_pdf/6e/3a/bmjopen-2012-001253.PMC3488752.pdf
Available from http://www.goldcopd.org 56.,Non-OADS,/arxiv_data1/oa_pdf/6e/3a/bmjopen-2012-001253.PMC3488752.pdf
Epidemiological study on effect of IR Pollution onHuman health (Adults) in Delhi August 2008. http://www.cpcb.nk.in/e-mail:cpcb@nic.in 59.,Non-OADS,/arxiv_data1/oa_pdf/6e/3a/bmjopen-2012-001253.PMC3488752.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001165).,Non-OADS,/arxiv_data1/oa_pdf/73/c6/bmjopen-2012-001165.PMC3488753.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001267).,Non-OADS,/arxiv_data1/oa_pdf/49/9c/bmjopen-2012-001267.PMC3488754.pdf
”http://www.mhlw.go.jp/za/0825/c04/ c04.html (accessed 31 Mar 2011).,Non-OADS,/arxiv_data1/oa_pdf/34/53/bmjopen-2012-001280.PMC3488755.pdf
The basic statistics 2011. http://www.stat.go.jp/data/kokusei/2010/kihon1/pdf/gaiyou1.pdf.,OADS,/arxiv_data1/oa_pdf/34/53/bmjopen-2012-001280.PMC3488755.pdf
Summary of VitalStatistics 2012. http://www.mhlw.go.jp/english/database/db-hw/populate/dl/01.pdf.,Non-OADS,/arxiv_data1/oa_pdf/34/53/bmjopen-2012-001280.PMC3488755.pdf
http://www.mhlw.go.jp/ houdou/2008/03/h0328-8.html.,Non-OADS,/arxiv_data1/oa_pdf/34/53/bmjopen-2012-001280.PMC3488755.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001288).,Non-OADS,/arxiv_data1/oa_pdf/01/84/bmjopen-2012-001288.PMC3488756.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001315).,Non-OADS,/arxiv_data1/oa_pdf/1a/d8/bmjopen-2012-001315.PMC3488758.pdf
"Hyattsville, MD: National Center for Health Statistics; 1994. ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Datasets/NHANES/NHANESIII/25a/sshormon.pdf (accessed 9 Jul 2010).",OADS,/arxiv_data1/oa_pdf/1a/d8/bmjopen-2012-001315.PMC3488758.pdf
":QLK6- CT-2002-02647)andcoordinatedbytheDepartmentof MedicalSociology,SocialMedicineandHealthEconomics at the University of Hamburg ( http://www.uke.de/ eurofamcare/).)",Non-OADS,/arxiv_data1/oa_pdf/66/3a/PSM-09-06.PMC3488802.pdf
3.StatistischesBundesamt.Pflegestatistik2009.PflegeimRahmen derPflegeversicherung–Deutschlandergebnisse.Wiesbaden: DESTATIS;2011.Availablefrom:https://www.destatis.de/DE/ Publikationen/Thematisch/Gesundheit/Pflege/Pflege Deutschlandergebnisse5224001099004.pdf?__blob= publicationFile 4.,Non-OADS,/arxiv_data1/oa_pdf/66/3a/PSM-09-06.PMC3488802.pdf
"(PotentialandLimitationofIndependentLivinginPrivate HouseholdsinGermany(MuGIII);EnglishSummary,available from:http://www.bmfsfj.de/RedaktionBMFSFJ/Abteilung3/Pdf- Anlagen/mug-3-results,property=pdf,bereich=bmfsfj,sprache= de,rwb=true.pdf) 16.",OADS,/arxiv_data1/oa_pdf/66/3a/PSM-09-06.PMC3488802.pdf
Availablefrom:http://www.pro-newsletter.com/images/PDF/ qoln32.pdf 33.,Non-OADS,/arxiv_data1/oa_pdf/66/3a/PSM-09-06.PMC3488802.pdf
Availablefrom:http://www.diw.de/documents/publikationen/ 73/diw_01.c.92679.de/04-20-1.pdf43.,Non-OADS,/arxiv_data1/oa_pdf/66/3a/PSM-09-06.PMC3488802.pdf
"Availablefrom:http://www.landtag.nrw.de/portal/WWW/ dokumentenarchiv/Dokument/MMZ13-1910.pdf Correspondingauthor: DanielLüdecke UniversityMedicalCenterHamburgEppendorf,Dept.of MedicalSociologyandHealthEconomics,Martinistr.52, 20246Hamburg,Germany,Phone:+49407410-52878 d.luedecke@uke.de Pleaseciteas LüdeckeD ,MnichE,KofahlC.Theimpactofsociodemographicfactors ontheutilisationofsupportservices forfamilycaregivers ofelderly dependents–resultsfromtheGermansampleoftheEUROFAMCARE study.",Non-OADS,/arxiv_data1/oa_pdf/66/3a/PSM-09-06.PMC3488802.pdf
"DOI: 10.3205/psm000084,URN:urn:nbn:de:0183-psm0000844 Thisarticleisfreelyavailablefrom http://www.egms.de/en/journals/psm/2012-9/psm000084.shtml Published: 2012-10-25 Copyright ©2012Lüdeckeetal .ThisisanOpenAccessarticledistributedunder thetermsoftheCreative CommonsAttributionLicense (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en).You arefree:toShare—tocopy,distributeandtransmitthework,provided theoriginalauthorandsourcearecredited.",Non-OADS,/arxiv_data1/oa_pdf/66/3a/PSM-09-06.PMC3488802.pdf
"Keywords: genetic structure, statistical parsimony, Asian citrus psyllid, citrus, citrus greening disease, Huanglongbing, novel COI primers (Accepted 29 February 2012; First published online 17 April 2012) The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.",Non-OADS,/arxiv_data1/oa_pdf/a5/51/S0007485312000181a.PMC3488809.pdf
"New mtCOI primers for D. citri were designed from an EST library generated at the USDA (Hunter et al.,2008) and available in GenBank ( http://www.ncbi.nlm.nih.gov/ ).",OADS,/arxiv_data1/oa_pdf/a5/51/S0007485312000181a.PMC3488809.pdf
"Integrated Pest management Florida, University of Florida, availableonline at http://ipm.ifas.ufl.edu/agriculture/citrus/psyllid.",Non-OADS,/arxiv_data1/oa_pdf/a5/51/S0007485312000181a.PMC3488809.pdf
"Florida Department of Agriculture Conservation Service, Division of Plant Industry Entomology Circular 180, Florida Division of Plant Industry, available online at http://www.freshfromflorida.com/pi/ enpp/ento/entcirc/ent180.pdf .",Non-OADS,/arxiv_data1/oa_pdf/a5/51/S0007485312000181a.PMC3488809.pdf
"Centers for Disease Control and Prevention (CDC): Atlanta, Georgia, 2009. http://apps.nccd.cdc.gov/brfss/index.asp.",Non-OADS,/arxiv_data1/oa_pdf/1b/28/nutd201222a.PMC3488810.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Vegetable intake correlates with weight loss LD Whigham et al 5 &2012 Macmillan Publishers Limited Nutrition and Diabetes",Non-OADS,/arxiv_data1/oa_pdf/1b/28/nutd201222a.PMC3488810.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Betaine inversely associates with metabolic stress J Yan et al 7 &2012 Macmillan Publishers Limited Nutrition and Diabetes",Non-OADS,/arxiv_data1/oa_pdf/30/15/nutd201223a.PMC3488811.pdf
"Supplementary material For supplementary material accompanying this paper, visit http://dx.doi.org/10.1017/S0033291712000591.",Non-OADS,/arxiv_data1/oa_pdf/5c/39/S0033291712000591a.PMC3488813.pdf
"The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence ,http://creativecommons.org/licenses/by-nc-sa/2.5/ ..",Non-OADS,/arxiv_data1/oa_pdf/81/29/S0007114511006891a.PMC3488814.pdf
http://www.imf.org/external/pubs/ft/weo/2011/01/weodata/index.aspx (accessed May 2011).,OADS,/arxiv_data1/oa_pdf/81/29/S0007114511006891a.PMC3488814.pdf
"2011;474(7352):450, http://dx.doi.org/10.1038/474450d.",Non-OADS,/arxiv_data1/oa_pdf/39/e1/cln-67-11-1235.PMC3488977.pdf
"2011;66(12):2099-104, http://dx.doi.org/10.1590/S1807-59322011001200 016.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2010;65(12):1295-304, http://dx.doi.org/10.1590/S1807- 59322010001200012.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2010;65(9):847-50, http://dx.doi.org/10.1590/S1807-59322010000900006.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2010;65(9):841- 6, http://dx.doi.org/10.1590/S1807-59322010000900005.9.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2010;65(7):663-74, http://dx.doi.org/10.1590/ S1807-59322010000700004.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2010;65(12):1239-45, http://dx.doi.org/ 10.1590/S1807-59322010001200004.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2011;66(4):573-7, http://dx.doi.org/10.1590/S1807-59322011000400009.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2011;66(6):1051-4, http://dx.doi.org/10.1590/S1807-59322011000 600022.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2010;65(9):871-6, http://dx.doi.org/10.1590/S1807-59322010000900010.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2011;66(2):211-6, http://dx.doi.org/10.1590/S1807-593220110002 00005.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2011;66(11):1879-86, http://dx.doi.org/ 10.1590/S1807-59322011001100006.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2011;66(9):1621- 5, http://dx.doi.org/10.1590/S1807-59322011000900020.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2011;66(7):1157-63, http://dx.doi.org/10.1590/S1807- 59322011000700006.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2011;66(5):823-7, http://dx.doi.org/10.1590/S1807- 59322011000500019.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2011;66(5):759-66, http://dx.doi.org/10.1590/S1807-59322011000500009.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2011;66(1):107-11, http://dx.doi.org/10.1590/S1807- 59322011000100019.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2010;65(6):593-7, http://dx.doi.org/10.1590/S1807-59322010000600006.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2010;65(12):1229-37, http://dx.doi.org/10.1590/S1807- 59322010001200003.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2011;66(4):549-56, http://dx.doi.org/ 10.1590/S1807-59322011000400005.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2011;66(7):1193-7, http://dx.doi.org/10.1590/S1807-59322011000 700012.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2011;66(6):933-7, http://dx.doi.org/ 10.1590/S1807-59322011000600002.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2011;66(5):879-87, http://dx.doi.org/10.1590/S1807-59322011000500027.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2011;66(3):425-30, http://dx.doi.org/10.1590/S1807-59322011000300011.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2011;66(7):1137-42, http://dx.doi.org/10.1590/S1807- 59322011000700003.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2011;66(4):649-56, http://dx.doi.org/10.1590/ S1807-59322011000400021.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2010;65(4):393-400, http://dx.doi.org/ 10.1590/S1807-59322010000400008.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2011;66(11):1887-94, http://dx.doi.org/10.1590/S1807-59322011001100 007.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2010;65(4):369-75, http://dx.doi.org/10.1590/S1807- 59322010000400004.37.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2011;66(12):2085-91, http://dx.doi.org/ 10.1590/S1807-59322011001200014.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2011;66(5):817-22, http://dx.doi.org/10.1590/S1807- 59322011000500018.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2011;66(2):267-74, http://dx.doi.org/10.1590/S1807-59322011000200015.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2011;66(10):1721-7, http://dx.doi.org/10.1590/S1807-59322011001000009.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2011;66(6):1081-7, http://dx.doi.org/10.1590/S1807- 59322011000600027.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2010;65(5):531-7, http://dx.doi.org/ 10.1590/S1807-59322010000500011.",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2011;66(8):1451-5, http://dx.doi.org/10.1590/S1807-59322011000800024.Pneumological in Clinics Rocha e Silva MCLINICS 2012;67(11):1237-1240 1240",Non-OADS,/arxiv_data1/oa_pdf/36/98/cln-67-11-1237.PMC3488978.pdf
"2008;49(1):87-92, http://dx.doi.org/10.1167/iovs.",Non-OADS,/arxiv_data1/oa_pdf/2c/0c/cln-67-11-1241.PMC3488979.pdf
"2002;134(6):926-7, http://dx.doi.org/10.1016/S0002- 9394(02)01793-2.CLINICS 2012;67(11):1241-1245 Intraocular pressure in preterm infants Lindenmeyer RL et al.",Non-OADS,/arxiv_data1/oa_pdf/2c/0c/cln-67-11-1241.PMC3488979.pdf
"1991;265(24):3265-9, http://dx.doi.org/ 10.1001/jama.1991.03460240061028.",Non-OADS,/arxiv_data1/oa_pdf/a8/da/cln-67-11-1247.PMC3488980.pdf
"2000;38(3):261-71, http://dx.doi.org/10.1097/ 00005650-200003000-00003.",Non-OADS,/arxiv_data1/oa_pdf/a8/da/cln-67-11-1247.PMC3488980.pdf
"2009;18(4):297-302, http://dx.doi.org/10.1136/qshc.2007.025924.",Non-OADS,/arxiv_data1/oa_pdf/a8/da/cln-67-11-1247.PMC3488980.pdf
"2006;4(5):410-6, http://dx.doi.org/10.1370/afm.553.",Non-OADS,/arxiv_data1/oa_pdf/a8/da/cln-67-11-1247.PMC3488980.pdf
"1992;152(10):2074- 80, http://dx.doi.org/10.1001/ archinte.1992.00400220090016.",Non-OADS,/arxiv_data1/oa_pdf/a8/da/cln-67-11-1247.PMC3488980.pdf
"2000;320(7237):774-7, http://dx.doi.org/10.1136/ bmj.320.7237.774.",Non-OADS,/arxiv_data1/oa_pdf/a8/da/cln-67-11-1247.PMC3488980.pdf
Available at: http://www.nap.edu/ catalog/9728.html.,Non-OADS,/arxiv_data1/oa_pdf/a8/da/cln-67-11-1247.PMC3488980.pdf
"2003;18(1):61-7, http://dx.doi.org/10.1046/ j.1525-1497.2003.20147.x.",Non-OADS,/arxiv_data1/oa_pdf/a8/da/cln-67-11-1247.PMC3488980.pdf
"2003;163(22):2716-24, http://dx.doi.org/10.1001/archinte.163.22.2716.",Non-OADS,/arxiv_data1/oa_pdf/a8/da/cln-67-11-1247.PMC3488980.pdf
"1987;40(5):373-83, http://dx.doi.org/ 10.1016/0021-9681(87)90171-8.",Non-OADS,/arxiv_data1/oa_pdf/a8/da/cln-67-11-1247.PMC3488980.pdf
"1993;270(24):2957-63, http://dx.doi.org/10.1001/ jama.1993.03510240069035.",Non-OADS,/arxiv_data1/oa_pdf/a8/da/cln-67-11-1247.PMC3488980.pdf
"1991;265( 24):3265-9, http://dx.doi.org/ 10.1001/jama.1991.03460240061028.",Non-OADS,/arxiv_data1/oa_pdf/a8/da/cln-67-11-1247.PMC3488980.pdf
"2006;14:350-9, http://dx.doi.org/10.1097/01.idc.0000227713.81012.ae.",Non-OADS,/arxiv_data1/oa_pdf/a8/da/cln-67-11-1247.PMC3488980.pdf
"Int J Qual Health Care 2009;21(4):279-84, http://dx.doi.org/10.1093/intqhc/mzp022.",OADS,/arxiv_data1/oa_pdf/a8/da/cln-67-11-1247.PMC3488980.pdf
"2009; 64(7):613-8, http://dx.doi.org/10.1590/S1807-59322009000700002.Adverse events in elderly hospitalized patients Szlejf C et al.CLINICS 2012;67(11):1247-1252 1252",Non-OADS,/arxiv_data1/oa_pdf/a8/da/cln-67-11-1247.PMC3488980.pdf
"2002;56(1):33-8, http://dx.doi.org/10.1046/j.0300-0664.2001.01457.x.",Non-OADS,/arxiv_data1/oa_pdf/cc/b2/cln-67-11-1253.PMC3488981.pdf
"1994;160:3(1)-10, http://dx.doi.org/10.1055/s-2008-1032364.",Non-OADS,/arxiv_data1/oa_pdf/cc/b2/cln-67-11-1253.PMC3488981.pdf
"2003;16(3):183-9, http://dx.doi.org/10.1016/ S0929-8266(02)00072-1.19.",Non-OADS,/arxiv_data1/oa_pdf/cc/b2/cln-67-11-1253.PMC3488981.pdf
"1996;335(2):99-107, http://dx.doi.org/10.1056/NEJM199607113350206.",Non-OADS,/arxiv_data1/oa_pdf/cc/b2/cln-67-11-1253.PMC3488981.pdf
"1989;11(6):184-91, http://dx.doi.org/10.1542/pir.11-6-184.",Non-OADS,/arxiv_data1/oa_pdf/cc/b2/cln-67-11-1253.PMC3488981.pdf
"1975;40(5):795-801, http://dx.doi.org/10.1210/jcem-40-5-795.",Non-OADS,/arxiv_data1/oa_pdf/cc/b2/cln-67-11-1253.PMC3488981.pdf
"1998;8(6):511- 5, http://dx.doi.org/10.1089/thy.1998.8.511.",Non-OADS,/arxiv_data1/oa_pdf/cc/b2/cln-67-11-1253.PMC3488981.pdf
"2001;45(5):669- 74, http://dx.doi.org/10.1159/000328285.",Non-OADS,/arxiv_data1/oa_pdf/cc/b2/cln-67-11-1253.PMC3488981.pdf
"1999;140(5):452-6, http://dx.doi.org/10.1530/ eje.0.1400452.",Non-OADS,/arxiv_data1/oa_pdf/cc/b2/cln-67-11-1253.PMC3488981.pdf
"2000;36(1):5-10, http://dx.doi.org/ 10.1016/S0720-048X(00)00147-9.",OADS,/arxiv_data1/oa_pdf/cc/b2/cln-67-11-1253.PMC3488981.pdf
"2004;32(1):24-8, http://dx.doi.org/ 10.1002/jcu.10215.CLINICS 2012;67(11):1253-1257 Resistive Index in Hashimoto’s Thyroiditis Sarikaya B et al.",Non-OADS,/arxiv_data1/oa_pdf/cc/b2/cln-67-11-1253.PMC3488981.pdf
"2010;15(3):451-8, http://dx.doi.org/10.1111/j.1440-1843.2010.01723.x.",Non-OADS,/arxiv_data1/oa_pdf/7e/e8/cln-67-11-1259.PMC3488982.pdf
"2009;187(5):263-70, http://dx.doi.org/10.1007/s00408-009-9165-3.",Non-OADS,/arxiv_data1/oa_pdf/7e/e8/cln-67-11-1259.PMC3488982.pdf
"2007;131(4):1125-32, http://dx.doi.org/10.1378/chest.06-2352.",Non-OADS,/arxiv_data1/oa_pdf/7e/e8/cln-67-11-1259.PMC3488982.pdf
"2003;14(2):77-88, http://dx.doi.org/10.1016/S0953-6205(03)00018-9.",Non-OADS,/arxiv_data1/oa_pdf/7e/e8/cln-67-11-1259.PMC3488982.pdf
"Immunol Rev 2008;226:191-204, http://dx.doi.org/10.1111/j.1600-065X.2008.",Non-OADS,/arxiv_data1/oa_pdf/7e/e8/cln-67-11-1259.PMC3488982.pdf
"2008;75(2):121-33, http://dx.doi.org/10.1159/000113629.",Non-OADS,/arxiv_data1/oa_pdf/7e/e8/cln-67-11-1259.PMC3488982.pdf
"2003;21(3):539-44, http://dx.doi.org/10.1183/09031936.03.00403902.",Non-OADS,/arxiv_data1/oa_pdf/7e/e8/cln-67-11-1259.PMC3488982.pdf
"2009;47(2):132- 6, http://dx.doi.org/10.1016/j.cyto.2009.05.016.",OADS,/arxiv_data1/oa_pdf/7e/e8/cln-67-11-1259.PMC3488982.pdf
"2005;2005(1):2-8, http://dx.doi.org/10.1155/ MI.2005.2.",Non-OADS,/arxiv_data1/oa_pdf/7e/e8/cln-67-11-1259.PMC3488982.pdf
"2008;(3): 307-14, http://dx.doi.org/10.1016/ j.cyto.2007.12.009.",OADS,/arxiv_data1/oa_pdf/7e/e8/cln-67-11-1259.PMC3488982.pdf
"2008;102(6)280-6, http://dx.doi.org/10.1016/j.rmed.2007.08.016.",OADS,/arxiv_data1/oa_pdf/7e/e8/cln-67-11-1259.PMC3488982.pdf
"1998;92(1):14-7, http://dx.doi.org/10.1016/ S0954-6111(98)90025-7.",Non-OADS,/arxiv_data1/oa_pdf/7e/e8/cln-67-11-1259.PMC3488982.pdf
"2007;85(2):103- 11, http://dx.doi.org/10.1038/sj.icb.7100027.",Non-OADS,/arxiv_data1/oa_pdf/7e/e8/cln-67-11-1259.PMC3488982.pdf
"2004;9(1):81-6, http://dx.doi.org/ 10.1111/j.1440-1843.2003.00529.x.",Non-OADS,/arxiv_data1/oa_pdf/7e/e8/cln-67-11-1259.PMC3488982.pdf
"1999;116(5):1292-6, http://dx.doi.org/10.1378/chest.116.5.1292.",Non-OADS,/arxiv_data1/oa_pdf/7e/e8/cln-67-11-1259.PMC3488982.pdf
"1998;158(18):2017-21, http://dx.doi.org/10.1001/archinte.158.18.2017.",Non-OADS,/arxiv_data1/oa_pdf/7e/e8/cln-67-11-1259.PMC3488982.pdf
"2006; 129(5):1253-8, http://dx.doi.org/ 10.1378/chest.129.5.1253.",Non-OADS,/arxiv_data1/oa_pdf/7e/e8/cln-67-11-1259.PMC3488982.pdf
"2010;73(3):545-50, http://dx.doi.org/10.1016/j.ejrad.2008.12.009.",OADS,/arxiv_data1/oa_pdf/7e/e8/cln-67-11-1259.PMC3488982.pdf
"2011; 66(4):549-56, http://dx.doi.org/10.1590/S1807-59322011000400005.",Non-OADS,/arxiv_data1/oa_pdf/7e/e8/cln-67-11-1259.PMC3488982.pdf
"2005;183(3):185-95, http://dx.doi.org/10.1007/s00408- 004-2533-0.",Non-OADS,/arxiv_data1/oa_pdf/7e/e8/cln-67-11-1259.PMC3488982.pdf
"2003;8(3):321-5, http://dx.doi.org/10.1046/j.1440-1843.2003.00474.x.",Non-OADS,/arxiv_data1/oa_pdf/7e/e8/cln-67-11-1259.PMC3488982.pdf
"2010;265(4):586-98, http://dx.doi.org/10.1016/ j.jtbi.2010.05.012.CLINICS 2012;67(11):1259-1263 Pleural inflammation in tuberculosis Antonangelo L et al.",Non-OADS,/arxiv_data1/oa_pdf/7e/e8/cln-67-11-1259.PMC3488982.pdf
"1970;172(4):755-773, http://dx.doi.org/10.1097/00000658- 197010000-00020.",Non-OADS,/arxiv_data1/oa_pdf/30/bd/cln-67-11-1265.PMC3488983.pdf
"2009;23(7):1433-40, http://dx.doi.org/10.1007/s00464-008-0223-3.",Non-OADS,/arxiv_data1/oa_pdf/30/bd/cln-67-11-1265.PMC3488983.pdf
"2010;148(4):893-7, http://dx.doi.org/10.1016/ j.surg.2010.07.008.",OADS,/arxiv_data1/oa_pdf/30/bd/cln-67-11-1265.PMC3488983.pdf
"2010;65(5):531-7, http://dx.doi.org/10.1590/ S1807-59322010000500011.",Non-OADS,/arxiv_data1/oa_pdf/30/bd/cln-67-11-1265.PMC3488983.pdf
"2011;66(1):107-11, http://dx.doi.org/10.1590/S1807- 59322011000100019.",Non-OADS,/arxiv_data1/oa_pdf/30/bd/cln-67-11-1265.PMC3488983.pdf
"2011;66(5):759-66, http://dx.doi.org/10.1590/S1807-59322011000500009.",Non-OADS,/arxiv_data1/oa_pdf/30/bd/cln-67-11-1265.PMC3488983.pdf
"2002;166(12 Pt 1): 1604-6, http://dx.doi.org/10.1164/rccm.200203-175CR.",Non-OADS,/arxiv_data1/oa_pdf/30/bd/cln-67-11-1265.PMC3488983.pdf
"2010;22(7):549-52, http://dx.doi.org/10.1016/j.jclinane.2009.",OADS,/arxiv_data1/oa_pdf/30/bd/cln-67-11-1265.PMC3488983.pdf
"2007;21(3):475-9, http://dx.doi.org/10.1007/s00464-006-9125-4.Diaphragmatic Pacing in Spinal Cord Injury Tedde ML et al.CLINICS 2012;67(11):1265-1269 1268",Non-OADS,/arxiv_data1/oa_pdf/30/bd/cln-67-11-1265.PMC3488983.pdf
"1998;53(3):273-89, http://dx.doi.org/10.1046/j.1365- 2044.1998.00337.x.",Non-OADS,/arxiv_data1/oa_pdf/30/bd/cln-67-11-1265.PMC3488983.pdf
"2008;18(3):423-7, http://dx.doi.org/10.1089/lap.2007.0097.",Non-OADS,/arxiv_data1/oa_pdf/30/bd/cln-67-11-1265.PMC3488983.pdf
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/ cftopic/pma/pma.cfm?num=H100006.21.,OADS,/arxiv_data1/oa_pdf/30/bd/cln-67-11-1265.PMC3488983.pdf
"2005;19(5):633-7, http://dx.doi.org/10.1007/s00464-004-8934-6.",Non-OADS,/arxiv_data1/oa_pdf/30/bd/cln-67-11-1265.PMC3488983.pdf
"2008;38(6):1546-52, http://dx.doi.org/10.1002/ mus.21123.",Non-OADS,/arxiv_data1/oa_pdf/30/bd/cln-67-11-1265.PMC3488983.pdf
"2011;6(5):289-97, http://dx.doi.org/10.1097/IMI.0b013e318237cc97.",Non-OADS,/arxiv_data1/oa_pdf/30/bd/cln-67-11-1265.PMC3488983.pdf
"2005;127(2):671-8, http://dx.doi.org/10.1378/chest.127.2.",Non-OADS,/arxiv_data1/oa_pdf/30/bd/cln-67-11-1265.PMC3488983.pdf
"2006;21(11):3098-105, http://dx.doi.org/10.1093/ndt/gfl237.",Non-OADS,/arxiv_data1/oa_pdf/5c/b2/cln-67-11-1271.PMC3488984.pdf
"2007;2(3):445-53, http://dx.doi.org/ 10.2215/CJN.03531006.",Non-OADS,/arxiv_data1/oa_pdf/5c/b2/cln-67-11-1271.PMC3488984.pdf
"2007; 11(3):214-7, http://dx.doi.org/ 10.1007/s10157-007-0484-5.",Non-OADS,/arxiv_data1/oa_pdf/5c/b2/cln-67-11-1271.PMC3488984.pdf
"2002;39(3): 503-12, http://dx.doi.org/10.1053/ajkd.2002.31400.",Non-OADS,/arxiv_data1/oa_pdf/5c/b2/cln-67-11-1271.PMC3488984.pdf
"1988;8(4):291-297, http://dx.doi.org/ 10.1159/000167603.",Non-OADS,/arxiv_data1/oa_pdf/5c/b2/cln-67-11-1271.PMC3488984.pdf
"2003;18(7): 1316-20, http://dx.doi.org/10.1093/ndt/gfg134.",Non-OADS,/arxiv_data1/oa_pdf/5c/b2/cln-67-11-1271.PMC3488984.pdf
"2010;25(1):124-9, http://dx.doi.org/10.1093/ndt/gfp422.",Non-OADS,/arxiv_data1/oa_pdf/5c/b2/cln-67-11-1271.PMC3488984.pdf
"2009;54(5):945-53, http://dx.doi.org/10.1053/ j.ajkd.2009.03.019.",Non-OADS,/arxiv_data1/oa_pdf/5c/b2/cln-67-11-1271.PMC3488984.pdf
"2008;28(Suppl 1):S34-41, http://dx.doi.org/10.1007/s10875-008-9187-2.",Non-OADS,/arxiv_data1/oa_pdf/61/ec/cln-67-11-1275.PMC3488985.pdf
"2010;65(3):327-33, http://dx.doi.org/10.1590/S1807-59322010000 300014.",Non-OADS,/arxiv_data1/oa_pdf/61/ec/cln-67-11-1275.PMC3488985.pdf
"2008;8(7):545-58, http://dx.doi.org/10.1038/nri2336.",Non-OADS,/arxiv_data1/oa_pdf/61/ec/cln-67-11-1275.PMC3488985.pdf
"1994;12:227-57, http://dx.doi.org/10.1146/ annurev.iy.12.040194.001303.",Non-OADS,/arxiv_data1/oa_pdf/61/ec/cln-67-11-1275.PMC3488985.pdf
"1988;31(8):1000-6, http://dx.doi.org/10.1002/ art.1780310810.",Non-OADS,/arxiv_data1/oa_pdf/61/ec/cln-67-11-1275.PMC3488985.pdf
"Int Arch Allergy Immunol 2010;152(4):401-6, http://dx.doi.org/10.1159/000288293.",Non-OADS,/arxiv_data1/oa_pdf/61/ec/cln-67-11-1275.PMC3488985.pdf
"1992;90(2):143-50, http://dx.doi.org/10.1016/0091-6749(92)90064-9.",Non-OADS,/arxiv_data1/oa_pdf/61/ec/cln-67-11-1275.PMC3488985.pdf
"1976;19(4):669-76, http://dx.doi.org/10.1002/1529-0131(197607/ 08)19:4,669::AID-ART1780190403 .3.0.CO;2-E.13.",Non-OADS,/arxiv_data1/oa_pdf/61/ec/cln-67-11-1275.PMC3488985.pdf
"1997;40(9):1725, http://dx.doi.org/10.1002/art.17804- 00928.",Non-OADS,/arxiv_data1/oa_pdf/61/ec/cln-67-11-1275.PMC3488985.pdf
"2005;6(1):2-8, http://dx.doi.org/10.1097/ 01.PCC.0000149131.72248.e6"",-1,""xxx/72248.e6.",Non-OADS,/arxiv_data1/oa_pdf/61/ec/cln-67-11-1275.PMC3488985.pdf
"1994;8(2):230-49, http://dx.doi.org/10.1007/BF00865490.",Non-OADS,/arxiv_data1/oa_pdf/61/ec/cln-67-11-1275.PMC3488985.pdf
"1992;35(6):630-40, http://dx.doi.org/10.1002/art.1780350606.",Non-OADS,/arxiv_data1/oa_pdf/61/ec/cln-67-11-1275.PMC3488985.pdf
"1997;40(5):809-13, http://dx.doi.org/10.1002/art.1780400506.",Non-OADS,/arxiv_data1/oa_pdf/61/ec/cln-67-11-1275.PMC3488985.pdf
"1996;72(2):98-102, http://dx.doi.org/10.2223/JPED.589.",Non-OADS,/arxiv_data1/oa_pdf/61/ec/cln-67-11-1275.PMC3488985.pdf
"1976;16(4):256-71, http://dx.doi.org/10.1159/ 000180610.",Non-OADS,/arxiv_data1/oa_pdf/61/ec/cln-67-11-1275.PMC3488985.pdf
"2003;12(2):95-9, http://dx.doi.org/10.1080/0962935031000097709.",Non-OADS,/arxiv_data1/oa_pdf/61/ec/cln-67-11-1275.PMC3488985.pdf
"1995;50(4):370-3, http://dx.doi.org/10.1111/j.1398-9995.1995.tb01163.x.",Non-OADS,/arxiv_data1/oa_pdf/61/ec/cln-67-11-1275.PMC3488985.pdf
"1993;2(3):187-91, http://dx.doi.org/10.1177/096120339300200311.",Non-OADS,/arxiv_data1/oa_pdf/61/ec/cln-67-11-1275.PMC3488985.pdf
"2002;11(7):426-9, http://dx.doi.org/10.1191/ 0961203302lu221oa.42.",Non-OADS,/arxiv_data1/oa_pdf/61/ec/cln-67-11-1275.PMC3488985.pdf
"2009;74(7):1120-5, http://dx.doi.org/10.1002/ccd.22141.",Non-OADS,/arxiv_data1/oa_pdf/31/dc/cln-67-11-1281.PMC3488986.pdf
"1998;186(1):24-34, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/31/dc/cln-67-11-1281.PMC3488986.pdf
"1989;209(6):676-81;discussion 682-3, http://dx.doi.org/10.1097/ 00000658-198906000-00004.",Non-OADS,/arxiv_data1/oa_pdf/31/dc/cln-67-11-1281.PMC3488986.pdf
"2001;53(4):508- 12, http://dx.doi.org/10.1002/ccd.1211.",Non-OADS,/arxiv_data1/oa_pdf/31/dc/cln-67-11-1281.PMC3488986.pdf
"2004;61(1):144-6, http://dx.doi.org/10.1002/ccd.10707.",Non-OADS,/arxiv_data1/oa_pdf/31/dc/cln-67-11-1281.PMC3488986.pdf
"2004;61(2):196-201, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/31/dc/cln-67-11-1281.PMC3488986.pdf
"2008;22(2):389-92, http://dx.doi.org/10.1089/end.",Non-OADS,/arxiv_data1/oa_pdf/31/dc/cln-67-11-1281.PMC3488986.pdf
"2011;18(18):2674-85, http://dx.doi.org/10.2174/092986711796011193.",Non-OADS,/arxiv_data1/oa_pdf/a5/47/cln-67-11-1285.PMC3488987.pdf
"2010;347:21-41, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a5/47/cln-67-11-1285.PMC3488987.pdf
"2006;18(1):77-82, http://dx.doi.org/10.1097/01.cco.0000198021.",Non-OADS,/arxiv_data1/oa_pdf/a5/47/cln-67-11-1285.PMC3488987.pdf
"2010;29(4):751-9, http://dx.doi.org/10.1007/ s10555-010-9261-0.",Non-OADS,/arxiv_data1/oa_pdf/a5/47/cln-67-11-1285.PMC3488987.pdf
"2008;10(2):R27, http://dx.doi.org/ 10.1186/bcr1984.",Non-OADS,/arxiv_data1/oa_pdf/a5/47/cln-67-11-1285.PMC3488987.pdf
"2011;17(4):667-77, http://dx.doi.org/10.1158/1078-0432.CCR-10-1133.",Non-OADS,/arxiv_data1/oa_pdf/a5/47/cln-67-11-1285.PMC3488987.pdf
"2008;187(2):74-9, http://dx.doi.org/ 10.1016/j.cancergencyto.2008.07.005.",Non-OADS,/arxiv_data1/oa_pdf/a5/47/cln-67-11-1285.PMC3488987.pdf
"2008; 68(15):6084-91, http://dx.doi.org/10.1158/0008-5472.CAN-07-6854.",Non-OADS,/arxiv_data1/oa_pdf/a5/47/cln-67-11-1285.PMC3488987.pdf
"2009;15(16):5049-59, http://dx.doi.org/10.1158/1078- 0432.CCR-09-0632.",Non-OADS,/arxiv_data1/oa_pdf/a5/47/cln-67-11-1285.PMC3488987.pdf
"2006;96(1):91- 5, http://dx.doi.org/10.1007/s10549-005-9048-0.",Non-OADS,/arxiv_data1/oa_pdf/a5/47/cln-67-11-1285.PMC3488987.pdf
"2007;13(20):6064-9, http://dx.doi.org/10.1158/1078- 0432.CCR-07-0266.",Non-OADS,/arxiv_data1/oa_pdf/a5/47/cln-67-11-1285.PMC3488987.pdf
"2005;65(7):2554-9, http://dx.doi.org/10.1158/ 0008-5472-CAN-04-3913.",Non-OADS,/arxiv_data1/oa_pdf/a5/47/cln-67-11-1285.PMC3488987.pdf
"2012;132(1):29-39, http://dx.doi.org/ 10.1007/s10549-011-1518-y.",Non-OADS,/arxiv_data1/oa_pdf/a5/47/cln-67-11-1285.PMC3488987.pdf
"2009;18(4):200-5, http://dx.doi.org/ 10.1097/PDM.0b013e31818e5fa4.",Non-OADS,/arxiv_data1/oa_pdf/a5/47/cln-67-11-1285.PMC3488987.pdf
"2007;318(5853):1108-13, http://dx.doi.org/10.1126/science.1145720.PIK3CA mutations in breast cancer patients Mangone FR et al.CLINICS 2012;67(11):1285-1290 1290",Non-OADS,/arxiv_data1/oa_pdf/a5/47/cln-67-11-1285.PMC3488987.pdf
"2002;122(2):645-50, http://dx.doi.org/ 10.1378/chest.122.2.645.",Non-OADS,/arxiv_data1/oa_pdf/7b/fa/cln-67-11-1291.PMC3488988.pdf
"2007;101(3):638-44, http://dx.doi.org/10.1016/ j.rmed.2006.06.002.",OADS,/arxiv_data1/oa_pdf/7b/fa/cln-67-11-1291.PMC3488988.pdf
"2000;157(5):669-82, http://dx.doi.org/ 10.1176/appi.ajp.157.5.669.",Non-OADS,/arxiv_data1/oa_pdf/7b/fa/cln-67-11-1291.PMC3488988.pdf
"1998;53(12):1066- 74, http://dx.doi.org/10.1136/thx.53.12.1066.",Non-OADS,/arxiv_data1/oa_pdf/7b/fa/cln-67-11-1291.PMC3488988.pdf
"2005;1:18, http://dx.doi.org/10.1186/1745- 0179-1-18.Physiotherapy, anxiety and asthma Laurino RA et al.CLINICS 2012;67(11):1291-1297 1296",Non-OADS,/arxiv_data1/oa_pdf/7b/fa/cln-67-11-1291.PMC3488988.pdf
"2007;62(12):1039-42, http://dx.doi.org/10.1136/ thx.2006.076430.",Non-OADS,/arxiv_data1/oa_pdf/7b/fa/cln-67-11-1291.PMC3488988.pdf
"2003;58(2):110-5, http://dx.doi.org/ 10.1136/thorax.58.2.110.",Non-OADS,/arxiv_data1/oa_pdf/7b/fa/cln-67-11-1291.PMC3488988.pdf
"1984;145:538-42, http://dx.doi.org/10.1192/bjp.145.5.538.",Non-OADS,/arxiv_data1/oa_pdf/7b/fa/cln-67-11-1291.PMC3488988.pdf
"1992;27(2):7 8-82, http://dx.doi.org/10.1007/ BF00788510.",Non-OADS,/arxiv_data1/oa_pdf/7b/fa/cln-67-11-1291.PMC3488988.pdf
"1988;152:4-14, http://dx.doi.org/10.1192/bjp.152.1.4.",Non-OADS,/arxiv_data1/oa_pdf/7b/fa/cln-67-11-1291.PMC3488988.pdf
"2007;44(5):407-10, http://dx.doi.org/10.1080/ 02770900701364320.",Non-OADS,/arxiv_data1/oa_pdf/7b/fa/cln-67-11-1291.PMC3488988.pdf
"2007;8:62, http://dx.doi.org/10.1186/1471-2296-8- 62.",Non-OADS,/arxiv_data1/oa_pdf/7b/fa/cln-67-11-1291.PMC3488988.pdf
"1991;6(5):401-7, http://dx.doi.org/10.1007/BF02598160.",Non-OADS,/arxiv_data1/oa_pdf/7b/fa/cln-67-11-1291.PMC3488988.pdf
"2010;138(2):331-7, http://dx.doi.org/10.1378/chest.09-2389.",Non-OADS,/arxiv_data1/oa_pdf/7b/fa/cln-67-11-1291.PMC3488988.pdf
"1992;30(1):75-7, http://dx.doi.org/10.1016/0005-7967(92)90101-L. 28.",OADS,/arxiv_data1/oa_pdf/7b/fa/cln-67-11-1291.PMC3488988.pdf
"2005;99(9):1152-9, http://dx.doi.org/10.1016/ j.rmed.2005.02.013.",OADS,/arxiv_data1/oa_pdf/7b/fa/cln-67-11-1291.PMC3488988.pdf
"1977;14(4):161-7, http://dx.doi.org/10.3109/02770907709104335.",Non-OADS,/arxiv_data1/oa_pdf/7b/fa/cln-67-11-1291.PMC3488988.pdf
"2005;67(6):989-96, http://dx.doi.org/ 10.1097/01.psy.0000188556.97979.13.",Non-OADS,/arxiv_data1/oa_pdf/7b/fa/cln-67-11-1291.PMC3488988.pdf
"2005;65(12):1595-610, http://dx.doi.org/10.2165/00003495-200565120-00001.",Non-OADS,/arxiv_data1/oa_pdf/7b/fa/cln-67-11-1291.PMC3488988.pdf
"1996;33(6):407-15, http://dx.doi.org/10.3109/02770909609068185.",Non-OADS,/arxiv_data1/oa_pdf/7b/fa/cln-67-11-1291.PMC3488988.pdf
"2007;8:62, http://dx.doi.org/10.1186/1471-2296-8-62.CLINICS 2012;67(11):1291-1297 Physiotherapy, anxiety and asthma Laurino RA et al.",Non-OADS,/arxiv_data1/oa_pdf/7b/fa/cln-67-11-1291.PMC3488988.pdf
"2005;35(9):779-830, http://dx.doi.org/10.2165/ 00007256-200535090-00004.",Non-OADS,/arxiv_data1/oa_pdf/33/c9/cln-67-11-1299.PMC3488989.pdf
"1999;20(6):788-804, http://dx.doi.org/10.1210/er.20.6.788.",Non-OADS,/arxiv_data1/oa_pdf/33/c9/cln-67-11-1299.PMC3488989.pdf
"2002;87(6):2460-6, http://dx.doi.org/10.1210/jc.87.6.2460.",Non-OADS,/arxiv_data1/oa_pdf/33/c9/cln-67-11-1299.PMC3488989.pdf
"2008;22(5):723-35, http://dx.doi.org/10.1016/j.beem.2008.08.007.",OADS,/arxiv_data1/oa_pdf/33/c9/cln-67-11-1299.PMC3488989.pdf
"2011;96(5):1258-68, http://dx.doi.org/10.1210/jc.2010-2865.",Non-OADS,/arxiv_data1/oa_pdf/33/c9/cln-67-11-1299.PMC3488989.pdf
"2009;5(4):203-11, http://dx.doi.org/10.1038/nrneph.2009.15.",Non-OADS,/arxiv_data1/oa_pdf/33/c9/cln-67-11-1299.PMC3488989.pdf
"2007;41(6):995-1004, http://dx.doi.org/ 10.1016/j.bone.2007.08.020.",OADS,/arxiv_data1/oa_pdf/33/c9/cln-67-11-1299.PMC3488989.pdf
"1991;88(4):1067-72, http://dx.doi.org/10.1172/ JCI115405.",Non-OADS,/arxiv_data1/oa_pdf/33/c9/cln-67-11-1299.PMC3488989.pdf
"2003;9(10):1313-7, http://dx.doi.org/ 10.1038/nm926.",Non-OADS,/arxiv_data1/oa_pdf/33/c9/cln-67-11-1299.PMC3488989.pdf
"1991;11(1):183-90, http://dx.doi.org/10.1161/ 01.ATV.11.1.183.",Non-OADS,/arxiv_data1/oa_pdf/33/c9/cln-67-11-1299.PMC3488989.pdf
"1998;18(2):152-6, http://dx.doi.org/10.1161/ 01.ATV.18.2.152.",Non-OADS,/arxiv_data1/oa_pdf/33/c9/cln-67-11-1299.PMC3488989.pdf
"2009;13(4):543-6, http://dx.doi.org/10.1089/gtmb.2009.0036.",Non-OADS,/arxiv_data1/oa_pdf/33/c9/cln-67-11-1299.PMC3488989.pdf
"2010;14(3):303-5, http://dx.doi.org/10.1089/ gtmb.2009.0199.",Non-OADS,/arxiv_data1/oa_pdf/33/c9/cln-67-11-1299.PMC3488989.pdf
"2008;12(3):443-51, http://dx.doi.org/10.1089/gte.2008.0025.",Non-OADS,/arxiv_data1/oa_pdf/33/c9/cln-67-11-1299.PMC3488989.pdf
"2012;364(1-2):299-301, http://dx.doi.org/10.1007/s11010-012-1230-1.",Non-OADS,/arxiv_data1/oa_pdf/33/c9/cln-67-11-1299.PMC3488989.pdf
"2012;32(1):259- 62, http://dx.doi.org/10.1007/s00296-010-1737-2.",Non-OADS,/arxiv_data1/oa_pdf/33/c9/cln-67-11-1299.PMC3488989.pdf
"2011;66(12):2113-9, http://dx.doi.org/ 10.1590/S1807-59322011001200018.",Non-OADS,/arxiv_data1/oa_pdf/33/c9/cln-67-11-1299.PMC3488989.pdf
"2010;1192:181-9, http://dx.doi.org/10.1111/j.1749-6632.2009.05317.x.",Non-OADS,/arxiv_data1/oa_pdf/33/c9/cln-67-11-1299.PMC3488989.pdf
"2002;73(4):1041- 7, http://dx.doi.org/10.1016/S0003-4975(01)03606-2.",Non-OADS,/arxiv_data1/oa_pdf/2d/35/cln-67-11-1309.PMC3488991.pdf
"2005;129(1):80-6, http://dx.doi.org/10.1016/ j.jtcvs.2004.04.040.",OADS,/arxiv_data1/oa_pdf/2d/35/cln-67-11-1309.PMC3488991.pdf
"J Heart Lung Transplant 2012;31(3):305-9, http://dx.doi.org/10.1016/j.healun.2011.10.005.",Non-OADS,/arxiv_data1/oa_pdf/2d/35/cln-67-11-1309.PMC3488991.pdf
"1999;18(12):1198-201, http://dx.doi.org/10.1016/S1053-2498(99)00088-1.",Non-OADS,/arxiv_data1/oa_pdf/2d/35/cln-67-11-1309.PMC3488991.pdf
"2010;36(4):490-93, http://dx.doi.org/10.1590/S1806- 37132010000400015.",Non-OADS,/arxiv_data1/oa_pdf/2d/35/cln-67-11-1309.PMC3488991.pdf
"2011;43(5):1520- 4, http://dx.doi.org/10.1016/j.transproceed.2010.12.001.",Non-OADS,/arxiv_data1/oa_pdf/2d/35/cln-67-11-1309.PMC3488991.pdf
"1999;18(4):320-7, http://dx.doi.org/10.1016/S1053-2498 (98)00032-1.",Non-OADS,/arxiv_data1/oa_pdf/2d/35/cln-67-11-1309.PMC3488991.pdf
"2000;19(10):976-83, http://dx.doi.org/ 10.1016/S1053-2498(00)00189-3.",Non-OADS,/arxiv_data1/oa_pdf/2d/35/cln-67-11-1309.PMC3488991.pdf
"2004;26(1):151-7, http://dx.doi.org/10.1016/j.ejcts.2004.02.019.",OADS,/arxiv_data1/oa_pdf/2d/35/cln-67-11-1309.PMC3488991.pdf
"2005;24(8):1081-90, http://dx.doi.org/10.1016/j.healun.2004.07.004.",OADS,/arxiv_data1/oa_pdf/2d/35/cln-67-11-1309.PMC3488991.pdf
"Anat Rec (Hoboken) 2007;290(5):491-500, http://dx.doi.org/ 10.1002/ar.20518.Lung preservation: Celsior vs. Perfadex Menezes AQ et al.CLINICS 2012;67(11):1309-1314 1314",Non-OADS,/arxiv_data1/oa_pdf/2d/35/cln-67-11-1309.PMC3488991.pdf
"1995;4(4):293-307, http://dx.doi.org/10.1007/BF01593882.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"2005;16(5):447-55, http://dx.doi.org/10.1007/s00198- 004-1762-7.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"1992;305(6862):1145-8, http://dx.doi.org/10.1136/ bmj.305.6862.1145.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"2001;30(5):371-3, http://dx.doi.org/10.1093/ageing/30.5.371.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"2002;3:11, http://dx.doi.org/10.1186/1471-2474- 3-11.11.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"2006;17(3):355-63, http://dx.doi.org/ 10.1007/s00198-005-2020-3.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"2003; 14(11):895-904, http://dx.doi.org/10.1007/s00198-003-1483-3.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"1996;96(6):26-33;quiz 34, http://dx.doi.org/10.2307/3464884 17.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"1993;31(6):750-6, http://dx.doi.org/ 10.1002/art.1780360603.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"1996;156(21):2469-75, http://dx.doi.org/10.1001/archinte.1996.004402000 87011.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"2005;16(8):861-70, http://dx.doi.org/10.1007/s00198-004-1774-3.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"2005;16(12):2175- 9, http://dx.doi.org/10.1007/s00198-005-2023-0.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"1993;72(8):648-55, http://dx.doi.org/ 10.3109/00016349309021159.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"1999;10(3):207-13, http://dx.doi.org/10.1007/s00198 0050217.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"2007;18(4):419-25, http://dx.doi.org/10.1007/s00198-006-0252-5.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"2010;66(2):206- 11, http://dx.doi.org/10.1016/j.maturitas.2010.03.009.",OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"2000;11(5):460-6, http://dx.doi.org/ 10.1007/s001980070115.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"2005;24:139-44, http://dx.doi.org/10.1007/ s10067-004-0991-7.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"1995;50(2):M91-8, http://dx.doi.org/ 10.1093/gerona/50A.2.M91.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"1999;10(2):150-60, http://dx.doi.org/10.1007/s001980 050210.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"1997;12(3):456-63, http://dx.doi.org/10.1359/jbmr.1997.12.3.456.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"2003;14(12):1007-12, http://dx.doi.org/ 10.1007/s00198-003-1510-4.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"2004;2:41, http://dx.doi.org/10.1186/1477-7525-2-41.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"2008;30(3):113-20, http://dx.doi.org/10.1590/ S0100-72032008005000001.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"2001;10(4):307-17, http://dx.doi.org/10.1023/A:1012200508847.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"2003;14(8):677-82, http://dx.doi.org/ 10.1007/s00198-003-1423-2.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"2005;16(11):1321-9, http://dx.doi.org/10.1007/s00198-005-1842-3.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"2008;27(2):151- 61, http://dx.doi.org/10.1007/s10067-007-0661-7.",Non-OADS,/arxiv_data1/oa_pdf/6e/b3/cln-67-11-1315.PMC3488992.pdf
"2005;128(4):2238-46, http://dx.doi.org/10.1378/ chest.128.4.2238.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2004;32(12):2398-402, http://dx.doi.org/10.1097/01.CCM.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"1994;105(5):1487-95, http://dx.doi.org/ 10.1378/chest.105.5.1487.5.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2001;16(9):590- 8, http://dx.doi.org/10.1046/j.1525-1497.2001.016009590.x.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2005;60(8):672-8, http://dx.doi.org/10.1136/thx.2004.030411.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2003;58(5):377-82, http://dx.doi.org/10.1136/thorax.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2005;33(4):257-63, http://dx.doi.org/10.1007/s15010-005-4096-2.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2000;28(2):68-73, http://dx.doi.org/10.1007/s15010 0050049.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2007;13(5):578-85, http://dx.doi.org/10.1097/MCC.0b013e3282c9ac2a.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2006;174(1):84-93, http://dx.doi.org/10.1164/rccm.200512-1922OC.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2004;279(47):48487-90, http://dx.doi.org/10.1074/jbc.R400025200.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2001;68(6):535-7, http://dx.doi.org/10.3949/ccjm.68.6.535.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2004;16(4):348-55, http://dx.doi.org/ 10.1111/j.0953-8194.2004.01172.x.Table 1 - Summary of the studied biomarkers and triggers.",OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2006;22(1):131-49,vii- viii, http://dx.doi.org/10.1016/j.ccc.2005.08.007.",OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"1998;18(2):173- 91, http://dx.doi.org/10.1023/A:1022564803093.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2004;43(25):8191-203, http://dx.doi.org/10.1021/bi0400094.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2006;52(1):112-9, http://dx.doi.org/10.1373/ clinchem.2005.060038.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2005;26(12): 2500-4, http://dx.doi.org/10.1016/ j.peptides.2005.04.019.",OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2008;12(1):R11, http://dx.doi.org/10.1186/cc6780.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"1998;351(9095):9-13, http://dx.doi.org/10.1016/S0140-6736 (97)03034-1.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2002;53(3):153-9, http://dx.doi.org/10.1080/15216540212336.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2004;8(5):342-9, http://dx.doi.org/10.1186/cc2890.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2001;29(1):80-7, http://dx.doi.org/10.1097/00003246-200101000-00019.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2008;34(11): 2084-91, http://dx.doi.org/10.1007/s00134-008-1173-x.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2005;9(1):R37-45, http://dx.doi.org/10.1186/cc3015.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"1994;203(1):631-9, http://dx.doi.org/10.1006/ bbrc.1994.2229.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"1993;194(2):720-5, http://dx.doi.org/10.1006/bbrc.1993.1881.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"1994;201(3):1160-6, http://dx.doi.org/ 10.1006/bbrc.1994.1827.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"1997;82(1):95-100, http://dx.doi.org/10.1210/jc.82.1.95.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2000;21(2):138-67, http://dx.doi.org/ 10.1210/er.21.2.138.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2005;51(10):1823-9, http://dx.doi.org/10.1373/ clinchem.2005.051110.44.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"1997;25(6):953-7, http://dx.doi.org/10.1097/00003246-199706000-00010.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"1990;71(2):452-63, http://dx.doi.org/10.1210/jcem- 71-2-452.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"1995;80(3):764-9, http://dx.doi.org/10.1210/jc.80.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2005;1(4):291-9, http://dx.doi.org/10.2147/vhrm.2005.1.4.291.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2008;134(5):947-54, http://dx.doi.org/10.1378/chest.08-1382.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2003;14(8):745-8, http://dx.doi.org/10.1097/00001721-200312000-00009.",Non-OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2004;126(4):1087- 92, http://dx.doi.org/10.1378/chest.126.4.1087.CLINICS 2012;67(11):1321-1325 Biomarkers in CAP: State-of-the-Art Review Seligman R et al.",OADS,/arxiv_data1/oa_pdf/af/d2/cln-67-11-1321.PMC3488993.pdf
"2001;145(2):107-18, http://dx.doi.org/10.1530/eje.0.1450107.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"2010;55(3):215-26, http://dx.doi.org/10.1016/ j.survophthal.2009.06.009.",OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"1990;150(5):948-50, http://dx.doi.org/10.1001/ archinte.1990.00390170010003.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"1978;96(7):1199- 209, http://dx.doi.org/10.1001/archopht.1978.03910060033007.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"2000;84(6):600-5, http://dx.doi.org/10.1136/bjo.84.6.600.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"1984;102(10):1469-72, http://dx.doi.org/10.1001/archopht.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"1981;7(1):21-31, http://dx.doi.org/10.1016/0301-5629(81)90019-3.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"2001;12(5):342-6, http://dx.doi.org/10.1097/00055735- 200110000-00003.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"2000;84(9):1027-30, http://dx.doi.org/ 10.1136/bjo.84.9.1027.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"1989;87(1):70-3, http://dx.doi.org/10.1016/ S0002-9343(89)80485-1.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"1993;111(2):197-201, http://dx.doi.org/10.1001/archopht.1993.1090020051022.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"1997;42(3):247-54, http://dx.doi.org/10.1016/S0039-6257(97)00094-5.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"1995;80(9):2830-3, http://dx.doi.org/10.1210/jc.80.9.2830.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"2004;89(2):930-5, http://dx.doi.org/10.1210/ jc.2003-031427.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"1984 Spring;5(2):200-20, http://dx.doi.org/10.1210/edrv-5-2-200.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"1977;1(4):397-8, http://dx.doi.org/10.1002/ana.410010412.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"2012;28(1):69-72, http://dx.doi.org/10.1097/IOP.0b013e31823c4a3a.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"2012;22(3):301-8, http://dx.doi.org/10.5301/ejo.5000018.CLINICS 2012;67(11):1327-1334 Imaging studies in Graves’ orbitopathy Gonc ¸alves ACP et al.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"2010;52(2):91-7, http://dx.doi.org/ 10.1007/s00234-009-0590-z.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"2004;28(1):80-6, http://dx.doi.org/10.1097/ 00004728-200401000-00013.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"2011;55(3):184-8, http://dx.doi.org/10.1590/S0004-27302011000300002.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"2005;56(1):20-4, http://dx.doi.org/ 10.1016/j.ejrad.2005.03.027.",OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"2002;46(3):341-5, http://dx.doi.org/10.1016/ S0021-5155(02)00485-9.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"1998;8(6):549-52, http://dx.doi.org/10.1089/thy.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"2007;91(4):455-8, http://dx.doi.org/10.1136/bjo.2006.094607.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"2008;63(3):301-6, http://dx.doi.org/10.1590/S1807-59322008000300003.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"2009;30(3):597-602, http://dx.doi.org/10.3174/ajnr.A1413.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"1981;99(5):807-9, http://dx.doi.org/10.1001/archopht.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"1985;103(2):213-5, http://dx.doi.org/10.1001/archopht.1985.01050020065021.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"2012;67(8):891-6, http://dx.doi.org/10.6061/clinics/2012(08)06.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"2009;82(979):541-4, http://dx.doi.org/10.1259/bjr/56958444.",Non-OADS,/arxiv_data1/oa_pdf/1d/20/cln-67-11-1327.PMC3488994.pdf
"2000;160:1683-9, http://dx.doi.org/10.1001/archinte.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2005;21(5):1565-73, http://dx.doi.org/10.1590/ S0102-311X2005000500030.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2003;22(2):268-73, http://dx.doi.org/10.1183/09031936.03.00075102.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2003;124(2):474-81, http://dx.doi.org/10.1378/chest.124.2.474.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2002;7(4):325-31, http://dx.doi.org/10.1046/j.1440-1843.2002.00408.x.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2003;22(3):413-7, http://dx.doi.org/10.1183/09031936.03.00121103.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2002;122(6):2003-8, http://dx.doi.org/ 10.1378/chest.122.6.2003.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2002;96(9):700-8, http://dx.doi.org/10.1053/ rmed.2002.1334.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2004;125(4) :1394-9, http://dx.doi.org/ 10.1378/chest.125.4.1394.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2002;57(11):951-7, http://dx.doi.org/10.1136/ thorax.57.11.951.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"1996;109(1):115-9, http://dx.doi.org/10.1378/chest.109.1.115.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2001;119:1691-5, http://dx.doi.org/10.1378/chest.119.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"1999;54(3):245-52, http://dx.doi.org/10.1136/thx.54.3.245.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"1997;350(9078):630-3, http://dx.doi.org/10.1016/S0140- 6736(96)08061-0.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"1990;142(3):555-62, http://dx.doi.org/10.1164/ ajrccm/142.3.555.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"1996;7(2):55-60, http://dx.doi.org/10.1111/j.1399-3038.1996.tb00107.x.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2003;112(5):819-27; quiz 828, http://dx.doi.org/10.1016/S0091- 6749(03)02011-6.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"1998;53(1):21-7, http://dx.doi.org/10.1136/thx.53.1.21.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"Thorax 2002;57(4):309-16, http://dx.doi.org/ 10.1136/thorax.57.4.309.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2002; 11(5):307-12, http://dx.doi.org/10.1080/09629350210000015719.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2004;34(1):59-64, http://dx.doi.org/10.1111/j.1365- 2222.2004.01844.x.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2003;97(8):947-54, http://dx.doi.org/ 10.1016/S0954-6111(03)00122-7.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2000;356(9240):1480-5, http://dx.doi.org/10.1016/S0140- 6736(00)02872-5.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2009;14(5):637-50, http://dx.doi.org/10.1111/j.1440- 1843.2009.01569.x.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2009;4:411-9, http://dx.doi.org/10.2147/COPD.S6133.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2007;28(2):289-96, http://dx.doi.org/10.1016/j.ccm.2007.02.014.",OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2003;167(3):418-24, http://dx.doi.org/ 10.1164/rccm.200203-183OC.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"5):187-94;discussion 203-5, http://dx.doi.org/10.1046/ j.1365-2222.1998.028s5187.x.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2001;76:1144-53, http://dx.doi.org/ 10.4065/76.11.1144.Differentiating airway diseases Athanazio RCLINICS 2012;67(11):1335-1343 1342",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"1998;4(2):85-92, http://dx.doi.org/10.1097/00063198- 199803000-00005.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2012;18(1):42-47, http://dx.doi.org/10.1097/MCP.0b013e32 834db255.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2011;128(3):467-78, http://dx.doi.org/10.1016/ j.jaci.2011.04.051.",OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2004;125(5):1714-8, http://dx.doi.org/10.1378/chest.125.5.1714.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2010;65(1):1-58, http://dx.doi.org/ 10.1136/thx.2010.136119.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2001;285(20):2583-93, http://dx.doi.org/10.1001/jama.285.20.2583.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2002;19(1):182- 91, http://dx.doi.org/10.1183/09031936.02.00283202.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"Chest 2000; 117(2 Suppl):63S-6S, http://dx.doi.org/10.1378/chest.117.2_suppl.63S.",OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"Inhaled tiotropium for stable chronic obstructive pulmonary disease: a meta analysis: .Thorax 2006;61(10):854-62, http://dx.doi.org/10.1136/thx.2006.063271.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2002;166:1358-63, http://dx.doi.org/ 10.1164/rccm.200206-512OC.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2005;60(4):343-9, http://dx.doi.org/10.1136/thx.2004.028720.",Non-OADS,/arxiv_data1/oa_pdf/3c/ae/cln-67-11-1335.PMC3488995.pdf
"2012;88(5):1198-204, http://dx.doi.org/10.1111/j.1751-1097.2012.01100.x.",Non-OADS,/arxiv_data1/oa_pdf/04/92/cln-67-11-1345.PMC3488996.pdf
"2012;17(1):674-87, http://dx.doi.org/10.3390/ molecules17010674.",Non-OADS,/arxiv_data1/oa_pdf/04/92/cln-67-11-1345.PMC3488996.pdf
"2011;18(11):1219-24, http://dx.doi.org/10.1097/gme.0b013e31821e2044.",Non-OADS,/arxiv_data1/oa_pdf/04/92/cln-67-11-1345.PMC3488996.pdf
"2010;10:82, http://dx.doi.org/10.1186/1472-6882-10-82.",Non-OADS,/arxiv_data1/oa_pdf/04/92/cln-67-11-1345.PMC3488996.pdf
"2010;10:48, http://dx.doi.org/10.1186/1472-6882-10-48.",Non-OADS,/arxiv_data1/oa_pdf/04/92/cln-67-11-1345.PMC3488996.pdf
"2010;71(4):291-6, http://dx.doi.org/10.1016/j.ando.2010.03.003.",OADS,/arxiv_data1/oa_pdf/04/92/cln-67-11-1345.PMC3488996.pdf
"2012;67(7):849-51, http://dx.doi.org/10.6061/clinics/2012(07)24.",Non-OADS,/arxiv_data1/oa_pdf/e8/b8/cln-67-11-1347.PMC3488997.pdf
"2005;9(6):312-6, http://dx.doi.org/10.1016/j.ijid.2004.08.003.",OADS,/arxiv_data1/oa_pdf/e8/b8/cln-67-11-1347.PMC3488997.pdf
"2012;67(5):419-24, http://dx.doi.org/10.6061/ clinics/2012(05)03.",Non-OADS,/arxiv_data1/oa_pdf/ce/3e/cln-67-11-1349.PMC3488998.pdf
"2011;2(11):367-76, http://dx.doi.org/10.5306/wjco.v2.i11.367.",Non-OADS,/arxiv_data1/oa_pdf/ce/3e/cln-67-11-1349.PMC3488998.pdf
"2009;361(10):958-67, http://dx.doi.org/10.1056/ NEJMoa0904554.",Non-OADS,/arxiv_data1/oa_pdf/ce/3e/cln-67-11-1349.PMC3488998.pdf
"2010;126(3):651-5, http://dx.doi.org/10.1002/ ijc.24746.",Non-OADS,/arxiv_data1/oa_pdf/ce/3e/cln-67-11-1349.PMC3488998.pdf
"2009;4(1):22, http://dx.doi.org/10.1097/JTO.0b013e3181914111.",Non-OADS,/arxiv_data1/oa_pdf/ce/3e/cln-67-11-1349.PMC3488998.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Annals of Botany 110: 1429–1438, 2012 doi:10.1093/aob/mcr316, available online at www.aob.oxfordjournals.org",Non-OADS,/arxiv_data1/oa_pdf/80/a4/mcr316.PMC3489139.pdf
"www.landesbioscience.com Plant Signaling & Behavior 1129Plant Signaling & Behavior 7:9, 1129-1131; September 2012; © 2012 Landes BioscienceShort CommuniCa tion *Correspondence to: Jean T. Greenberg; Email: jgreenbe@midway.uchicago.edu Submitted: 05/31/12; Accepted: 06/30/12http://dx.doi.org/10.4161/psb/Plants possess many resistance (R) proteins that directly or indi - rectly interact with effector proteins to detect pathogen infec - tion.",Non-OADS,/arxiv_data1/oa_pdf/2b/96/psb-7-1129.PMC3489644.pdf
Nature  2006; 444:323-9; PMID:17108957; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/96/psb-7-1129.PMC3489644.pdf
Plant J 2002; 29:569-79; PMID:11874570; http://dx.doi.org/10.1046/j.1365-313X.2002.029005569.x.,OADS,/arxiv_data1/oa_pdf/2b/96/psb-7-1129.PMC3489644.pdf
Science 2002; 295:2073-6; PMID:11847307; http://dx.doi.org/10.1126/science.1067554.,OADS,/arxiv_data1/oa_pdf/2b/96/psb-7-1129.PMC3489644.pdf
EMBO J 2006; 25:2007-16; PMID:16619029; http://dx.doi.org/10.1038/sj.emboj.7601084.,OADS,/arxiv_data1/oa_pdf/2b/96/psb-7-1129.PMC3489644.pdf
J Biol Chem 2004; 279:2101-8; PMID:14583611; http://dx.doi.org/10.1074/jbc.M310029200.,OADS,/arxiv_data1/oa_pdf/2b/96/psb-7-1129.PMC3489644.pdf
Plant Physiol 2012; 158:1803-18; PMID:22319072; http://dx.doi.org/10.1104/pp.111.190686.,Non-OADS,/arxiv_data1/oa_pdf/2b/96/psb-7-1129.PMC3489644.pdf
Mol Microbiol 2006; 62:26-44; PMID:16942603; http://dx.doi.org/10.1111/j.1365-2958.2006.05350.x.,OADS,/arxiv_data1/oa_pdf/2b/96/psb-7-1129.PMC3489644.pdf
gM Cr ops  & Food 2012; 3:265-72; https://www.landesbioscience.,Non-OADS,/arxiv_data1/oa_pdf/c4/52/bbug-3-307.PMC3489702.pdf
2012 octo ber 16;  Available from: http://encodeproject.org/ eNCoDe/ 2. the eNCoDe Pr oject Consortium.,Non-OADS,/arxiv_data1/oa_pdf/97/76/bbug-3-309.PMC3489703.pdf
Case C-36/11 Pioneer Hi Bred Italia Srl v Ministero delle  Politiche agricole alimentari e forestali [2012]; Available from: http://eur-lex.europa.eu/LexUri serv/Le xUri serv.,Non-OADS,/arxiv_data1/oa_pdf/97/76/bbug-3-309.PMC3489703.pdf
A vailable  from: http://www.goldenrice.org/  2.,Non-OADS,/arxiv_data1/oa_pdf/97/76/bbug-3-309.PMC3489703.pdf
Am J Clin Nutr 2012; 96:658-64; PM iD:22854406; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/76/bbug-3-309.PMC3489703.pdf
Proc Natl Acad sci U sA 2012; in press; PM iD: 23027958;  http://dx.doi.or g/10.1073/pnas.1210057109.,Non-OADS,/arxiv_data1/oa_pdf/97/76/bbug-3-309.PMC3489703.pdf
2012  october 3; A vailable from: http://www.the-scientist.,Non-OADS,/arxiv_data1/oa_pdf/97/76/bbug-3-309.PMC3489703.pdf
2012 october 4; A vailable from:   http://www.efsa.europa.eu/en/press/news/121004.htm3.,Non-OADS,/arxiv_data1/oa_pdf/97/76/bbug-3-309.PMC3489703.pdf
2012  september;   Available from: http://www.bfr.bund.de/cm/343/veroef-fentlichung-von-seralini-et-al-zu-einer-fuetterungss-tudie-an-ratten-mit-gentechnischveraendertem-mais-nk603-sowie-einer-glyphosathaltigen-formulierung.pdf,Non-OADS,/arxiv_data1/oa_pdf/97/76/bbug-3-309.PMC3489703.pdf
"Model validation was achieved using data sets not used in the construction of the model and which encom - pass multiple biological functions (from transcriptomics to metabolomics) and scales (from single cells to microbial   populations).Digital biology A new era has begun roy D. Sleator Department of Biological Sciences; Cork inst itute of tech nology; Bishopstown, Cork, irel and Correspondence to: Roy D. Sleator; Email: roy.sleator@cit.ie Submitted: 09/26/12; Accepted: 09/26/12http://dx.doi.org/10.4161/bioe.22367Despite the authors’ own asser - tion that the model is a “first draft;”  it has nonetheless revealed a number of important, and hitherto unknown, insights into the M. genitalium  life- cycle.",Non-OADS,/arxiv_data1/oa_pdf/5a/c2/bbug-3-311.PMC3489704.pdf
Science 2010; 329:52-6; PMID:20488990; http://dx.doi.org/10.1126/science.1190719.,Non-OADS,/arxiv_data1/oa_pdf/5a/c2/bbug-3-311.PMC3489704.pdf
Bioeng Bugs 2010; 1:231-2; PMID:21327054; http://dx.doi.org/10.4161/bbug.1.4.12465.,OADS,/arxiv_data1/oa_pdf/5a/c2/bbug-3-311.PMC3489704.pdf
Cell 2012; 150:389-401; PMID:22817898; http://dx.doi.org/10.1016/j.cell.2012.05.044.,OADS,/arxiv_data1/oa_pdf/5a/c2/bbug-3-311.PMC3489704.pdf
Biotechnol Bioeng 2007; 97:397-409; PMID:17149771; http://dx.doi.org/10.1002/bit.21251.5.,Non-OADS,/arxiv_data1/oa_pdf/5a/c2/bbug-3-311.PMC3489704.pdf
Science 2002; 295:1669-78; PMID:11872831; http://dx.doi.org/10.1126/sci-ence.1069883.,OADS,/arxiv_data1/oa_pdf/5a/c2/bbug-3-311.PMC3489704.pdf
Nat Biotechnol 2010; 28:245-8; PMID:20212490; http://dx.doi.org/10.1038/nbt.1614.,OADS,/arxiv_data1/oa_pdf/5a/c2/bbug-3-311.PMC3489704.pdf
PLoS Comput Biol 2009; 5:e1000285; PMID:19214212; http://dx.doi.org/10.1371/journal.pcbi.1000285.,Non-OADS,/arxiv_data1/oa_pdf/5a/c2/bbug-3-311.PMC3489704.pdf
Cell 2012; 150:248-50; PMID:22817888; http://dx.doi.org/10.1016/j.cell.2012.07.001.,OADS,/arxiv_data1/oa_pdf/5a/c2/bbug-3-311.PMC3489704.pdf
MBio 2010; 1:e00024-10; PMID:20689751; http://dx.doi.org/10.1128/mBio.00024-10.,Non-OADS,/arxiv_data1/oa_pdf/5a/c2/bbug-3-311.PMC3489704.pdf
PLoS Comput Biol 2011; 7:e1002010; PMID:21423716; http://dx.doi.org/10.1371/journal.pcbi.1002010.,OADS,/arxiv_data1/oa_pdf/5a/c2/bbug-3-311.PMC3489704.pdf
Bioeng  Bugs 2012; 3:80-5; PMID:22095055; http://dx.doi.org/10.4161/bbug.18303.,OADS,/arxiv_data1/oa_pdf/5a/c2/bbug-3-311.PMC3489704.pdf
"www.landesbioscience.com  Bioengineered  313Bioengineered 3:6, 313-319; Nov ember/December 2012; © 2012 Landes Bioscience Exp Ert Comm ENtary Exp Ert Comm ENtary Keywords:  bioengineering, food preser - vative, food grade, lantibiotic, bacterio - cin, nisin, lacticin 3147 Submitted: 05/14/12Revised: 07/20/12Accepted: 07/24/12http://dx.doi.org/10.4161/bioe.21601 Correspondence to: Paul D. Cotter;   Email: paul.cotter@teagasc.ieWhile the bacteriocin Nisin has  been employed by the food indus - try for 60 y, it remains the only bacte - riocin to be extensively employed as a food preservative.",Non-OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Nat Rev Microbiol  2005; 3:777-88; PMID:16205711; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Mol Microbiol 2001; 40:465-75; PMID:11309128; http://dx.doi.org/10.1046/j.1365-2958.2001.02398.x.,OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Gene 1995; 162:163-4; PMID:7557409; http://dx.doi.org/10.1016/0378-1119(95)00342-4.,OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Chem Biol 2010; 17:1151-60; PMID:21035738; http://dx.doi.org/10.1016/j.chem - biol.2010.08.011.,OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
J Mol Microbiol Biotechnol 2007; 13:226-34; PMID:17827973; http://dx.doi.org/10.1159/000104747.,Non-OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Antonie Van Leeuwenhoek 1996; 69:193-202; PMID:8775979; http://dx.doi.org/10.1007/BF00399424.,Non-OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Antonie Van Leeuwenhoek 1996; 69:161-9; PMID:8775976; http://dx.doi.org/10.1007/BF00399421.,Non-OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Appl Environ Microbiol 2007; 73:5809-16; PMID:17660303; http://dx.doi.org/10.1128/A EM.01104- 07.,OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Mol Microbiol 2010; 78:1077-87; PMID:21091497; http://dx.doi.org/10.1111/j.1365-2958.2010.07406.x.,OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Cell Mol Life Sci 2008; 65:455-76; PMID:17965835; http://dx.doi.org/10.1007/s00018-007-7171-2.,OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Appl Microbiol Biotechnol 2004; 64:806-15; PMID:15048591; http://dx.doi.org/10.1007/s00253-004-1599-1.,Non-OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Mol Microbiol 2008; 69:218-30; PMID:18485077; http://dx.doi.org/10.1111/j.1365-2958.2008.06279.x.,Non-OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
PLoS One 2011; 6:e20852; PMID:21760885; http://dx.doi.org/10.1371/journal.pone.0020852.,Non-OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Bioeng Bugs 2010; 1:408-12; PMID:21468208; http://dx.doi.org/10.4161/bbug.1.6.13642.,Non-OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Microb Biotechnol 2012; 5:501-8; PMID:22260415; http://dx.doi.org/10.1111/j.1751-7915.2011.00324.x.,Non-OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Nat Rev Gastroenterol Hepatol 2011; 8:523-31; PMID:21844910; http://dx.doi.org/10.1038/nrgas - tro.2011.133.20.,Non-OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
J Biol Chem 2005; 280:9243-50; PMID:15611086; http://dx.doi.org/10.1074/jbc.M412712200.,OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Lett Appl Microbiol 2004; 39:451-8; PMID:15482437; http://dx.doi.org/10.1111/j.1472-765X.2004.01608.x.,OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
J Antimicrob Chemother 2009; 64:546-51; PMID:19561147; http://dx.doi.org/10.1093/jac/dkp221.,Non-OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
J Biol Chem 1999; 274:37544-50; PMID:10608807; http://dx.doi.org/10.1074/jbc.274.53.37544.,OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Mol Gen Genet 1996; 253:217-24; PMID:9003306; http://dx.doi.org/10.1007/s004380050315.,Non-OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Appl Environ Microbiol 2003; 69:702-6; PMID:12514066; http://dx.doi.org/10.1128/AEM.69.1.702-706.2003.,OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Mol Microbiol 2006; 62:735-47; PMID:17076667; http://dx.doi.org/10.1111/j.1365-2958.2006.05398.x.,OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Microb Biotechnol 2010; 3:222-34; PMID:21255322; http://dx.doi.org/10.1111/j.1751-7915.2009.00145.x.,Non-OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Bioeng Bugs 2010; 1:345-51; PMID:21326835; http://dx.doi.org/10.4161/bbug.1.5.12353.7.,OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Biochemistry 1997; 36:6968-76; PMID:9188693; http://dx.doi.org/10.1021/bi970008u.,Non-OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Science 1999; 286:2361-4; PMID:10600751; http://dx.doi.org/10.1126/science.286.5448.2361.,OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Eur J Biochem 1997; 247:114-20; PMID:9249016; http://dx.doi.org/10.1111/j.1432-1033.1997.00114.x.,Non-OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Appl Environ Microbiol 2003; 69:1051-8; PMID:12571028; http://dx.doi.org/10.1128/AEM.69.2.1051-1058.2003.,OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Appl Environ Microbiol 2003; 69:3777-83; PMID:12839744; http://dx.doi.org/10.1128/AEM.69.7.3777-3783.2003.,OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Biochemistry 2002; 41:9508-15; PMID:12135373; http://dx.doi.org/10.1021/bi025856q.,Non-OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Appl Environ Microbiol 2000; 66:4798-802; PMID:11055926; http://dx.doi.org/10.1128/AEM.66.11.4798-4802.2000.,OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Annu Rev Biochem  2012; 81:479-505; PMID:22404629; http://dx.doi.org/10.1146/annurev-biochem-060110-113521.,Non-OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Electron J Biotechnol 2006; 9:1-25; http://dx.doi.org/10.2225/vol9-issue4-full - text-12.50.,Non-OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Appl Microbiol Biotechnol 2012; PMID:22526797; http://dx.doi.org/10.1007/s00253-012-4041-0.,Non-OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Int Dairy J 1995; 5:785-95; http://dx.doi.org/10.1016/0958-6946(95)00032-1.47.,OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Mol Microbiol 2009; 72:1126-36; PMID:19400806; http://dx.doi.org/10.1111/j.1365-2958.2009.06708.x.,Non-OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Chem Biol 2009; 16:490-8; PMID:19477413; http://dx.doi.org/10.1016/j.chembiol.2009.03.011.,OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
Mol Microbiol 2009; 72:1438-47; PMID:19432794; http://dx.doi.org/10.1111/j.1365-2958.2009.06733.x.,Non-OADS,/arxiv_data1/oa_pdf/e9/ff/bbug-3-313.PMC3489705.pdf
"Biotechnol Biofuels 2012; 5:14; PMID:22424089; http://dx.doi.org/10.1186/1754-6834-5-14Keywords:  bioethanol, co-fermentation  of pentoses with glucose, sugar transport,  substrate channeling Submitted: 06/18/12Revised: 07/10/12Accepted: 07/11/12http://dx.doi.org/10.4161/bioe.21444 *Correspondence to: Mislav Oreb;   Email: m.oreb@bio.uni-frankfurt.deEconomically feasible production of  second-generation biofuels requires  efficient co-fermentation of pentose and hexose sugars in lignocellulosic hydroly - sates under very harsh conditions.",Non-OADS,/arxiv_data1/oa_pdf/e7/9d/bbug-3-347.PMC3489712.pdf
Appl Microbiol Biotechnol 2010; 87:1303-15; PMID:20535464; http://dx.doi.org/10.1007/s00253-010-2707-z.,OADS,/arxiv_data1/oa_pdf/e7/9d/bbug-3-347.PMC3489712.pdf
Curr Opin Biotechnol 2009; 20:300-6; PMID:19545992; http://dx.doi.org/10.1016/j.copbio.2009.06.001.,OADS,/arxiv_data1/oa_pdf/e7/9d/bbug-3-347.PMC3489712.pdf
Biotechnol Biofuels 2010; 3:24; PMID:21080929; http://dx.doi.org/10.1186/1754-6834-3-24.to approach the main goal—efficient co- fermentation of pentoses and glucose.,Non-OADS,/arxiv_data1/oa_pdf/e7/9d/bbug-3-347.PMC3489712.pdf
Appl Environ Microbiol 2003; 69:740-6; PMID:12570990; http://dx.doi.org/10.1128/AEM.69.2.740-746.2003.,OADS,/arxiv_data1/oa_pdf/e7/9d/bbug-3-347.PMC3489712.pdf
Yeast 2009; 26:371-82; PMID:19504622; http://dx.doi.org/10.1002/yea.1673.,OADS,/arxiv_data1/oa_pdf/e7/9d/bbug-3-347.PMC3489712.pdf
FEMS Yeast Res 2011; 11:299-306; PMID:21251209; http://dx.doi.org/10.1111/j.1567-1364.2011.00719.x.,OADS,/arxiv_data1/oa_pdf/e7/9d/bbug-3-347.PMC3489712.pdf
Yeast 2006; 23:455-64; PMID:16652391; http://dx.doi.org/10.1002/yea.1370.11.,OADS,/arxiv_data1/oa_pdf/e7/9d/bbug-3-347.PMC3489712.pdf
FEMS Yeast Res 2009; 9:511-25; PMID:19459982; http://dx.doi.org/10.1111/j.1567-1364.2009.00509.x.,OADS,/arxiv_data1/oa_pdf/e7/9d/bbug-3-347.PMC3489712.pdf
Appl Environ Microbiol 2011; 77:3311-9; PMID:21421781; http://dx.doi.org/10.1128/AEM.02651-10.,OADS,/arxiv_data1/oa_pdf/e7/9d/bbug-3-347.PMC3489712.pdf
Biotechnol Biofuels 2011; 4:38; PMID:21992610; http://dx.doi.org/10.1186/1754-6834-4-38.,Non-OADS,/arxiv_data1/oa_pdf/e7/9d/bbug-3-347.PMC3489712.pdf
Biochemistry 2011; 50:8674-81; PMID:21892826; http://dx.doi.org/10.1021/bi200958s.,Non-OADS,/arxiv_data1/oa_pdf/e7/9d/bbug-3-347.PMC3489712.pdf
Metab Eng 2010; 12:537-51; PMID:20816840; http://dx.doi.org/10.1016/j.ymben.2010.08.003.4.,OADS,/arxiv_data1/oa_pdf/e7/9d/bbug-3-347.PMC3489712.pdf
Renew Sustain Energy Rev 2011; 15:4950-62; http://dx.doi.org/10.1016/j.rser.2011.07.058.,OADS,/arxiv_data1/oa_pdf/e7/9d/bbug-3-347.PMC3489712.pdf
Appl Environ Microbiol 2009; 75:2304-11; PMID:19218403; http://dx.doi.org/10.1128/AEM.02522-08.,OADS,/arxiv_data1/oa_pdf/e7/9d/bbug-3-347.PMC3489712.pdf
Appl Environ Microbiol 2003; 69:4144-50; PMID:12839792; http://dx.doi.org/10.1128/AEM.69.7.4144-4150.2003.,OADS,/arxiv_data1/oa_pdf/e7/9d/bbug-3-347.PMC3489712.pdf
Appl Environ Microbiol 2008; 74:2043-50; PMID:18263741; http://dx.doi.org/10.1128/AEM.02395-07.,OADS,/arxiv_data1/oa_pdf/e7/9d/bbug-3-347.PMC3489712.pdf
FEMS Yeast Res 2005; 5:399-409; PMID:15691745; http://dx.doi.org/10.1016/j.femsyr.2004.09.010.,OADS,/arxiv_data1/oa_pdf/e7/9d/bbug-3-347.PMC3489712.pdf
Biotechnol Biofuels 2012; 5:14; PMID:22424089; http://dx.doi.org/10.1186/1754-6834-5-14.,Non-OADS,/arxiv_data1/oa_pdf/e7/9d/bbug-3-347.PMC3489712.pdf
"In contrast, TLR3 is activated when dsRNA gener - ated in infected cells is released and inter - nalized into the endosome of bystander TAMable tumor-associated macrophages   in response to innate RNA sensing tsukasa Seya,* h iroaki Shime and Misako Matsumoto Department of Microbiology and Immunology; Graduate School of Medicine; h okkaido u niversity; Sapporo, Japan Keywords:  TLR3, TICAM-1, tumor-infiltrating macrophages, polyI:C, immunotherapy *Correspondence to: Tsukasa Seya; Email: seya-tu@pop.med.hokudai.ac.jp Submitted: 02/27/12; Revised: 03/02/12; Accepted: 03/02/12http://dx.doi.org/10.4161/onci.19894phagocytes,2 such as dendritic cells (DC)  and macrophages.",Non-OADS,/arxiv_data1/oa_pdf/04/f2/onci-1-1000.PMC3489733.pdf
Proc Natl Acad Sci USA  2012; 109:2066-71; PMID:22308357; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/04/f2/onci-1-1000.PMC3489733.pdf
Proc Natl Acad Sci USA  1975; 72:3666-70; PMID:1103152; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/04/f2/onci-1-1000.PMC3489733.pdf
J Immunol 2011; 186:2422-9;  PMID:21242525; http://dx.doi.org/10.4049/jimmu- nol.1002845.,Non-OADS,/arxiv_data1/oa_pdf/04/f2/onci-1-1000.PMC3489733.pdf
Nature  1997; 388:394-7; PMID:9237759; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/f2/onci-1-1000.PMC3489733.pdf
J Exp Med  2011; 208:2357-66; PMID:22065672; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/04/f2/onci-1-1000.PMC3489733.pdf
Rev Med Virol  2011; 21:67-77; PMID:21312311; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/f2/onci-1-1000.PMC3489733.pdf
J Biol Chem 2011; 286:10702- 11; PMID:21266579; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/04/f2/onci-1-1000.PMC3489733.pdf
J Exp Med 2010; 207:2675-87; PMID:21059856; http://dx.doi.org/10.1084/jem.20091573.the Janeway/Medzhitov concept9 may be  adaptable to tumor immunology that pat - tern recognition receptor (PRR) stimula - tion by a specific ligand triggers innate  immune response and facilitates establish - ment of the cellular immune system.,Non-OADS,/arxiv_data1/oa_pdf/04/f2/onci-1-1000.PMC3489733.pdf
"This is not a new idea, nor one that ever has been ignored by cancer immunologists, but it is re-emerging nev - ertheless in the mainstream because of mechanistic advances in understanding Immunological thought in the mainstream   of cancer research Past divorce, recent remarriage and elective affinities   of the future George C. Prendergast Lankenau Institute for Medical r esearch; Wynnewood, P a US a Correspondence to: George Prendergast; Email: prendergast@limr.org Submitted: 05/17/12; Accepted: 05/29/12http://dx.doi.org/10.4161/onci.20909how cancer cells master their tissue micro - environment and host, and how these pro - cesses are integrated with oncogenesis and  epigenetic alterations in cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/6a/94/onci-1-793.PMC3489734.pdf
Proc Natl Acad Sci USA  2011; 108:7142-7; PMID:21482773; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6a/94/onci-1-793.PMC3489734.pdf
N Engl J Med 2008; 358:2664-5;  PMID:18565858; http://dx.doi.org/10.1056/ NEJMp0803663.,OADS,/arxiv_data1/oa_pdf/6a/94/onci-1-793.PMC3489734.pdf
Oncogene 2008; 27:3889- 900; PMID:18317452; http://dx.doi.org/10.1038/ onc.2008.35.6.,Non-OADS,/arxiv_data1/oa_pdf/6a/94/onci-1-793.PMC3489734.pdf
N Engl J Med 2012; 366:883- 92; PMID:22397650; http://dx.doi.org/10.1056/ NEJMoa1113205.,OADS,/arxiv_data1/oa_pdf/6a/94/onci-1-793.PMC3489734.pdf
Nat Rev Clin Oncol 2011; 8:151-60; PMID:21364688;  http://dx.doi.org/10.1038/nrclinonc.2010.223.,Non-OADS,/arxiv_data1/oa_pdf/6a/94/onci-1-793.PMC3489734.pdf
Nat  Rev Drug Discov 2012; 11:215-33; PMID:22301798;  http://dx.doi.org/10.1038/nrd3626.,OADS,/arxiv_data1/oa_pdf/6a/94/onci-1-793.PMC3489734.pdf
Nat Med  2011; 17:1094-100; PMID:21873989; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6a/94/onci-1-793.PMC3489734.pdf
Cancer Res  2005; 65:8065-8; PMID:16166276; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6a/94/onci-1-793.PMC3489734.pdf
Radiology  2005; 235:259-65; PMID:15695622; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6a/94/onci-1-793.PMC3489734.pdf
N Engl J Med 1997; 336:897- 904; PMID:9070469; http://dx.doi.org/10.1056/ NEJM199703273361301.,Non-OADS,/arxiv_data1/oa_pdf/6a/94/onci-1-793.PMC3489734.pdf
Science 2011; 331:1565-70;  PMID:21436444; http://dx.doi.org/10.1126/sci-ence.1203486.,OADS,/arxiv_data1/oa_pdf/6a/94/onci-1-793.PMC3489734.pdf
Nature 2001;  410:1107-11; PMID:11323675; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6a/94/onci-1-793.PMC3489734.pdf
Am J Pathol 2010; 176:2082- 7; PMID:20228228; http://dx.doi.org/10.2353/ ajpath.2010.091173.Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/6a/94/onci-1-793.PMC3489734.pdf
"OncoImmunology 1:6, 798-809; September 2012; © 2012 Landes Bioscience ReSeaR ch papeR 798 OncoImmunology Volume 1 Issue 6*Correspondence to: Marjolein van Egmond; Email: m.vanegmond@vumc.nl Submitted: 03/15/12; Revised: 04/17/12; Accepted: 04/18/12http://dx.doi.org/10.4161/onci.20427Introduction Solid tumors not only consist of malignant cells, but also con - tain non-malignant stromal cells like fibroblasts and endothelial  cells as well as a variety of hematopoietic immune cells.",Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Science 2010; 327:656- 61; PMID:20133564; http://dx.doi.org/10.1126/sci- ence.1178331.3.,OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Immunity  2010; 32:593-604; PMID:20510870; http://dx.doi.org/10.1016/j.immuni.2010.05.007.,OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
T rends Immunol 2002; 23:549-55;  PMID:12401408; http://dx.doi.org/10.1016/S1471- 4906(02)02302-5.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Semin Cancer Biol 2008; 18:349-55;  PMID:18467122; http://dx.doi.org/10.1016/j.sem- cancer.2008.03.004.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Curr  Opin Immunol 2008; 20:669-75; PMID:18852045;  http://dx.doi.org/10.1016/j.coi.2008.09.007.,OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Nature 2009; 457:102-6; PMID:19122641;  http://dx.doi.org/10.1038/nature07623.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Mol Biol Cell  2005; 16:1330-40; PMID:15635104; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Int J Mol Sci 2011; 12:1009-29; PMID:21541039;  http://dx.doi.org/10.3390/ijms12021009.,OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Cell  Res 2005; 15:483-94; PMID:16045811; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Int J Cancer 2003; 107:359- 64; PMID:14506734; http://dx.doi.org/10.1002/ ijc.11423.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
J Clin Pathol 2007; 60:267- 72; PMID:16731595; http://dx.doi.org/10.1136/ jcp.2005.034181.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Gynecol Oncol 2010; 119:114-20; PMID:20619446;  http://dx.doi.org/10.1016/j.ygyno.2010.05.029.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Ann  Oncol 2007; 18:269-74; PMID:17065588; http://dx.doi.org/10.1093/annonc/mdl370.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Cancer Res 2006; 66:11432-40; PMID:17145890;  http://dx.doi.org/10.1158/0008-5472.CAN-06-1867.24.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Cancer Metastasis Rev  2006; 25:315-22; PMID:16967326; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Cancer Cell 2008; 13:23- 35; PMID:18167337; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
J Leukoc Biol 2008; 84:623- 30; PMID:18467655; http://dx.doi.org/10.1189/ jlb.1107762.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Nat Rev  Cancer 2004; 4:71-8; PMID:14708027; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
J T ransl  Med 2007; 5:62; PMID:18047662; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Cancer Metastasis Rev 2006; 25:357-71;  PMID:17016763; http://dx.doi.org/10.1007/s10555- 006-9003-5.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Cancer Res  2006; 66:605-12; PMID:16423985; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Clin Cancer Res 2007; 13:1472-9;  PMID:17332291; http://dx.doi.org/10.1158/1078- 0432.CCR-06-2073.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
J Pathol 2005; 207:147-55; PMID:16104052; http://dx.doi.org/10.1002/path.1830.,OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
J Exp Med 2001; 193:727-40; PMID:11257139; http://dx.doi.org/10.1084/ jem.193.6.727.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
J Biol Chem 2012; 287:2984- 95; PMID:22139901; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Cancer Lett 2008; 262:77- 86; PMID:18187256; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Eur J Immunol 2008; 38:3269-73; PMID:19039773; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
J Proteome Res  2010; 9:1913-22; PMID:20085282; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Nat Immunol 2010; 11:889-96;  PMID:20856220; http://dx.doi.org/10.1038/ni.1937.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Novartis Found Symp  2004; 256:158-68; PMID:15027489; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Cancer Sci 2007; 98:405-10;  PMID:17214745; http://dx.doi.org/10.1111/j.1349- 7006.2007.00402.x.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Gastroenterology  2009; 137:2018-29; PMID:19555692; http://dx.doi.org/10.1053/j.gastro.2009.06.047.58.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
J Clin Invest 2011; 121:4746- 57; PMID:22056381; http://dx.doi.org/10.1172/ JCI58814.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Cancer Res 2009; 69:2133-40; PMID:19223554; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Cancer Cell 2008; 14:299- 311; PMID:18835032; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
Cancer Cell  2009; 16:91-102; PMID:19647220; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
J Exp  Med 2008; 205:1261-8; PMID:18490490; http://dx.doi.org/10.1084/jem.20080108.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
J Immunol 2009; 182:3105- 11; PMID:19234207; http://dx.doi.org/10.4049/jim- munol.0800224.,Non-OADS,/arxiv_data1/oa_pdf/2d/10/onci-1-798.PMC3489735.pdf
"OncoImmunology 1:6, 810–821; September 2012; © 2012 Landes Bioscience ReSeaR ch papeR 810 OncoImmunology Volume 1 Issue 6*Correspondence to: Timothy Kute; Email: tkute@wakehealth.edu Submitted: 03/16/12; Revised: 04/18/12; Accepted: 04/20/12http://dx.doi.org/10.4161/onci.20447Introduction Personalized medicine offers the best opportunity for successful  treatments while minimizing side effects.",Non-OADS,/arxiv_data1/oa_pdf/5f/4d/onci-1-810.PMC3489736.pdf
N Engl J Med  2001; 344:783-92; PMID:11248153; http://dx.doi.org/10.1056/NEJM200103153441101.,OADS,/arxiv_data1/oa_pdf/5f/4d/onci-1-810.PMC3489736.pdf
Cancer  2010; 116:2856-67; PMID:20564392; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5f/4d/onci-1-810.PMC3489736.pdf
N Engl J Med 2005; 353:1659-72; PMID:16236737;  http://dx.doi.org/10.1056/NEJMoa052306.,OADS,/arxiv_data1/oa_pdf/5f/4d/onci-1-810.PMC3489736.pdf
Cancer Biol Ther  2011; 11:793-800; PMID:21307659; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5f/4d/onci-1-810.PMC3489736.pdf
Nat Rev Mol Cell Biol 2006; 7:505-16; PMID:16829981; http://dx.doi.org/10.1038/ nrm1962.,OADS,/arxiv_data1/oa_pdf/5f/4d/onci-1-810.PMC3489736.pdf
Oncogene 2007; 26:3637-43; PMID:17530017; http://dx.doi.org/10.1038/sj.onc.1210379.,OADS,/arxiv_data1/oa_pdf/5f/4d/onci-1-810.PMC3489736.pdf
Clin Cancer Res 2004; 10:5650-5; PMID:15355889;  http://dx.doi.org/10.1158/1078-0432.CCR-04-0225.,Non-OADS,/arxiv_data1/oa_pdf/5f/4d/onci-1-810.PMC3489736.pdf
Nat Med 2000; 6:443-6;  PMID:10742152; http://dx.doi.org/10.1038/74704.,OADS,/arxiv_data1/oa_pdf/5f/4d/onci-1-810.PMC3489736.pdf
Cancer Res 2007; 67:11991-9;  PMID:18089830; http://dx.doi.org/10.1158/0008-5472.CAN-07-2068.,Non-OADS,/arxiv_data1/oa_pdf/5f/4d/onci-1-810.PMC3489736.pdf
Breast Cancer Res T reat  2001; 70:123-9; PMID:11768602; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5f/4d/onci-1-810.PMC3489736.pdf
Cytometry  A 2004; 57:86-93; PMID:14750129; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5f/4d/onci-1-810.PMC3489736.pdf
Cancer Immunol Immunother  2009; 58:1887-96; PMID:19340424; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5f/4d/onci-1-810.PMC3489736.pdf
Assay Drug  Dev Technol 2004; 2:363-72; PMID:15357917;  http://dx.doi.org/10.1089/adt.2004.2.363.,OADS,/arxiv_data1/oa_pdf/5f/4d/onci-1-810.PMC3489736.pdf
Chem Res Toxicol  2005; 18:154-61; PMID:15720119; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/4d/onci-1-810.PMC3489736.pdf
J Immunol Methods  2006; 309:25-33; PMID:16423365; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5f/4d/onci-1-810.PMC3489736.pdf
Cancer Res 2007; 67:11991-9;  PMID:18089830; http://dx.doi.org/10.1158/0008- 5472.CAN-07-2068.,Non-OADS,/arxiv_data1/oa_pdf/5f/4d/onci-1-810.PMC3489736.pdf
Anticancer  Drugs 2007; 18:23-8; PMID:17159499; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5f/4d/onci-1-810.PMC3489736.pdf
Mol Cancer Ther 2007; 6:2065-72; PMID:17620435; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5f/4d/onci-1-810.PMC3489736.pdf
"OncoImmunology 1:6, 822-828; September 2012; © 2012 Landes Bioscience ReSeaR ch papeR 822 OncoImmunology Volume 1 Issue 6*Correspondence to: Yvonne Paterson; Email: yvonne@mail.med.upenn.edu Submitted: 03/27/12; Revised: 04/23/12; Accepted: 04/23/12http://dx.doi.org/10.4161/onci.20491Introduction Interleukin 17 (IL-17), a proinflammatory cytokine that is upreg - ulated during immune responses to infection and injury, has been  associated with a variety of cancers; however, the role of IL-17 in tumor formation remains unclear.",Non-OADS,/arxiv_data1/oa_pdf/36/8b/onci-1-822.PMC3489737.pdf
J Immunol 2009; 183:4169-75;  PMID:19767566; http://dx.doi.org/10.4049/jimmu- nol.0901017.,Non-OADS,/arxiv_data1/oa_pdf/36/8b/onci-1-822.PMC3489737.pdf
Blood 2003; 101:2620-7; PMID:12411307; http://dx.doi.org/10.1182/blood- 2002-05-1461.,Non-OADS,/arxiv_data1/oa_pdf/36/8b/onci-1-822.PMC3489737.pdf
Blood 2002; 99:2114-21; PMID:11877287; http://dx.doi.org/10.1182/blood.V99.6.2114.,Non-OADS,/arxiv_data1/oa_pdf/36/8b/onci-1-822.PMC3489737.pdf
J Exp Med 2011; 208:491-503;  PMID:21383056; http://dx.doi.org/10.1084/ jem.20100269.,Non-OADS,/arxiv_data1/oa_pdf/36/8b/onci-1-822.PMC3489737.pdf
Cancer Res 2007; 67:5-8; PMID:17210676; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/8b/onci-1-822.PMC3489737.pdf
Cancer Immunol Immunother 2005; 54:477-88; PMID:15750832; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/8b/onci-1-822.PMC3489737.pdf
J Immunol  2010; 185:5879-87; PMID:20956351; http://dx.doi.org/10.4049/jimmunol.1001763.12.,Non-OADS,/arxiv_data1/oa_pdf/36/8b/onci-1-822.PMC3489737.pdf
Blood 2009; 114:1141-9;  PMID:19470694; http://dx.doi.org/10.1182/blood- 2009-03-208249.,Non-OADS,/arxiv_data1/oa_pdf/36/8b/onci-1-822.PMC3489737.pdf
"www.landesbioscience.com OncoImmunology 829OncoImmunology 1:6, 829–839; September 2012; © 2012 Landes Bioscience ReSeaR ch papeR ReSeaR ch papeR *Correspondence to: Jean-Philippe Girard; Email: Jean-Philippe.Girard@ipbs.fr Submitted: 04/11/12; Revised: 04/20/12; Accepted: 04/23/12http://dx.doi.org/10.4161/onci.20492Introduction The incidence of metastatic melanoma has increased over the  past three decades and the death rate continues to rise faster than the rate of most other cancers.",Non-OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
Ann  Oncol 2009; 20:1-7; PMID:19617292; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
J Clin Oncol 2010; 28:4531-8; PMID:20516428; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
Science  2006; 313:1960-4; PMID:17008531; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
N Engl J Med 2003; 348:203-13; PMID:12529460;  http://dx.doi.org/10.1056/NEJMoa020177.,OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
Cancer Res 2011; 71:5601-5; PMID:21846822;  http://dx.doi.org/10.1158/0008-5472.CAN-11-1316.,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
Nat Rev Immunol 2006; 6:295-307;  PMID:16557261; http://dx.doi.org/10.1038/nri1806.,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
J Clin Oncol  2006; 24:5373-80; PMID:17135638; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
Nat Med 2004; 10:942-9;  PMID:15322536; http://dx.doi.org/10.1038/nm1093.,OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
Cancer Res 2011; 71:6391-9;  PMID:21900403; http://dx.doi.org/10.1158/0008-5472.CAN-11-0952.,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
J Exp Med 2010; 207:1791-804; PMID:20660615; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
Immunity 2001; 14:111-21;  PMID:11239444; http://dx.doi.org/10.1016/S1074- 7613(01)00094-2.,OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
Nat Immunol 2004;  5:141-9; PMID:14704792; http://dx.doi.org/10.1038/ ni1029.,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
Immunity 2002; 17:737-47; PMID:12479820; http://dx.doi.org/10.1016/S1074-7613(02)00480-6.,OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
Nat Rev Clin Oncol  2009; 6:256-8; PMID:19390551; http://dx.doi.org/10.1038/nrclinonc.2009.42.,OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
Cancer Immunol  Immunother 2003; 52:670-9; PMID:12920482; http://dx.doi.org/10.1007/s00262-003-0425-4.18.,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
Nat Rev Immunol 2003; 3:867- 78; PMID:14668803; http://dx.doi.org/10.1038/nri1222.,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
Nat Rev Immunol  2006; 6:205-17; PMID:16498451; http://dx.doi.org/10.1038/nri1786.,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
Proc Natl Acad Sci USA  2004; 101:17807-12; PMID:15591109; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
Cancer Res 2011; 71:5678-87;  PMID:21846823; http://dx.doi.org/10.1158/0008- 5472.CAN-11-0431.,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
Lancet Oncol  2012; 13:32-42; PMID:22225723; http://dx.doi.org/10.1016/S1470-2045(11)70155-3.,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
J Clin Invest 2006; 116:1935- 45; PMID:16778987; http://dx.doi.org/10.1172/ JCI27745.,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
Nature 2011; 479:542-6; PMID:22080953;  http://dx.doi.org/10.1038/nature10540.,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
Annu Rev Immunol 2011; 29:235-71;  PMID:21219185; http://dx.doi.org/10.1146/annurev- immunol-031210-101324.,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
J  Invest Dermatol 1997; 108:914-9; PMID:9182821;  http://dx.doi.org/10.1111/1523-747.ep12292705.,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
J Clin Oncol 2007; 25:869-75; PMID:17327608;  http://dx.doi.org/10.1200/JCO.2006.08.9755.,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
J  Natl Cancer Inst 1989; 81:1893-904; PMID:2593166;  http://dx.doi.org/10.1093/jnci/81.24.1893.,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
Cancer 1996; 77:1303- 10; PMID:8608507; http://dx.doi.org/10.1002/ (SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5.,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
J Clin Oncol  2005; 23:2346-57; PMID:15800326; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
J Clin Oncol 2006; 24:3164-71; PMID:16809739; http://dx.doi.org/10.1200/ JCO.2005.05.2498.,OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
J Clin Oncol 2007; 25:3802-7;  PMID:17761969; http://dx.doi.org/10.1200/ JCO.2006.10.2822.,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
Cancer Immunol  Immunother 2011; 60:1153-60; PMID:21553145;  http://dx.doi.org/10.1007/s00262-011-1026-2.,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
Immunol Today 1995; 16:449-57;  PMID:7546210; http://dx.doi.org/10.1016/0167- 5699(95)80023-9.,Non-OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
Nat Med 2008; 14:28-36; PMID:18157142; http://dx.doi.org/10.1038/ nm1699.,OADS,/arxiv_data1/oa_pdf/c1/b3/onci-1-829.PMC3489738.pdf
Robinson; Email: bruce.robinson@uwa.edu.au Submitted: 04/14/12; Accepted: 04/24/12http://dx.doi.org/10.4161/onci.20493Introduction One of the critical questions in tumor immunology is how the  host senses the presence of the many potential antigens that are present in each tumor.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Nature 2001; 411:1058-64; PMID:11429607;  http://dx.doi.org/10.1038/35082583.,OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Nat Rev Immunol 2010; 10:403- 14; PMID:20498667; http://dx.doi.org/10.1038/ nri2780.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Immunol Cell Biol 1999; 77:552-8; PMID:10571677; http://dx.doi.org/10.1046/j.1440-711.1999.00876.x.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Immunity  2006; 25:153-62; PMID:16860764; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
J Exp Med 2008; 205:1621-34; PMID:18591406;  http://dx.doi.org/10.1084/jem.20071365.8.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Handb Exp Pharmacol 2009:31-49; http://dx.doi.org/10.1007/978-3-540-71029-5_2.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Cancer Immunol Immunother 2008; 57:1665-73;  PMID:18311487; http://dx.doi.org/10.1007/s00262-008-0487-4.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Semin Cancer Biol 2002; 12:33-42; PMID:11926410; http://dx.doi.org/10.1006/scbi.2001.0400.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
J Immunol 2009; 182:2726-37;  PMID:19234167; http://dx.doi.org/10.4049/jimmu- nol.0803479.16.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Immunology  1999; 97:130-7; PMID:10447724; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Melanoma Res 2007; 17:169-76; PMID:17505262;  http://dx.doi.org/10.1097/CMR.0b013e3281844531.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Nat Med 2010; 16:98- 105; PMID:20037595; http://dx.doi.org/10.1038/ nm.2074.,OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Ann Surg Oncol 2003; 10:575- 81; PMID:12794026; http://dx.doi.org/10.1245/ ASO.2003.03.054.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Ann Oncol  2009; 20:41-8; PMID:18653702; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Immunol Cell Biol 2005; 83:451-61;  PMID:16174093; http://dx.doi.org/10.1111/j.1440- 711.2005.01371.x.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Clin  Chem Lab Med 2011; 49:1579-90; PMID:21801030;  http://dx.doi.org/10.1515/CCLM.2011.628.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Clin Chem  2011; 57:1242-55; PMID:21784769; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Future Oncol 2011; 7:849- 71; PMID:21732757; http://dx.doi.org/10.2217/ fon.11.32.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
BJU  Int 2000; 85:270-5; PMID:10671880; http://dx.doi.org/10.1046/j.1464-410x.2000.00406.x.,OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
N Engl J Med 2008; 359:2814-23; PMID:19109576;  http://dx.doi.org/10.1056/NEJMra0805239.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Cell 2006; 127:679-95; PMID:17110329;  http://dx.doi.org/10.1016/j.cell.2006.11.001.,OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
J Immunol Methods  1994; 171:131-7; PMID:8176234; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Cancer Res 2007; 67:5009-16;  PMID:17510433; http://dx.doi.org/10.1158/0008- 5472.CAN-06-4494.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Eur J Immunol 2010; 40:1617- 27; PMID:20373290; http://dx.doi.org/10.1002/ eji.200940153.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Eur J Immunol  2002; 32:2385-92; PMID:12207322; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Annu  Rev Immunol 2000; 18:767-811; PMID:10837075;  http://dx.doi.org/10.1146/annurev.immunol.18.1.767.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Annu Rev Immunol  2003; 21:685-711; PMID:12615891; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Nat Rev Immunol 2007; 7:543-55;  PMID:17589544; http://dx.doi.org/10.1038/nri2103.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Cell Death Differ  2008; 15:39-50; PMID:17948027; http://dx.doi.org/10.1038/sj.cdd.4402247.22.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Eur J  Cardiothorac Surg 2007; 32:863-7; PMID:17936004;  http://dx.doi.org/10.1016/j.ejcts.2007.09.014.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Langenbecks Arch Surg 2009; 394:105-13;  PMID:18626657; http://dx.doi.org/10.1007/s00423- 008-0369-4.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
J Exp Med  2007; 204:2889-97; PMID:17984307; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
Cancer Immunol  Immunother 2006; 55:495-502; PMID:16001163;  http://dx.doi.org/10.1007/s00262-005-0023-8.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
J Exp Med 2003; 197:985- 95; PMID:12695490; http://dx.doi.org/10.1084/jem.20021804.,Non-OADS,/arxiv_data1/oa_pdf/bc/67/onci-1-840.PMC3489739.pdf
"www.landesbioscience.com OncoImmunology 847OncoImmunology 1:6, 847–855; September 2012; © 2012 Landes Bioscience ReSeaR ch papeR ReSeaR ch papeR *Correspondence to: Paul L. Hermonat and Rongcheng Luo; Email: plhermonat@uams.edu and lrc@nfhoc.com Submitted: 02/25/12; Revised: 04/23/12; Accepted: 04/25/12http://dx.doi.org/10.4161/onci.20504Introduction One approach in immunotherapy is the genetic manipulation of  professional antigen presenting dendritic cells (DC) for the stim - ulation of cytotoxic T lymphocytes (CTL).1 Protocols for gener - ating DC from peripheral blood monocytes (and other sources) have been widely used and permit the convenient ex vivo manip - ulation of DC for laboratory and clinical studies.",Non-OADS,/arxiv_data1/oa_pdf/dd/4c/onci-1-847.PMC3489740.pdf
Annu Rev Immunol 1991; 9:271-96;  PMID:1910679; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/onci-1-847.PMC3489740.pdf
J Exp Med 1994; 179:1109- 18; PMID:8145033; http://dx.doi.org/10.1084/ jem.179.4.1109.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/onci-1-847.PMC3489740.pdf
J Exp Med 1994; 180:83- 93; PMID:8006603; http://dx.doi.org/10.1084/jem.180.1.83.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/onci-1-847.PMC3489740.pdf
J Interferon Cytokine Res  2000; 20:21-30; PMID:10670649; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dd/4c/onci-1-847.PMC3489740.pdf
Cancer Gene Ther 2001; 8:948-57; PMID:11781657;  http://dx.doi.org/10.1038/sj.cgt.7700391.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/onci-1-847.PMC3489740.pdf
Cancer Gene  Ther 2004; 12:304-12; http://dx.doi.org/10.1038/sj.cgt.7700785.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/onci-1-847.PMC3489740.pdf
Vaccine 2006; 24:1615-24;  PMID:16806599; http://dx.doi.org/10.1016/j.vac- cine.2005.09.055.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/onci-1-847.PMC3489740.pdf
Proc Natl Acad Sci USA 1984; 81:6466- 70; PMID:6093102; http://dx.doi.org/10.1073/ pnas.81.20.6466.9.,OADS,/arxiv_data1/oa_pdf/dd/4c/onci-1-847.PMC3489740.pdf
J Virol 2006; 80:11899- 910; PMID:17005662; http://dx.doi.org/10.1128/ JVI.00890-06.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/onci-1-847.PMC3489740.pdf
J Virol 2007; 81:5385-94; PMID:17314166; http://dx.doi.org/10.1128/ JVI.02516-06.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/onci-1-847.PMC3489740.pdf
Gene Ther 2006; 13:29-39; PMID:16136165; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dd/4c/onci-1-847.PMC3489740.pdf
Cancer Immunol Immunother  2010; 59:779-87; PMID:20091029; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/onci-1-847.PMC3489740.pdf
J Biomed Biotechnol 2010; 2010:270985; PMID:20490265;  http://dx.doi.org/10.1155/2010/270985.,OADS,/arxiv_data1/oa_pdf/dd/4c/onci-1-847.PMC3489740.pdf
J Immunother 2008; 31:359-69; PMID:18391760;  http://dx.doi.org/10.1097/CJI.0b013e318165f5d2.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/onci-1-847.PMC3489740.pdf
Vet Immunol Immunopathol 2010; 137:322- 6; PMID:20599278; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/dd/4c/onci-1-847.PMC3489740.pdf
J Gen Virol 1986; 67:2325- 34; PMID:3097247; http://dx.doi.org/10.1099/0022-1317-67-11-2325.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/onci-1-847.PMC3489740.pdf
Proc Natl Acad Sci USA  2004; 101:2434-9; PMID:14983027; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dd/4c/onci-1-847.PMC3489740.pdf
Hum Gene Ther  2001; 12:71-6; PMID:11177544; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dd/4c/onci-1-847.PMC3489740.pdf
Genomics 1988; 3:59-66; PMID:3220478;  http://dx.doi.org/10.1016/0888-7543(88)90160-7.,OADS,/arxiv_data1/oa_pdf/dd/4c/onci-1-847.PMC3489740.pdf
Gene 1999; 238:397-405; PMID:10570967;  http://dx.doi.org/10.1016/S0378-1119(99)00347-9.26.,OADS,/arxiv_data1/oa_pdf/dd/4c/onci-1-847.PMC3489740.pdf
Cancer Gene Ther 2000; 7:308- 15; PMID:10770641; http://dx.doi.org/10.1038/ sj.cgt.7700105.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/onci-1-847.PMC3489740.pdf
Mol Ther 2011; 19:1245- 53; PMID:21364542; http://dx.doi.org/10.1038/ mt.2011.37.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/onci-1-847.PMC3489740.pdf
BMC Microbiol 2009; 9:79;  PMID:19389243; http://dx.doi.org/10.1186/1471- 2180-9-79.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/onci-1-847.PMC3489740.pdf
"OncoImmunology 1:6, 856–862; September 2012; © 2012 Landes Bioscience ReSeaR ch papeR 856 OncoImmunology Volume 1 Issue 6*Correspondence to: Kasper Hoebe; Email: kasper.hoebe@cchmc.org Submitted: 03/18/12; Revised: 04/30/12; Accepted: 05/01/12http://dx.doi.org/10.4161/onci.20580Introduction The interaction between the immune system and cancer devel - opment is a bidirectional relationship involving elimination and  adaptation.",Non-OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
J Clin Invest 2007; 117:1137-46; PMID:17476343;  http://dx.doi.org/10.1172/JCI31405.,Non-OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
Nature 2007; 450:903- 7; PMID:18026089; http://dx.doi.org/10.1038/ nature06309.,OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
Nature 2012; 482:400-4; PMID:22318521;  http://dx.doi.org/10.1038/nature10755.4.,Non-OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
AdvImmunol 2006; 90:1-50;  PMID:16730260; http://dx.doi.org/10.1016/S0065- 2776(06)90001-7.,OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
Cell 2010; 142:847-56; PMID:20850008;  http://dx.doi.org/10.1016/j.cell.2010.08.031.7.,OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
Semin Cancer Biol 2006; 16:344-7;  PMID:16914325; http://dx.doi.org/10.1016/j.sem-cancer.2006.07.004.,Non-OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
Cold Spring Harb  Perspect Biol 2012; 4:4; PMID:22383753; http://dx.doi.org/10.1101/cshperspect.a007229.,Non-OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
Semin Immunol  2006; 18:145-50; PMID:16740393; http://dx.doi.org/10.1016/j.smim.2006.03.003.,OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
Immunol  Today 1990; 11:237-44; PMID:2201309; http://dx.doi.org/10.1016/0167-5699(90)90097-S.,Non-OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
Blood 2005; 105:4722-9; PMID:15713798;  http://dx.doi.org/10.1182/blood-2004-09-3796.,Non-OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
J Exp Med 2000; 192:337-46; PMID:10934222;  http://dx.doi.org/10.1084/jem.192.3.337.,OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
Science 2012; 335:344-8; PMID:22267813;  http://dx.doi.org/10.1126/science.1215621.,Non-OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
Nat Immunol 2007; 8:659-64; PMID:17579639; http://dx.doi.org/10.1038/ni0707-659.,Non-OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
Methods Mol Biol  2009; 517:239-51; PMID:19378030; http://dx.doi.org/10.1007/978-1-59745-541-1_15.,Non-OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
Genome Res 2004; 14:901- 7; PMID:15123587; http://dx.doi.org/10.1101/ gr.1949704.,OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
PLoS One 2011; 6:21979;  PMID:21760938; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
Blood 2006; 107:159-66; PMID:16150947;  http://dx.doi.org/10.1182/blood-2005-04-1351.,Non-OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
Eur J Immunol2000;  30:787-93; PMID:10741393; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
Proc Natl Acad Sci USA 1999; 96:3870- 5; PMID:10097130; http://dx.doi.org/10.1073/ pnas.96.7.3870.,OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
Immunity 2007; 27:698-710;  PMID:18031694; http://dx.doi.org/10.1016/j.immu- ni.2007.11.005.,OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
Nature 1998; 395:462-9;  PMID:9774102; http://dx.doi.org/10.1038/26683.,Non-OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
Nat Immunol 2005; 6:1002-10; PMID:16127454;  http://dx.doi.org/10.1038/ni1242.,Non-OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
J Exp Med 2005; 202:181-92; PMID:15998796; http://dx.doi.org/10.1084/jem.20050449.11.,Non-OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
Immunol Cell  Biol 2005; 83:1-8; PMID:15661035; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
J Exp Med 1985;  162:1745-59; PMID:3877776; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
Nat Immunol 2008; 9:495-502;  PMID:18425106; http://dx.doi.org/10.1038/ni1581.,Non-OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
Blood 2009; 113:6593-602;  PMID:19406986; http://dx.doi.org/10.1182/blood- 2009-01-201467.,Non-OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
Cancer Res 2008; 68:4026-30; PMID:18519658;  http://dx.doi.org/10.1158/0008-5472.CAN-08-0427.,Non-OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
J Mol Med (Berl) 2007; 85:1069-76; PMID:17891368; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ce/0f/onci-1-856.PMC3489741.pdf
"www.landesbioscience.com OncoImmunology 863OncoImmunology 1:6, 863–873; September 2012; © 2012 Landes Bioscience ReSeaR ch papeR ReSeaR ch papeR *Correspondence to: Jennifer D. Stone; Email: jstone@illinois.edu Submitted: 04/21/12; Revised: 05/01/12; Accepted: 05/02/12http://dx.doi.org/10.4161/onci.20592Introduction Tumor cells express various proteins and epitopes on their sur - face that differentiate them from healthy cells, either by levels  of expression or by revealing novel epitopes not seen in normal “self.” Hence, it is possible for the adaptive immune system to tar - get these cells (reviewed in refs.",Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Blood 2011; 118:830-1;  PMID:21799095; http://dx.doi.org/10.1182/blood-2011-06-357541.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Clin Ther  1999; 21:309-18; PMID:10211534; http://dx.doi.org/10.1016/S0149-2918(00)88288-0.,OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Semin Cancer Biol 2002; 12:3-13; PMID:11926409; http://dx.doi.org/10.1006/ scbi.2001.0404.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Immunol Today 1993; 14:491-9; PMID:8274189; http://dx.doi.org/10.1016/0167- 5699(93)90264-L. 9.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Cancer Res 2004; 64:6319-26; PMID:15342421;  http://dx.doi.org/10.1158/0008-5472.CAN-04-1341.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Cancer Res  2007; 67:3919-26; PMID:17440107; http://dx.doi.org/10.1158/0008-5472.CAN-06-2112.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Science 2002; 298:850- 4; PMID:12242449; http://dx.doi.org/10.1126/sci- ence.1076514.13.,OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
J Clin Oncol  2005; 23:2346-57; PMID:15800326; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Science 2006; 314:126-9; PMID:16946036;  http://dx.doi.org/10.1126/science.1129003.,OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Nat Immunol 2001; 2:957-61;  PMID:11577349; http://dx.doi.org/10.1038/ni1001- 957.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Hum Gene Ther  2009; 20:1240-8; PMID:19702439; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Blood 2007; 109:2331-8; PMID:17082316; http://dx.doi.org/10.1182/blood-2006-05-023069.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Curr Gene  Ther 2010; 10:77-90; PMID:20222863; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Blood  2003; 101:1637-44; PMID:12393484; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Sci T ransl  Med 2011; 3:95; PMID:21832238; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
N Engl J Med 2011; 365:725- 33; PMID:21830940; http://dx.doi.org/10.1056/ NEJMoa1103849.,OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Nature  1985; 314:628-31; PMID:2859527; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Cancer Res  2009; 69:4941-4; PMID:19509221; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Mol Immunol 2006; 43:1129- 43; PMID:16139892; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
J Exp Med 1989; 170:217-32; PMID:2787379; http://dx.doi.org/10.1084/ jem.170.1.217.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Curr Opin Immunol  2010; 22:223-30; PMID:20207527; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Cancer Immunol  Immunother 2012; PMID:22274776; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
J Gene Med  2012; PMID:22262649; http://dx.doi.org/10.1002/ jgm.2604.,OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Blood 2005; 105:4247-54;  PMID:15728125; http://dx.doi.org/10.1182/blood- 2004-11-4564.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Gene Ther 2000; 7:1063-6; PMID:10871756;  http://dx.doi.org/10.1038/sj.gt.3301206.,OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
J Immunol 2009; 183:5563-74;  PMID:19843940; http://dx.doi.org/10.4049/jimmu- nol.0900447.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Blood 2002; 100:3155-63;  PMID:12384413; http://dx.doi.org/10.1182/blood- 2002-04-1041.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
J Immunol Methods  2008; 339:175-84; PMID:18854190; http://dx.doi.org/10.1016/j.jim.2008.09.016.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Methods Enzymol 2012;  503:189-222; PMID:22230570; http://dx.doi.org/10.1016/B978-0-12-396962-0.00008-2.,OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
J Immunol 2009; 183:1166-78; PMID:19553539;  http://dx.doi.org/10.4049/jimmunol.0900054.47.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Exp Cell Res 2011; 317:1255- 60; PMID:21419116; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Cytometry 1996; 26:137-47;  PMID:8817090; http://dx.doi.org/10.1002/ (SICI)1097-0320(19960615)26:2<137::AID- CYTO7>3.0.CO;2-D. 49.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Cytometry 1998; 33:166- 78; PMID:9773877; http://dx.doi.org/10.1002/ (SICI)1097-0320(19981001)33:2<166::AID- CYTO11>3.0.CO;2-S. 50.,OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Cytometry 1998; 33:188- 96; PMID:9773879; http://dx.doi.org/10.1002/ (SICI)1097-0320(19981001)33:2<188::AID- CYTO13>3.0.CO;2-Q.,OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Immunol Invest 2006; 35:93-114; PMID:16531332; http://dx.doi.org/10.1080/08820130500496878.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Int J Cancer 1997; 74:365- 73; PMID:9291423; http://dx.doi.org/10.1002/ (SICI)1097-0215(19970822)74:4<365::AID- IJC1>3.0.CO;2-T. 53.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Lancet Oncol 2009; 10:1179-87;  PMID:19959074; http://dx.doi.org/10.1016/S1470- 2045(09)70315-8.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Clin Cancer Res 2006; 12:3085-91;  PMID:16707606; http://dx.doi.org/10.1158/1078- 0432.CCR-05-2436.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Cancer T reat Rev  2009; 35:121-36; PMID:19008049; http://dx.doi.org/10.1016/j.ctrv.2008.09.003.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Mol Ther 2010; 18:843- 51; PMID:20179677; http://dx.doi.org/10.1038/ mt.2010.24.,OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Proc Natl Acad Sci USA  1970; 65:129-36; PMID:5263744; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Proc Natl Acad Sci USA  2002; 99:16613-8; PMID:12464682; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Gene Ther 2000;  7:35-42; PMID:10680014; http://dx.doi.org/10.1038/ sj.gt.3301051.,OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
J Immunother 2007; 30:684-93; PMID:17893561;  http://dx.doi.org/10.1097/CJI.0b013e3180de5d90.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Hum Gene Ther  1999; 10:559-63; PMID:10094199; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
J Immunol 2010; 184:4284-94; PMID:20220093;  http://dx.doi.org/10.4049/jimmunol.0903701.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
Mol Immunol 1997; 34:1157-65;  PMID:9566763; http://dx.doi.org/10.1016/S0161-5890(97)00144-2.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/onci-1-863.PMC3489742.pdf
"OncoImmunology 1:6, 874–883; September 2012; © 2012 Landes Bioscience ReSeaR ch papeR 874 OncoImmunology Volume 1 Issue 6*Correspondence to: Andrew Bateman and Edward James; Email: A.R.Bateman@soton.ac.uk and eddjames@soton.ac.uk Submitted: 03/13/12; Revised: 05/04/12; Accepted: 05/04/12http://dx.doi.org/10.4161/onci.20636Introduction Recognition of tumor cells by the immune system is essential  for effective antitumor immune responses.",Non-OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
Annu Rev Immunol 2001; 19:197-223;  PMID:11244035; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
EMBO J 2004; 23:255-9; PMID:14685277;  http://dx.doi.org/10.1038/sj.emboj.7600019.,OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
Nature 2001;  409:1055-60; PMID:11234016; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
Semin Immunol 2006; 18:151- 8; PMID:16730454; http://dx.doi.org/10.1016/j.smim.2006.03.002.5.,Non-OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
Blood 2004; 103:664-72; PMID:14504081;  http://dx.doi.org/10.1182/blood-2003-05-1716.,Non-OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
Eur J Immunol  2001; 31:2680-9; PMID:11536166; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
Glycoconj J 2006; 23:5-17; PMID:16575518;  http://dx.doi.org/10.1007/s10719-006-5433-0.9.,Non-OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
Blood 2005; 106:2252-8; PMID:15933055; http://dx.doi.org/10.1182/blood-2005-03-1154.,Non-OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
Blood 2005; 106:338-44; PMID:15769894;  http://dx.doi.org/10.1182/blood-2004-09-3775.,Non-OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
Nat Rev Immunol 2005; 5:112-24;  PMID:15688039; http://dx.doi.org/10.1038/nri1549.,Non-OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
J T ransl Med 2009; 7:50; PMID:19549307;  http://dx.doi.org/10.1186/1479-5876-7-50.,Non-OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
PLoS  One 2010; 5:13740; PMID:21060788; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
Nat Immunol 2004; 5:1143-8; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
J Gen Virol 1986; 67:2259-65;  PMID:3760826; http://dx.doi.org/10.1099/0022- 1317-67-10-2259.23.,Non-OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
Blood 2004; 104:3267-75; PMID:15242871; http://dx.doi.org/10.1182/ blood-2004-01-0380.,Non-OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
Nat Immunol 2000; 1:433-40; PMID:11062504;  http://dx.doi.org/10.1038/80877.,Non-OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
Blood  2005; 105:3051-7; PMID:15632206; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
Blood 2008; 111:3155-62;  PMID:18192509; http://dx.doi.org/10.1182/blood- 2007-09-110312.13.,Non-OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
Nat  Med 1999; 5:405-11; PMID:10202929; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
Immunity  2003; 19:561-9; PMID:14563320; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
J Exp Med  2002; 195:343-51; PMID:11828009; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
J Immunol 2010; 184:5637-44; PMID:20404273;  http://dx.doi.org/10.4049/jimmunol.0901644.,Non-OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
J Immunol  2009; 182:2221-30; PMID:19201876; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
J Clin Invest  2009; 119:1251-63; PMID:19349689; http://dx.doi.org/10.1172/JCI36022.,Non-OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
Immunology 2007; 121:439-47; PMID:17614877; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
J Gen Virol 2005; 86:1885-90; PMID:15958666;  http://dx.doi.org/10.1099/vir.0.80891-0.,Non-OADS,/arxiv_data1/oa_pdf/59/5b/onci-1-874.PMC3489743.pdf
"OncoImmunology 1:6, 884–893; September 2012; © 2012 Landes Bioscience ReSeaR ch papeR 884 OncoImmunology Volume 1 Issue 6*Correspondence to: Serena Pellegatta; Email: serenapellegatta@gmail.com Submitted: 03/15/12; Revised: 05/04/12; Accepted: 05/04/12http://dx.doi.org/10.4161/onci.20637Introduction The current standard treatment for glioblastoma (GB) involves  surgery, radiotherapy and chemotherapy with temozolomide (TMZ) and is associated with an overall survival (OS) of 14.6 mo.",Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
"To determine whether GLAST peptide- based immunotherapy is protective against GL261 gliomas, we used the SYFPEITHI (http://www.syfpeithi.de/) and BIMAS (www.bimas.cit.nih.gov/molbio/hla_bind/) binding-motif algorithms to identify high-scoring target peptides contain - ing both the murine major histocompatibility complex (MHC) H-2D b and the human HLA-A*0201.",Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
N Engl J Med 2005; 352:987-96; PMID:15758009;  http://dx.doi.org/10.1056/NEJMoa043330.,OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Lancet Oncol  2009; 10:459-66; PMID:19269895; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Clin Cancer Res 2005; 11:5515-25; PMID:16061868;  http://dx.doi.org/10.1158/1078-0432.CCR-05-0464.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Cancer Res 2008; 68:5955-64;  PMID:18632651; http://dx.doi.org/10.1158/0008- 5472.CAN-07-5973.5.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Clin  Cancer Res 2008; 14:3098-104; PMID:18483377;  http://dx.doi.org/10.1158/1078-0432.CCR-07-4875.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
J T ransl Med 2007; 5:67; PMID:18093335;  http://dx.doi.org/10.1186/1479-5876-5-67.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
J Neurooncol 2003; 64:13- 20; PMID:12952282; http://dx.doi.org/10.1007/ BF02700016.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
J Immunother 2004; 27:452-9; PMID:15534489; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Clin Cancer Res 2005; 11:4160-7; PMID:15930352; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Mol Cancer Ther 2009; 8:2773-9;  PMID:19825799; http://dx.doi.org/10.1158/1535- 7163.MCT-09-0124.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
J T ransl Med 2007; 5:10;  PMID:17295916; http://dx.doi.org/10.1186/1479-5876-5-10.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
J Clin Oncol  2011; 29:330-6; PMID:21149657; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Nature 2004; 432:396- 401; PMID:15549107; http://dx.doi.org/10.1038/ nature03128.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
J Exp Med 1992; 176:587- 92; PMID:1380064; http://dx.doi.org/10.1084/jem.176.2.587.,OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Science  1995; 270:1811-5; PMID:8525373; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Cancer Res 2010; 70:490-500; PMID:20068181;  http://dx.doi.org/10.1158/0008-5472.CAN-09-1890.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Vaccine 2006; 24:5119-32; PMID:16704888;  http://dx.doi.org/10.1016/j.vaccine.2006.04.010.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Nat  Rev Immunol 2008; 8:59-73; PMID:18097448;  http://dx.doi.org/10.1038/nri2216.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Nat Rev Drug Discov 2012; 11:215-33; PMID:  22252132; http://dx.doi.org/10.1038/nrd3626; http:// dx.doi.org/10.1038/nrd3626.27.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Nat Immunol 2009; 10:1118-24;  PMID:19749763; http://dx.doi.org/10.1038/ni.1787.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Cancer  Res 2007; 67:6451-8; PMID:17616706; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Brain Pathol 2012; 22:159-74;  PMID: 20493562; http://dx.doi.org/10.1111/j.1750-3639.2011.00515.x.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Clin Cancer Res 2010; 16:800-13;  PMID:20103663; http://dx.doi.org/10.1158/1078- 0432.CCR-09-2730.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Cancer Res 2004; 64:7596-603;  PMID:15492287; http://dx.doi.org/10.1158/0008- 5472.CAN-04-1627.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Brain 2006; 129:2416-25; http://dx.doi.org/10.1093/brain/ awl205; PMID:16891318.,OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Neuro Oncol 2010; 12:7-13; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Cancer Immunol  Immunother 2008; 57:123-31; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Nature  1990; 347:669-71; PMID:1699135; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Eur J  Immunol 1995; 25:3482-8; http://dx.doi.org/10.1002/ eji.1830251241; PMID:8566041.15.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Mol Cancer 2004; 3:25; PMID:15469606; http://dx.doi.org/10.1186/1476-4598-3-25.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Cancer Res 2004; 64:7011-21;  PMID:15466194; http://dx.doi.org/10.1158/0008- 5472.CAN-04-1364.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Cancer Res 2006; 66:10247-52;  PMID:17079441; http://dx.doi.org/10.1158/0008- 5472.CAN-06-2048.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Neuroscience  1992; 51:295-310; PMID:1465194; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
J Exp Med 2001; 194:1847-59; PMID:11748285;  http://dx.doi.org/10.1084/jem.194.12.1847.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Immunology  2002; 106:590-601; PMID:12153523; http://dx.doi.org/10.1046/j.1365-2567.2002.01459.x.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Immunity 2005; 22:175-84; PMID:15723806;  http://dx.doi.org/10.1016/j.immuni.2004.12.008.,OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
Science 2011; 331:1565-70;  PMID:21436444; http://dx.doi.org/10.1126/sci- ence.1203486.,OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
J Clin Oncol 2010; 28:4722-9; PMID:20921459;  http://dx.doi.org/10.1200/JCO.2010.28.6963.,Non-OADS,/arxiv_data1/oa_pdf/2e/8e/onci-1-884.PMC3489744.pdf
" review Oncoi mmunology 1:6, 894-907; September 2012; © 2012 Landes Bioscience 894 Oncoi mmunology volume 1 issue 6Introduction In 1985, the laboratory of Christiane Nüsslein-Volhard character - ized for the first time Toll , a gene that regulates the dorsal-ventral  embryonic polarity of the fruit fly Drosophila melanogaster .1,2 For  her discoveries concerning the genetic control of early embryonic  development, Christiane Nüsslein-Volhard shared the 1995 Nobel  *Correspondence to: Guido Kroemer; Email: kroemer@orange.fr Submitted: 05/30/12; Accepted: 05/30/12http://dx.doi.org/10.4161/onci.20931Toll-like receptors (TLr s) have first been characterized for  their capacity to detect conserved microbial components like  lipopolysaccharide (LPS) and double-stranded r NA, resulting  in the elicitation of potent (innate) immune responses against invading pathogens.",Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer 1983;  52:958-66; PMID:6883280; http://dx.doi.org/10.1002/1097-0142(19830915)52:6<958::AID- CNCR2820520604>3.0.CO;2-Z.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Med Pediatr Oncol 1983; 11:79-90; PMID:6572783;  http://dx.doi.org/10.1002/mpo.2950110204.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer 1982;  49:1530-6; PMID:7039813; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Br J Cancer 1973; 28:365-76; PMID:4271320; http://dx.doi.org/10.1038/ bjc.1973.162.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Lancet 1977; 2:1107- 10; PMID:73013; http://dx.doi.org/10.1016/S0140- 6736(77)90549-9.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
"Cancer 1983;  51:1083-90; PMID:6185212; http://dx.doi.org/10.1002/1097-0142(19830315)51:6<1083::AID- CNCR2820510619>3.0.CO;2-M. 41. Cooper MR, Pajak TF , Nissen NI, Brunner  K, Stutzman L, Bank A, et al.",Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer 1982; 49:2226- 30; PMID:6804082; http://dx.doi.org/10.1002/1097- 0142(19820601)49:11<2226::AID- CNCR2820491104>3.0.CO;2-R. 42.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Science 2010; 327:1345-50;  PMID:20223979; http://dx.doi.org/10.1126/sci- ence.1177319.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
N  Engl J Med 2007; 356:1908-10; PMID:17494923;  http://dx.doi.org/10.1056/NEJMp078053.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Int J Infect Dis 2010; 14:744- 51; PMID:20413340; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Infect Dis 1997; 176:1559-66; PMID:9395368; http://dx.doi.org/10.1086/514155.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
N Engl J Med 1951; 245:496-501; PMID:14875197; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Nature 1969; 221:863-4; PMID:4303807;  http://dx.doi.org/10.1038/221863a0.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Science 1970; 170:1217-8; PMID:4920656;  http://dx.doi.org/10.1126/science.170.3963.1217.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Science 1971; 174:1240- 2; PMID:5002466; http://dx.doi.org/10.1126/sci- ence.174.4015.1240.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Science 1971; 172:271-3;  PMID:4323415; http://dx.doi.org/10.1126/sci-ence.172.3980.271.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Br Med J 1971; 4:189- 94; PMID:4940157; http://dx.doi.org/10.1136/ bmj.4.5781.189.References 1.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cell 1985; 42:791-8; PMID:3931919;  http://dx.doi.org/10.1016/0092-8674(85)90275-2.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cell 1985; 42:779-89;  PMID:3931918; http://dx.doi.org/10.1016/0092- 8674(85)90274-0.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Nature 1978; 276:565-70; PMID:103000;  http://dx.doi.org/10.1038/276565a0.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Science 1983; 221:23- 9; PMID:17737996; http://dx.doi.org/10.1126/sci- ence.221.4605.23.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Annu Rev Immunol 2003; 21:335-76; PMID:12524386;  http://dx.doi.org/10.1146/annurev.immu- nol.21.120601.141126.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cell 1996; 86:973-83;  PMID:8808632; http://dx.doi.org/10.1016/S0092- 8674(00)80172-5.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Science  1995; 270:1804-6; PMID:8525370; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Proc Natl Acad Sci USA 2005; 102:9577- 82; PMID:15976025; http://dx.doi.org/10.1073/ pnas.0502272102.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Nat Rev Immunol 2010; 10:826- 37; PMID:21088683; http://dx.doi.org/10.1038/ nri2873.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Nat  Rev Drug Discov 2012; 11:215-33; PMID:22301798;  http://dx.doi.org/10.1038/nrd3626.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Leukoc Biol  2003; 74:277-86; PMID:12885945; http://dx.doi.org/10.1189/jlb.0103026.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Infect Immun 2003; 71:4238-49; PMID:12874299; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Nat Immunol 2002; 3:196-200;  PMID:11812998; http://dx.doi.org/10.1038/ni758.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Surg Oncol 1984; 26:86-90; PMID:6429448;  http://dx.doi.org/10.1002/jso.2930260204.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer Immunol Immunother 1983; 14:167- 71; PMID:6340825; http://dx.doi.org/10.1007/ BF00205355.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
N Engl J Med 1984; 310:737- 43; PMID:6366550; http://dx.doi.org/10.1056/NEJM198403223101201.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer 1984; 54:193-8; PMID:6202387; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer 1985;  55:1236-43; PMID:3882219; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer  1975; 36:2421-7; PMID:1212660; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer 1977; 40:2731-9; PMID:336190; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
JAMA 1976; 236:2187- 9; PMID:989809; http://dx.doi.org/10.1001/ jama.1976.03270200025023.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Urology 1982; 20:401- 3; PMID:6755855; http://dx.doi.org/10.1016/0090- 4295(82)90464-2.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer  1978; 41:2456-63; PMID:657108; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Lancet 1974; 2:1096-100; PMID:4139404; http://dx.doi.org/10.1016/S0140- 6736(74)90867-8.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer  1983; 51:57-60; PMID:6821809; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer  1976; 37:684-92; PMID:766947; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Ann NY Acad Sci  1976; 277:187-94; PMID:1069548; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer 1982; 50:1100-6; PMID:7104950;  http://dx.doi.org/10.1002/1097-0142(19820915)50:6  < 1100::AID-CNCR2820500613>3.0.CO;2-6.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cell Immunol 1976; 21:1-19; PMID:764975; http://dx.doi.org/10.1016/0008- 8749(76)90322-1.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer  1985; 55:707-12; PMID:3967167; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer  1981; 48:1353-62; PMID:7023654; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer  1984; 53:384-9; PMID:6362814; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer  1982; 49:1754-61; PMID:7042073; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Steroid Biochem 1985; 23:1147- 50; PMID:3912620; http://dx.doi.org/10.1016/0022-4731(85)90034-2.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Breast Cancer  Res T reat 1983; 3:61-8; PMID:6367862; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer 1986; 58:2411-6;  PMID:2876770; http://dx.doi.org/10.1002/1097- 0142(19861201)58:11<2411::AID- CNCR2820581110>3.0.CO;2-C. 54.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Urol  Oncol 2012; 30:259-65; PMID:20843705; http://dx.doi.org/10.1016/j.urolonc.2010.02.007.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Gynecol Oncol 1990; 39:239- 43; PMID:2258063; http://dx.doi.org/10.1016/0090- 8258(90)90244-F .,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer  Sci 2009; 100:1991-5; PMID:19656158; http://dx.doi.org/10.1111/j.1349-7006.2009.01271.x.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Eur Urol 2003; 44:423-8;  PMID:14499675; http://dx.doi.org/10.1016/S0302- 2838(03)00371-3.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Oncoimmunol 2012; 1:179-88; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Oncoimmunol  2012; 1:306-15; http://dx.doi.org/10.4161/ onci.19549.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Oncoimmunol 2012;  1:28-37; http://dx.doi.org/10.4161/onci.1.1.17938.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Nature 1957;  179:314-5; PMID:13407710; http://dx.doi.org/10.1038/179314a0.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Biochemistry 1964; 3:411-8; PMID:14155106; http://dx.doi.org/10.1021/ bi00891a018.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Urol  Int 1986; 41:254-9; PMID:3538593; http://dx.doi.org/10.1159/000281212.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
N Engl J Med 1991; 325:1205- 9; PMID:1922207; http://dx.doi.org/10.1056/ NEJM199110243251703.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Urol Int  1990; 45:137-41; PMID:2190405; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Urol  1996; 156:1602-5; PMID:8863547; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Urol 2000; 163:68-71; PMID:10604316;  http://dx.doi.org/10.1016/S0022-5347(05)67974-8.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
"A multicen- tre, randomised prospective trial comparing three  intravesical adjuvant therapies for intermediate-risk superficial bladder cancer: low-dose bacillus Calmette- Guerin (27 mg) versus very low-dose bacillus Calmette- Guerin (13.5 mg) versus mitomycin C. Eur Urol  2007; 52:1398-406; PMID:17485161; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Urol 1996; 155:483-7; PMID:8558641; http://dx.doi.org/10.1016/S0022- 5347(01)66427-9.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Urol Int 1993; 51:67-72; PMID:8351757;  http://dx.doi.org/10.1159/000282516.83.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Med Pediatr  Oncol 1977; 3:237-42; PMID:618010; http://dx.doi.org/10.1002/mpo.2950030304.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer  1980; 46:1128-34; PMID:7214296; http://dx.doi.org/10.1002/1097-0142(19800901)46:5<1128::AID- CNCR2820460509>3.0.CO;2-3.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cardiovasc Intervent  Radiol 1982; 5:260-3; PMID:7159889; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Urology 1985; 25:119-23; PMID:3881870; http://dx.doi.org/10.1016/0090- 4295(85)90525-4.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer 2004; 100:1692-8; PMID:15073858;  http://dx.doi.org/10.1002/cncr.20166.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Int J Immunopharmacol 1994; 16:887- 93; PMID:7868293; http://dx.doi.org/10.1016/0192- 0561(94)90043-4.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer Immunol Immunother  1994; 38:287-93; PMID:8162610; http://dx.doi.org/10.1007/BF01525505.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Pancreas  1996; 12:260-6; PMID:8830332; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer Invest 1997; 15:522-30; PMID:9412657;  http://dx.doi.org/10.3109/07357909709047593.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Anticancer Drugs 1997; 8:500-8; PMID:9215614; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Immunother 1999; 22:401-6; PMID:10546155;  http://dx.doi.org/10.1097/00002371-199909000- 00003.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Melanoma Res 2001; 11:325-35; PMID:11479420;  http://dx.doi.org/10.1097/00008390-200108000-00002.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Surg Endosc 2002; 16:654-8;  PMID:11972208; http://dx.doi.org/10.1007/s00464- 001-8187-6.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer Immunol Immunother 2002; 50:653-62;  PMID:11862417; http://dx.doi.org/10.1007/s00262- 001-0241-7.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Expert Rev Vaccines 2003; 2:219-29; PMID:12899573; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Biological activities of  chemically synthesized analogues of the nonreducing  sugar moiety of lipid A. FEBS Lett 1984; 167:226- 30; PMID:6698210; http://dx.doi.org/10.1016/0014-5793(84)80131-3.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Rev Infect  Dis 1984; 6:567-72; PMID:6382555; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer Immunol  Immunother 1984; 18:107-12; PMID:6391653;  http://dx.doi.org/10.1007/BF00205743.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Int J Immunopharmacol 1986; 8:881- 6; PMID:3804533; http://dx.doi.org/10.1016/0192-0561(86)90088-3.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Int J  Immunopharmacol 1991; 13:605-11; PMID:1783474;  http://dx.doi.org/10.1016/0192-0561(91)90083-J.127.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Eur J Biochem 1969; 7:370-9; PMID:4307215;  http://dx.doi.org/10.1111/j.1432-033.1969.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Can J Biochem 1970;  48:55-62; PMID:4326916; http://dx.doi.org/10.1139/ o70-010.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Cell  Physiol 1976; 87:71-8; PMID:1081990; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Exp Med 1977; 146:611-6; PMID:301553;  http://dx.doi.org/10.1084/jem.146.2.611.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Tohoku J Exp Med  1984; 144:385-96; PMID:6528335; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Mol Immunol 1985; 22:291- 4; PMID:4000132; http://dx.doi.org/10.1016/0161- 5890(85)90164-6.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Br J Cancer 1973; 27:370- 89; PMID:4713170; http://dx.doi.org/10.1038/ bjc.1973.45.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Nature 2001; 413:732-8; PMID:11607032; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Nature  1998; 395:284-8; PMID:9751057; http://dx.doi.org/10.1038/26239.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Vaccine 2011; 29:9276-83; PMID:21856349; http://dx.doi.org/10.1016/j.vac- cine.2011.08.037.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Lancet Oncol 2012; 13:100-10;  PMID:22075170; http://dx.doi.org/10.1016/S1470- 2045(11)70287-X.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Lancet Oncol 2012;  13:10-2; PMID:22075169; http://dx.doi.org/10.1016/ S1470-2045(11)70324-2.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Antiviral Res 1988; 10:209- 23; PMID:2465735; http://dx.doi.org/10.1016/0166- 3542(88)90032-0.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Antiviral Res 1991; 15:315-22;  PMID:1659313; http://dx.doi.org/10.1016/0166-3542(91)90012-G. 205.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Infect Dis 1993; 167:731-5; PMID:8382722; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Lancet  2004; 364:1757-65; PMID:15541448; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Lancet 2006; 367:1247-55;  PMID:16631880; http://dx.doi.org/10.1016/S0140- 6736(06)68439-0.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Lancet 2007; 369:2161-70;  PMID:17602732; http://dx.doi.org/10.1016/S0140- 6736(07)60946-5.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Lancet 2009; 374:301-14;  PMID:19586656; http://dx.doi.org/10.1016/S0140- 6736(09)61248-4.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Lancet 2009; 374:1975-85;  PMID:19962185; http://dx.doi.org/10.1016/S0140-6736(09)61567-1.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Adv Ther 2009; 26:983-98;  PMID:20024678; http://dx.doi.org/10.1007/s12325- 009-0079-5.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Vaccine  2010; 28:6247-55; PMID:20643092; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Korean Med Sci  2010; 25:1197-204; PMID:20676333; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Lancet Oncol 2011; 12:862-70; PMID:21865087; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Int Immunopharmacol  2005; 5:1205-12; PMID:15914325; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer Immunol Immunother 2010; 59:1185-95; PMID:20336295; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Expert Opin Investig Drugs  1998; 7:1475-82; PMID:15992044; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Cancer Immunol  Immunother 2004; 53:642-50; PMID:14985860;  http://dx.doi.org/10.1007/s00262-004-0501-4.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Immunother  2004; 27:124-35; PMID:14770084; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Proc Natl Acad Sci USA 2008; 105:1650- 5; PMID:18216244; http://dx.doi.org/10.1073/ pnas.0707140104.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Arch Dermatol 1998; 134:25- 30; PMID:9449906; http://dx.doi.org/10.1001/arch- derm.134.1.25.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Infect Dis 1998; 178:551-5; PMID:9697742; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
AIDS 1999; 13:2397-404; PMID:10597781; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Br J Dermatol  2000; 143:1026-31; PMID:11069514; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Infect 2000; 41:148-51; PMID:11023759;  http://dx.doi.org/10.1053/jinf.2000.0709.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Nat Rev Immunol  2011; 11:558-65; PMID:21779033; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Invest Dermatol  2006; 126:1338-47; PMID:16575388; http://dx.doi.org/10.1038/sj.jid.5700286.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Clin Invest 2012; 122:575-85; PMID:22251703;  http://dx.doi.org/10.1172/JCI61034.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Am Acad Dermatol 2007; 56:63- 8; PMID:17190622; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Pediatr Dermatol 2011; 28:259-66; PMID:21615472;  http://dx.doi.org/10.1111/j.1525-470.2011.01520.x.220.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Arch Dermatol  2005; 141:467-73; PMID:15837864; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Am Acad Dermatol 1999; 41:1002-7; PMID:10570388; http://dx.doi.org/10.1016/S0190- 9622(99)70261-6.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Am Acad Dermatol  2001; 44:807-13; PMID:11312429; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Arch Dermatol 2002; 138:1165-71; PMID:12224977; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Br J Dermatol  2002; 147:1227-36; PMID:12452875; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Dermatol Surg 2004; 30:429-30; PMID:15008876; http://dx.doi.org/10.1111/j.1524-4725.2004.30116.x.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Arch Dermatol 2004; 140:1284- 5; PMID:15492200; http://dx.doi.org/10.1001/ archderm.140.10.1284-b.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Clin Exp Dermatol  2004; 29:518-25; PMID:15347339; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Am J Med 1997; 102:28-37;  PMID:9217660; http://dx.doi.org/10.1016/S0002- 9343(97)00181-2.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J  Am Acad Dermatol 1998; 38:230-9; PMID:9486679;  http://dx.doi.org/10.1016/S0190-9622(98)70243-9.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Interferon Cytokine  Res 1995; 15:537-45; PMID:7553223; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Br J Cancer  1996; 74:1482-6; PMID:8912549; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Arch Dermatol Res 2004; 296:6-11; PMID:15083310;  http://dx.doi.org/10.1007/s00403-004-0465-4.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Am Acad Dermatol 2004; 50:714- 21; PMID:15097955; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Arch Dermatol 2004; 140:1542;  PMID:15611446; http://dx.doi.org/10.1001/ archderm.140.12.1542-a.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Am Acad Dermatol  2004; 51:547-55; PMID:15389189; http://dx.doi.org/10.1016/j.jaad.2004.02.022.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Gynecol Oncol  2007; 107:219-22; PMID:17655918; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
N  Engl J Med 2008; 358:1465-73; PMID:18385498;  http://dx.doi.org/10.1056/NEJMoa072685.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Br J Cancer 2010; 102:1129- 36; PMID:20234368; http://dx.doi.org/10.1038/ sj.bjc.6605611.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Gynecol Oncol 2011; 121:157- 62; PMID:21239049; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Am J Obstet Gynecol 2012; 206:42;  PMID:21907959; http://dx.doi.org/10.1016/j.ajog.2011.06.105.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
South Med J 2006; 99:396- 402; PMID:16634252; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Eur Acad Dermatol Venereol 2010; 24:490-2;  PMID:19840203; http://dx.doi.org/10.1111/j.1468- 3083.2009.03451.x.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Low Genit T ract Dis 2012; 16:59- 63; PMID:21964211; http://dx.doi.org/10.1097/ LGT.0b013e31822d2484.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
T ranspl Infect Dis 2008; 10:59-62; PMID:17428275; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Obstet Gynecol 2012; 119:442- 4; PMID:22270432; http://dx.doi.org/10.1097/ AOG.0b013e318236f1a0.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Eur Acad  Dermatol Venereol 2004; 18:626-9; PMID:15324413;  http://dx.doi.org/10.1111/j.1468-3083.2004.01025.x.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J  Laryngol Otol 2003; 117:720-2; PMID:14561362;  http://dx.doi.org/10.1258/002221503322334576.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Dermatolog T reat  2003; 14:233-6; PMID:14660271; http://dx.doi.org/10.1080/09546630310016763.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Laryngol Otol 2009; 123:240- 2; PMID:18485256; http://dx.doi.org/10.1017/ S0022215108002570.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Dermatol Surg 2002; 28:518- 23; PMID:12081683; http://dx.doi.org/10.1046/ j.1524-4725.2002.01196.x.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Gynecol Oncol 2002; 85:67-70;  PMID:11925122; http://dx.doi.org/10.1006/ gyno.2001.6539.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Gynecol Oncol 2004; 92:167-74;  PMID:14751153; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Am J Obstet Gynecol 2006; 194:377-80; PMID:16458632; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Br J Dermatol 2000; 143:843-5;  PMID:11069469; http://dx.doi.org/10.1046/j.1365- 2133.2000.03787.x.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Br J Dermatol  2003; 149:66-70; PMID:14616356; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Br J Dermatol 2004; 151:485-8;  PMID:15327559; http://dx.doi.org/10.1111/j.1365-2133.2004.05983.x.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Arch Dermatol 2005; 141:510-4; PMID:15837872; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Int J Dermatol  2005; 44:428-34; PMID:15869545; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Int J Dermatol 2008; 47:519-21; PMID:18412875;  http://dx.doi.org/10.1111/j.1365-4632.2008.03562.x.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Dermatol Surg 2008; 34:147-51; PMID:18093206;  http://dx.doi.org/10.1111/j.1524-4725.2007.34031.x.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Arch Dermatol 2011; 147:1191-5;  PMID:22006136; http://dx.doi.org/10.1001/archder- matol.2011.260.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Am Acad Dermatol 2001; 44:462-70; PMID:11209116; http://dx.doi.org/10.1067/ mjd.2001.111335.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Dermatol  Surg 2001; 27:143-6; PMID:11207687; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Clin Exp Dermatol 2003; 28:10-2; PMID:14616804;  http://dx.doi.org/10.1046/j.1365-2230.28.s1.4.x.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Am Acad Dermatol 2006; 55:1092- 4; PMID:17097406; http://dx.doi.org/10.1016/j.jaad.2006.06.031.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Am Acad Dermatol 2006; 55:324-7; PMID:16844522;  http://dx.doi.org/10.1016/j.jaad.2006.04.004.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
J Am Acad Dermatol  2010; 62:573-81; PMID:20133012; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
T rials 2010; 11:42; PMID:20409337; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Dermatol Ther 2011; 24:375-7; PMID:21689248;  http://dx.doi.org/10.1111/j.1529-8019.2011.01423.x.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Melanoma Res 2011; 21:235-43; PMID:21464773; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Prostate 2009; 69:917-27; PMID:19267352; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Clin Cancer Res 2010; 16:338-47; PMID:20048335;  http://dx.doi.org/10.1158/1078-0432.CCR-09-2046.292.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Clin  Exp Dermatol 2012; PMID:22300351; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Ann Dermatol 2011; 23:229-31; PMID:21747627;  http://dx.doi.org/10.5021/ad.2011.23.2.229.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Br  J Dermatol 2004; 150:1198-201; PMID:15214911;  http://dx.doi.org/10.1111/j.1365-2133.2004.05993.x.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Am J Clin Dermatol  2006; 7:155-69; PMID:16734503; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Dermatology  2002; 205:135-8; PMID:12218228; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Br J Dermatol  2007; 156:337-45; PMID:17223875; http://dx.doi.org/10.1111/j.1365-2133.2006.07664.x.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
Br J Dermatol 2008; 159:606-14;  PMID:18616776; http://dx.doi.org/10.1111/j.1365- 2133.2008.08709.x.,Non-OADS,/arxiv_data1/oa_pdf/92/1f/onci-1-894.PMC3489745.pdf
"5 In this age of proteomic, genomic and other “omic” approaches,  it has become fairly straightforward to characterize tumor cells in  *Correspondence to: Jacques Thibodeau;  Email: jacques.thibodeau@umontreal.caSubmitted: 05/31/12; Accepted: 06/21/12http://dx.doi.org/10.4161/onci.21205The success of immunotherapy relies on the participation of all  arms of the immune system and the role of CD4+ T lymphocytes  in preventing tumor growth is now well established.",Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Cancer Immunol Immunother 2011; 60:1161-71;  PMID:21626032; http://dx.doi.org/10.1007/s00262- 011-1012-8.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Semin  Immunopathol 2011; 33:335-40; PMID:21461991; http://dx.doi.org/10.1007/s00281-011-0264-x.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
J Exp Med 2012; 209:201- 9; PMID:22330682; http://dx.doi.org/10.1084/ jem.20112275.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Science 2011; 331:1565-70;  PMID:21436444; http://dx.doi.org/10.1126/sci- ence.1203486.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Nature 2011; 474:609-15; PMID:21720365; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
J Mol Diagn 2004;  6:59-83; PMID:15096561; http://dx.doi.org/10.1016/ S1525-1578(10)60493-X.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Nature 2009; 462:510- 3; PMID:19898495; http://dx.doi.org/10.1038/nature08511.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Immunotherapy 2011; 3:915-7; PMID:21843076; http://dx.doi.org/10.2217/imt.11.83.11.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Br J Cancer  2009; 100:1697-703; PMID:19384299; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Carcinogenesis 2011; 32:643-9; PMID:21304053;  http://dx.doi.org/10.1093/carcin/bgr019.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Autoimmun  Rev 2011; 10:331-5; PMID:21167321; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
J Immunother  2004; 27:472-7; PMID:15534491; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
J Immunol 2010; 185:6545-54; PMID:21048115; http://dx.doi.org/10.4049/jimmu- nol.1001867.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
J Exp Med 2010; 207:2469- 77; PMID:20921286; http://dx.doi.org/10.1084/jem.20092450.19.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Cancer Immunol  Immunother 1999; 48:363-70; PMID:10501848;  http://dx.doi.org/10.1007/s002620050587.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Clin  Cancer Res 2011; 17:6985-91; PMID:22068654;  http://dx.doi.org/10.1158/1078-0432.CCR-11-1331.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Immunity  2005; 22:633-42; PMID:15894280; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Biochim  Biophys Acta 2002; 1542:1-13; PMID:11853874;  http://dx.doi.org/10.1016/S0167-4889(01)00166-5.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Immunol Rev 1999; 172:255-66; PMID:10631951; http://dx.doi.org/10.1111/j.1600-065X.1999.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
J Clin Endocrinol Metab 1990;  71:740-7; PMID:2203800; http://dx.doi.org/10.1210/ jcem-71-3-740.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Ann N Y Acad  Sci 2003; 987:9-14; PMID:12727619; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Cancer Immunol Immunother 2008; 57:1461- 70; PMID:18343923; http://dx.doi.org/10.1007/ s00262-008-0483-8.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Arch  Dermatol Res 2009; 301:189-93; PMID:19104823; http://dx.doi.org/10.1007/s00403-008-0922-6.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
J Exp Med 1999; 189:1659-68; PMID:10330445;  http://dx.doi.org/10.1084/jem.189.10.1659.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Cancer T reat Rev 2007; 33:741-56;  PMID:17854999; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Int J Biochem Cell Biol  2009; 41:66-71; PMID:18817889; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Autophagy 2009; 5:1026- 9; PMID:19556870; http://dx.doi.org/10.4161/ auto.5.7.9163.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Annu Rev Immunol  1997; 15:749-95; PMID:9143706; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Int J Cancer 2010; 127:1614-24; PMID:20091859; http://dx.doi.org/10.1002/ijc.25183.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Melanoma Res 2004; 14:453-61; PMID:15577315;  http://dx.doi.org/10.1097/00008390-200412000- 00004.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Cancer Immunol Immunother  2007; 56:1513-37; PMID:17503040; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Arthritis Res Ther 2012; 14:R54;  PMID:22404985; http://dx.doi.org/10.1186/ar3767.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Proc Natl Acad Sci U S A 1997; 94:6886- 91; PMID:9192661; http://dx.doi.org/10.1073/ pnas.94.13.6886.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Int Immunol  2006; 18:1591-602; PMID:16987935; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Int Immunol  2000; 12:757-65; PMID:10837403; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Cancer Res  2011; 71:2507-17; PMID:21310823; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Leuk Res 2006; 30:487-9; PMID:16191436;  http://dx.doi.org/10.1016/j.leukres.2005.08.013.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Clin Cancer Res 2008; 14:7667-73; PMID:19047092;  http://dx.doi.org/10.1158/1078-0432.CCR-08-0479.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Cancer Res 2004; 64:5546-50; PMID:15313888; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Immunogenetics 2002; 54:591-5;  PMID:12439622; http://dx.doi.org/10.1007/s00251- 002-0500-6.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Br J Haematol  2009; 145:334-43; PMID:19245431; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
J Immunol  2009; 182:3335-41; PMID:19265109; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Cell 2009; 137:1062- 75; PMID:19524509; http://dx.doi.org/10.1016/j.cell.2009.03.048.27.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Int J Cancer 1987; 40:598- 603; PMID:3316049; http://dx.doi.org/10.1002/ ijc.2910400504.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Int J Cancer 2004; 112:399- 406; PMID:15382064; http://dx.doi.org/10.1002/ ijc.20441.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Clin Immunol Immunopathol 1995;  75:26-32; PMID:7882591; http://dx.doi.org/10.1006/clin.1995.1048.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Cell 2002; 109(Suppl):S21-33;  PMID:11983150; http://dx.doi.org/10.1016/S0092-8674(02)00696-7.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Mol Immunol 2007; 44:2923- 32; PMID:17300840; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
J Biochem  2006; 140:147-54; PMID:16954532; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Eur J Immunol  2008; 38:1225-30; PMID:18389477; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Cytokine  2012; 59:27-30; PMID:22503116; http://dx.doi.org/10.1016/j.cyto.2012.03.015.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Virchows Arch A Pathol  Anat Histopathol 1988; 412:315-22; PMID:3125670;  http://dx.doi.org/10.1007/BF00750257.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Leuk Res 1984; 8:55-62;  PMID:6583461; http://dx.doi.org/10.1016/0145- 2126(84)90031-6.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Cancer Immunol Immunother 2008; 57:389-98; PMID:17724589; http://dx.doi.org/10.1007/s00262- 007-0381-5.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
J Immunol  2010; 184:5654-62; PMID:20400704; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
T rends Biotechnol  2011; 29:550-7; PMID:21663987; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Methods Mol Biol 2010; 629:453-93;  PMID:20387166; http://dx.doi.org/10.1007/978-1- 60761-657-3_28.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Cell 2012; 148:1081- 4; PMID:22424219; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Adv  Drug Deliv Rev 1998; 31:131-42; PMID:10837621; http://dx.doi.org/10.1016/S0169-409X(97)00097-5.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Hum Gene Ther 2009; 20:1269- 78; PMID:19619001; http://dx.doi.org/10.1089/ hum.2009.067.75.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
J Virol  2007; 81:1319-26; PMID:17121795; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Int Immunol 2010; 22:863-73;  PMID:21059769; http://dx.doi.org/10.1093/intimm/ dxq440.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Expert Opin Biol Ther  2009; 9:451-64; PMID:19344282; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Nat Rev Immunol  2009; 9:581-93; PMID:19498381; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
N Engl J Med 2008; 358:2698-703; PMID:18565862;  http://dx.doi.org/10.1056/NEJMoa0800251.67.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Eur J Immunol  2010; 40:899-910; PMID:20039301; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Science  2007; 316:612-6; PMID:17463291; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
J Biol Chem 2002; 277:2709-15; PMID:11602608; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
J Gene Med 2005; 7:686- 95; PMID:15693037; http://dx.doi.org/10.1002/ jgm.713.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
Science 1991; 251:70- 2; PMID:1702555; http://dx.doi.org/10.1126/sci- ence.1702555.,OADS,/arxiv_data1/oa_pdf/02/e1/onci-1-908.PMC3489746.pdf
"Cell death has been categorized as apoptotic or necrotic and, until recently, apoptosis  *Correspondence to: Tsukasa Seya; Email: seya-tu@pop.med.hokudai.ac.jp Submitted: 05/28/12; Accepted: 06/22/12http://dx.doi.org/10.4161/onci.21244The engagement of Toll-like receptor 3 (TLR3) leads to the  oligomerization of the adaptor TICAM-1 (TRIF), which can induces either of three acute cellular responses, namely,  cell survival coupled to Type I interferon production, or cell  death, via apoptosis or necrosis.",Non-OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Cell 2009;  137:1112-23; PMID:19524513; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Nature  2011; 471:368-72; PMID:21368762; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Cell Host Microbe 2012; 11:290- 7; PMID:22423968; http://dx.doi.org/10.1016/j.chom.2012.01.016.,OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Semin Immunol 2001; 13:67- 72; PMID:11289801; http://dx.doi.org/10.1006/ smim.2000.0297.,Non-OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Hepatology 2011; 54:425- 33; PMID:21538444; http://dx.doi.org/10.1002/ hep.24399.,Non-OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Eur J Immunol 2007; 37:3311-8; PMID:18034428;  http://dx.doi.org/10.1002/eji.200737744.,Non-OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
J Immunol 2011; 187:3953-61;  PMID:21911604; http://dx.doi.org/10.4049/jimmu- nol.1100524.,Non-OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Nat Med 2007; 13:851-6; PMID:17572686;  http://dx.doi.org/10.1038/nm1603.,OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Nat Rev Immunol 2008; 8:279-89;  PMID:18340345; http://dx.doi.org/10.1038/nri2215.,Non-OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
J Exp Med 2008; 205:2609-21; PMID:18838547;  http://dx.doi.org/10.1084/jem.20081370.,Non-OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Proc Natl Acad Sci U S A 2011; 108:20054-9; PMID:22123964; http://dx.doi.org/10.1073/ pnas.1116302108.,OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
J Biol Chem 2004; 279:12542-50; PMID:14729660;  http://dx.doi.org/10.1074/jbc.M310175200.,OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Sci Signal 2010;  3:re4; PMID:20354226; http://dx.doi.org/10.1126/ scisignal.3115re4.,OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Cell  2009; 137:1100-11; PMID:19524512; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Cell Death Differ  2009; 16:3-11; PMID:18846107; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Oncogene  2008; 27:6452-61; PMID:18955972; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
J Biol Chem 2003; 278:49751-62; PMID:14519765; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Nat Immunol 2008; 9:1037-46; PMID:18641654;  http://dx.doi.org/10.1038/ni.1638.,Non-OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Mol Cell 2011; 43:449-63; PMID:21737330; http://dx.doi.org/10.1016/j.molcel.2011.06.011.,OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Cell 1997;  91:295-8; PMID:9363937; http://dx.doi.org/10.1016/ S0092-8674(00)80412-2.,OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Science  2010; 327:291-5; PMID:20075244; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
"Ann N Y Acad Sci 2008; 1143:1- 20; PMID:19076341; http://dx.doi.org/10.1196/ annals.1443.020.Termination of Inflammation Inflammation often drives tissue repair and regeneration, and  the microenvironment formed during inflammation serves a basis for assembling cells that initiate tissue development and reorganization ( Fig.",Non-OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Nature 2008; 451:725-9; PMID:18256672;  http://dx.doi.org/10.1038/nature06537.,OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Nature 2009; 462:99-103;  PMID:19890330; http://dx.doi.org/10.1038/ nature08512.,Non-OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Nat Cell Biol 2008; 10:1349- 55; PMID:18820689; http://dx.doi.org/10.1038/ncb1794.,OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Immunity 2012; 36:635-45;  PMID:22483800; http://dx.doi.org/10.1016/j.immu- ni.2012.03.008.,OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Immunity 2012; 36:646-57; PMID:22483802;  http://dx.doi.org/10.1016/j.immuni.2012.03.009.,OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
J Leukoc Biol 2009; 85:905-10; PMID:19276179;  http://dx.doi.org/10.1189/jlb.0109005.,Non-OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Cell Host Microbe  2008; 4:198-208; PMID:18779046; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
J Exp Med  2011; 208:2357-66; PMID:22065672; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Nature  2005; 433:887-92; PMID:15711573; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Cell Res 2006; 16:154-61; PMID:16474428; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
J Interferon Cytokine  Res 2010; 30:113-22; PMID:20187777; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Annu Rev Immunol 1999; 17:593- 623; PMID:10358769; http://dx.doi.org/10.1146/ annurev.immunol.17.1.593.43.,Non-OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Nat Immunol 2010; 11:785-97;  PMID:20720586; http://dx.doi.org/10.1038/ni.1923.,Non-OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Microbiol Immunol 2011; 55:373-7;  PMID:21517948; http://dx.doi.org/10.1111/j.1348- 0421.2011.00319.x.,Non-OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
N Engl J Med 2007; 356:2131-42; PMID:17522398;  http://dx.doi.org/10.1056/NEJMoa067208.,OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Proc Natl Acad Sci U S A 2012; 109:2066-71; PMID:22308357; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
J Clin Immunol 2007; 27:363-71; PMID:17370119; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
Cancer Immunol Immunother 2009; 58:1175-84;  PMID:19184005; http://dx.doi.org/10.1007/s00262- 008-0652-9.,Non-OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
2012; 1(5):699-717; PMID:  3429574; http://dx.doi.org/10.4161/onci.20696.,Non-OADS,/arxiv_data1/oa_pdf/00/aa/onci-1-917.PMC3489747.pdf
"OncoImmunology 1:6, 924-929; September 2012; © 2012 Landes Bioscience Aut OphA gIc punctum 924 OncoImmunology Volume 1 Issue 6Keywords:  adjuvants, inflammation  reprogramming, immune signaling,  immune activation, immunostimulation Submitted: 07/02/12Accepted: 07/04/12http://dx.doi.org/10.4161/onci.21358 Correspondence to: George C. Prendergast;   prendergast@limr.org: Aging entails the accumulation of  neoantigens comprised of aggre - gated, oxidized, mutated and misfolded biomolecules, including advanced-gly - cation end projects (AGEs).",Non-OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Nature 2008; 454:436-44;  PMID:18650914; http://dx.doi.org/10.1038/ nature07205.,Non-OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Science 2010; 328:627-9; PMID:20431016;  http://dx.doi.org/10.1126/science.1188628.,OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Science 2009; 325:1552-5; PMID:19762646; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
J Infect Dis 2012; 205:152- 61; PMID:21990421; http://dx.doi.org/10.1093/ infdis/jir621.,OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Proc Natl Acad Sci U S A  2008; 105:17073-8; PMID:18952840; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Cancer Immunol Immunother 2010; 59:1655- 63; PMID:20640572; http://dx.doi.org/10.1007/s00262-010-0891-4.,Non-OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
J Immunol 2009; 182:7509-17; PMID:19494274; http://dx.doi.org/10.4049/jimmu - nol.0804328.,Non-OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Proc Natl Acad Sci U S A  2008; 105:6690-5; PMID:18436652; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Immunol Rev 2008; 222:206-21; PMID:18364004; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Cell 2012; 149:410-24; PMID:22424946;  http://dx.doi.org/10.1016/j.cell.2012.02.044.,OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
J Immunol 2010; 185:1993- 8; PMID:20686167; http://dx.doi.org/10.4049/jim - munol.1000108.13.,Non-OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Nat Med  2007; 13:1050-9; PMID:17704786; http://dx.doi.org/10.1038/nm1622.,OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Cancer Res 2010; 70:855-8;  PMID:20086177; http://dx.doi.org/10.1158/0008- 5472.CAN-09-3566.,Non-OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Cell Cycle  2009; 8:3723-8; PMID:19855167; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Science 2011; 334:1573-7; PMID:22174255; http://dx.doi.org/10.1126/sci - ence.1208347.,OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Oncogene 2010; 29:5346-58; PMID:20661219; http://dx.doi.org/10.1038/onc.2010.292.,Non-OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Expert Opin Investig Drugs  2011; 20:875-80; PMID:21619470; http://dx.doi.org/10.1517/13543784.2011.583918.,Non-OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Cancer Res 2010; 70:6407-11;  PMID:20682793; http://dx.doi.org/10.1158/0008- 5472.CAN-10-1544.,Non-OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Cancer Immunol Immunother 2012; 61:283-8; PMID:22146892; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
J  Immunol 2011; 187:676-83; PMID:21677139;  http://dx.doi.org/10.4049/jimmunol.1003884.,Non-OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Bioessays 2006; 28:309-15; PMID:16479578;  http://dx.doi.org/10.1002/bies.20342.,OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Cell 2012; 149:1635- 46; PMID:22608085; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Nat Chem  Biol 2011; 7:885-7; PMID:22002720; http://dx.doi.org/10.1038/nchembio.687.,OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Immunol Cell Biol 2005; 83:674-86;  PMID:16266320; http://dx.doi.org/10.1111/j.1440- 1711.2005.01366.x.,Non-OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Clin Mol Allergy  2012; 10:5; PMID:22397506; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Cancer Res 2005;  65:10555-61; PMID:16288048; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Burns 2010; 36:239-51;  PMID:19501971; http://dx.doi.org/10.1016/j.burns.2009.04.002.,OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Immunity 2012; 36:322-35;  PMID:22444630; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Cancer Lett 2011; 313:123-8;  PMID:21974805; http://dx.doi.org/10.1016/j.can - let.2011.09.003.,Non-OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
J Biol Chem 2002;  277:42299-305; PMID:12194966; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Clin  Exp Metastasis 2012; 29:561-72; PMID:22484915;  http://dx.doi.org/10.1007/s10585-012-9471-7.,Non-OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Trends Parasitol 2012; 28:93- 8; PMID:22257556; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
Adv Cancer Res 2008; 101:277- 348; PMID:19055947; http://dx.doi.org/10.1016/ S0065-230X(08)00408-9.,Non-OADS,/arxiv_data1/oa_pdf/11/be/onci-1-924.PMC3489748.pdf
"OncoImmunology 1:6, 930-934; September, 2012; © 2012 Landes Bioscience Aut OphA gIc punctum 930 OncoImmunology Volume 1 Issue 6pOInt-Of-VIew Keywords:  cancer immunosurveillance,  early tumor growth, immune escape,  melanoma, microenvironment; tumor antigens Submitted: 07/06/12Accepted: 07/11/12http://dx.doi.org/10.4161/onco.21455 *Correspondence to: Giorgio Parmiani;   Email: parmiani.giorgio@hsr.itEarly events responsible of tumor  growth in patients with a normal  immune system are poorly understood.",Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Science 2010; 330:827-30;  PMID:21051638; http://dx.doi.org/10.1126/sci - ence.1195300.,OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Baillieres Best Pract Res Clin Obstet Gynaecol  2000; 14:827-37; PMID:11023803; http://dx.doi.org/10.1053/beog.2000.0122.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Curr Opin Biotechnol 2007; 18:460-6;  PMID:18023337; http://dx.doi.org/10.1016/j.cop - bio.2007.10.007.,OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Clin Cancer Res 2010; 16:800-13; PMID:20103663; http://dx.doi.org/10.1158/1078- 0432.CCR-09-2730.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Nature 2010; 466:133-7;  PMID:20596026; http://dx.doi.org/10.1038/ nature09161.,OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Clin Cancer Res  2010; 16:461-73; PMID:20068105; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Cancer Res  2005; 65:9328-37; PMID:16230395; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
J Invest Dermatol 2010; 130:1877-86; PMID:20376064; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Nature  2008; 456:593-8; PMID:19052619; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Cancer Res 2010; 70:388-97;  PMID:20048081; http://dx.doi.org/10.1158/0008- 5472.CAN-09-2153.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Cancer Res 2011; 71:3098-109; PMID:21393506;  http://dx.doi.org/10.1158/0008-5472.CAN-10-3997.14.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
J Clin Invest 2008;  118:3660-70; PMID:18924608; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Cancer Res 2012; 72:2473-80; PMID:22414581; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Nature 2010; 463:191- 6; PMID:20016485; http://dx.doi.org/10.1038/nature08658.,OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Cancer Treat Res 2009; 146:109-21; PMID:19415197; http://dx.doi.org/10.1007/978-0-387-78574-5_10.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Eur J Immunol 1999; 29:592- 601; PMID:10064075; http://dx.doi.org/10.1002/ (SICI)1521-4141(199902)29:02<592::AID- IMMU592>3.0.CO;2-2.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Cancer Cell 2010; 17:121-34; PMID:20138013;  http://dx.doi.org/10.1016/j.ccr.2009.12.019.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Cancer Metastasis Rev  2010; 29:309-16; PMID:20405169; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Cancer Res 2008; 68:650-6; PMID:18245463; http://dx.doi.org/10.1158/0008- 5472.CAN-07-2491.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Cancer Res 2008; 68:715-23; PMID:18245471; http://dx.doi.org/10.1158/0008-5472.CAN-07- 2103.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
"Science 2010; 328:749-52;  PMID:20339029; http://dx.doi.org/10.1126/sci - ence.1185837.Acknowledgements The authors’ work was supported by Grants  of the Alliance Against Cancer (Rome) and the Italian Association for Cancer Research (AIRC, Milano).",Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Science 2011; 331:1565- 70; PMID:21436444; http://dx.doi.org/10.1126/sci - ence.1203486.,OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Expert  Opin Biol Ther 2005; 5:463-76; PMID:15934826;  http://dx.doi.org/10.1517/14712598.5.4.463.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Science 1972; 176:170-1;  PMID:5014438; http://dx.doi.org/10.1126/sci - ence.176.4031.170.,OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Int J Cancer 1980; 26:87-92; PMID:7239715; http://dx.doi.org/10.1002/ijc.2910260114.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
N Engl J Med 2005;  353:2135-47; PMID:16291983; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Cancer Res 2004; 64:1595-9; PMID:14996715; http://dx.doi.org/10.1158/0008-5472.CAN-03- 3231.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Cancer Cell 2005; 7:211-7; PMID:15766659; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
J Invest Dermatol  2011; 131:1460-8; PMID:21390049; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Clin Cancer Res 2009; 15:7036-44; PMID:19903780; http://dx.doi.org/10.1158/1078- 0432.CCR-09-1544.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Ann Oncol 2007; 18:226-32; PMID:17116643; http://dx.doi.org/10.1093/ annonc/mdl158.41.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Cancer Res  2010; 70:697-708; PMID:20068175; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Clin  Cancer Res 2009; 15:6745-7; PMID:19903779;  http://dx.doi.org/10.1158/1078-0432.CCR-09-2377.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
Clin Cancer Res 2009; 15:7029-35; PMID:19903777; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/58/b1/onci-1-930.PMC3489749.pdf
"Sine r eker hadrup Department of h ematology; Center for Cancer Immune t herapy (CCI t); university h ospital h erlev; h erlev, Denmark; Immunology and Microbiology;   Institute for International h ealth; u niversity of Copenhagen, Copenhagen, Denmark Keywords:  melanoma, T-cell epitopes, tumor infiltrating lymphocytes, antigens, CD8 T cells Correspondence to: Sine Reker Hadrup; Email: sine.reker.hadrup@regionh.dk Submitted: 03/30/12; Accepted: 04/09/12http://dx.doi.org/10.4161/onci.20303antigen specific T cells.4,5 Studies were  conducted either for all mentioned alleles  or for HLA-A2 only.2,3 Based on TILs from three different  centers it was shown that T-cell popula - tions recognizing described T cell epitopes are low-frequent and only a small fraction of the described melanoma-associated antigens are recognized.",OADS,/arxiv_data1/oa_pdf/84/b6/onci-1-935.PMC3489750.pdf
J Clin Oncol  2005; 23:2346-57; PMID:15800326; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/b6/onci-1-935.PMC3489750.pdf
Cancer Res 2012; In  press; http://dx.doi.og/10.1158/0008-5472.CAN-11-2614.,Non-OADS,/arxiv_data1/oa_pdf/84/b6/onci-1-935.PMC3489750.pdf
Nat Methods 2009;  6:520-6; PMID:19543285; http://dx.doi.org/10.1038/ nmeth.1345.,OADS,/arxiv_data1/oa_pdf/84/b6/onci-1-935.PMC3489750.pdf
Nat Med 2006; 12:246-51;  PMID:16462803; http://dx.doi.org/10.1038/nm1360.,OADS,/arxiv_data1/oa_pdf/84/b6/onci-1-935.PMC3489750.pdf
Nucleic Acids  Res 2011; 39:1171-6; PMID:21071412; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/b6/onci-1-935.PMC3489750.pdf
Nature 2012; 482:400-4; PMID:22318521;  http://dx.doi.org/10.1038/nature10755.,Non-OADS,/arxiv_data1/oa_pdf/84/b6/onci-1-935.PMC3489750.pdf
Science 2011; 331:1565-70;  PMID:21436444; http://dx.doi.org/10.1126/sci- ence.1203486.,OADS,/arxiv_data1/oa_pdf/84/b6/onci-1-935.PMC3489750.pdf
J Immunol  Methods 2007; 320:119-31; PMID:17306825; http://dx.doi.org/10.1016/j.jim.2007.01.001.expressed by an alternative ORF.,Non-OADS,/arxiv_data1/oa_pdf/84/b6/onci-1-935.PMC3489750.pdf
"4 DEN injected 14 d after birth Distinct anti-tumoral functions of adaptive  immune cells in liver cancer Carlo Schneider and Frank t acke* Department of Medicine III; u niversity h ospital; rwth -Aachen; Aachen, Germany Keywords:  adaptive immunity, liver cancer, tumor, DEN, mouse models Abbreviations:  HCC, hepatocellular carcinoma; DEN, diethylnitrosamine *Correspondence to: Frank Tacke; Email: frank.tacke@gmx.net Submitted: 03/31/12; Accepted: 04/09/12http://dx.doi.org/10.4161/onci.20304i.p.",Non-OADS,/arxiv_data1/oa_pdf/94/29/onci-1-937.PMC3489751.pdf
Hepatology 2009; 50:261-74; PMID:19554540; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/94/29/onci-1-937.PMC3489751.pdf
PLoS One 2010; 5:11049;  PMID:20548789; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/94/29/onci-1-937.PMC3489751.pdf
Cancer Cell 2010; 17:121-34; PMID:20138013;  http://dx.doi.org/10.1016/j.ccr.2009.12.019.8.,Non-OADS,/arxiv_data1/oa_pdf/94/29/onci-1-937.PMC3489751.pdf
Nature 2007; 450:903- 7; PMID:18026089; http://dx.doi.org/10.1038/ nature06309.,OADS,/arxiv_data1/oa_pdf/94/29/onci-1-937.PMC3489751.pdf
Hepatology 2004; 40:667-76; PMID:15349906;  http://dx.doi.org/10.1002/hep.20375.,Non-OADS,/arxiv_data1/oa_pdf/94/29/onci-1-937.PMC3489751.pdf
Cancer Cell 2009; 16:295- 308; PMID:19800575; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/94/29/onci-1-937.PMC3489751.pdf
"3 This type of “Flagellated” cancer cells propel   anti-tumor immunity Johan Garaude1 and J. Magarian Blander2 1Institute for r esearch in Biotherapy; I nSErM U1040; Montpellier, France; 2department of Medicine; Immunology Institute; t he t isch c ancer Institute; Mount Sinai School   of Medicine; n ew York, n Y USA Keywords:  Toll-like receptor, Nod-like receptor, flagellin, pattern recognition receptor, vaccination, immunotherapy,  inflammasome, T cell response, adaptive immunity, innate immunity Correspondence to: Johan Garaude and J. Magarian Blander; Email: johan.garaude@inserm.fr and julie.blander@mssm.edu Submitted: 04/03/12; Accepted: 04/09/12http://dx.doi.org/10.4161/onci.20305the use of innate immune receptor agonists in cancer therapies has suffered from many drawbacks.",Non-OADS,/arxiv_data1/oa_pdf/60/84/onci-1-940.PMC3489752.pdf
Nat Med  2007; 13:552-9; PMID:17479101; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/60/84/onci-1-940.PMC3489752.pdf
